[('  Only those SNPs that passed QC for all consortia were used for imputation.', {'entities': [(65, 75, 'imputation')]}),
 (' HapMap reference data were used (HapMap phase III, CHB+CHD+JPT data from IMPUTE2 website).', {'entities': [(74, 80, 'imputation')]}),
 (' Prior to GWAS, each study imputed the HapMap set of approximately 2.', {'entities': [(27, 34, 'imputation')]}),
 (', imputation of missing genotypes) () from the 1,000 Genomes Project Phase 1 v3 reference panel.', {'entities': [(2, 12, 'imputation')]}),
 (' We then tested each available SNP (observed and imputed) to assess the association with AAO by using p -values (two-tailed) from a linear regression model (LRM), with an additive coding per SNP, and adjusting for sex and significant principal components.', {'entities': [(49, 56, 'imputation')]}),
 ('Association tests were performed by regressing personality traits on imputed dosages of SNPs in the 23andMe sample.', {'entities': [(69, 76, 'imputation')]}),
 ('_,  The data sets were imputed to a common panel of 2.', {'entities': [(23, 30, 'imputation')]}),
 ('_,  Imputed dosage data were used as input, excluding SNPs with a poor imputation quality score (R_2  < 0.', {'entities': [(71, 81, 'imputation'), (4, 11, 'imputation')]}),
 ('0 chip, and imputation was performed with IMPUTE2_,   in 1000 Genomes phase 1 data (March 2012 v.', {'entities': [(12, 22, 'imputation'), (42, 48, 'imputation')]}),
 (' In population-based studies, multiple linear regression models assuming an additive mode of inheritance were applied to test for association with genotyped or imputed SNPs by accounting for age, sex and BMI in Model 1, and without the adjustment for BMI in Model 2.', {'entities': [(160, 167, 'imputation')]}),
 (' Further SNP exclusion included the following criteria: imputation quality score <0.', {'entities': [(56, 66, 'imputation')]}),
 (' SNPs successfully genotyped on iCOGS but not included on the chips used for the GWAS were imputed within each GWAS before combining results with iCOGS data.', {'entities': [(91, 98, 'imputation'), (42, 45, 'negation')]}),
 (' The resulting genotype data for 14,598,181 SNPs were subjected to further quality control checks and selected for high imputation accuracy ( > 0.', {'entities': [(120, 130, 'imputation')]}),
 (' Summary of Studies Included in this Analysis To maximize coverage across studies, genome-wide imputations were performed for each study using typed SNPs.', {'entities': [(95, 106, 'imputation')]}),
 (' We also examined linkage disequilibrium (LD) with D′ between all pairs of biallelic SNPs using imputed data, which were generated on the basis of the Japanese and Chinese (JPT/ CHB) HapMap reference (http://hapmap.', {'entities': [(96, 103, 'imputation')]}),
 ('1) following the Best Practices for Imputation on the IMPUTE2 website (https://mathgen.', {'entities': [(36, 46, 'imputation'), (54, 60, 'imputation')]}),
 (' Samples were genotyped on the Illumina Human610-Quad platform and imputed by the GENEVA\xa0Coordinating Center using the IMPUTE2 software and the 1000 Genomes Project reference panel (June 2011 release).', {'entities': [(67, 74, 'imputation'), (119, 125, 'imputation')]}),
 (' Samples from 24 Stage 1, case-parent triads were also genotyped using this platform, for comparisons with genotypes that were imputed in Stage 1.', {'entities': [(127, 134, 'imputation')]}),
 (' A pre-phasing strategy with SHAPEIT software version 1 (see URLs) was adopted to improve the imputation performance.', {'entities': [(94, 104, 'imputation')]}),
 (' Imputed SNPs were analyzed using linear regression for ln-RTL using SNPTEST_,  , adjusted for covariates age, gender, BMI, T2D and the five principal component ().', {'entities': [(1, 8, 'imputation')]}),
 (' MACH (Markov-Chain Haplotyper) was used for imputation (Release22, Build36) after applying the following exclusion filters: 1) not in HapMap; 2) frequency < 0.', {'entities': [(45, 55, 'imputation'), (1, 5, 'imputation'), (128, 131, 'negation')]}),
 ('3 for MACH) were excluded from association analysis.', {'entities': [(6, 10, 'imputation')]}),
 ('0) using mach2qtl software, and genomic control correction was applied.', {'entities': [(9, 14, 'imputation')]}),
 ('51, p-value < 10_−5 ) in at least two of the three main ethnic subgroups were excluded from the imputation process.', {'entities': [(96, 106, 'imputation')]}),
 (' The detailed description of imputation is in ().', {'entities': [(29, 39, 'imputation')]}),
 ('0 was used to perform imputation for the MESA Caucasian participants (chromosomes 1–22) using HapMap Phase I and II - CEU as the reference panel (release #24 - NCBI Build 36 (dbSNP b126)).', {'entities': [(22, 32, 'imputation')]}),
 ('4 in IMPUTE)\nand were included in the meta-analysis.', {'entities': [(5, 11, 'imputation')]}),
 (' The imputed SNPs were screened further for Mendelian errors, minor allele frequency and missingness.', {'entities': [(5, 12, 'imputation')]}),
 ('Each GWAS sample was tested for association between phenotypes and genotyped and imputed SNPs under an additive mode of inheritance.', {'entities': [(81, 88, 'imputation')]}),
 ('  We performed inverse variance weighted meta-analysis of summary statistics of the phase 1 and phase 2 summary statistics from imputed data using METAL ().', {'entities': [(128, 135, 'imputation')]}),
 (' We used the inverse variance method for meta-analysis, combining data\nfrom the three studies for SNPs with an imputation INFO score of >0.', {'entities': [(111, 121, 'imputation')]}),
 ('01), poor genotype call rate (< 95%), and deviations from Hardy–Weinberg equilibrium (P  < 1 × 10_−6 ) before imputation.', {'entities': [(110, 120, 'imputation')]}),
 ('99 in the CEU Hapmap phase 2 population and the 1000 Genomes project using Beagle and IMPUTE, respectively, and applied the QT analysis.', {'entities': [(86, 92, 'imputation'), (75, 81, 'imputation')]}),
 ('edu//abecasis/MACH/) with HapMap2 as a reference.', {'entities': [(14, 18, 'imputation')]}),
 (' For UK stages 1 and 2 and CGEMS, the imputed genotype probabilities were used to derive a 1-degree-of-freedom association score statistic and its corresponding variance for each SNP.', {'entities': [(38, 45, 'imputation')]}),
 (' For the metaanalysis, only single nucleotide polymorphisms (SNPs) with minor allele frequency ≥ 1%, Hardy Weinberg Equilibrium P -value > 10_−6 , and imputation quality scores ≥ 0.', {'entities': [(151, 161, 'imputation')]}),
 (' Because the PanScan II and PanC4 datasets had only ∼320,000 SNPs in common, imputation was performed in separate dataset.', {'entities': [(77, 87, 'imputation')]}),
 (' Imputation was carried out using IMPUTE for the NTR/NESDA, SAGE and EGP samples (consisting of unrelated individuals).', {'entities': [(1, 11, 'imputation'), (34, 40, 'imputation')]}),
 (' Details of the GWAS arrays and genotyping,\nQC, and imputation are provided in  and .', {'entities': [(52, 62, 'imputation')]}),
 (' This process was carried out to determine whether there was any spurious association due to genotyping or imputation artifacts.', {'entities': [(107, 117, 'imputation')]}),
 (' We imputed SNP genotype data using MACH 1.', {'entities': [(4, 11, 'imputation'), (36, 40, 'imputation')]}),
 (' An imputation quality score of ≥ 30% was used as a final quality control filter.', {'entities': [(4, 14, 'imputation')]}),
 (' After imputation, the mean of the 9 BP measures was used in the current analysis.', {'entities': [(7, 17, 'imputation')]}),
 (' The LD reference was based on HRC imputed genotypes.', {'entities': [(35, 42, 'imputation')]}),
 (' Genotype imputation was performed in the French primary cohort, using the Swiss cohort as a template.', {'entities': [(10, 20, 'imputation')]}),
 (' Each cohort imputed up to ∼30 M variants using MACH () or IMPUTE2 () considering the 1000 Genomes Project CEU release March 2012 (http://mathgen.', {'entities': [(13, 20, 'imputation'), (59, 65, 'imputation'), (48, 52, 'imputation')]}),
 (' We found the LD between all the genotyped SNPs and the imputed SNP rs7741164 is moderately low.', {'entities': [(56, 63, 'imputation')]}),
 ('7 for MACH-based imputations and INFO metric >0.', {'entities': [(17, 28, 'imputation'), (6, 10, 'imputation')]}),
 ('3 and MAF * imputation quality * N events ≥10.', {'entities': [(12, 22, 'imputation')]}),
 (' The association between imputed SNPs from the selected genes and ΔTG was tested using the same total association models described above for the GWAS analyses.', {'entities': [(25, 32, 'imputation')]}),
 (' Imputed probes were also removed if HWE p-values were < 10_−6  in controls or if the minor allele frequency (MAF) was < 1%.', {'entities': [(1, 8, 'imputation')]}),
 (' We imputed all non-genotyped SNPs in 20 autosomal chromosomes based on HapMap II CEU database (release 21).', {'entities': [(4, 11, 'imputation'), (16, 20, 'negation')]}),
 ('     After quality control criteria were finalized for each individual and each sample collection (SNPs with call rates of <95% were excluded; ), IMPUTE2 (ref.', {'entities': [(146, 152, 'imputation')]}),
 (' Four of the top five SNPs found to be significantly associated with PTH concentration in individuals of European ancestry were imputed, with the following mean ratios of observed variance of the allele dosage to the expected binomial variance at Hardy–Weinberg equilibrium: rs6127099, oevar=0.', {'entities': [(128, 135, 'imputation')]}),
 ('Novel SNPs with an IMPUTE2 r _2  <0.', {'entities': [(19, 25, 'imputation')]}),
 (' For each prior GWAS-established SNP, we identified and tested all genotyped or imputed proxy SNPs in JHS that were estimated to be in high LD (r _2  > 0.', {'entities': [(80, 87, 'imputation')]}),
 (' We imputed genotypes for all SNPs that were polymorphic (MAF > 0.', {'entities': [(4, 11, 'imputation')]}),
 (' For rs7741164, we tried to genotype as many samples as possible because of its relative low imputation quality.', {'entities': [(93, 103, 'imputation')]}),
 (' A standard preimputation quality control of the genotyping data was implemented at the individual and single-nucleotide polymorphism (SNP) level using pairwise identity-by-descent values ().', {'entities': [(15, 25, 'imputation')]}),
 (' Prior to imputation, all SNPs were filtered using the criteria described above.', {'entities': [(10, 20, 'imputation')]}),
 (' A set of 274,604 SNPs that were common to all of the genotyping chips were used for imputation, which was performed using the program MACH .', {'entities': [(85, 95, 'imputation'), (135, 139, 'imputation')]}),
 (' Imputation was performed using IMPUTE () or MACH () for roughly 2.', {'entities': [(1, 11, 'imputation'), (32, 38, 'imputation'), (45, 49, 'imputation')]}),
 (' Because commercially designed genotyping probes were not readily available, we performed Sanger sequencing by designing primers to amplify and sequence the 200-bp region around the imputed SNP markers for two separate 96-well plates.', {'entities': [(182, 189, 'imputation'), (54, 57, 'negation')]}),
 (' We imputed the region surrounding the Duffy antigen/chemokine receptor gene (DARC ) on chromosome 1, specifically to infer the rs2814778 genotypes for the 120 AA subjects not genotyped on the 1 M array.', {'entities': [(4, 11, 'imputation'), (172, 175, 'negation')]}),
 ('edu/csg/abecasis/MACH/) [].', {'entities': [(17, 21, 'imputation')]}),
 (' This procedure ensured that the same imputation input was used in the overall imputation.', {'entities': [(38, 48, 'imputation')]}),
 (' We performed an additional association analysis on the imputed variants in the TAOK3  region using the missing data likelihood score test implemented in SNPTEST v2 package [].', {'entities': [(56, 63, 'imputation')]}),
 ('To help localize the associations in the genome-wide significant regions, ungenotyped variants were imputed based on the reference panel from the 1000 Genomes Project().', {'entities': [(100, 107, 'imputation')]}),
 (' Data were imputed on 1000 Genomes phase 1 haplotypes (September 2013 release) with Minimac2 on default settings_, .', {'entities': [(11, 18, 'imputation')]}),
 (' Imputation was performed with the use of IMPUTE2 with the March 2012 haplotype release of the 1000 Genomes Project as a reference.', {'entities': [(1, 11, 'imputation'), (42, 48, 'imputation')]}),
 ('1%) and low imputation information (<0.', {'entities': [(12, 22, 'imputation')]}),
 ('Following study-specific quality control measures (), all contributing GWAS common SNPs were imputed using the HapMap phase II CEU reference panel for European-descent studies, and CEU+YRI+CHB+JPT HapMap release 22 for the African-American and Hispanic GWAS.', {'entities': [(93, 100, 'imputation')]}),
 (' We had previously evaluated this\napproach by masking and then imputing genotyped loci and found a high\ncorrelation between the genotyped and imputed allele dosages (Pearson\nr  > 0.', {'entities': [(63, 71, 'imputation')]}),
 (' All studies imputed their genotype data to ~2.', {'entities': [(13, 20, 'imputation')]}),
 ('Markers reported in the prior COGENT study () were updated to build 37 coordinates, but were originally imputed against the HRC reference panel () via the Sanger imputation server.', {'entities': [(104, 111, 'imputation')]}),
 ('3 (MACH) were removed from the analyses.', {'entities': [(3, 7, 'imputation')]}),
 (' Haplotypes were phased using MACH () (RISC, EUGENE2, and Stanford).', {'entities': [(30, 34, 'imputation')]}),
 (' Individual-level genotype data from the NTR and Generation R were imputed together based on the Genome of the Netherlands reference set.', {'entities': [(67, 74, 'imputation')]}),
 ('0 was used to perform imputation for the Caucasian participants (chromosomes 1–22) using HapMap phase I and II–CEU as the reference panel (release #24 - NCBI Build 36 (dbSNP b126)).', {'entities': [(22, 32, 'imputation')]}),
 (' For those candidate SNPs that were not directly genotyped or imputed in our study, we identified proxy SNPs with r _2  >0.', {'entities': [(62, 69, 'imputation'), (36, 39, 'negation')]}),
 ('01, p-HWE <1×10-6 , or imputation quality score <0.', {'entities': [(23, 33, 'imputation')]}),
 ('  Regional association plots (Supplemental Figure 3) were created using imputed and meta-analyzed data.', {'entities': [(72, 79, 'imputation')]}),
 (' SHAPEIT2 () was used to pre-phase the chromosomes and Impute2 () was used for imputation.', {'entities': [(79, 89, 'imputation'), (55, 62, 'imputation')]}),
 (' In the GW-GxAD analysis, we tested the interaction between the imputed minor allele dosage and DSM-IV AD diagnosis for the RSB score, after adjusting for DSM-IV CD, OD, and ND diagnoses, age, and the first three ancestry PCs.', {'entities': [(64, 71, 'imputation')]}),
 (' For imputed data sets, association tests were performed using likelihood score tests for missing data as implemented in SNPTEST.', {'entities': [(5, 12, 'imputation')]}),
 (' Finally, the imputed genetic dataset was filtered, excluding SNPs with MAF<0.', {'entities': [(14, 21, 'imputation')]}),
 (' \npresents a discussion of the limitations of using imputed data.', {'entities': [(52, 59, 'imputation')]}),
 (' Additional imputation within ±500 kb flanking region of rs3943077 at WDR11-FGFR2  was performed based on the haplotypes from the 1000 Genomes Project Phase 1 release (November 2010) of all Asian samples (ASN) in a subset of 3778 individuals from three Stage 1 cohorts, including SP2_1M, SP2_610K and CLHNS.', {'entities': [(12, 22, 'imputation')]}),
 (' MaCH (), Minimac (), and haplotype patterns from the 1000 Genomes Project reference panel were used to impute SNP genotypes not directly assayed by the GWAS arrays.', {'entities': [(104, 110, 'imputation'), (1, 5, 'imputation'), (125, 128, 'negation')]}),
 (' Genotyping, quality control, and imputation are described by Smith et al.', {'entities': [(34, 44, 'imputation')]}),
 (' The MHC region on chromosome 6 (chr6:25092012-35092011) was extracted from the post-QC dataset and used to impute 199 classical HLA alleles using HLA*IMP:02.', {'entities': [(108, 114, 'imputation')]}),
 (' Imputation-based association for non-genotyped SNPs was performed using the same IBS matrix for the genotyped SNPs by EMMAX.', {'entities': [(1, 11, 'imputation'), (34, 38, 'negation')]}),
 ('05) or low imputation accuracy (R _2  < 0.', {'entities': [(11, 21, 'imputation')]}),
 ('ESHG (), and then imputed using Impute2 v2.', {'entities': [(18, 25, 'imputation'), (32, 39, 'imputation')]}),
 (' Genotyped and imputed variants with MAF < 0.', {'entities': [(15, 22, 'imputation')]}),
 (' In addition to calculating the quality metrics output by IMPUTE2, we also calculated “oevar” (the ratio of the observed variance of imputed dosages to the expected binomial variance) by using the MaCH imputation software.', {'entities': [(133, 140, 'imputation'), (58, 64, 'imputation'), (197, 201, 'imputation')]}),
 (' In total, over 9M genotyped or imputed autosomal SNPs were analyzed.', {'entities': [(32, 39, 'imputation')]}),
 (' Phased haplotypes for HapMap II CEU subjects (n  = 60 founders) were used as the reference for imputing genotypes in the subset of Stage 1 triads in which all members were reported to be non-Hispanic and Caucasian (n  = 284 triads).', {'entities': [(96, 104, 'imputation'), (188, 192, 'negation')]}),
 (' Imputation was performed with IMPUTE (), MaCH (,) and Minimac ().', {'entities': [(1, 11, 'imputation'), (31, 37, 'imputation'), (42, 46, 'imputation')]}),
 (' Genotyping, imputation methods and the association analysis method used in the deCODE sample are previously described.', {'entities': [(13, 23, 'imputation')]}),
 (' Finally, we assessed the heritability due to genotyped and imputed SNPs and estimated the genetic correlation between ER-positive and ER-negative breast cancer.', {'entities': [(60, 67, 'imputation')]}),
 (' Imputation was implemented with FISH [], a fast and accurate diploid genotype imputation algorithm that we previously developed.', {'entities': [(79, 89, 'imputation'), (1, 11, 'imputation')]}),
 ('We employed a model with the imputed minor allele dosage as the dependent variable used DSM-IV symptom count (Sympcount_adj ) for OD and each of three other major SD diagnoses (CD, AD, and ND) as ordinal predictors (with adjustment for sex, age, and the first three PCs of ancestry []).', {'entities': [(29, 36, 'imputation')]}),
 (' After imputation, >8 million high-quality polymorphisms were tested for association.', {'entities': [(7, 17, 'imputation')]}),
 (' We used a linear regression framework implemented in the MACH2QTL version 1.', {'entities': [(58, 63, 'imputation')]}),
 (' An imputation info score of 0.', {'entities': [(4, 14, 'imputation')]}),
 (' In SAGE we did not have the advantage of family based cleaning; therefore, we based our analysis on 4,058,415 common SNPs that met imputation quality control criteria across both SAGE and COGA datasets.', {'entities': [(132, 142, 'imputation'), (16, 19, 'negation')]}),
 ('html) for the primary association analyses for the imputed genotypes, as well as for conditional analyses.', {'entities': [(51, 58, 'imputation')]}),
 (' We ran the pooled analysis using SNPs with an imputation dosage allele r _2  of at least 0.', {'entities': [(47, 57, 'imputation')]}),
 (' Association analyses of the genotyped SNPs were performed using the PLINK software, and the imputed SNPs were analyzed using the expectation-maximization (EM) option in SNPTEST v2.', {'entities': [(93, 100, 'imputation')]}),
 (' Imputation was done in a two step procedure.', {'entities': [(1, 11, 'imputation')]}),
 (' Then we imputed ungenotyped SNPs via IMPUTE2 [].', {'entities': [(9, 16, 'imputation'), (38, 44, 'imputation')]}),
 (' Information on genealogy-based imputation, the Centaurs genotyping platform and likelihood ratio statistical testing (including a detailed description of the genotyping, sequencing and statistical methods) is available in the .', {'entities': [(32, 42, 'imputation')]}),
 ('01 in either cases or controls,\nHardy-Weinberg equilibrium P  < 1 ×\n10_−5  in controls, and significantly different missing\ngenotype rates between cases and controls (P  < 1\n× 10_−5 ), a total of 1,532,051 genotyped and imputed\nautosomal SNPs from the BAS, 2,042,781 from the CAS, and 2,228,999 SNPs from the\ncombined two GWAS samples were retained for subsequent association analysis.', {'entities': [(220, 227, 'imputation')]}),
 (' To enable meta-analysis, each study performed genotype imputation using the cosmopolitan (all ethnicities combined) 1000 Genomes phase 1 v.', {'entities': [(56, 66, 'imputation')]}),
 ('To increase coverage and facilitate comparison with other datasets, imputed genotype data were obtained using MACH (,), using all SNPs that passed the QC steps described above, and employing a 1:1 mixture of HapMap phase II CEU and YRI data as the reference panel for imputation.', {'entities': [(68, 75, 'imputation'), (110, 114, 'imputation')]}),
 ('Imputation of the alpha-globin gene locus was performed using the IMPUTE2 package (,).', {'entities': [(0, 10, 'imputation'), (66, 72, 'imputation')]}),
 (' For each SNP, imputed dosage was then summed for each of the five phenotype groups.', {'entities': [(15, 22, 'imputation')]}),
 (' Summary-level imputed data from one additional cohort (VISP) was added to the stage I meta-analysis.', {'entities': [(15, 22, 'imputation')]}),
 ('Each GWAS sample was tested for association between normalized phenotype residuals and genotyped and imputed genotypes under an additive mode of inheritance.', {'entities': [(101, 108, 'imputation')]}),
 (' Genotype imputation with the Haplotype Reference Consortium reference panel, which included 1,023 low-pass whole-genome-sequenced HUNT samples, was conducted on the Michigan Imputation Server with minimac3.', {'entities': [(10, 20, 'imputation'), (175, 185, 'imputation')]}),
 (' For all other samples, genotype data were imputed using MACH software.', {'entities': [(43, 50, 'imputation'), (57, 61, 'imputation')]}),
 (' Participants of the SiGN study were imputed to a combined reference panel consisting of 1000 Genomes phase 1 plus Genome of the Netherlands.', {'entities': [(37, 44, 'imputation')]}),
 (' Prephasing and imputation were done by Jae Hoon Sul\xa0at\xa0UCLA using Beagle (v.', {'entities': [(16, 26, 'imputation'), (67, 73, 'imputation')]}),
 (' Because 1000 Genomes Project data was based on the NCBI Build 37 reference genome, we conducted liftover (see URLs) on our scan data from Build 36 to 37 before imputation.', {'entities': [(161, 171, 'imputation')]}),
 (' A detailed description regarding genotyping platforms and imputation procedures for each study is provided in Tables S2 and S3.', {'entities': [(59, 69, 'imputation')]}),
 (' Poorly imputed SNPs (r _2 <0.', {'entities': [(8, 15, 'imputation')]}),
 (' The imputed data was filtered to restrict the analysis to ACPA positive cases and SNPs with MAF≥1% and imputation-r_2 ≥0.', {'entities': [(5, 12, 'imputation')]}),
 (' The imputation was performed using 5MB segments over the length of each chromosome from the first to last position appearing in the reference panel.', {'entities': [(5, 15, 'imputation')]}),
 (' Genotype imputation was performed using MACH 1.', {'entities': [(10, 20, 'imputation'), (41, 45, 'imputation')]}),
 (' For Oncoarray data tests of association between imputed SNPs and TGCT was performed under a probabilistic dosage model in in SNPTESTv2.', {'entities': [(49, 56, 'imputation')]}),
 ('Each cohort was genotyped as specified in  and performed ancestry-specific imputation up to ~2.', {'entities': [(75, 85, 'imputation')]}),
 ('Logistic regression was performed on imputed genotype dosages under an additive model using SNPTEST software.', {'entities': [(37, 44, 'imputation')]}),
 (' Detailed descriptions of genotyping methods, quality control steps, and imputation methods can be found in Supplementary Materials, Text S1 and Table S1.', {'entities': [(73, 83, 'imputation')]}),
 (' A simulation to determine the effect of varying quality control thresholds on imputation quality () showed that the minor variation in quality control thresholds and imputation reference panels between sites was unlikely to have influenced imputation accuracy.', {'entities': [(79, 89, 'imputation')]}),
 (" Subsequently, the blanked genotypes were re-imputed using MERLIN [] (based on local relatives' genotypes, or if uncertain then using a weighted average of possible genotypes).", {'entities': [(45, 52, 'imputation')]}),
 (' A large genome-wide set of independent autosomal SNPs (which have been genotyped or imputed in each data set) is selected (after pruning to restrict linkage disequilibrium between SNPs); then the effect size beta for the test of association of each tested allele in the first data set is used as a weighting factor to create a polygenic score for each subject in the second data set as the sum across all SNPs for the number of test alleles carried by the subject, times the weight for each allele.', {'entities': [(85, 92, 'imputation')]}),
 ('Association testing in the Australian sample was performed in MERLIN_,  , using the dosage scores from the imputation.', {'entities': [(107, 117, 'imputation')]}),
 (' As previously described, imputation of genotype data was performed from the 1000 Genomes Project Phase 1 reference panel using Impute2.', {'entities': [(26, 36, 'imputation'), (128, 135, 'imputation')]}),
 (' Imputation was performed using Impute2 software and the 1000 Genomes Phase 1 reference panel.', {'entities': [(1, 11, 'imputation')]}),
 ('edu/wiki/Mach2dat:_Association_with_MACH_output) were used for imputation analysis.', {'entities': [(63, 73, 'imputation'), (9, 14, 'imputation')]}),
 (' After exclusion of imputed SNPs with MAF < 0.', {'entities': [(20, 27, 'imputation')]}),
 (' All groups uploaded individual genotype and phenotype data to a\ncentral computer cluster, and the PGC Statistical Analysis Group conducted\nuniform quality control, imputation and association analyses.', {'entities': [(165, 175, 'imputation')]}),
 (' Each study performed single-marker association analyses with BMI calculated from measured or self-reported height and weight at adolescence or early adulthood, as the dependent variable, using an additive genetic model implemented in MACH2QTL (Y.', {'entities': [(235, 240, 'imputation')]}),
 (' Imputed data were merged with genotyped data, giving preference to measured genotype when imputed and genotyped data were both available for a particular SNP.', {'entities': [(91, 98, 'imputation'), (1, 8, 'imputation')]}),
 (' Details of genotyping and imputation quality control have been previously published () and are described in the online supplement.', {'entities': [(27, 37, 'imputation')]}),
 (' Both genotyped and imputed SNPs were included in these analyses, which yielded 1,211,988 million SNPs after QC procedures.', {'entities': [(20, 27, 'imputation')]}),
 (' Standard quality control of GWAS was applied and genotype imputation was performed using the 1000 Genomes cosmopolitan reference panel as described above.', {'entities': [(59, 69, 'imputation')]}),
 (' Variant genotypes were coded as imputed allele dosages.', {'entities': [(33, 40, 'imputation')]}),
 ('r644) and then imputed with IMPUTE2 (v.', {'entities': [(15, 22, 'imputation'), (28, 34, 'imputation')]}),
 (' Post-1KG imputed association\ndata were used for SNPs with INFO > 0.', {'entities': [(10, 17, 'imputation')]}),
 (' In the first stage, a genome-wide association analysis was performed on the ProtecT samples using the software package MACH2DAT(, ), employing a logistic regression model based on an expected allelic dosage model for SNPs.', {'entities': [(120, 125, 'imputation')]}),
 (' Prior to meta-analyses, we excluded imputed SNPs with imputation quality score and/or imputation R_2  <0.', {'entities': [(37, 44, 'imputation')]}),
 ('3, released March 2012) as the imputation reference panel.', {'entities': [(31, 41, 'imputation')]}),
 (' For this, we used HapMap-imputed dosages of the independently associated SNPs reported by Sabater-Lleal et al.', {'entities': [(26, 33, 'imputation')]}),
 (' To identify loci significantly associated with baseline skin pigmentation and tanning status, we associated high quality imputed and resequenced SNPs and indels with these pigmentation phenotypes using a linear mixed model, with a covariance matrix of relatedness as a random effect.', {'entities': [(122, 129, 'imputation')]}),
 (' In the current study, we focused only on the SNPs imputed with high imputation quality (RSQR\u2009≥\u20090.', {'entities': [(51, 58, 'imputation')]}),
 (' Briefly, post QC data were imputed to 1000 Genomes [] after converting to genome build 37 using liftOver [] and stratifying by chromosome to parallelize imputation processing.', {'entities': [(28, 35, 'imputation')]}),
 (' Genotypes were imputed as implemented in IMPUTE2 with the use of the 1000 Genomes Phase 3 integrated reference panel.', {'entities': [(16, 23, 'imputation'), (42, 48, 'imputation')]}),
 (' the imputation yield).', {'entities': [(5, 15, 'imputation')]}),
 (' However, data from all of the CHOP cohorts were imputed together.', {'entities': [(49, 56, 'imputation')]}),
 ('5 were present in the imputed SNP dataset, that site could not be evaluated for sharing.', {'entities': [(22, 29, 'imputation'), (59, 62, 'negation')]}),
 (' The low LD makes the imputation of the SNP rs7741164 intrinsically difficult.', {'entities': [(22, 32, 'imputation')]}),
 (' Quality control procedures were similar for both imputed and directly measured SNPs, with the addition of standard imputation quality metrics for imputed SNPs (see [] for details).', {'entities': [(50, 57, 'imputation')]}),
 ('2 of Merlin, was used to test for significant correlation of transcript levels with imputed allele dosages of variants; inverse normalization was applied to the expression levels, and the top two principal components and an indicator variable for lesional/normal skin were included as covariates in the association model.', {'entities': [(84, 91, 'imputation')]}),
 ('03, the imputation quality was <0.', {'entities': [(8, 18, 'imputation')]}),
 (' Genotype–phenotype association with imputed allele dosages for autosomal SNPs was carried out with logistic regression as implemented by PLINK ().', {'entities': [(37, 44, 'imputation')]}),
 (' The iCOGS, OncoArray and six of the GWAS data sets were imputed using a two-stage imputation approach, with SHAPEIT for phasing and IMPUTEv2 (ref.', {'entities': [(57, 64, 'imputation'), (133, 139, 'imputation')]}),
 (' The IMPUTE version 2 software was used to infer genotypes at additional loci for the cases and both control sets.', {'entities': [(5, 11, 'imputation')]}),
 (' Un-genotyped single nucleotide polymorphisms (SNPs) were imputed as previously described ().', {'entities': [(58, 65, 'imputation'), (1, 4, 'negation')]}),
 (' Using mach2qtl or SNPtest software we performed linear regressions of the BP response phenotype on SNP dosages adjusting for sex, age, pre-diuretic treatment BP and principal components.', {'entities': [(7, 12, 'imputation')]}),
 (' We subsequently removed SNPs with poor imputation quality (r_2 <0.', {'entities': [(40, 50, 'imputation')]}),
 (' Despite the high efficiency of the imputation process, it was not possible to obtain imputed types for every known polymorphism.', {'entities': [(36, 46, 'imputation'), (63, 66, 'negation')]}),
 (' Autosomal SNPs directly genotyped or imputed with high confidence were tested for association with case-control status in each study while adjusting for significant covariates, such as age and sex.', {'entities': [(38, 45, 'imputation')]}),
 ('Imputation was carried out with the program IMPUTE v2 [], using the combined 1000 Genomes project samples as the reference sample (1000 Genomes Phase I integrated haplotypes, NCBI build b37, release date December 2013, no singletons).', {'entities': [(0, 10, 'imputation'), (44, 50, 'imputation'), (219, 221, 'negation')]}),
 (' Subsequent identical SNP filters after imputation and GWAS analyses\nwere applied to summary statistics at the meta-analysis level.', {'entities': [(40, 50, 'imputation')]}),
 (' Imputed SNPs with a MAF < 0.', {'entities': [(1, 8, 'imputation')]}),
 ('21 for data generated from the IMPUTE2 approach detailed in the paragraph above.', {'entities': [(31, 37, 'imputation')]}),
 ('To test for the presence of additional independent VTE-associated SNPs at each of the replicated loci, we re-analyzed in each discovery study a GWAS conditioning on the imputed allelic dose of each replicated SNP and meta-analyzed the results by the same strategy as the original GWAS analysis.', {'entities': [(169, 176, 'imputation')]}),
 (' Imputation target variants were limited to those with at least two copies of the minor allele observed in any of the four reference panel super-populations, yielding 27 728, 264 total variants in the imputed dataset.', {'entities': [(201, 208, 'imputation'), (1, 11, 'imputation')]}),
 ('1 and the 1000 Genomes Project (1000G) Phase I (a) reference panel (2010/11 data freeze, 2011/6 haplotypes), and analysis was performed as described previously using the post-imputation probabilities and the first five principal components (PC) as covariates (), leading to association results for a total of 6 948 682 SNPs with INFO of >0.', {'entities': [(175, 185, 'imputation')]}),
 (' Single nucleotide polymorphism (SNP)-level QC was performed on APDGC and ADGC datasets separately for all steps up to and including imputation.', {'entities': [(133, 143, 'imputation')]}),
 (' For the Icelandic data set, the analysis was restricted to directly genotyped individuals to avoid complication in combining imputation of SNPs and imputation of ungenotyped individuals.', {'entities': [(126, 136, 'imputation')]}),
 (' To reduce the multiple comparisons penalty of evaluating all imputed SNPs, our investigation of imputed data was focused only on GWAS regions with prior evidence of association in the primary (genotyped) analysis (P \u2009<\u200910_−4 ).', {'entities': [(62, 69, 'imputation')]}),
 (' For imputation, the prephasing/imputation stepwise approach implemented in IMPUTE2 and SHAPEIT was used (chunk size of 3\u2009Mb and default parameters).', {'entities': [(5, 15, 'imputation'), (76, 82, 'imputation')]}),
 (' The imputation reference was the HapMap2 Central EUrope (CEU) panel ().', {'entities': [(5, 15, 'imputation')]}),
 ('Approximately 50% of the SNPs for the OncoArray were selected as a ‘GWAS backbone’ (Illumina HumanCore), which aimed to provide high coverage for the majority of common variants through imputation.', {'entities': [(186, 196, 'imputation')]}),
 (' We genotyped newly identified SNPs using the TAQMAN or KASPar assay in the replication datasets, except the NHS and HPFS studies, in which we had pre-existing genotype/imputation data.', {'entities': [(169, 179, 'imputation')]}),
 ('01 and imputation INFO\u2009≥\u20090.', {'entities': [(7, 17, 'imputation')]}),
 (' Imputation of autosomal genotypic data used Markov Chain Haplotyping software (MACH v.', {'entities': [(1, 11, 'imputation'), (80, 84, 'imputation')]}),
 (' We used the SNP2HLA software to impute classical HLA alleles from genotype data for HLA-A, HLA-B, HLA-C, HLA-DRB1, HLA-DQA1, HLA-DQB1, HLA-DPA1  and HLA-DPB1  and their corresponding amino acid polymorphisms from the genotype data (methods described in ).', {'entities': [(33, 39, 'imputation')]}),
 ('edu/csg/abecasis/MACH or proper-info <0.', {'entities': [(17, 21, 'imputation')]}),
 (' The missing genotypes were replaced with imputed genotypes using the option “-pgs_miss” and the buffer region was increased to 500KB (“-buffer 500”).', {'entities': [(42, 49, 'imputation')]}),
 (' 10,996,499 imputed autosomal SNPs that passed the QC were analyzed for additive and genotypic models using SNPTEST2, taking the imputed genotype uncertainty (frequentist score test) and the first two principal components (PCs) of genetic structure into account.', {'entities': [(12, 19, 'imputation')]}),
 (' Imputation to HapMap CEU was conducted using IMPUTE, BEAGLE, or MACH.', {'entities': [(1, 11, 'imputation'), (46, 52, 'imputation'), (54, 60, 'imputation'), (65, 69, 'imputation')]}),
 ('We performed a meta-analysis on directly genotyped and imputed SNPs from individuals of European ancestry in seven studies, with a total of 17,248 individuals (stage 1).', {'entities': [(55, 62, 'imputation')]}),
 (' All association tests were done by using the combined imputed SNP data set as described above.', {'entities': [(55, 62, 'imputation')]}),
 (' We assessed imputed SNP quality by establishing a probability threshold for merging genotypes at 0.', {'entities': [(13, 20, 'imputation')]}),
 (' Imputation was also performed in these samples ().', {'entities': [(1, 11, 'imputation')]}),
 (' When replication SNPs were not available in replication populations due to differences in genotyping platforms, we identified and evaluated the associations at SNPs that were either in strong linkage disequilibrium with the identified SNP or analysed the imputed SNP data.', {'entities': [(256, 263, 'imputation'), (28, 31, 'negation')]}),
 ('0 chip, and imputation was performed with MaCH.', {'entities': [(12, 22, 'imputation'), (42, 46, 'imputation')]}),
 (' SHAPEIT2 was used for prephasing, and IMPUTE2 was used for imputation.', {'entities': [(60, 70, 'imputation'), (39, 45, 'imputation')]}),
 (' Poorly imputed SNPs (with r _2  < 0.', {'entities': [(8, 15, 'imputation')]}),
 (' To assess imputation accuracy, squared Pearson correlation coefficients (r_2 ) between IMPUTE2 genotype dosage and MassARRAY genotype were calculated.', {'entities': [(11, 21, 'imputation'), (88, 94, 'imputation')]}),
 ('uk/impute/impute_v2.', {'entities': [(3, 9, 'imputation')]}),
 ('We sought to leverage LD differences between populations contributing to the trans-ancestry meta-analysis and to take advantage of the improved coverage of common and low-frequency variation offered by 1000G or 1000G and UK10K combined imputation to localise variants driving each distinct association signal achieving locus-wide significance.', {'entities': [(236, 246, 'imputation')]}),
 (' Consequently, data for 2,450,547 genotyped or imputed autosomal SNPs were available for the primary analysis of serum urate concentrations, and data for 2,538,056 SNPs were available for the primary gout analysis.', {'entities': [(47, 54, 'imputation')]}),
 (' We used genome-wide autosomal SNPs that were well imputed (INFO > 0.', {'entities': [(51, 58, 'imputation')]}),
 (' We maximised sample size for the subtype analyses by pooling as many possible samples while sacrificing some array content, leaving 228 189 autosomal SNPs as a basis for imputation after the quality control was completed.', {'entities': [(171, 181, 'imputation')]}),
 (' Chromosome X variants were imputed based on 1000 Genomes Project EUR + AFR + AMR + ASN reference samples.', {'entities': [(28, 35, 'imputation')]}),
 (' Prediction of the untyped SNP in the case-control datasets of GWA data was carried out using IMPUTE and SNPTEST on HapMap.', {'entities': [(94, 100, 'imputation')]}),
 ('05 and imputation accuracy >80%, 231 HLA alleles were available for analysis.', {'entities': [(7, 17, 'imputation')]}),
 ('0 platform was used for genotyping and MACH v1.', {'entities': [(39, 43, 'imputation')]}),
 (' We did not use allele dosages in the analyses to account for imputation uncertainty.', {'entities': [(62, 72, 'imputation'), (8, 11, 'negation')]}),
 (' () (for additional quality control steps and imputation using MACH, see the ), yielding 1,954,455 SNPs in 1,273 subjects.', {'entities': [(46, 56, 'imputation'), (63, 67, 'imputation')]}),
 (' estimated squared correlation between imputed and actual genotypes) <0.', {'entities': [(39, 46, 'imputation')]}),
 (' Imputed SNPs with an r_2  < 0.', {'entities': [(1, 8, 'imputation')]}),
 (' Imputation was performed within each study and genotyping array using the HapMap Phase 2 CEU reference panel and MACH software package v1.', {'entities': [(1, 11, 'imputation'), (114, 118, 'imputation')]}),
 (' The 259 individuals were imputed by using 2,245 individuals as the reference panel.', {'entities': [(26, 33, 'imputation')]}),
 (' Because rs37972 and rs37973 were not genotyped on that platform, corresponding genotypes were inferred by means of imputation with the Markov Chain Haplotyping software on the basis of HapMap Phase 2 Release 22 data.', {'entities': [(116, 126, 'imputation'), (34, 37, 'negation')]}),
 ('Imputation of classical HLA genotypes was performed using published statistical methodology and a reference panel of over 1,500 samples with classical HLA and SNP genotype data from the 1958 Birth Cohort and the International HapMap Project.', {'entities': [(0, 10, 'imputation')]}),
 ('  We imputed the classical human leukocyte antigen (HLA) alleles at HLA A, B, C, DPB1, DQA1, DQB1 and DRB1 using the program HiBAG and its corresponding Hispanic reference dataset.', {'entities': [(5, 12, 'imputation')]}),
 (' SNPs with a low MAF (<1%) or a low imputation quality (MACH: R _2  < 0.', {'entities': [(36, 46, 'imputation'), (56, 60, 'imputation')]}),
 (' Overlapping regions were removed after imputation.', {'entities': [(40, 50, 'imputation')]}),
 (' Quality control, imputation, and genotyped or inferred SNP-filtering procedures were performed separately per cohort, including data for cases and controls.', {'entities': [(18, 28, 'imputation')]}),
 (' We did not impute genome-wide SNP genotypes for the ARIC sample.', {'entities': [(12, 18, 'imputation'), (8, 11, 'negation')]}),
 (' Long-range linkage disequilibrium (LD) between HLA loci and SNPs across the MHC region offers an alternative approach through imputation to interrogate HLA.', {'entities': [(127, 137, 'imputation')]}),
 (' Genotypes were obtained using high-density SNP arrays, and then imputed for ~2.', {'entities': [(65, 72, 'imputation')]}),
 (' For the purposes of this replication study, after imputation we selected the SNPs from the discovery set that showed genome-wide significance, checked their quality and subsequently analyzed the SNPs.', {'entities': [(51, 61, 'imputation')]}),
 (' Imputation was carried out using IMPUTE2 v2.', {'entities': [(1, 11, 'imputation'), (34, 40, 'imputation')]}),
 (' To generate the principal components we used a set of 79,974 SNPs that were imputed with R_2 >0.', {'entities': [(77, 84, 'imputation')]}),
 (' SNPs data were analyzed either as allele dosages or imputation\nprobabilities, depending on the imputation software used (see ).', {'entities': [(53, 63, 'imputation')]}),
 ('  We first identified principal components (PCs) representing axes of ancestral variation to adjust for population stratification () and imputed untyped SNPs using the HapMap3 data.', {'entities': [(137, 144, 'imputation')]}),
 ('01 and high imputation quality (RSQR\u2009≥\u20090.', {'entities': [(12, 22, 'imputation')]}),
 (' The first four QC stages include removal of plates containing mostly dead cells, imputation of grossly errant raw fluorescence units (RFUs) in individual wells, QC for the negative control RFUs (10% dimethyl sulfoxide (DMSO)) and QC for drug vehicle RFUs (2% DMSO).', {'entities': [(82, 92, 'imputation')]}),
 (' Rs334 was imputed (imputation quality rsq=0.', {'entities': [(11, 18, 'imputation')]}),
 ('005 were removed prior to imputation performed using BEAGLE v3.', {'entities': [(26, 36, 'imputation'), (53, 59, 'imputation')]}),
 ('90 was applied to call imputed genotypes.', {'entities': [(23, 30, 'imputation')]}),
 (' Outlier, multi-allelic and low-MAF (<1%) SNPs were excluded from phasing and imputation procedures.', {'entities': [(78, 88, 'imputation')]}),
 (' The markers rs6602880 (chr 10) and rs144166867 (chr X) were probably false positives due to poor imputation for these regions.', {'entities': [(98, 108, 'imputation')]}),
 (' Because imputation of genotypes is established as standard practice in the analysis of genotype array data, we imputed the autosomal SNPs of all studies to the Utah residents with Northern and Western European ancestry from the Centre d’etude du polymorphisme humain (CEPH) collection (CEU) population in HapMap II (available at: http://hapmap.', {'entities': [(9, 19, 'imputation')]}),
 ('Imputation was performed using the 1000 Genomes reference data (1000G Phase 1 V3, http://www.', {'entities': [(0, 10, 'imputation')]}),
 ('For each of the four ancestry-specific GWAS, we collated the number of study subjects genotyped or imputed at each SNP, the effect allele frequency, the effect (β) for the effect allele and the standard error from the most restrictive of our models, Model 3, for use in a trans-ethnic meta-analysis using MANTRA ().', {'entities': [(99, 106, 'imputation')]}),
 (' As the other prior studies of cognitive performance () and education () were imputed to the 1000 genomes phase 3 reference panel, summary statistics were used as provided (URL: https://ctg.', {'entities': [(78, 85, 'imputation')]}),
 ('2012-08-15) to impute ~31 million SNPs based on the 1000G v3 ALL reference panel.', {'entities': [(15, 21, 'imputation')]}),
 (' SNPs with minor allele frequency (MAF) < 1% or imputation quality score (estimated r_2 ) < 0.', {'entities': [(48, 58, 'imputation')]}),
 (' Phased chromosome 3 haplotypes of the 587 CAP Caucasians with genome-wide genotype data were estimated in MaCH using 20 rounds and 200 states [].', {'entities': [(107, 111, 'imputation')]}),
 ('  1000 Genome imputed dosage data were tested for association with breastfeeding using the additive family-based association test in Merlin-off line ().', {'entities': [(14, 21, 'imputation')]}),
 ('We performed deep sequencing of the region containing the top imputed SNPs to determine the quality of the imputation as detailed in .', {'entities': [(62, 69, 'imputation')]}),
 ('Imputation of ungenotyped SNPs was conducted by MACH () and minimac () using data of JPT/CHS/CHD subjects from 1000 genome project phase 1 (release 16 March 2012) as a reference.', {'entities': [(0, 10, 'imputation'), (48, 52, 'imputation')]}),
 ('Within each study, SNPs with minor allele frequency <1% or imputation quality <0.', {'entities': [(59, 69, 'imputation')]}),
 (' To facilitate combining results of genome-wide association scans based on the different genotyping platforms, we imputed missing genotypes based on reference haplotypes from the phased CHB + JPT HapMap data release 22 reference dataset using MACH or IMPUTE (,).', {'entities': [(114, 121, 'imputation'), (251, 257, 'imputation'), (243, 247, 'imputation')]}),
 (' Accounting for genotype uncertainty, allelic dosages of imputed SNPs were analysed using the software mach2qtl (see Web Resources).', {'entities': [(57, 64, 'imputation'), (103, 108, 'imputation')]}),
 (' The imputation protocols used MaCH for haplotype phasing and minimac for imputation and are freely available online (http://enigma.', {'entities': [(5, 15, 'imputation'), (31, 35, 'imputation')]}),
 (' The inflation factor, lambda, for imputed SNPs was 1.', {'entities': [(35, 42, 'imputation')]}),
 (' Only imputed genotypes with minor allele frequencies ≥1% and R-sqr ≥0.', {'entities': [(6, 13, 'imputation')]}),
 ('We performed imputation of unobserved genotypes using phased haplotypes from the Haplotype Reference Consortium panel (version r1.', {'entities': [(13, 23, 'imputation')]}),
 (' We applied the same quality control criteria and imputation procedure as GWAS data.', {'entities': [(50, 60, 'imputation')]}),
 (' Imputing raw data to the latest release of 1000 Genomes would be ideal; however, due to the data-sharing requirements of the cohorts included in this analysis, only summary statistics were available for these datasets.', {'entities': [(1, 9, 'imputation')]}),
 (' Mendelian inconsistencies were removed, after which data were imputed to 1000 genomes (hg19) using SHAPEIT and IMPUTE2.', {'entities': [(63, 70, 'imputation'), (112, 118, 'imputation')]}),
 (' The imputed genotype with the highest posterior probability was correct in 97% of cases (rising to 98% if we only consider those genotypes where the maximum posterior probability is >0.', {'entities': [(5, 12, 'imputation')]}),
 (' Quality control was performed on imputed SNPs to filter out SNPs with low frequency (MAF of <0.', {'entities': [(34, 41, 'imputation')]}),
 ('50 or MACH <\u20090.', {'entities': [(6, 10, 'imputation')]}),
 ('5 million imputed genotypes, for a total of 27.', {'entities': [(10, 17, 'imputation')]}),
 (' [] The PGC performed a mega-analysis, which required centralizing the genotype data from all GWA samples prior to performing consistent QC, imputation and association analysis.', {'entities': [(141, 151, 'imputation')]}),
 (' Info scores for the imputed SNVs per participating cohort are presented in .', {'entities': [(21, 28, 'imputation')]}),
 (' As reference, we used the INMA 1000 Genomes imputation [restricted to variants with MAF\u2009>\u20090.', {'entities': [(45, 55, 'imputation')]}),
 (' The imputation was carried out using the IMPUTE software .', {'entities': [(5, 15, 'imputation'), (42, 48, 'imputation')]}),
 (' Details of study population, genotyping, quality control and imputation in each study are described in detail in the .', {'entities': [(62, 72, 'imputation')]}),
 (' The remaining content of the OncoArray was selected as a ‘GWAS backbone’ (Illumina HumanCore), which aimed to provide high coverage for most common variants through imputation.', {'entities': [(166, 176, 'imputation')]}),
 ('01) and variants with low imputation accuracy (oevar_imp or info score <0.', {'entities': [(26, 36, 'imputation')]}),
 ('1 panel on the Michigan Imputation Server v1.', {'entities': [(24, 34, 'imputation')]}),
 (' Measured genotypes for the ~281,000 SNPs passing QC in all genotyping batcheswere used to impute to 1000 Genomes SNPs (Release 20100804) via the recommended pre-phasing method in MACH and Minimac, using the publicly available EUR phased haplotypes as reference panel (from the formatted 1000 Genomes haplotype files supplied by the software authors’ web site, for this purpose).', {'entities': [(91, 97, 'imputation'), (180, 184, 'imputation')]}),
 (' Using the 1000 Genomes Project phase I integrated variant set as the reference panel (October 2011 release), 20,109,249 SNPs were imputed.', {'entities': [(131, 138, 'imputation')]}),
 (' Any SNP imputed with information content r_2 <0.', {'entities': [(9, 16, 'imputation')]}),
 (' SNP QC prior to imputation included using filters of MAF < 1%, HWE-p  < 1e–6 and call rate < 95%.', {'entities': [(17, 27, 'imputation')]}),
 (' In each cohort, imputation quality threshold of Proper_INFO > 0.', {'entities': [(17, 27, 'imputation')]}),
 (' To impute classic HLA  alleles, we used a reference data set from the Type 1 Diabetes Genetics Consortium, which includes genotype data for 7,261 SNPs selected across the entire MHC, high-resolution 4-digit typing data for 424 classic alleles at HLA–A, B, C, DRB1, DQA1, DBQ1, DPA1 , and DPB1 , and 1,276 amino acids corresponding to serologically defined antigens in 5,225 individuals of European descent (–).', {'entities': [(4, 10, 'imputation')]}),
 (' Imputation was performed using Impute2 software [] and the 1,000 Genomes Phase 1 reference panel.', {'entities': [(1, 11, 'imputation')]}),
 (' We, additionally, imputed using the HapMap2 reference (120 haplotypes, ~2.', {'entities': [(19, 26, 'imputation')]}),
 (' Minimac software was used to perform targeted imputation of the 3 Mb region surrounding each identified SNP based on the ALL ancestry panel from the 1000G Phase I Integrated Release Version 3 Haplotypes, which contains haplotypes of 1,092 individuals of all ethnic background.', {'entities': [(47, 57, 'imputation')]}),
 (' Before genotype imputation of the genotyped case samples, we applied numerous\xa0QC criteria to ensure unbiased genotype calls between cohorts.', {'entities': [(17, 27, 'imputation')]}),
 (' The IMPUTE2 algorithm [] was used to impute additional genotypes that were available in the 1000 Genomes reference panel, but not directly genotyped.', {'entities': [(38, 44, 'imputation'), (5, 11, 'imputation'), (127, 130, 'negation')]}),
 ('9, indicating good-quality imputation.', {'entities': [(27, 37, 'imputation')]}),
 (' Genotypes were pooled together after QC, phased and imputed to the 1000Genomes data set phase I v3 using MaCH and minimac.', {'entities': [(53, 60, 'imputation'), (106, 110, 'imputation')]}),
 ('In order to test for replication of the STAR*D findings, we identified 18 SNPs in the GENDEP dataset that were genotyped or imputed that corresponded with our top 25 STAR*D results.', {'entities': [(124, 131, 'imputation')]}),
 (' We further used imputed genotypes to integrate additional genetic variants not directly genotyped on either array.', {'entities': [(17, 24, 'imputation'), (76, 79, 'negation')]}),
 (' Imputed low frequency SNPs (MAF 1-5%) that showed evidence of association were also directly genotyped to confirm the imputation.', {'entities': [(119, 129, 'imputation'), (1, 8, 'imputation')]}),
 (' In the second step, genotype imputation of all subjects was conducted using the rate maps estimated in the first step.', {'entities': [(30, 40, 'imputation')]}),
 (' If three or less items were missing, missing data were imputed by taking the individual’s average score for the valid items of that dimension.', {'entities': [(56, 63, 'imputation')]}),
 ('Association analyses of all three imputed data sets were carried out using score tests (option-method score  in SNPTEST v2) for three genetic models, () additive, () recessive and () dominant, based on the imputed genotype probabilities after adjustment by the study-specific covariates.', {'entities': [(34, 41, 'imputation')]}),
 (' Genotypes were imputed with IMPUTE2 () using the genotyped SNPs and the 1000 Genomes reference panel released in June 2011 (http://www.', {'entities': [(16, 23, 'imputation'), (29, 35, 'imputation')]}),
 (' SNPs with low imputation quality were filtered using metrics specific to the imputation method and thresholds used in their previous GWAS analyses.', {'entities': [(15, 25, 'imputation')]}),
 (' For all four imputed sets, imputed loci with INFO score (r _2  for MaCH) < 0.', {'entities': [(14, 21, 'imputation'), (68, 72, 'imputation')]}),
 (' Association analyses between the imputed SNP probabilities and adjusted differences and means were conducted using SNPtest ().', {'entities': [(34, 41, 'imputation')]}),
 (' Phased haplotypes were then used to impute\nour non-typed SNPs using IMPUTE2 [].', {'entities': [(37, 43, 'imputation'), (69, 75, 'imputation'), (48, 52, 'negation')]}),
 (' Briefly, the replication P  value criteria reflects the small size of the HSCR case sample, avoidance of batch effects, considerations on minor allele frequency (MAF) and imputation info score, and prior functional knowledge of HSCR disease.', {'entities': [(172, 182, 'imputation')]}),
 (' After imputation, from each study we removed monomorphic variants or those with imputation quality r _2 -hat < 0.', {'entities': [(7, 17, 'imputation')]}),
 ('5 million SNPs) by MACH (version 1.', {'entities': [(19, 23, 'imputation')]}),
 (' The IMPUTE2 program was used for imputing untyped SNPs using the post-QCed PEGASUS genotype dataset (960 samples with 561,091 markers) and phased haplotypes from the 1000 genome CEU reference panel.', {'entities': [(34, 42, 'imputation'), (5, 11, 'imputation')]}),
 ('3 (indicating deviation from Hardy–Weinberg equilibrium and poor quality of imputation, sometimes denoted as Rsq) were removed from the analysis.', {'entities': [(76, 86, 'imputation')]}),
 ('edu//abecasis/MaCH/, \nHaploReg:\nhttp://www.', {'entities': [(14, 18, 'imputation')]}),
 ('In the GWAS, logistic regression was performed using mach2dat software (version 1.', {'entities': [(53, 58, 'imputation')]}),
 ('org) using the IMPUTE computer program ().', {'entities': [(15, 21, 'imputation')]}),
 (' Then, IMPUTE v2.', {'entities': [(7, 13, 'imputation')]}),
 ('_,   Association tests were performed with mach2dat using the fractional dosages output.', {'entities': [(43, 48, 'imputation')]}),
 ('5 million SNPs was performed using MACH v1.', {'entities': [(35, 39, 'imputation')]}),
 (' We then performed more accurate imputation for any region with a SNP with P<10  in the OCAC analyses or the OCAC/CIMBA meta-analysis.', {'entities': [(33, 43, 'imputation')]}),
 ('ALSPAC, YFS, RAINE and TEENAGE all had 1000 Genomes imputed data for chromosome 16 available.', {'entities': [(52, 59, 'imputation')]}),
 (' The 53 SNPs included the 41 most significant SNPs with P \u2009<\u200910_−4  from our discovery GWAS (n \u2009=\u200941), plus 12 imputed SNPs with P \u2009<\u200910_−4  located on chromosome 15 near rs1110060, the only genotyped SNP with marginal significance.', {'entities': [(111, 118, 'imputation')]}),
 (' Genotyping information in the 10 studies participating in the GWASNEO Consortium - = no threshold applied In order to compare results at the SNP level, we imputed ~2.', {'entities': [(156, 163, 'imputation'), (86, 88, 'negation')]}),
 (' In the AD-stratified GWAS, we tested the association of the imputed allele dosage with RSB score considered as the phenotype, after adjustment for DSM-IV cocaine dependence (CD), opioid dependence (OD), and nicotine dependence (ND) diagnoses, age, and the first three ancestry PCs.', {'entities': [(61, 68, 'imputation')]}),
 (' For the association tests, PLINK (), ProbABEL (), SNPtest () or MACH2QTL () was used.', {'entities': [(65, 70, 'imputation')]}),
 (' For the replication in UK-ROI and GoKinD US, rs4972593 was selected from the UK-ROI and GoKinD US GWAS data, where the quality control and imputation procedures were the same as described above.', {'entities': [(140, 150, 'imputation')]}),
 (' Imputation was done to 1000 Genomes Project Phase 1 version 3 integrated haplotypes produced with SHAPEIT2 for chromosome 1–22; for chromosome X, the previous version was used.', {'entities': [(1, 11, 'imputation')]}),
 (' SNPs were imputed to August, 2010 release of the 1000 Genomes haplotypes using default settings of minimac and were excluded if their minor allele frequency was less than 0·01 or imputation quality (Rsq) was less than 0·30 across all samples, leaving 6 026 385 SNPs for analyses.', {'entities': [(11, 18, 'imputation')]}),
 (' For each cohort in CARDIoGRAM, logistic regression was first used to test for association with CAD assuming an additive genetic model with adjustment for age and sex and taking into account the uncertainty of possibly imputed genotypes.', {'entities': [(219, 226, 'imputation')]}),
 ('5\u2009M (1069 families) Therefore, since imputation is computationally intensive for trio data sets and we needed the parental genotype data, we combined the three data sets and investigated SNPs common to all three arrays, as was carried out in ref.', {'entities': [(37, 47, 'imputation')]}),
 (' Data from CFS, FHS, MESA, MrOS, and Starr were phased using SHAPEIT () and imputed using IMPUTE2 (), and a 1000 Genomes Project phase 3 background (version 5; all populations, which contains haplotypes on 2,504 samples for a total of approximately 81.', {'entities': [(76, 83, 'imputation'), (90, 96, 'imputation')]}),
 (' We used posterior probability to call the genotype from imputation data and then performed association analyses on imputed data.', {'entities': [(57, 67, 'imputation')]}),
 (' Imputation and association analysis of the non-pseudoautosomal region of the chromosome X data were based on females (2,907 AN cases and 10,594 controls).', {'entities': [(1, 11, 'imputation'), (44, 48, 'negation')]}),
 (' Quality control before imputation was applied in each study separately.', {'entities': [(24, 34, 'imputation')]}),
 (' Including imputed SNPs, the numbers were increased to 1,216,189 and 1,216,074, respectively.', {'entities': [(11, 18, 'imputation')]}),
 (' Genome-wide typing and imputations were available for 6,296 cohort members with measurements of standing and sitting height at age 44–45 years.', {'entities': [(24, 35, 'imputation')]}),
 (' Individual datasets were imputed genome wide separately using the IMPUTE.', {'entities': [(26, 33, 'imputation'), (67, 73, 'imputation')]}),
 (' GWAS in the LLFS was performed using all the assayed and imputed SNPs (n = 9.', {'entities': [(58, 65, 'imputation')]}),
 (' Variants were filtered postimputation to those with MAF≥1%, minor allele count ≥10 in both patients and controls, and SNPtest INFO estimate of imputation quality ≥0.', {'entities': [(28, 38, 'imputation')]}),
 (' Imputations were based on 537,371 genotyped SNPs in common with the reference data (G-C and A-T SNPs were excluded).', {'entities': [(1, 12, 'imputation')]}),
 (' lists the genotyping platforms and algorithms; SNP inclusion criteria; quality control; and imputation software.', {'entities': [(93, 103, 'imputation')]}),
 (' We previously found that combining imputed SNPs derived from cases and controls genotyped on different arrays has the potential to create artifactual differences leading to biased genotype-phenotype associations.', {'entities': [(36, 43, 'imputation')]}),
 (' Variants with low imputation quality (INFO\u2009≤0.', {'entities': [(19, 29, 'imputation')]}),
 (' Given m  SNPs (from typed or imputed datasets) for association with TB, we expected around m  × 0.', {'entities': [(30, 37, 'imputation')]}),
 (' For the KS_HPFS set, we used the same program to impute 2 543 887 autosomal SNPs based on haplotypes from the HapMap database phase II data build 35 (CEU) ().', {'entities': [(50, 56, 'imputation')]}),
 (' The conditional and joint analyses were carried out after converting imputed dosage data to hard-called genotypes (as required by the GCTA software).', {'entities': [(70, 77, 'imputation')]}),
 (' The QC procedure for the genotypes used for imputation is identical to that described earlier.', {'entities': [(45, 55, 'imputation')]}),
 (' Before the meta-analysis, we applied quality filters to each study, filtering out SNPs with a minor allele frequency below 1% and SNPs with poor imputation quality (MACH r2_hat ≤ 0.', {'entities': [(146, 156, 'imputation'), (166, 170, 'imputation')]}),
 (' To facilitate the meta-analysis, the imputation of unobserved genotypes from the HAPMAP II CEU Panel (Release 22, NCBI Build36, dbSNP b126) was conducted within each cohort.', {'entities': [(38, 48, 'imputation')]}),
 ('8, which indicates a high degree of imputation accuracy.', {'entities': [(36, 46, 'imputation')]}),
 (' impute hape t The association between natural log-transformed lactate and imputed SNP dosage was evaluated using linear regression adjusting for age, sex, study centre, BMI, waist circumference, and statistically significant principal components (principal components 1, 2, 3, and 5 in European-American subjects, and none was significant in African-American subjects).', {'entities': [(1, 7, 'imputation')]}),
 (' Control sample genotypes from the replication studies were imputed using the same reference panel that was used in the GWAS.', {'entities': [(60, 67, 'imputation')]}),
 (' Poorly imputed SNPs (with R _2  < 0.', {'entities': [(8, 15, 'imputation')]}),
 (' For each of the four GWAS, genotypes were imputed using HapMap 2 data.', {'entities': [(43, 50, 'imputation')]}),
 ('  SNP imputation was performed in batches dividing the cohorts\naccording to genotyping platforms.', {'entities': [(6, 16, 'imputation')]}),
 ('0\xa0% for all imputed SNPs.', {'entities': [(12, 19, 'imputation')]}),
 (' Poorly imputed SNPs (r-squared or proper_info < 0.', {'entities': [(8, 15, 'imputation')]}),
 ('4 for IMPUTE, average minor allele frequency of <1% across studies, and SNPs missing from >50% of the cohorts contributing to each outcome.', {'entities': [(6, 12, 'imputation')]}),
 (' SNPs with a median imputation quality <60% and minor allele frequency <5% were excluded before this analysis.', {'entities': [(20, 30, 'imputation')]}),
 (' Imputation was carried out using the IMPUTE program on the basis of the NCBI (build 36) and dbSNP (build 126) databases.', {'entities': [(1, 11, 'imputation'), (38, 44, 'imputation')]}),
 (' The Dutch GWAS cohorts (RCDII, controls, and CeD) were typed with the Illumina Hap550 BeadChip platform imputed with IMPUTE2 [].', {'entities': [(105, 112, 'imputation'), (118, 124, 'imputation')]}),
 (' The HCHS/SOL samples were imputed together with genotyped SNPs passing the quality filter and representing unique genomic positions on the autosomes and non-pseudoautosomal portion of the X chromosome.', {'entities': [(27, 34, 'imputation'), (154, 158, 'negation')]}),
 (' For each SNP, the ratio of the observed versus expected variance of the dosage were served as the measure of imputation quality.', {'entities': [(110, 120, 'imputation')]}),
 (' Since the current study, especially GWAS, had limited\npower to find signals in SNPs with low allele frequency (see ), we filtered SNPs in each data set again after imputation based on allele frequency and used\nSNPs showing r_2 >0.', {'entities': [(165, 175, 'imputation')]}),
 ('86) led to a better imputation quality compared with that using the CHB+JPT panel (error rate 3.', {'entities': [(20, 30, 'imputation')]}),
 (' In summary, 654,966\nhigh-quality variants (auto-somal, non-monomorphic, bi-allelic variants with\nHardy–Weinberg Equilibrium (HWE) P  > 5 ×\n10_−6 , with a call rate of >99% across the INTERVAL\ngenotyping batches in which a variant passed QC, and a global call rate of\n>75% across all INTERVAL genotyping batches) were used for imputation.', {'entities': [(327, 337, 'imputation'), (56, 60, 'negation')]}),
 (' ARIC samples that passed quality review (n=1,132) were imputed separately using the same reference panel.', {'entities': [(56, 63, 'imputation')]}),
 (' Details on genotyping methods and imputation for the 17 participating cohorts are presented in .', {'entities': [(35, 45, 'imputation')]}),
 ('0 BeadChips (Illumina), with whole genome imputation being performed using IMPUTE2 against the 1KG phase I integrated variant set (March 2012).', {'entities': [(42, 52, 'imputation'), (75, 81, 'imputation')]}),
 (' Prior to imputation, SNPs were tested for HWE, and SNPs with HWE P  < 10_−6  were removed.', {'entities': [(10, 20, 'imputation')]}),
 (' (see the  for imputation details).', {'entities': [(15, 25, 'imputation')]}),
 (' Since different genotype platforms were used for the discovery and replication samples, we used imputed markers to maximize the shared SNPs between the 2 datasets, and to fine map the regions of interest.', {'entities': [(97, 104, 'imputation')]}),
 (' Imputations of non-genotyped SNPs in the discovery cohorts were carried out within each study using either MACH_,   or IMPUTE,_,   and HapMap CEU v21a or v22 as reference ().', {'entities': [(1, 12, 'imputation'), (120, 126, 'imputation'), (108, 112, 'imputation'), (16, 20, 'negation')]}),
 (' We carried out TDT tests on imputed variants of high quality (r_2  ≥ 0.', {'entities': [(29, 36, 'imputation')]}),
 ('We imputed all known SNPs across the genome on the basis of the genotyped SNPs in the 1,161 cases and 1,353 controls used in the initial GWAS and haplotype data from HapMap Phase 2 CHB and JPT subjects (release 24) using the IMPUTE program (v2.', {'entities': [(3, 10, 'imputation'), (225, 231, 'imputation')]}),
 (' For individuals who were taking antihypertensive medication, blood pressure was imputed by adding 10 and 5 mmHg for SBP and DBP, respectively.', {'entities': [(81, 88, 'imputation')]}),
 ('Summary statistics, including effect allele and other allele oriented to\nthe + strand, effect allele frequency, chromosome and position (hg19),\nand imputation quality were uploaded to a secure site at the Brigham and\nWomen’s Hospital/Channing Division of Network Medicine.', {'entities': [(148, 158, 'imputation')]}),
 (' This panel was used to impute ~ 2.', {'entities': [(24, 30, 'imputation')]}),
 (' Individuals were genotyped at Illumina on the HCHS/SOL custom 15041502 B3 array, and imputed to 1000 Human Genomes Phase I data.', {'entities': [(86, 93, 'imputation')]}),
 (' All studies imputed variant dosages using reference panels from the 1000 Genomes Project using markov chain haplotyping (MACH) or IMPUTE (,–).', {'entities': [(13, 20, 'imputation'), (131, 137, 'imputation'), (122, 126, 'imputation')]}),
 (' We imputed the classical human leukocyte antigen (HLA) alleles at HLA A, B, C, DPB1, DQA1, DQB1 and DRB1 using the program HiBAG and its corresponding Hispanic reference dataset.', {'entities': [(4, 11, 'imputation')]}),
 (' The remaining 23 variants were imputed using the IMPUTE2 (; ) software package, and haplotypes from all available populations in the 1000 Genomes Project Phase 1 as a reference panel (), obtained with SHAPEIT ().', {'entities': [(32, 39, 'imputation'), (50, 56, 'imputation')]}),
 ('Details of genotyping methods, quality controls and imputation procedures are provided in the .', {'entities': [(52, 62, 'imputation')]}),
 (' The MaCH-Admix() algorithm was used for imputation.', {'entities': [(41, 51, 'imputation'), (5, 9, 'imputation')]}),
 (' Quality control filters for the imputed data set excluded SNPs with Hardy-Weinberg equilibrium p  values <0.', {'entities': [(33, 40, 'imputation')]}),
 (' samples of non-European ancestry), genotyping, quality control and imputation methods for each discovery sample are presented in .', {'entities': [(68, 78, 'imputation'), (12, 16, 'negation')]}),
 (' SNP genotypes were imputed using MACH software (version 1.', {'entities': [(20, 27, 'imputation'), (34, 38, 'imputation')]}),
 ('5 million imputed SNPs using an additive SNP model for each of the two ideal CV health phenotypes.', {'entities': [(10, 17, 'imputation')]}),
 (' Variants with poor imputation quality (IMPUTE or BEAGLE quality score\u2009<\u20090.', {'entities': [(20, 30, 'imputation'), (40, 46, 'imputation'), (50, 56, 'imputation')]}),
 ('html) and IMPUTE2 (https://mathgen.', {'entities': [(10, 16, 'imputation')]}),
 (' These 1000 genome imputations were available in FHS, SHIP and KORA.', {'entities': [(19, 30, 'imputation')]}),
 (' Phenotypes for the association analyses were defined as the sex-specific standardized residuals from linear regression of each outcome variable (BUA, VOS or heel BMD) on age, age-squared, weight, height and machine type (if more than one machine was used).', {'entities': [(208, 212, 'imputation')]}),
 (' Only SNPs common to cases and controls were used for imputation.', {'entities': [(54, 64, 'imputation')]}),
 (' Logistic models were fitted using mach2dat software, which calculates significance levels for estimated parameters using a likelihood-ratio test_, .', {'entities': [(35, 40, 'imputation')]}),
 (' For SNPs that were only genotyped in Set 1 subjects and were imputed in Set 2 subjects, association tests were calculated for each set separately and the results were combined by meta-analysis using PLINK (,).', {'entities': [(62, 69, 'imputation')]}),
 (' Haplotypes of bi-allelic variants, including SNPs and bi-allelic insertions/deletions (indels), were extracted to form reference panels for imputation.', {'entities': [(141, 151, 'imputation')]}),
 ('To increase genomic coverage, we used Shapeit2 (), Minimac3 (see Web Resources), and the 1000 Genomes Project (1KGP) reference panels to perform genotype imputation to integrate additional SNPs that were not directly genotyped.', {'entities': [(154, 164, 'imputation'), (204, 207, 'negation')]}),
 ('org/announcements/june-2011-data-release-2011-06-23) and the IMPUTE2 (http://mathgen.', {'entities': [(61, 67, 'imputation')]}),
 (' SNPs with an IMPUTE2 Info score less than 0.', {'entities': [(14, 20, 'imputation')]}),
 (' Each study was imputed up to the phase 1 integrated (March 2012 release) multi-ethnic reference panel from the 1000 Genomes Project.', {'entities': [(16, 23, 'imputation')]}),
 (' We accounted for within-family correlations for members of COPD pedigrees in Costa Rica using a kinship coefficient matrix, and generalized estimation equation (GEE) models were used for the analysis of COPD (a binary outcome) using the imputed genotype probabilities (dosage) generated by MaCH-Admix.', {'entities': [(238, 245, 'imputation'), (291, 295, 'imputation')]}),
 (' To demonstrate the imputation quality of our GWAS SNPs, we correlated the variant calls from deep sequencing with a set of imputed SNPs from the GWAS signal.', {'entities': [(20, 30, 'imputation')]}),
 (' The 962 subjects of the replication cohorts () were genotyped for 96 followed-up SNPs by Illumina GoldenGate genotyping with VeraCode technology (Illumina), as well as our French primary cohort for 33 out of the 96 SNPs that were initially imputed in this cohort.', {'entities': [(241, 248, 'imputation')]}),
 (' Directly genotyped SNPs are denoted in blue; those imputed are shown in green.', {'entities': [(52, 59, 'imputation')]}),
 (' In addition, rs75932628 could not be successfully imputed on the basis of the GenADA data (information content associated with the additive test, <0.', {'entities': [(51, 58, 'imputation'), (31, 34, 'negation')]}),
 (' Application of the same quality control filters described above to the 46,180,700 imputed SNPs, with the addition of excluding SNPs with Hardy-Weinberg equilibrium P  values < 0.', {'entities': [(83, 90, 'imputation')]}),
 (' All studies used imputed genotypes based on at least the 1000G phase 1 multiancestral reference panel and conducted logistic regression analyses (or Cox regression for longitudinal population-based cohort studies) for five stroke traits (AS, AIS, LAS, CES, and SVS) with all measured and imputed genetic variants in dosage format by using appropriate software under an additive genetic model with a minimum of sex and age as covariates.', {'entities': [(18, 25, 'imputation')]}),
 (' Both the directly genotyped and imputed SNPs were aligned to the HapMap reference strand.', {'entities': [(33, 40, 'imputation')]}),
 (' We imputed the un-genotyped SNPs using Minimac software () based on linkage disequilibrium (LD) information from the 1000 Genomes database with Han Chinese in Beijing (CHB) and Japanese in Tokyo (JPT) as the reference set (released June 2010).', {'entities': [(4, 11, 'imputation'), (16, 19, 'negation')]}),
 ('The genotyped and imputed SNP were used to test for association with IA susceptibility using a logistic regression model.', {'entities': [(18, 25, 'imputation')]}),
 (' The imputation and phasing of genotypes were carried out using IMPUTE2 (see URLs) with cosmopolitan population haplotypes based on data from 2535 individuals from 26 distinct populations around the world obtained from the 1000 Genomes project Phase 3 (Jun 2014) release for reference panel construction.', {'entities': [(5, 15, 'imputation'), (64, 70, 'imputation')]}),
 ('01) or poor imputation quality (estimated R _2  of <0.', {'entities': [(12, 22, 'imputation')]}),
 ('hat (MACH), .', {'entities': [(5, 9, 'imputation')]}),
 (' Genotype imputation was performed using the pre-phasing/imputation stepwise approach implemented in IMPUTE2 / SHAPEIT (chunk size of 3 Mb and default parameters _,  .', {'entities': [(10, 20, 'imputation'), (101, 107, 'imputation')]}),
 (' Imputed genotypes were encoded in the logistic model as the expected allele count.', {'entities': [(1, 8, 'imputation')]}),
 (' Imputation was calculated with reference to HapMap release 22 CEU population data using IMPUTE (see URLs) version 2 for the UK Twin Cohort and the 1958 Birth Cohort.', {'entities': [(1, 11, 'imputation'), (89, 95, 'imputation')]}),
 (' Genotypes were imputed to 1000 Genomes Phase 1 version 3 (April 19, 2012) using IMPUTE2 software and reference panels from all 1000 Genomes populations, and alleles with confidence >0.', {'entities': [(16, 23, 'imputation'), (81, 87, 'imputation')]}),
 (' Prior to imputation, we excluded individuals with incorrect gender assignments or whose gender could not be determined by genotype, and individuals with missing rate per person >5%.', {'entities': [(10, 20, 'imputation'), (102, 105, 'negation')]}),
 ('_*  To standardize genotyping across cohorts and allow for meta-analysis, participant-level genotype data were imputed to more than 2.', {'entities': [(111, 118, 'imputation')]}),
 (' Imputed SNPs were restricted based on MAF >1% and overall IMPUTE2 INFO scores >0.', {'entities': [(1, 8, 'imputation'), (59, 65, 'imputation')]}),
 (' The first 10 principal components and sex were included as covariates in the analysis of the pediatric and the adult cohort and because the imputation at the eMERGE Coordinating Center was conducted for each genotyping platform and site separately, chip type and site were also used as covariates in the adults.', {'entities': [(141, 151, 'imputation')]}),
 (' Genetics protocols were developed to standardize the filtering, imputation and association of genome-wide genotype data (see ENIGMA protocols in URLs).', {'entities': [(65, 75, 'imputation')]}),
 ('uk/impute/data_download_1000G_phase1_integrated.', {'entities': [(3, 9, 'imputation')]}),
 ('edu/csg/abecasis/MACH/download/) with a total of 1092 individuals (AFR 246, AMR 181, ASN 286, and EUR 379)().', {'entities': [(17, 21, 'imputation')]}),
 (' Minor and major alleles, MAF and the corresponding LD were computed using the haplotype data downloaded from MACH.', {'entities': [(110, 114, 'imputation')]}),
 (' We performed VanderWaerden rank transformations of the beta values to account for skewed distributions in the beta-values, and conducted linear regression of the SNP genotypes on the transformed beta values, adjusted for age and CNV overlapping the CpG probe; missing CNV values were imputed using the median for the non-missing samples within each region.', {'entities': [(285, 292, 'imputation'), (318, 322, 'negation')]}),
 ('07 or MACH2QTL v1.', {'entities': [(6, 11, 'imputation')]}),
 ('8, missing data rate >10% after imputation, and MAF <5%.', {'entities': [(32, 42, 'imputation')]}),
 (' Further details about ancestry determinations and imputation are given in Supplementary Material, Section 1.', {'entities': [(51, 61, 'imputation')]}),
 ('QC procedures for sample and variant were carried out, and genotypes were imputed, prior to analysis as outlined in  and .', {'entities': [(74, 81, 'imputation')]}),
 (' After imputation, the variants were considered for further analysis if they were not monomorphic, had an IMPUTE info score greater than 0.', {'entities': [(7, 17, 'imputation'), (106, 112, 'imputation'), (82, 85, 'negation')]}),
 ('  Imputed genotype data was analyzed using an additive genetic model.', {'entities': [(2, 9, 'imputation')]}),
 (' Each GWAS sample was imputed by the respective reference panel with the closest ancestry.', {'entities': [(22, 29, 'imputation')]}),
 (' Steve Rich from T1DGC in 2012, were used as the reference panel for the imputation of complete or additional HLA alleles and SNPs in the MHC region.', {'entities': [(73, 83, 'imputation')]}),
 (' 6: 29–34 Mb) to impute 92 two-digit classical alleles, 152 four-digit classical alleles and 763 amino acid polymorphisms of the 8 class I and class II HLA genes (HLA-A , HLA-B , HLA-C , HLA-DRB1 , HLA-DQA1 , HLA-DQB1 , HLA-DPA1  and HLA-DPB1 ).', {'entities': [(17, 23, 'imputation')]}),
 ('We performed imputation of subject genotypes separately by array.', {'entities': [(13, 23, 'imputation')]}),
 (' SNPs selected from imputation by EZimputer () had a dosage r squared >0.', {'entities': [(20, 30, 'imputation')]}),
 (' Imputed genotypes were coded as the estimated number of copies of a specified allele (dosage).', {'entities': [(1, 8, 'imputation')]}),
 ('  After imputation, SNPs with r_2 <0.', {'entities': [(8, 18, 'imputation')]}),
 (' Genotype data were imputed with reference to HapMap 2 East Asian populations.', {'entities': [(20, 27, 'imputation')]}),
 (' Alleles imputed with confidence > 80% were retained for association testing.', {'entities': [(9, 16, 'imputation')]}),
 (' All of the genotype data have been imputed to the 1000G and passed the QC steps as described above.', {'entities': [(36, 43, 'imputation')]}),
 (' We excluded data for all monomorphic SNPs and those with an imputation r _2  <0.', {'entities': [(61, 71, 'imputation')]}),
 (' Phased genotype data were also downloaded for the 85 CEU and 88 YRI sequenced in the 1000 Genomes Project and used to impute the additional 93 CEU and 90 YRI samples genotyped in HapMap r28 with BEAGLE, which considers the relatedness of the trios in the imputation.', {'entities': [(119, 125, 'imputation'), (196, 202, 'imputation')]}),
 (' After imputing each array separately, we aggregated the data across windows and runs, including only sites that were imputed with an Impute2 info metric ≥ 0.', {'entities': [(7, 15, 'imputation'), (134, 141, 'imputation')]}),
 (' To estimate IBD, we phased intersected genotypes for the ‡Khomani and Nama populations both separately (number of SNPs = 300,370 in ‡Khomani, 525,934 in Nama) and jointly (number of SNPs = 241,929) using Beagle (v4.', {'entities': [(205, 211, 'imputation')]}),
 ('02), after\nimputing all three studies to the 1KG data density, and conducted a\nmeta-analysis.', {'entities': [(11, 19, 'imputation')]}),
 ('644) and imputed with IMPUTE2 (v.', {'entities': [(9, 16, 'imputation'), (22, 28, 'imputation')]}),
 ('0 were genotyped on the Human Core Exome microarray, which contains both exome-focused SNP content and tagging SNPs for genome-wide imputation.', {'entities': [(132, 142, 'imputation')]}),
 (' Imputation used the IMPUTE2 software (; ) and estimated haplotypes using a reference panel of 1092 samples from International HapMap Consortium Phases 2 and 3 haplotypes.', {'entities': [(1, 11, 'imputation'), (21, 27, 'imputation')]}),
 (' In the Irish AD collection (Table S1), case and control subjects were genotyped on different platforms, and therefore only the 131,692 SNVs in common between the platforms were used to inform imputation.', {'entities': [(193, 203, 'imputation')]}),
 (' ethods For both LS and non-LS, logistic regression analysis of genotyped and imputed single-nucleotide polymorphisms (SNPs) was performed with expected genotype count using the posterior probabilities.', {'entities': [(78, 85, 'imputation'), (24, 28, 'negation')]}),
 (' An additional 15 ASN samples genotyped in HapMap r28 were imputed to 1000 Genomes using BEAGLE version 3.', {'entities': [(59, 66, 'imputation'), (89, 95, 'imputation')]}),
 (' Detailed information about HLA imputations are described in the supplemental methods section.', {'entities': [(32, 43, 'imputation')]}),
 ('The 5,955 SNPs obtained in the MHC after all QCs were used for the imputation process.', {'entities': [(67, 77, 'imputation')]}),
 (' For both the case-control and trio studies, logistic regression was used to test for association between imputed allelic dosages and the sex-specific asthma status (e.', {'entities': [(106, 113, 'imputation')]}),
 (' We did genome-wide dataset analyses at every site with MACH2DAT.', {'entities': [(56, 61, 'imputation')]}),
 (' _, We performed imputation separately for each genotyping project data set.', {'entities': [(17, 27, 'imputation')]}),
 ('edu/chaolong/LASER/ Mach2dat: https://genome.', {'entities': [(20, 25, 'imputation')]}),
 ('[] Imputation results were filtered using a minimum imputation quality score, indicated by an RSQ_HAT estimate of > 0.', {'entities': [(52, 62, 'imputation'), (3, 13, 'imputation')]}),
 (' All SNPs with acceptable imputation quality (r_2  > 0.', {'entities': [(26, 36, 'imputation')]}),
 ('5 million imputed genotypes were generated.', {'entities': [(10, 17, 'imputation')]}),
 (' The imputed genotypes were coded by the allele dosage for each SNP in the analysis.', {'entities': [(5, 12, 'imputation')]}),
 (' We performed inverse variance weighted meta-analysis of summary statistics of the phase 1 and phase 2 summary statistics from imputed data using METAL ().', {'entities': [(127, 134, 'imputation')]}),
 (' Individual genotypes from admixed and continental reference samples were phased using BEAGLE 3.', {'entities': [(87, 93, 'imputation')]}),
 (' Subjects were systematically genotyped, QCd, and imputed using the 1000 Genomes Project [] Phase I reference panel.', {'entities': [(50, 57, 'imputation')]}),
 (' Each GWAS sample was tested for association between normalized phenotype residuals and genotyped and imputed genotypes under an additive mode of inheritance.', {'entities': [(102, 109, 'imputation')]}),
 (" Subjects' genotypes for untyped SNPS were imputed to the 1000 Genomes Project.", {'entities': [(43, 50, 'imputation')]}),
 (' We imputed the OncoArray and GWAS datasets through a two-stage imputation approach, using SHAPEIT for phasing and IMPUTEv2 (ref.', {'entities': [(4, 11, 'imputation'), (115, 121, 'imputation')]}),
 (' To improve coverage, we augmented the set of SNPs tested for association through imputation using MACH ().', {'entities': [(82, 92, 'imputation'), (99, 103, 'imputation')]}),
 (' Next, the RS-I and RS-II cohorts were imputed separately using the HapMap Phase II CEU reference panel (Build 36) as the reference panel and using a two-step procedure imputation algorithm implemented in the program MACH.', {'entities': [(39, 46, 'imputation'), (217, 221, 'imputation')]}),
 ('5 million SNPs using the program MACH ().', {'entities': [(33, 37, 'imputation')]}),
 (' Samples from the six GWASs were imputed separately.', {'entities': [(33, 40, 'imputation')]}),
 (' Manhattan plot of primary RTL GWAS analysis of the Sikh discovery cohort using directly genotyped and imputed SNPs on X axis and −log10 p-value on Y axis.', {'entities': [(103, 110, 'imputation')]}),
 (' HapMap release 22 CEU (HapMap sample comprised of Utah residents with Northern and Western European ancestry) build 36 was generally used as reference for imputation (two studies used build 35).', {'entities': [(156, 166, 'imputation')]}),
 (' To ensure the accuracy of results, imputed data were only included if the quality of imputation was high, defined as a ratio of observed to expected binomial dosage variance (r _2 ) of >0.', {'entities': [(36, 43, 'imputation')]}),
 ('5%, or imputation quality scores < 0.', {'entities': [(7, 17, 'imputation')]}),
 (' The imputation and all subsequent analyses were restricted to autosomal variants.', {'entities': [(5, 15, 'imputation')]}),
 ('  Genotype quality control prior to imputation was conducted separately for four strata: subjects in the San Diego cohort with the Illumina 550 array genotyping data; subjects in the San Diego cohort with the Illumina 650 array genotyping data; subjects in the US cohort with the Omni 2.', {'entities': [(36, 46, 'imputation')]}),
 (' Genotype imputation was performed using IMPUTE2 and the phase I integrated variant set release (v3) (,) and the 1,000 Genomes cosmopolitan reference haplotypes ().', {'entities': [(10, 20, 'imputation'), (41, 47, 'imputation')]}),
 ('\nImputation using HapMap3 reference genotypes (as in the primary analysis) was\nnot possible due to persisting difficulties with the phased chromosome X data,\nbut we were able to impute using 1000 Genomes Project data.', {'entities': [(178, 184, 'imputation'), (1, 11, 'imputation'), (79, 82, 'negation')]}),
 (' We removed the imputed SNPs with <0.', {'entities': [(16, 23, 'imputation')]}),
 (' We then discarded all SNPs with imputation r _2  < 0.', {'entities': [(33, 43, 'imputation')]}),
 (' Before imputation, studies applied study-specific quality filters on samples and SNP call rate, minor allele frequency and Hardy–Weinberg disequilibrium (see Supplementary Material, Table S1 for details).', {'entities': [(8, 18, 'imputation')]}),
 ('  Imputation analyses of untyped SNPs were performed using BEAGLE version 3.', {'entities': [(2, 12, 'imputation'), (59, 65, 'imputation')]}),
 (' Quality control filters for samples and SNPs were applied within each study prior to imputation ().', {'entities': [(86, 96, 'imputation')]}),
 ('5 million imputed and genotyped autosomal SNPs using additive model fixed-effects meta-analysis as implemented in METAL (version 2010-08-01).', {'entities': [(10, 17, 'imputation')]}),
 (' The regression model in this case included imputed allele dosages of the most significantly associated variant as an additional covariate.', {'entities': [(44, 51, 'imputation')]}),
 (' A total of 1006 children were included for smooth surface analysis (among them, 919 also having imputed data), and 979 children were included for pit-and-fissure surface analysis (among them, 895 also having imputed data).', {'entities': [(97, 104, 'imputation')]}),
 ('Cohort-specific genome-wide association analyses were first run in the discovery cohorts, using high-density Illumina or Affymetrix SNP arrays, followed by imputation to the HapMap CEU release 22 imputation panel.', {'entities': [(156, 166, 'imputation')]}),
 ('9, imputation quality <0.', {'entities': [(3, 13, 'imputation')]}),
 (' Over 38 million SNPs were imputed based on 1000 Genomes Phase I Intergrated Release Version 3 reference panels.', {'entities': [(27, 34, 'imputation')]}),
 (' To assess the accuracy of imputation for this low-frequent variant, we genotyped rs138715366 in the Northern Finland Birth Cohort (NFBC) 1966 ().', {'entities': [(27, 37, 'imputation')]}),
 (' Details about HapMap2 imputation in each cohort are found in .', {'entities': [(23, 33, 'imputation')]}),
 (' We used best-guess imputation for variants with imputation quality >0.', {'entities': [(20, 30, 'imputation')]}),
 (' Each cohort applied standard quality control filtering before genetic\nimputations.', {'entities': [(71, 82, 'imputation')]}),
 (' Prior to imputation, a consistency test of allele frequency between the GWAS and reference samples was examined with the chi-square test.', {'entities': [(10, 20, 'imputation')]}),
 (' Imputation was performed for individual batches based on\nethnicity using the 1000 Genomes Project dataset (phase 3, version 5a,\nrelease 2013-05-02, 1000genomes.', {'entities': [(1, 11, 'imputation')]}),
 (' A two-step imputation approach was used: step 1 estimated per SNP error and per interval crossover rates at 50 iterations from a random sample of 200 genotyped individuals, while step 2 used these model parameters to assign allele dosages and genotypes based on a maximum likelihood approach.', {'entities': [(12, 22, 'imputation')]}),
 ('Only SNPs with imputation quality R \n_2  > 0.', {'entities': [(15, 25, 'imputation')]}),
 (' We first pre-phased the trio GWAS data and then imputed SNPs using a phased reference panel.', {'entities': [(49, 56, 'imputation')]}),
 (' Following imputation_, , SNPs were quality filtered (MAF ≥ 1% and info score ≥ .', {'entities': [(11, 21, 'imputation')]}),
 (' EA and AA samples were imputed separately.', {'entities': [(24, 31, 'imputation')]}),
 ('9 between directly measured and imputed genotypes after masking input genotypes (for genotyped markers only).', {'entities': [(32, 39, 'imputation')]}),
 ('\nVariants were phased using SHAPEIT3 and imputed using a combined 1000 Genomes\nPhase 3-UK10K reference panel.', {'entities': [(41, 48, 'imputation')]}),
 ("54 million HapMap SNPs (release 22, build 36, CEU population) were imputed using the HERITAGE QC'ed genotyped GWAS data and MACH software, as previously described.", {'entities': [(67, 74, 'imputation'), (124, 128, 'imputation')]}),
 (' Imputation results were filtered at an r _2  threshold of 0.', {'entities': [(1, 11, 'imputation')]}),
 ('Genotyping, quality control, data cleaning and imputation were performed independently in each study using different genetic platforms and software as outlined in .', {'entities': [(47, 57, 'imputation')]}),
 (' Prior to exploratory factor analysis, missing data points were imputed using the Proc MI statistical procedure in SAS (SAS Institute, Cary, N.', {'entities': [(64, 71, 'imputation')]}),
 ('To estimate the association between each SNP and risk of lung cancer, genotyped or imputed allele dosage for each SNP was tested for association in unconditional logistic regressions assuming an additive genetic model for the effect of risk allele.', {'entities': [(83, 90, 'imputation')]}),
 ('In the screening phase HLA-A, -B, -C, -DRB1, -DQA1 and -DQB1 genotypes were imputed from SNP data as described previously (; ).', {'entities': [(76, 83, 'imputation')]}),
 (' Imputation and imputation QC were independently performed within the APDGC samples and within each of the 9 ADGC control cohorts.', {'entities': [(16, 26, 'imputation'), (1, 11, 'imputation')]}),
 (' Studies without available HRC imputation were included based on imputation to the 1000 Genomes Phase 1 integrated v3 panel (March 2012).', {'entities': [(31, 41, 'imputation')]}),
 (' Imputation was performed with BEAGLE (http://faculty.', {'entities': [(1, 11, 'imputation'), (31, 37, 'imputation')]}),
 (' We have shown this approach eliminates this potential bias and retains high imputation quality.', {'entities': [(77, 87, 'imputation')]}),
 (' Prephasing and imputation methods for each study are described in .', {'entities': [(16, 26, 'imputation')]}),
 (' Imputation was done with IMPUTE or the Markov\nChain–based haplotyper (MaCH).', {'entities': [(1, 11, 'imputation'), (26, 32, 'imputation'), (71, 75, 'imputation')]}),
 (' Stringent imputation quality and accuracy filters were applied to genotypes resulting from the imputation (info ≥ 0.', {'entities': [(11, 21, 'imputation')]}),
 (' All imputed SNPs with imputation quality r_2  >0.', {'entities': [(5, 12, 'imputation')]}),
 (' Details of the genotyping platforms and imputation methods for the GWAS are provided in Table\xa0 and Supplementary Material, Table S1.', {'entities': [(41, 51, 'imputation')]}),
 ('9 using the Beagle genetic analysis software package [15] for the PGC samples), 110,942 autosomal SNPs were selected, with a linkage disequilibrium (r_2 ) <0.', {'entities': [(12, 18, 'imputation')]}),
 (' In regions showing suggestive evidence (at least one SNP with p < 10_−6 ), imputed genotypes were tested.', {'entities': [(76, 83, 'imputation')]}),
 (' The imputed dosage data were used for the analysis.', {'entities': [(5, 12, 'imputation')]}),
 (' To pool the genotypes, we used the genotypes that were imputed separately within each platform.', {'entities': [(56, 63, 'imputation')]}),
 (' Genomic coverage in each study was then expanded by imputing unmeasured variants against the HapMap and/or 1000 Genomes reference haplotypes, including the X chromosome.', {'entities': [(53, 61, 'imputation')]}),
 ('A detailed description for genotyping, quality assurance/quality control, and imputation is provided in .', {'entities': [(78, 88, 'imputation')]}),
 (' Release 2012-05-29 of minimac was used to impute SNP and indel genotypes based on phased chromosomal haplotypes from the 379 individuals in the EUR subpopulation of release 3, phase 1 of the 1000 Genomes Project.', {'entities': [(43, 49, 'imputation')]}),
 (' After data cleaning and quality control, 5697 individuals and 889 659 SNPs remained for imputation.', {'entities': [(89, 99, 'imputation')]}),
 (' SNPs with\nimputation INFO scores of <0.', {'entities': [(11, 21, 'imputation')]}),
 (' Imputation produces an allele dosage for each SNP, which is a weighted sum of the minor allele frequency (0, 1, or 2) and the posterior probability that the imputed SNP belongs to each of these frequency categories.', {'entities': [(158, 165, 'imputation'), (1, 11, 'imputation')]}),
 (' After imputation, ∼10.', {'entities': [(7, 17, 'imputation')]}),
 (' Imputation of 2,416,663 SNPs from the HapMap release 22 build 36 CHB+JPT samples was conducted using MACH software.', {'entities': [(1, 11, 'imputation'), (102, 106, 'imputation')]}),
 ('40 with IMPUTE2 were excluded from the analyses.', {'entities': [(8, 14, 'imputation')]}),
 ('For Japanese CD patients, genomic DNA was obtained from peripheral blood leukocytes by standard phenol–chloroform extraction and precipitation or by utilizing an NA1000 Automated Nucleic Acid Extraction Machine (Kurabo) or PAXgene DNA Kit (BD).', {'entities': [(203, 207, 'imputation')]}),
 (' Poorly imputed SNPs, defined by an information measure <0.', {'entities': [(8, 15, 'imputation')]}),
 (', including subtle population stratification effects, that is, the first four multi-dimensional scaling or PC (principal component) scores for each individual from a stratification analysis) on both genotyped and imputed SNPs.', {'entities': [(213, 220, 'imputation')]}),
 (' We could impute these two SNPs with a high accuracy of 0.', {'entities': [(10, 16, 'imputation')]}),
 (' 728,129 SNPs remained for\nimputation.', {'entities': [(27, 37, 'imputation')]}),
 (' For the X chromosome, only genotyped SNPs were analyzed due to the technical limitations of imputing X-linked SNPs.', {'entities': [(93, 101, 'imputation')]}),
 (' Imputation was carried out using haplotypes from HapMap Phase 2.', {'entities': [(1, 11, 'imputation')]}),
 ('  We determined all the most significantly associated SNPs (or an appropriate surrogate) in the GWAS results from METASTROKE, a study of 12,389 individuals with ischemic stroke and 62,004 controls with imputation to the Hapmap2 reference panel.', {'entities': [(202, 212, 'imputation')]}),
 (' The following tools were used for primary GWAS: ProbABEL, SNPTEST, FAST, mach2dat (http://www.', {'entities': [(74, 79, 'imputation')]}),
 (' Accuracy of imputation was assessed using sequence data of 200 CRC cases.', {'entities': [(13, 23, 'imputation')]}),
 (' For individual-level genotype data, we retained genotypes having a probability ≥80% (from the gprob metric in Beagle); otherwise that genotype was set to missing.', {'entities': [(111, 117, 'imputation')]}),
 (' All SNPs with imputation genotyping rate < 98% and MAF < 0.', {'entities': [(15, 25, 'imputation')]}),
 (' Genotype and imputation quality control were performed in each study separately.', {'entities': [(14, 24, 'imputation')]}),
 (' Following quality control, the data were imputed using the subset of ∼281,000 markers which were available across all chips.', {'entities': [(42, 49, 'imputation')]}),
 ('05, in Hardy-Weinberg equilibrium (P > 1×10_−6 ), imputation R_2  > 0.', {'entities': [(50, 60, 'imputation')]}),
 (' The Markov Chain Haplotyping software, IMPUTE or MACH, were adopted for imputation.', {'entities': [(73, 83, 'imputation'), (40, 46, 'imputation'), (50, 54, 'imputation')]}),
 (' Imputation quality scores, defined as the average posterior probability of the most likely genotype across all samples, were high.', {'entities': [(1, 11, 'imputation')]}),
 (' Before quality control (QC), we imputed 56,389 SNPs with the help of IMPUTE2 ().', {'entities': [(33, 40, 'imputation'), (70, 76, 'imputation')]}),
 (' Of the 38 loci, 18 had at least one polymorphic OMIM SNP in the imputed Finnish test set of seven cohorts (Corogene controls, FTC, GenMets, HBCS, NFBC1966, YFS and PredictCVD, combined N  = 12,834).', {'entities': [(65, 72, 'imputation')]}),
 (' Abbreviations: β,  effect of the genetic variant; SE, standard error of the effect estimate; P _HET , P-value  for heterogeneity; Rsq, imputation quality.', {'entities': [(136, 146, 'imputation')]}),
 ('r778) [, ] and imputed using IMPUTE2 [] to the same 1000G reference panel as described for GOLDN for a total of 26,862,499 imputed variants (of which 1,335,851 were indels).', {'entities': [(15, 22, 'imputation'), (29, 35, 'imputation')]}),
 ('uk/impute/impute.', {'entities': [(3, 9, 'imputation')]}),
 ('html) to impute missing genotypes, with HapMap2 (Centre d’Etude du Polymorphisme Humain from Utah population, release 23, forward strand) as the reference panel (hg18).', {'entities': [(9, 15, 'imputation')]}),
 (' We included imputed data from a SNP in the combined analysis if the estimated correlation between the genotype scores and the true genotypes (r 2) was >0.', {'entities': [(13, 20, 'imputation')]}),
 (' Studies performed genomic imputation using 1000 Genomes phase 1 reference samples.', {'entities': [(27, 37, 'imputation')]}),
 (' Haplotype analyses were performed on best-guessed genotypes from imputed SNPs with imputation quality score greater than 0.', {'entities': [(66, 73, 'imputation')]}),
 (' Imputation used all population subsets from 1000G Phase 3 v5 as reference panel; haplotype phasing was performed using SHAPEIT ().', {'entities': [(1, 11, 'imputation')]}),
 (' To account for different marker sets and identifiers between the two imputed datasets, the final analysis included only those overlapping SNPs that were matched on chromosome, nucleotide position, and alleles.', {'entities': [(70, 77, 'imputation')]}),
 (' To allow imputation with MACH for the haploid non-PAR regions of the male X chromosome, the phased haplotypes were duplicated.', {'entities': [(10, 20, 'imputation'), (26, 30, 'imputation'), (47, 51, 'negation')]}),
 ('3, IMPUTE proper_info ≤0.', {'entities': [(3, 9, 'imputation')]}),
 (' After quality control, high-quality genotypes for 586,178 SNPs were available for GW imputation using all populations of release 1 of phase 3 of the 1000 Genomes Project.', {'entities': [(86, 96, 'imputation')]}),
 ('15 software (Rotterdam, The Netherlands; imputed to plus strand of NCBI build 36, HapMap release #22; see URLs) for the analyses.', {'entities': [(41, 48, 'imputation')]}),
 (' Second, we reran the replication and joint meta-analysis including only those cohorts that imputed to 1000G.', {'entities': [(92, 99, 'imputation')]}),
 (' GSA and MEGA samples were imputed separately.', {'entities': [(27, 34, 'imputation')]}),
 (' To allow for combination of the data derived from different genotyping platforms and to improve coverage of the genome, genotype imputation was performed by each participating study using either MACH or IMPUTE with HapMap CHD + JPT data (release #22, build 36) as the imputation reference panel (Supplementary Material, Table S2).', {'entities': [(130, 140, 'imputation'), (204, 210, 'imputation'), (196, 200, 'imputation')]}),
 (' Finally, after excluding markers with MAF less than 1%, Hardy–Weinberg equilibrium (P <10_−6 ), missing strand information, or discrepancies with the mlinfo  file, we used the MACH software (version 1.', {'entities': [(177, 181, 'imputation')]}),
 (' We also used imputation reference panels to impute variants that were missing, or poorly captured, from previous GWASs of 39,655 subjects ( and ).', {'entities': [(14, 24, 'imputation')]}),
 (' Imputed SNP markers with imputation quality scores r_2 <0.', {'entities': [(26, 36, 'imputation'), (1, 8, 'imputation')]}),
 (' These data were imputed using multiple imputation implemented in SPSS statistical software version 20 (IBM Corp.', {'entities': [(17, 24, 'imputation')]}),
 (' For participants taking anti-hypertensive medications, BP was imputed by adding 10 mm Hg to systolic BP (SBP) and 5 mm Hg to diastolic BP (DBP).', {'entities': [(63, 70, 'imputation')]}),
 ('2 () was used to impute 2-Mb intervals of Chr3: 168492101–170492101; Chr11: 874072–2874072; Chr20: 9988099–11988099 and Chr6: 19766697–21766697 (GRCh37/hg19) using a 1000 Genomes Phase 1 integrated variant set (release v3) updated on August 26, 2012.', {'entities': [(17, 23, 'imputation')]}),
 (' Genotyped SNPs passing quality control metrics described\nabove and reference haplotypes from HapMap Phase 2 (release 22 on NCBI build 36)\nwere used to impute approximately 2.', {'entities': [(152, 158, 'imputation')]}),
 (' As previously described (), we imputed classical alleles and amino acid polymorphisms in HLA-A , HLA-B , HLA-C , HLA-DPA1 , HLA-DPB1 , HLA-DQA1 , HLA-DQB1  and HLA-DRB1  at a four-digit resolution, as well as an additional 3,117 SNPs across the MHC, using a large reference panel of 2,767 individuals of European descent.', {'entities': [(32, 39, 'imputation')]}),
 (' For age bins containing more than 250 individuals, a genome-wide association analysis (GWAS) of SNP main effects was conducted by regressing each BP trait (SBP, DBP, MAP, and PP) onto the allele dosage (the observed [genotyped data] or estimated [imputed data] number of copies of the coded allele in an individual) while adjusting for age, age-squared, body-mass-index, gender, and field center (if a multicenter study).', {'entities': [(248, 255, 'imputation')]}),
 ('05, Hardy-Weinberg P value < 1×10_−6 , call rate<95%, or imputation quality score r_2 <0.', {'entities': [(57, 67, 'imputation')]}),
 (' Prior to imputation, additional data cleaning was performed using PLINK v1.', {'entities': [(10, 20, 'imputation')]}),
 (' For each SNP, the imputation software estimates its overall imputation quality score.', {'entities': [(19, 29, 'imputation')]}),
 (' For the top candidate gene(s) or region(s), we increased marker density by using all imputed markers within the gene or region in the discovery dataset to examine the association pattern within the region.', {'entities': [(86, 93, 'imputation')]}),
 (' Pre-imputation quality control filters were applied at the sample level (exclusion criteria: call rate <98%, sex discrepancy, relatedness, duplicate discordance, and HapMap discordance) and single nucleotide polymorphism (SNP) level (exclusion criteria: call rate <98%, replicate discordance, and Mendelian errors).', {'entities': [(5, 15, 'imputation')]}),
 (' Variants with an\nimputation quality metric of < 0.', {'entities': [(18, 28, 'imputation')]}),
 ('Imputation to the HapMap CEU panel was conducted using either MACH , IMPUTE , Beagle _,  or BIMBAM  with filters and quality control parameters as shown in .', {'entities': [(0, 10, 'imputation'), (69, 75, 'imputation'), (78, 84, 'imputation'), (62, 66, 'imputation')]}),
 ('  For the discovery analysis, the ARIC, GHS1 and 2, GAIT2, Martha and PROCARDIS studies performed linear regression analyses using an additive model of inheritance between 1000 Genome-imputed SNPs and natural-logarithm-transformed FXI levels, with adjustments for age, sex, and accounting for population stratification and cryptic relatedness (adjustment for MDS or PCA components).', {'entities': [(184, 191, 'imputation')]}),
 (' Imputed SNPs were excluded if\nimputation quality was below 0.', {'entities': [(31, 41, 'imputation'), (1, 8, 'imputation')]}),
 (' Imputation was performed using IMPUTE2 (https://mathgen.', {'entities': [(1, 11, 'imputation'), (32, 38, 'imputation')]}),
 (' Variants passing genotyping or imputation quality control in all cohorts were included for analysis.', {'entities': [(32, 42, 'imputation')]}),
 ('To account for the population structure in the admixed SAC in imputing the untyped genotypes, we considered the imputation model based on population genetic parameters in the coalescent framework implemented in IMPUTE2 ().', {'entities': [(62, 70, 'imputation'), (211, 217, 'imputation')]}),
 ('The GEFOS-seq consortium recently conducted a sequencing- and imputation-based GWAS meta-analysis of FNK- and SPN-BMDs in over 50,000 (discovery + replication) subjects of European ancestry.', {'entities': [(62, 72, 'imputation')]}),
 ('edu/myers/; IMPUTE, http://mathgen.', {'entities': [(12, 18, 'imputation')]}),
 (' In\nMARTHA and EOVT, logistic regression was conducted and adjusted for the\nfirst four principal components of ancestry, with PLINK [] being used for\ngenotyped SNPs and Mach2dat [; ]\nfor imputed ones.', {'entities': [(187, 194, 'imputation'), (169, 174, 'imputation')]}),
 (' Imputed variants were retained for downstream association analyses if they attained\xa0established GWAS quality control thresholds: IMPUTE2 info ≥ 0.', {'entities': [(1, 8, 'imputation'), (130, 136, 'imputation')]}),
 (' Imputed genotype dosages were compared between cases and controls, adjusting for the first 3 principal components of the genomic kinship matrix.', {'entities': [(1, 8, 'imputation')]}),
 (' Imputation was performed via the Sanger\nImputation Server (https://imputation.', {'entities': [(68, 78, 'imputation'), (1, 11, 'imputation')]}),
 (' Imputed allele dosages were modelled with an additive mode of inheritance.', {'entities': [(1, 8, 'imputation')]}),
 (' Following imputation, genotype probabilities ⩾ 0.', {'entities': [(11, 21, 'imputation')]}),
 ('_ and   For all datasets, data were imputed by a two-stage design.', {'entities': [(36, 43, 'imputation')]}),
 (' Imputed SNPs were excluded if they had (i) a call rate of <95%; (ii) a MAF of <0.', {'entities': [(1, 8, 'imputation')]}),
 (' After filtering out SNPs with a call rate <95% (SNP call rate is the percentage of patients who have a confident genotype call for each SNP according to Affymetrix quality control criteria) and minor allele frequency <1%; the remaining SNPs (484,623 typed SNPs and 1,091,393 imputed SNPs) were assessed in a GWAS for their association with vincristine-induced neuropathy, in St.', {'entities': [(276, 283, 'imputation')]}),
 (' In each cohort, imputed genotypes were tested for association with ALS status by logistic regression analysis (SNPTESTv2.', {'entities': [(17, 24, 'imputation')]}),
 (' For familiar samples (FHS and IFS), 200 unrelated founder individuals were randomly selected to estimate model parameters, which were then used to impute all family members.', {'entities': [(148, 154, 'imputation')]}),
 (' Markers were\nincluded for analysis if they passed genotyping or imputation quality control (as\nappropriate) in all genome-wide cohorts.', {'entities': [(65, 75, 'imputation')]}),
 ('To determine whether our signals represent independent effects on growth during puberty from previously reported related phenotypes, we performed linear regression using an additive model on the primary pubertal growth phenotypes, adjusting each of the six markers (imputed genotype dose) for the previously reported marker nearby our signal.', {'entities': [(266, 273, 'imputation')]}),
 (' Serum and urinary metabolite ratios with at least one SNP that passed this filter were then subjected in a second step to the SNPTEST-based GWAS pipeline using imputed genotype data, as for single metabolites and FEs.', {'entities': [(161, 168, 'imputation')]}),
 (' The files downloaded contained the\nconsolidated imputed epigenetic data based on the P  value\nsignals from each of the individual epigenetic marks in each of the cell types\nwithin whole blood.', {'entities': [(49, 56, 'imputation')]}),
 (' After exclusion of SNPs with poor imputation quality (MACH r _2  < 0.', {'entities': [(35, 45, 'imputation'), (55, 59, 'imputation')]}),
 (' To determine whether other independent signals existed in the region in addition to the selected SNPs from stepwise regression, we conducted conditional regression analyses of the entire region controlling for the imputed dosage of the selected SNPs.', {'entities': [(215, 222, 'imputation')]}),
 (' For each imputed SNP, we calculated R _2  for imputation quality (the ratio of observed to expected variance of imputed dosage, also called “oevar”) and excluded SNPs with R _2  < .', {'entities': [(10, 17, 'imputation')]}),
 ('info (IMPUTE) or OEvar (BIMBAM), was < 0.', {'entities': [(6, 12, 'imputation')]}),
 ('html () or BEAGLE ().', {'entities': [(11, 17, 'imputation')]}),
 ('html IMPUTE2: http://mathgen.', {'entities': [(5, 11, 'imputation')]}),
 (' All studies imputed variant dosages using the phase I version 3 or version 2 reference panels from the 1000 Genomes Project using MACH or IMPUTE (see further ) ().', {'entities': [(13, 20, 'imputation'), (139, 145, 'imputation'), (131, 135, 'imputation')]}),
 (' GWAS analyses of imputed SNPs were performed on the standardized residuals using an additive genetic model in PLINK (v.', {'entities': [(18, 25, 'imputation')]}),
 (' The genotyping platforms used and imputation approach was similar to METASTROKE.', {'entities': [(35, 45, 'imputation')]}),
 (' The following exclusion criteria\nwere applied to SNPs in each individual study before meta-analysis: 1) beta\nestimates > 5 or < −5; 2) invalid standard error (NA or\nzero value); 3) imputation quality score (RSQ) ≤ 0.', {'entities': [(182, 192, 'imputation')]}),
 (' Following standard QC procedures, imputation was performed using MACH software (version 1.', {'entities': [(35, 45, 'imputation'), (66, 70, 'imputation')]}),
 (' For the African American data, 10,050,748 markers with imputation accuracy R _2  > 0.', {'entities': [(56, 66, 'imputation')]}),
 ('16, Beagle 3.', {'entities': [(4, 10, 'imputation')]}),
 (' The cleaned genotype data were imputed to 1000 genomes (EUR and AFR, Phase 3, b37, October 2014) with build hg19 using SHAPEIT (https://mathgen.', {'entities': [(32, 39, 'imputation')]}),
 (' After quality control measures, 948 children (523 with asthma) and ~7 million genotyped and imputed SNPs were included in the genome-wide association analysis.', {'entities': [(93, 100, 'imputation')]}),
 ('96 million SNPs genotyped in 90 HapMap CEU individuals (release 23); analyses were performed using two different imputation algorithms: PLINK (http://pngu.', {'entities': [(113, 123, 'imputation')]}),
 ('05), 28 per cent have an imputation r> 0.', {'entities': [(25, 35, 'imputation')]}),
 (' For study collections of Chinese, Malay and Indian descent, a second reference panel consisting of related haplotypes from HapMap 3 release 3 and the Singapore Genome Variation Project (SVGP) were also used for the imputation.', {'entities': [(216, 226, 'imputation')]}),
 (' Samples from the four studies were imputed separately.', {'entities': [(36, 43, 'imputation')]}),
 (' For the initial GWAS and replicate samples, areal BS values of lumbar spine (L1–L4) were measured using dual energy X-ray absorptiometry (DXA) machines (Hologic Inc.', {'entities': [(144, 148, 'imputation')]}),
 (' We imputed cases and controls together.', {'entities': [(4, 11, 'imputation')]}),
 (' In particular, the numbers of SNPs with MACH r _2  > 0.', {'entities': [(41, 45, 'imputation')]}),
 (' A total of 2,239 study participants with complete genotype and phenotype data, and 11,892,802 SNPs/indels (1,131,426 genotyped and 10,761,376 imputed) were included in the GWAS analysis of CYP2A6 activity (ratio of total 3HCOT to COT).', {'entities': [(143, 150, 'imputation')]}),
 ('Imputation of the German and Dutch discovery samples was performed using IMPUTE 2 (v2.', {'entities': [(0, 10, 'imputation'), (73, 79, 'imputation')]}),
 (' SNPs with imputation r_2  > 0.', {'entities': [(11, 21, 'imputation')]}),
 ('An overview of SNP genotyping, quality control (QC), and imputation is given in .', {'entities': [(57, 67, 'imputation')]}),
 (' Finally, to check the consistency of the results, we re-genotyped the Spanish samples for the associated signals using predesigned TaqMan 5′ SNP genotyping assays (assay IDs: C__16222465_10, C__25614474_20, and C___2397211_10) in a 7900HT Fast Real-Time PCR System (Applied Biosystems) and compared the TaqMan types with the corresponding imputed data.', {'entities': [(340, 347, 'imputation')]}),
 ('For every region containing at least one SNP showing evidence for association with FVC (P  < 5 × 10_−7 ), the SNP with the smallest P  value that also had a N effective ≥ 80% (the N effective is the product of sample size and the imputation quality summed across studies) of the total stage 1 sample size was followed up in a second stage using in silico  data from 9 cohorts (, ).', {'entities': [(230, 240, 'imputation')]}),
 (' Overall significance tests for each SNP were performed using a fixed-effects meta-analysis; data were only included for a given study if the imputation accuracy r _2  was >0.', {'entities': [(142, 152, 'imputation')]}),
 (' Two independent reverse transcription reactions were performed and the efficiency of knockdown for AIPL1  (Hs04185077_m1), PTPMT1  (Hs00378514_m1), BCR (Hs01036532_m1) or DDX54 (Hs_00225320_m1) (Life Technologies) for triplicate wells was determined using Taqman fast chemistry on the Viia7 PCR machine (LifeTechnologies).', {'entities': [(296, 300, 'imputation')]}),
 (' The array genotype data from the CHOP CTD and LVOTD trios have previously been used to impute additional genotypes against Hapmap reference data and these genotyped and imputed data were used in our previous GWAS.', {'entities': [(88, 94, 'imputation')]}),
 (' SNPs with MAF <1% or with imputation quality (info score) <0.', {'entities': [(27, 37, 'imputation')]}),
 (' The score method in SNPtest generates a relative information measure on the scale of (0,1) of the observed statistical information from the imputation for the estimate of allele frequency of the SNPs, and was used to assess confidence in the meta-analysis p  values.', {'entities': [(141, 151, 'imputation')]}),
 ('3 for MACH and <0.', {'entities': [(6, 10, 'imputation')]}),
 ('40 with IMPUTE2, were excluded, as were SNPs exhibiting a significant deviation from Hardy–Weinberg equilibrium (P  < 1 × 10_−8 ) in controls.', {'entities': [(8, 14, 'imputation')]}),
 (' Imputed SNPs with imputation _2  (i.', {'entities': [(19, 29, 'imputation'), (1, 8, 'imputation')]}),
 ('0 SNP array used to genotype the CARe African-American sample, and were thus directly genotyped rather than imputed.', {'entities': [(108, 115, 'imputation')]}),
 (' In the procedure, the following SNPs were removed: SNPs with minor allele count < 3; SNPs with imputation quality Proper_INFO < 0.', {'entities': [(96, 106, 'imputation')]}),
 (' We assessed the accuracy of the imputation in three ways.', {'entities': [(33, 43, 'imputation')]}),
 ('3 (IMPUTE), or that were present in <2 studies were excluded.', {'entities': [(3, 9, 'imputation')]}),
 ('5M HapMap SNPs was obtained using MACH software.', {'entities': [(34, 38, 'imputation')]}),
 (' Genotype imputation for additional SNPs was performed using MACH v.', {'entities': [(10, 20, 'imputation'), (61, 65, 'imputation')]}),
 (' Details for plasma L-arginine measurement, genotyping and imputation were described previously ().', {'entities': [(59, 69, 'imputation')]}),
 ('_,   The imputation reference set consisted of 2184 phased haplotypes from the full 1000 Genomes Project data set (February 2012; 40\u2009318\u2009253 variants).', {'entities': [(9, 19, 'imputation')]}),
 ('GWAS results of SNPs with a minor allele frequency (MAF) ≥ 1% and an imputation quality > 30% were analyzed in a fixed-effect meta-analysis (METAL software) within each ancestry group, with genomic control (GC) correction of the individual GWAS results of each contributing cohort and the final meta-analysis results.', {'entities': [(69, 79, 'imputation')]}),
 (' We used a linear mixed-effects model to account for cryptic population structure and relatedness to model the association between genotyped variants (when available for a particular position) or imputed variants (dosages) and AF, as implemented in BOLT-LMM.', {'entities': [(196, 203, 'imputation')]}),
 ('05 before performing the HLA imputations.', {'entities': [(29, 40, 'imputation')]}),
 (' We excluded imputed SNPs when the quality score (IMPUTE) or Rsq  (MACH) was <0.', {'entities': [(13, 20, 'imputation'), (50, 56, 'imputation'), (67, 71, 'imputation')]}),
 (' Imputations were performed by phasing the four SNPs with PHASE and assuming the AG haplotype to be a perfect tag.', {'entities': [(1, 12, 'imputation')]}),
 ('6 filters to all imputed variants, around 9 million variants were found suitable for association analysis.', {'entities': [(17, 24, 'imputation')]}),
 (' Each cohort\nperformed imputation with the phase 1 reference panels of the 1000 Genomes Project ().', {'entities': [(23, 33, 'imputation')]}),
 (" Imputation results were summarized as an ‘allele dosage', which was defined as the expected number of copies of the minor allele of that SNP (a continuous value between 0 and 2) for each genotype.", {'entities': [(1, 11, 'imputation')]}),
 (' MACH or IMPUTE software_–  were used in the imputation ().', {'entities': [(45, 55, 'imputation'), (9, 15, 'imputation'), (1, 5, 'imputation')]}),
 ('Imputation was conducted genome-wide on the GenoMEL Phase 1 samples, excluding SNPs with MAF<0.', {'entities': [(0, 10, 'imputation')]}),
 (' The contribution of the ungenotyped affected individuals through this familial imputation to the effective sample size of the affected individuals, n _a,eff , was estimated using the Fisher information.', {'entities': [(80, 90, 'imputation')]}),
 (' Germline genotypes were imputed into the 1000 Genomes Project reference panel (October 2014 release) using IMPUTE2 (refs.', {'entities': [(25, 32, 'imputation'), (108, 114, 'imputation')]}),
 (' Leipzig (discovery sample), NFBC1986, STRIP (discovery sample) and PANIC (discovery sample) contributed unimputed data from the Metabochip.', {'entities': [(107, 114, 'imputation'), (105, 114, 'NO imputation')]}),
 ('5 for IMPUTE http://mathgen.', {'entities': [(6, 12, 'imputation')]}),
 (' Only SNPs that had minor allele frequencies >1% and imputation quality score >0.', {'entities': [(53, 63, 'imputation')]}),
 (' 42) or MaCH/Minimac software () was used to impute the genotypes of all participants with haplotypes derived from samples of European ancestry in the 1000 Genome Project (2010 interim release based on the sequence data freeze from 4 August 2010 and phased haplotypes from December 2010).', {'entities': [(45, 51, 'imputation'), (8, 12, 'imputation')]}),
 (' Before imputation, participants with a genotyping yield of less than 98% were removed; SNPs with a yield of less than 98%, a minor allele frequency of less than 1%, or a deviation from Hardy–Weinberg equilibrium (P<1.', {'entities': [(8, 18, 'imputation')]}),
 (' After imputation, we excluded from the statistical analyses SNPs with MAF<0.', {'entities': [(7, 17, 'imputation')]}),
 (' All SNVs, both genotyped and imputed, were tested using an additive model, adjusted by age, sex, and the first 10 PCs.', {'entities': [(30, 37, 'imputation')]}),
 (' Details of the genotyping quality control and imputation can be found in .', {'entities': [(47, 57, 'imputation')]}),
 (' After phasing of individuals using SHAPEIT-2, genotypes from a reference panel (a combined 1000 Genomes/UK10K reference panel) were imputed (statistically transferred) into UK Biobank participants via IMPUTE2 software.', {'entities': [(133, 140, 'imputation'), (202, 208, 'imputation')]}),
 (' SNPs imputed with Rsq <0.', {'entities': [(6, 13, 'imputation')]}),
 (' The ARIC samples were included as another unphased reference panel to maximize available information at each imputed single nucleotide polymorphism (SNP).', {'entities': [(110, 117, 'imputation')]}),
 ('  On the basis of the genotyped single-nucleotide polymorphisms (SNPs) and haplotype information in the National Center for Biotechnology Information build 35 of phase II Hapmap CEU data, we imputed genotypes for >2.', {'entities': [(191, 198, 'imputation')]}),
 (' After quality control, a total of 820,017 genotyped SNPs remained for genotype imputation.', {'entities': [(80, 90, 'imputation')]}),
 (' Imputation of hard genotype calls may be used to infer missing values based on the linkage among SNP sets.', {'entities': [(1, 11, 'imputation')]}),
 (' To allow for meta-analysis across different marker sets, imputation of the polymorphic SNPs from the HapMap2 European CEU population was performed using MACH () or IMPUTE () or BimBam ().', {'entities': [(58, 68, 'imputation'), (165, 171, 'imputation'), (154, 158, 'imputation')]}),
 (' We imputed SNPs, classic HLA  alleles (at both 4-and 2-digit resolution), and their amino acid polymorphisms in the 1,962 individuals from our GWAS, using Beagle software as previously described ().', {'entities': [(4, 11, 'imputation'), (156, 162, 'imputation')]}),
 (' The phasing and imputation for each genotyping platform were separated.', {'entities': [(17, 27, 'imputation')]}),
 (' ) and in Sydney MAS using mach2qtl (Li et al.', {'entities': [(27, 32, 'imputation')]}),
 ('For each of the three GWAS (Bonn1CSF, Bonn2CSF and ADNI), genotype data were imputed using the 1000 Genomes () reference data, May 2012 release, and the IMPUTEv2 software package ().', {'entities': [(77, 84, 'imputation'), (153, 159, 'imputation')]}),
 (' Details of individual exclusion criteria for imputation and principal component generation are reported in the  section.', {'entities': [(46, 56, 'imputation')]}),
 (' After all of these QC and filtering steps, 782,456 SNPs remained before imputation.', {'entities': [(73, 83, 'imputation')]}),
 ('html () or BEAGLE (), as for studies included in Stage 1.', {'entities': [(11, 17, 'imputation')]}),
 (' The genomic window imputed was 29.', {'entities': [(20, 27, 'imputation')]}),
 (' To further refine our association results, we performed genotype imputation using reference 1000 Genomes Project data (March 2010 release).', {'entities': [(66, 76, 'imputation')]}),
 (' Genotype data from each study had been imputed to the HapMap phase 2 reference panel [], except for JUPITER which was imputed to the 1000genomes pilot data, using either MACH, Impute, or BIMBAM software [–], resulting in a total of approximately 2.', {'entities': [(40, 47, 'imputation'), (177, 183, 'imputation'), (171, 175, 'imputation')]}),
 (' After merging the imputed and genotyped data, we used the program SNPTEST to perform frequentist tests of association at each SNP under a missing data logistic regression model.', {'entities': [(19, 26, 'imputation')]}),
 (' SNPs with call rate >95%, MAF >1%, Hardy–Weinberg equilibrium P >10_−6 , and an imputation info score >0.', {'entities': [(81, 91, 'imputation')]}),
 ('We imputed classical HLA alleles and corresponding amino acid polymorphisms using a combined Asian and European reference panel with high-density SNP genotypes and 4-digit classical HLA allele genotypes (530 Asian individuals and 5,225 European individuals) using SNP2HLA software (see URLs), as described elsewhere.', {'entities': [(3, 10, 'imputation')]}),
 (' After quality control, 8,229\ncase and 36,329 control samples were included in the analysis, and\n436,746 SNPs were available for imputation in the USA and Italy cohorts,\nand 420,131 SNPs were available in the UK, French and Belgium\ncohorts.', {'entities': [(129, 139, 'imputation')]}),
 (' At the individual level, sex compatibility was checked by imputing sex from X-chromosome genotype data with PLINK [].', {'entities': [(59, 67, 'imputation')]}),
 (' Those that could be imputed accurately (imputation r _2  > .', {'entities': [(21, 28, 'imputation')]}),
 (' We employed MACH (version1.', {'entities': [(13, 17, 'imputation')]}),
 (' After QC, a total of 1,633,452 SNPs were available for final analysis using the imputed dosages.', {'entities': [(81, 88, 'imputation')]}),
 (' Association analyses in the RS sample were performed with MACH2QTL () via GRIMP () (which uses genotype dosage value as a predictor in a linear regression framework).', {'entities': [(59, 64, 'imputation')]}),
 (' We applied linear regression between allele dosages obtained from imputations and natural-log FeNO adjusted for sex and age at time of measurement.', {'entities': [(67, 78, 'imputation')]}),
 (' Before meta-analysis of the results from the 36 GWAS, we excluded SNPs with poor imputation quality score (r _2  hat ≤ 0.', {'entities': [(82, 92, 'imputation')]}),
 ('90 were set to missing and imputed genotypes with probability ≥0.', {'entities': [(27, 34, 'imputation')]}),
 (' Data from the two different chips were separately phased using SHAPEIT2 and imputed to the 1000 Genomes reference panel (Phase 1 v3) using Minimac3.', {'entities': [(77, 84, 'imputation')]}),
 (' In ADNI, we excluded any SNPs imputed with an R _2  value of <0.', {'entities': [(31, 38, 'imputation')]}),
 (' For imputed SNPs, we used the expected number of copies of the risk allele (the dosage), which has been shown to provide unbiased estimates in the association test for imputed SNPs.', {'entities': [(5, 12, 'imputation')]}),
 (' We imputed SNPs against the 1000 Genomes phase I version 3 integrated set via IMPUTE2 (v.', {'entities': [(4, 11, 'imputation'), (79, 85, 'imputation')]}),
 ('790 [], and IMPUTE2 v2.', {'entities': [(12, 18, 'imputation')]}),
 (' For the unrelated samples, association was examined by the linear regression model with MACH2QTL [], in which allele dosage was taken as the predictor for the phenotype.', {'entities': [(89, 94, 'imputation')]}),
 ('_,  We did the imputation using the Michigan Imputation Server.', {'entities': [(15, 25, 'imputation'), (45, 55, 'imputation')]}),
 (' Finally, we performed fine mapping of the top regions associated with plasma renin activity (since these regions reached or were close to genome-wide significance) and of the candidate genes REN  and CYP11B2  (+/- 500 kb around the gene) based on imputations to the 1000 genome dataset.', {'entities': [(248, 259, 'imputation')]}),
 (' To search for independent signals among the over 1000 genome-wide significance SNPs in the HLA region, we included significant SNPs with minor allele frequency > 5% and imputation quality (ratio of allele dosage variance and expected binomial variance) > 0.', {'entities': [(170, 180, 'imputation')]}),
 (' Additional genotypes were imputed using IMPUTE version2 () to a 1000 Genomes reference panel that contained all available ethnicities with singleton and monomorphic sites removed (May 2011 1000 genomes release, and the phase release was December 2013 from the impute2 website (https://mathgen.', {'entities': [(27, 34, 'imputation'), (41, 47, 'imputation')]}),
 (' Analyses were performed in R (including GenABEL and SNPMatrix), ProbABEL, MACH, Haploview  and Stata (R, http://www.', {'entities': [(75, 79, 'imputation')]}),
 (' being a subset of the imputed version of an existing dataset of ∼19,000 individuals (also used for example in Luong et\xa0al.', {'entities': [(23, 30, 'imputation')]}),
 ('Imputation was done by Dr.', {'entities': [(0, 10, 'imputation')]}),
 ('_,   Only variants with at least two copies of the minor allele present in any of the four 1000 Genomes continental panels were imputed.', {'entities': [(128, 135, 'imputation')]}),
 (' We used SHAPEIT for whole-chromosome prephasing and IMPUTE2 (ref.', {'entities': [(53, 59, 'imputation')]}),
 (' MACH software (version 1.', {'entities': [(1, 5, 'imputation')]}),
 (' Genotype data of 23andMe were imputed (minimac2 software []) using the reference haplotypes from the 1000 Genomes project [] (2013 September release).', {'entities': [(31, 38, 'imputation')]}),
 (' Results from this are presented in , showing >99% mean imputation accuracy.', {'entities': [(56, 66, 'imputation')]}),
 (' Data for imputed SNPs that were non-autosomal or that had a MAF <5% were also excluded from all statistical analyses.', {'entities': [(10, 17, 'imputation'), (33, 37, 'negation')]}),
 (' Masked variant analysis, whereby genotyped SNPs were imputed in order to assess imputation accuracy, demonstrated high-quality imputation, with mean concordance of 0.', {'entities': [(54, 61, 'imputation')]}),
 (' Total RNA was extracted and sequenced on an Illumina HiSeq 2000 machine (see  for more details).', {'entities': [(65, 69, 'imputation')]}),
 (' These QA/QC procedures yielded a total of 12,803 unique study participants for imputation and downstream association analyses.', {'entities': [(80, 90, 'imputation')]}),
 (' All samples genotyped on the Axiom array (n=2115) were imputed together using the 1000 Genomes haplotypes (n=1094) as the phased reference panel.', {'entities': [(56, 63, 'imputation')]}),
 (' Total RNA was extracted using the NucleoSpin microRNA kit (Macherey-Nagel, Düren, Germany) and converted to cDNA using the AffinityScript cDNA Synthesis kit (Agilent Technologies, Santa Clara, CA, USA).', {'entities': [(60, 64, 'imputation')]}),
 ('2 million polymorphic markers); ARIC and HCHS/SOL were imputed using a 1000 Genomes Project phase 1 background.', {'entities': [(55, 62, 'imputation')]}),
 (' A two-stage procedure for imputation was used during which data was first prephased using MACH and subsequently imputed using MINIMAC with the 1000G Phase I v3 Shapeit2 Reference (2010-11 data freeze, 2013-09 haplotypes) panel (http://www.', {'entities': [(27, 37, 'imputation'), (91, 95, 'imputation')]}),
 (' Genotyped SNPs that passed quality control procedures were then imputed to approximately 2.', {'entities': [(65, 72, 'imputation')]}),
 (' IMPUTE v2 () was used to perform imputation () of an additional approximately 2 million SNPs in each race/ethnic group for inclusion in GWAS analyses.', {'entities': [(34, 44, 'imputation'), (1, 7, 'imputation')]}),
 ('  All studies imputed approximately 2.', {'entities': [(14, 21, 'imputation')]}),
 (' Shapeit2 [] and Impute-2 [] were used to impute genotype data from the HapMap [] and the 1000 Genomes Project Consortium [].', {'entities': [(42, 48, 'imputation'), (17, 23, 'imputation')]}),
 (' After\nimputation, 11,314,818 SNPs in GSA and 11,351,136 SNPs in MEGA were obtained.', {'entities': [(7, 17, 'imputation')]}),
 ('0 [], with the precompiled “HapMap 3 + 1000GP CEU+TSI” panels from the IMPUTE website used as reference for imputation.', {'entities': [(108, 118, 'imputation'), (71, 77, 'imputation')]}),
 (' The 1KGP reference panels used for imputation contain a large number of variants, 39.', {'entities': [(36, 46, 'imputation')]}),
 (' Before imputation, 806,466 SNPs pass QC in at least one batch (>99% of the array content).', {'entities': [(8, 18, 'imputation')]}),
 (' Following imputation, we kept variants passing a standard imputation quality threshold (R _2 ≥0·3) for further analysis.', {'entities': [(11, 21, 'imputation')]}),
 (' R _2  was used to assess the imputation quality.', {'entities': [(30, 40, 'imputation')]}),
 (' This parser was designed to read raw results files from a variety of association software packages (mach2qtl, PLINK, SOLAR, SNPTEST, QUICKTEST, Merlin-offline and ProbABEL), perform a series of tests on the incoming data to ensure quality, correctly assign the effect allele (dependent on both the imputation and association programs used) and correctly scale the β values and standard errors from association into the same units.', {'entities': [(299, 309, 'imputation'), (101, 106, 'imputation')]}),
 ('3 for MACH) were used for the association analysis.', {'entities': [(6, 10, 'imputation')]}),
 (' The imputed SNPs were also modeled additively, but a non-integral dosage value (between 0 and 2) was used to incorporate the uncertainty in the imputation algorithm.', {'entities': [(5, 12, 'imputation'), (54, 58, 'negation')]}),
 (' Additional details on genotyping and imputation in each cohort are provided in the Supplemental Methods.', {'entities': [(38, 48, 'imputation')]}),
 (' Details on genotyping and imputations are provided in .', {'entities': [(27, 38, 'imputation')]}),
 ('1 locus harboring rs7741164, we also attempted imputation of the NCI data set using minimac2 () for a 4 Mb window ranging from 39 493 412 to 43 493 412 (hg19) using only the ASN subset (n  = 286) from the same version of 1000 Genomes data as the reference with the phased inference haplotypes either from SHAPEIT () or MaCH () program.', {'entities': [(47, 57, 'imputation'), (319, 323, 'imputation')]}),
 ('Before imputation, individuals of non-European origin and with genotyping frequency lower than 95% were excluded.', {'entities': [(7, 17, 'imputation'), (34, 38, 'negation')]}),
 ('The imputation for all cohorts was performed with a 1000 Genomes version 1 phase 3 reference panel containing 379 Europeans, 246 Africans and African Americans, 286 Asians, and 181 Latin Americans.', {'entities': [(4, 14, 'imputation')]}),
 (' Detailed descriptions of the quality-control and imputation procedures are summarized for all studies elsewhere (see  Supplementary Table 3 under “Supplemental data” in the online issue).', {'entities': [(50, 60, 'imputation')]}),
 (' Genotyped SNPs passing quality control were used as input for 1000 Genomes imputation, following the same procedure outlined in the .', {'entities': [(76, 86, 'imputation')]}),
 (' After imputation, we pruned out SNPs with quality scores of <0.', {'entities': [(7, 17, 'imputation')]}),
 (' Concordance between the imputed alleles and sequenced alleles was assessed in each allele frequency bin where allele frequencies were calculated from the Dutch samples included in the Genome of the Netherlands cohort.', {'entities': [(25, 32, 'imputation')]}),
 (' Study-specific SNP filters for imputation quality and minor allele frequency (MAF) were imposed, as described for each study.', {'entities': [(32, 42, 'imputation')]}),
 (' Phased haplotypes from HapMap II CEU were used to impute ∼2.', {'entities': [(51, 57, 'imputation')]}),
 (' The overall concordance rate between imputed and directly assayed genotypes was 99.', {'entities': [(38, 45, 'imputation')]}),
 (' SNPs imputed in all datasets were not included in the analysis sample; only SNPs genotyped on at least one of the arrays (1,195,878 SNPs) were considered for inclusion in the analysis.', {'entities': [(6, 13, 'imputation'), (35, 38, 'negation')]}),
 (' Excepting 31 genotyped SNPs passing quality control with unknown strand orientation, all SNPs (typed and imputed) were combined and strand oriented to the mlinfo file from MACH.', {'entities': [(106, 113, 'imputation'), (173, 177, 'imputation')]}),
 (' Classical alleles for HLA-A , HLA-B , and HLA-C  were imputed for each case-control cohort separately by HLA_∗ IMP and best guess genotypes with probability >0.', {'entities': [(55, 62, 'imputation')]}),
 (' Imputation of un-typed genotyped SNPs was performed with BEAGLE 3.', {'entities': [(1, 11, 'imputation'), (58, 64, 'imputation'), (15, 18, 'negation')]}),
 (' For these subjects, the father and at least one child were also enrolled and directly typed for DRB1 alleles, with SNP-based imputation available for the remaining class I and class II loci.', {'entities': [(126, 136, 'imputation')]}),
 ('Pre-imputation filtering was carried out to exclude SNPs with a minor allele frequency (MAF) below 1%, a P -value for Hardy–Weinberg equilibrium below 10e−6, a call rate below 95% across all samples and across all SNPs.', {'entities': [(4, 14, 'imputation')]}),
 (' Common SNP genotypes were imputed to HapMap phase 2 (release 21).', {'entities': [(27, 34, 'imputation')]}),
 (' For the remaining association tests that included all the genotyped and imputed SNPs, we used the standard P  ≤ 5 × 10_−8  threshold for genome wide significance.', {'entities': [(73, 80, 'imputation')]}),
 (' Genotyping was an expansion and re-imputation of the dataset used in Medland et\xa0al.', {'entities': [(36, 46, 'imputation')]}),
 ('Imputation and haplotype estimation (phasing) were carried out for autosomal SNPs using Minimac2 and SHAPEIT() with the 1000 Genomes Project Phase 3 as the reference data for the Chinese and Japanese GWAS.', {'entities': [(0, 10, 'imputation')]}),
 ('18 (depending on chromosome) followed by imputation by minimac (v.', {'entities': [(41, 51, 'imputation')]}),
 (' For samples of unrelated subjects, association was examined by the linear regression model with MACH2QTL (,), in which allele dosage was taken as the predictor for the phenotype.', {'entities': [(97, 102, 'imputation')]}),
 (' The concordance between imputed SNPs and those obtained from sequencing was calculated for all individuals and for those individuals that are heterozygous or homozygous for the rare allele in the sequencing data.', {'entities': [(25, 32, 'imputation')]}),
 (' Genotype imputation was performed using MACH or Beagle software.', {'entities': [(10, 20, 'imputation'), (49, 55, 'imputation'), (41, 45, 'imputation')]}),
 ('In the discovery stage, imputation of allele dosage of ungenotyped SNPs\nusing the HapMap Phase 2 (JPT+CHB) data was carried out using MACH_, .', {'entities': [(24, 34, 'imputation'), (134, 138, 'imputation')]}),
 (' In the Follow-up stage studies, all studies were imputed using 1000 Genomes Phase 1 integrated reference panel prior to association testing.', {'entities': [(50, 57, 'imputation')]}),
 ('  Imputation for the SAGE data was performed using BEAGLE version 3.', {'entities': [(2, 12, 'imputation'), (51, 57, 'imputation')]}),
 (' Imputation for the SAGE data was performed using BEAGLE version 3.', {'entities': [(1, 11, 'imputation'), (50, 56, 'imputation')]}),
 (' Phasing and imputation of the X Chromosome was performed using the -chrX  flag and the gender of each sample was provided.', {'entities': [(13, 23, 'imputation')]}),
 (' Each study imputed their genotype data to the ~2.', {'entities': [(12, 19, 'imputation')]}),
 (' Appropriate options were used for X chromosome phasing and imputation (–chrX was set for SHAPEIT2 for phasing, and –chrX and gender information were provided to IMPUTE2 for imputation).', {'entities': [(60, 70, 'imputation'), (162, 168, 'imputation')]}),
 ('We imputed untyped genotypes with Impute version 2 (https://mathgen.', {'entities': [(3, 10, 'imputation'), (34, 40, 'imputation')]}),
 (' We used allele dosages from the\nimputation to account for uncertainty of imputed genotypes.', {'entities': [(33, 43, 'imputation')]}),
 (' We filtered imputed SNPs and indels based on minor allele frequency (MAF)<1% in the 1000 Genomes populations of African (AFR) or European (EUR) descent, leaving 6,809,218 SNPs and 739,119 indels in the AAs and 6,727,359 SNPs and 729,634 indels in the EAs.', {'entities': [(13, 20, 'imputation')]}),
 (' This extended our SNP association testing to a total of 11,892,802 genome wide variants post quality control checks (1,131,426 genotyped and 10,761,376 imputed SNPs/indels).', {'entities': [(153, 160, 'imputation')]}),
 (' We excluded variants with low minor allele counts (<30) and low imputation quality (<0.', {'entities': [(65, 75, 'imputation')]}),
 (' SNPs for which Hardy-Weinberg equilibrium testing resulted in P <  10_−4  to < 10_−6  (cohort-specific) were excluded from imputation.', {'entities': [(124, 134, 'imputation')]}),
 (' After imputation, we analyzed each GWAS data set for association\n(SNPTEST), fitting an additive\nmodel.', {'entities': [(7, 17, 'imputation')]}),
 (' Specifically, 11 of the 17 participating cohorts were imputed to the combined UK10K and 1000 Genomes reference panel (total number of imputed individuals included in the meta-analysis = 25,589).', {'entities': [(55, 62, 'imputation')]}),
 (' For this reason, we did not expect an exhaustive scan of all imputed SNPs to be fruitful.', {'entities': [(62, 69, 'imputation'), (25, 28, 'negation')]}),
 (' For the KNG1  locus, the aim was to include all SNPs identified in the discovery, conditional and the GCTA approximate conditional joint selection analyses; however, two of the SNPs from the GCTA analysis failed the imputation quality filter, so the final analysis comprised SNPs rs710446, rs76438938 and rs5030095, which generated five haplotypes.', {'entities': [(217, 227, 'imputation')]}),
 (' Imputed variants with an R -squared value of less than 0.', {'entities': [(1, 8, 'imputation')]}),
 (' Genetic markers retained following imputation had to pass stringent imputation quality and accuracy filters before entering the analysis phase.', {'entities': [(36, 46, 'imputation')]}),
 (' For imputed SNPs, SNPs were removed if they had an average r _2  < 0.', {'entities': [(5, 12, 'imputation')]}),
 (' Filtering and imputation methods are detailed in the .', {'entities': [(15, 25, 'imputation')]}),
 (' Results from analyses with imputed SNPs and each independent platform were merged and rank ordered by P  value.', {'entities': [(28, 35, 'imputation')]}),
 ('5 million SNPs were imputed from HapMap data.', {'entities': [(20, 27, 'imputation')]}),
 (' In the replication samples rs16953002 and rs8050136 were genotyped, with the exception of rs8050136 being imputed in the Harvard samples.', {'entities': [(107, 114, 'imputation')]}),
 (' The cleaned genotype data were imputed to 1000G reference panels (phase 1) using IMPUTE2.', {'entities': [(32, 39, 'imputation'), (82, 88, 'imputation')]}),
 (' Post-imputation QC was performed as previously outlined (http://biobank.', {'entities': [(6, 16, 'imputation')]}),
 ('0×10_−04 ) was applied in the association analysis of hypertriglyceridemia with imputed SNPs because of the imputation uncertainty.', {'entities': [(80, 87, 'imputation')]}),
 (' Each cohort ran their own optimal pre-imputation genotype QC.', {'entities': [(39, 49, 'imputation')]}),
 ('We performed genotype imputation in the familial lung cancer study, using the software package IMPUTE2 v2.', {'entities': [(22, 32, 'imputation'), (95, 101, 'imputation')]}),
 (' After quality control steps including filtering for MAF ≥ 5% on the imputed SNPs were applied, 1,575 of 1,716 ADNI participants and 5,574,300 SNPs remained for subsequent analyses.', {'entities': [(69, 76, 'imputation')]}),
 (' In the Health and Retirement Study, imputation was performed using the HapMap2 CEU reference panel.', {'entities': [(37, 47, 'imputation')]}),
 ('To improve genomic coverage, we used the imputation method implemented in the software package MACH using HapMap3 with the CEU reference population (Li et al.', {'entities': [(41, 51, 'imputation'), (95, 99, 'imputation')]}),
 ('01, IMPUTE2 information score <0.', {'entities': [(4, 10, 'imputation')]}),
 ('  πˆ πˆ πˆ πˆ πˆ πˆ πˆ π π   ˆ ˆ ˆ   We used logistic regression to test the association of MDD diagnosis\nwith imputed SNP dosages under an additive model.', {'entities': [(111, 118, 'imputation')]}),
 (' To distribute imputation computation to multiple parallel CPUs, chromosomes were split into non-overlapping fragments each of 10 Mb length.', {'entities': [(15, 25, 'imputation'), (93, 97, 'negation')]}),
 (' Imputed data in the xMHC for SNPs, amino acids, or the HLA four-digit code were filtered as follows: (1) variants with a success call rate below 95%, (2) variants with a MAF below 1%, and (3) all individuals with a SNP success call rate below 95% were excluded.', {'entities': [(1, 8, 'imputation')]}),
 ('  In order to evaluate pleiotropy with the ischemic stroke phenotype, we selected the variant with the lowest P-value at each independent novel atrial fibrillation locus and performed a lookup in the results from 1000 Genomes imputed GWAS meta-analyses from the Neurology Working Group of the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium (4348 stroke patients and 80,613 referents) and the METASTROKE consortium (10,307 ischemic stroke cases and 19,326 referents) of the International Stroke Genetics Consortium (ISGC).', {'entities': [(226, 233, 'imputation')]}),
 (' Genotypes were imputed using MACH/minimac software to the 1,000 Genomes Phase I version 3 reference panel (all populations).', {'entities': [(16, 23, 'imputation'), (30, 34, 'imputation')]}),
 (' Briefly, variants with MAF <1%, imputation quality <0.', {'entities': [(33, 43, 'imputation')]}),
 ('To increase coverage of common variants in the genotyped platform, particularly in the region where our most significant genotyped SNP GWAS results were found, imputation was done on the EUR array (for a comparison of SNP imputation vs other multiple imputation techniques, see Supplementary 1).', {'entities': [(160, 170, 'imputation')]}),
 ('4 million variants using Beagle (), IMPUTE (), or MACH ().', {'entities': [(36, 42, 'imputation'), (25, 31, 'imputation'), (50, 54, 'imputation')]}),
 (' Details on the genotyping, quality control and imputation efforts are described in  - .', {'entities': [(48, 58, 'imputation')]}),
 (' Stage 1 comprised a meta-analysis of directly genotyped and imputed SNPs in 7,467 patients diagnosed with BD by direct interview and 27,303 controls drawn from published BD case-control studies, dbGaP, and WTCCC2.', {'entities': [(61, 68, 'imputation')]}),
 (' The imputed SNPs with minor allele frequency (MAF) <0.', {'entities': [(5, 12, 'imputation')]}),
 (' Imputation of missing genotypes and of new SNPs was performed with IMPUTE2 v.', {'entities': [(1, 11, 'imputation'), (68, 74, 'imputation')]}),
 (' For studies contributing unimputed metabochip data to the discovery analysis, we excluded SNPs with a SNP call rate of <0.', {'entities': [(28, 35, 'imputation'), (26, 35, 'NO imputation')]}),
 ('Genome-wide imputation of allele dosages was performed using the June 2011 panel from 1000 Genomes build 37 for imputation of genotypes (http://www.', {'entities': [(12, 22, 'imputation')]}),
 (' DNA extraction, genotyping, imputation and initial quality control were completed by 23andMe, Inc.', {'entities': [(29, 39, 'imputation')]}),
 (' MACH [] was used to impute 2.', {'entities': [(21, 27, 'imputation'), (1, 5, 'imputation')]}),
 (' All single-nucleotide polymorphisms (SNPs) and insertion/deletions with an IMPUTE2 () Info score less than 0.', {'entities': [(76, 82, 'imputation')]}),
 (' To produce consistent datasets and enable meta-analysis of studies across different genotyping platforms, the cohorts performed genomic imputation on the HapMap Phase 2 available genotypes with MACH or IMPUTE, using the appropriate ancestry as templates.', {'entities': [(137, 147, 'imputation'), (203, 209, 'imputation'), (195, 199, 'imputation')]}),
 (' To restrict the analyses to well imputed SNPs, we included only SNPs with MAF\u2009>\u20090.', {'entities': [(34, 41, 'imputation')]}),
 (' Logistic regression was also used in association testing of the imputed HLA serotype data in relation to the primary phenotype, as well as in further analysis, in which the 3 most significant SNPs were conditioned on an imputed HLA serotype variant.', {'entities': [(65, 72, 'imputation')]}),
 (' In addition, as a supplementary analysis, we also imputed genotypes of SNPs not represented on the Affymetrix array using the 1000 Genomes phase 3 version 5 reference panel, mixed population (), on the University of Michigan Imputation Server (), and assessed their PM associations using the same model above (, available online).', {'entities': [(51, 58, 'imputation'), (226, 236, 'imputation'), (77, 80, 'negation')]}),
 (' The target imputation set included approximately 27.', {'entities': [(12, 22, 'imputation')]}),
 (' Before meta-analysis, SNPs were removed in each study if they had a minor allele frequency <1%, an extreme deviation from Hardy–Weinberg equilibrium (P  < 1 × 10_−6 ), and/or an imputation quality score <0.', {'entities': [(179, 189, 'imputation')]}),
 (' GWAS analysis was done using logistic regression on 6,162,479 imputed SNP dosages under an additive genetic model using PLINK v1.', {'entities': [(63, 70, 'imputation')]}),
 (' mach2dat  was used to perform the association analyses for the genome-wide analysis, and PLINK  was used to perform the association analyses for the HLA imputed analysis.', {'entities': [(154, 161, 'imputation'), (1, 6, 'imputation')]}),
 ('edu/csg/yli/mach/tour/imputation.', {'entities': [(22, 32, 'imputation'), (12, 16, 'imputation')]}),
 (' Prior to imputation, a consistency test of allele frequency between GWA samples and reference samples was examined with the Chi-square test.', {'entities': [(10, 20, 'imputation')]}),
 (' To increase the spectrum of variants tested in the current study of overall survival, we used MACH software to impute untyped markers using linkage disequilibrium (LD) and haplotype information from HapMap phase II CEU and CHB+JPT as the reference sets for PanScan and ChinaPC participants, respectively.', {'entities': [(112, 118, 'imputation'), (95, 99, 'imputation')]}),
 (' Hidden Markov model–based algorithms were used to infer unobserved genotypes probabilistically as implemented in either MACH (), IMPUTE (), or BimBam () Imputation quality-control metrics included the ratio of observed/expected variance of the allele dose ≤0.', {'entities': [(154, 164, 'imputation'), (130, 136, 'imputation'), (121, 125, 'imputation')]}),
 (', regression of phenotype on the number of reference alleles) or equivalently the imputed dosage for imputed genotypes.', {'entities': [(82, 89, 'imputation')]}),
 (' Genotyping was performed on the Illumina OmniExpressExome-8v1 array and imputed to the HRC reference panel.', {'entities': [(73, 80, 'imputation')]}),
 (' A total of 2\xa0232\xa0944 SNPs passed filters for both quality and informativeness (polymorphic and unduplicated) and were carried forward for imputation and downstream association analyses.', {'entities': [(139, 149, 'imputation')]}),
 (' We then removed SNPs with low imputation quality (R -squared <0.', {'entities': [(31, 41, 'imputation')]}),
 (' We then performed genome-wide association analysis on these residuals using the software package mach2qtl ().', {'entities': [(98, 103, 'imputation')]}),
 ('30 with MACH1/minimac or an information measure Is < 0.', {'entities': [(8, 13, 'imputation')]}),
 (' Further QC information and genotype imputation methods are found in .', {'entities': [(37, 47, 'imputation')]}),
 (' Within each study, GRANVIL was used to test for association of each trait with accumulations of minor alleles (“mutational load”) at successfully imputed rare variants (MAF ≤ 1% and info ≥ 0.', {'entities': [(147, 154, 'imputation')]}),
 (' Tables and figures specify whether each SNP association was genotyped, imputed, or meta-analyzed.', {'entities': [(72, 79, 'imputation')]}),
 (' We used all SNPs in the 1000 Genomes Project Phase 1 v3 release that had MAF >1% and imputation quality score R _2  >0.', {'entities': [(86, 96, 'imputation')]}),
 ('6 million imputed autosomal variants\nagainst levels of 2,994 plasma proteins in 3,301 individuals of European descent\n(Methods, ).', {'entities': [(10, 17, 'imputation')]}),
 ('24)() incorporating 2 to 4 principal components, age\nand gender as covariates, with dosage of imputed SNPs selected based on\na Minimac3 R_2  value of imputation accuracy greater than 0.', {'entities': [(94, 101, 'imputation')]}),
 ('To further investigate the evidence of association at the PICALM, ARRP-21  and ZNF292  loci, we imputed SNPs in the region ±500 kb of PICALM  and ZNF292  and in ±750 kb of the ARRP-21  locus with minor allele frequency >0.', {'entities': [(96, 103, 'imputation')]}),
 (' Imputation for the\nJapanese and French population was performed separately at Kyoto University in Japan and the INSERM UMR 1220 in France,\nrespectively, and only summary statistics for the French imputation data were available due to restriction of data sharing policy\nof the control samples.', {'entities': [(197, 207, 'imputation'), (1, 11, 'imputation')]}),
 (' The analysis utilised the best-guess genotypes from the imputation analysis.', {'entities': [(57, 67, 'imputation')]}),
 ('Genotyping and imputation protocols have been described previously in ().', {'entities': [(15, 25, 'imputation')]}),
 (' Across all samples 39,235,157 SNPs were imputed, with the actual number of SNPs imputed for each individual varying based on the regional density of array genotypes available.', {'entities': [(41, 48, 'imputation')]}),
 ('Variants were kept for association if: (1) imputation info score ≥0.', {'entities': [(43, 53, 'imputation')]}),
 (' Variants to be replicated that were not observed in the original data set were imputed using IMPUTE2 (ref.', {'entities': [(80, 87, 'imputation'), (94, 100, 'imputation'), (37, 40, 'negation')]}),
 (' Standard preimputation quality control included the removal of individuals and SNPs with call rates less than 98% and filtering out SNPs with a minor allele frequency less than 1%.', {'entities': [(13, 23, 'imputation')]}),
 (' Genotype data were then imputed by the Sanger Imputation Service with the\xa0combined UK10K and 1000 Genomes Phase 3 reference panels,_,   the same reference panel used for the UK Biobank control samples.', {'entities': [(25, 32, 'imputation'), (47, 57, 'imputation')]}),
 (' For imputed SNPs, it has been shown that the inverse variance is approximately proportional to the imputation quality.', {'entities': [(5, 12, 'imputation')]}),
 (' Post-imputation QC followed the same criteria that were applied to the genotyped SNPs.', {'entities': [(6, 16, 'imputation')]}),
 (' After imputation and quality control analyses, a total of about 2.', {'entities': [(7, 17, 'imputation')]}),
 (' Prior to meta-analysis, all markers with imputation info < 0.', {'entities': [(42, 52, 'imputation')]}),
 ('5 genotype data were then imputed using IMPUTE2 (v2.', {'entities': [(26, 33, 'imputation'), (40, 46, 'imputation')]}),
 ('56 million SNPs using the MACH algorithm with HapMap data for Utah residents of northern and western European ancestry as the reference.', {'entities': [(26, 30, 'imputation')]}),
 (' Participant genotype data were imputed against the March 2012 ‘v3’ release of 1000 Genomes reference haplotypes ().', {'entities': [(32, 39, 'imputation')]}),
 (' The imputed data were analyzed using a meta-analysis.', {'entities': [(5, 12, 'imputation')]}),
 (' Previous studies have described details on genotyping quality control and imputation for the ECLIPSE cohort (–).', {'entities': [(75, 85, 'imputation')]}),
 (' Imputation was carried out in each of the seven dbGaP GWA data sets/subsets individually.', {'entities': [(1, 11, 'imputation')]}),
 (' For imputed data only SNPs with a confidence score >0.', {'entities': [(5, 12, 'imputation')]}),
 (' A two-step imputation process was performed using SHAPEIT for haplotype phasing and IMPUTE2 for imputation, yielding a total of 39 345 920 imputed SNPs.', {'entities': [(12, 22, 'imputation'), (85, 91, 'imputation')]}),
 ('Directly genotyped SNPs from high-density genotyping platforms (Illumina and Affymetrix) and imputed SNPs were analyzed for association (see Supplementary Material, Table S1).', {'entities': [(93, 100, 'imputation')]}),
 ('org), a hidden Markov model was used, as implemented in MACH (version 1.', {'entities': [(56, 60, 'imputation')]}),
 (' Additional information about recruitment, genotyping, imputation, and quality control for the study cohorts is provided in .', {'entities': [(55, 65, 'imputation')]}),
 (' Only imputed genotypes with minor allele frequencies ≥1%, INFO ≥0.', {'entities': [(6, 13, 'imputation')]}),
 (' To account for imputation uncertainty, we used the 1000 Genomes\nimputation allele dosage in linear models.', {'entities': [(16, 26, 'imputation')]}),
 (' The reference haplotypes most relevant to the study population by allelic consistency are chosen automatically and it has shown that the cosmopolitan reference haplotypes produce high imputation accuracy ().', {'entities': [(185, 195, 'imputation')]}),
 (' Association analyses were conducted in each cohort of measured and imputed autosomal SNP allele dosage with fibrinogen values, using a linear regression model assuming additive genetic effects adjusted for age and sex.', {'entities': [(68, 75, 'imputation')]}),
 (' Imputation quality, as assessed by the IMPUTE2 imputation r _2  value in the OncoArray data set, was ≥0.', {'entities': [(48, 58, 'imputation'), (1, 11, 'imputation'), (40, 46, 'imputation')]}),
 (' In addition to the genotyped SNPs, we imputed genotypes for 2.', {'entities': [(39, 46, 'imputation')]}),
 (' Using a reference sample of Europeans (CEU) from phase 3 of the HapMap Project (), missing genotyped SNPs were imputed using BEAGLE 3.', {'entities': [(112, 119, 'imputation'), (126, 132, 'imputation')]}),
 (' As the imputation using the 1000 Genomes CEU+CHB+JPT reference panel (error rate 3.', {'entities': [(8, 18, 'imputation')]}),
 (' Further details regarding the quality assurance, ancestry analyses, imputation, and data cleaning efforts are available in the Quality Control Report issued by the University of Washington GCC for our project, available online.', {'entities': [(69, 79, 'imputation')]}),
 (' Using results from individual GWAS, we identified the 500 SNPs with the lowest p-values from each of the studies after exclusion of SNPs that could not be imputed or failed QC filtering.', {'entities': [(156, 163, 'imputation'), (149, 152, 'negation')]}),
 ('6 million SNPs [imputation R_2  > 0.', {'entities': [(16, 26, 'imputation')]}),
 (' Genotype data within the 1 Mb regions flanking the two loci were extracted and then imputed using Minimac2 and SHAPEIT with the 1000 Genomes Project Phase 3 as the reference data.', {'entities': [(85, 92, 'imputation')]}),
 (' We then computed the correlation between what was genotyped in 1000 Genomes and this imputed value.', {'entities': [(86, 93, 'imputation')]}),
 (' Association analysis of imputed SNPs was performed assuming an underlying additive model with the use of the software package MACH2DAT, which regresses affection status against expected dosage at each imputed locus.', {'entities': [(25, 32, 'imputation'), (127, 132, 'imputation')]}),
 (' This locus-specific map was used as a reference panel for TNFSF13B  locus imputation in the case–control and SardiNIA cohorts.', {'entities': [(75, 85, 'imputation')]}),
 (' To standardize genotyping across the GWAS and facilitate meta-analysis, we imputed participant-level genotyping data using MACH 1.', {'entities': [(76, 83, 'imputation'), (124, 128, 'imputation')]}),
 (' An additional post-imputation filtering was carried out using the same exclusion criteria as in the pre-imputation stage, and removing imputed SNPs with an Impute2 info metric below 0.', {'entities': [(20, 30, 'imputation'), (157, 164, 'imputation')]}),
 ('edu/browning/beagle/beagle.', {'entities': [(13, 19, 'imputation')]}),
 (' Genotype imputation in AABC was conducted using IMPUTE2  software () to a cosmopolitan panel of all 1000 Genome Project subjects (March 2012 release).', {'entities': [(10, 20, 'imputation'), (49, 55, 'imputation')]}),
 (' After genotyping QC and imputation, a total number of 2,380,486 SNPs were included.', {'entities': [(25, 35, 'imputation')]}),
 (' Prediction of the untyped SNPs was carried out using IMPUTEv2, based on HapMap Phase III haplotypes release 2 (HapMap Data Release 27/phase III Feb 2009 on NCBI B36 assembly, dbSNP26) and 1000genomes.', {'entities': [(54, 60, 'imputation')]}),
 (' Stratified Q-Q plots were generated for minor allele frequency (MAF) and imputation quality strata to assess potential sources of inflation.', {'entities': [(74, 84, 'imputation')]}),
 (' In Stage I, two separate GWA analyses for CHD across 2,543,016 genotyped or imputed SNPs (with imputed SNPs expressed as allele dosage) were performed in the NHS and HPFS sets by means of logistic regression under an additive genetic model using the ProbABEL package.', {'entities': [(77, 84, 'imputation')]}),
 ('0 among all ethnic groups) and our examination of this association was based on the imputed alleles.', {'entities': [(84, 91, 'imputation')]}),
 ('\nSNPs with imputation accuracy score ≥ 0.', {'entities': [(11, 21, 'imputation')]}),
 (' Some imputed single nucleotide polymorphisms (SNPs) were removed based on the following criteria: r _2  < 0.', {'entities': [(6, 13, 'imputation')]}),
 (' Pathway size was determined by the total number of genes in the pathway to which SNPs in the imputed GWAS data set could be mapped.', {'entities': [(94, 101, 'imputation')]}),
 (' Imputation was based on genotyped SNPs with a MAF >10% and that met all other quality control criteria.', {'entities': [(1, 11, 'imputation')]}),
 ('Details on genotyping, imputation, and quality control are presented in .', {'entities': [(23, 33, 'imputation')]}),
 (' After imputation, SNPTEST was used to perform statistical association tests for each individual SNP, under a logistic regression model with adjustment for sex and the top 10 PCs from EIGENSOFT.', {'entities': [(7, 17, 'imputation')]}),
 (' On the basis of the genotyped single-nucleotide polymorphisms (SNPs) and haplotype information in the National Center for Biotechnology Information build 35 of phase II Hapmap CEU data, we imputed genotypes for >2.', {'entities': [(190, 197, 'imputation')]}),
 ('Genome-wide significant SNPs in the discovery stage were directly genotyped in 1,783 individuals from the UKGPCS1 study () using TaqMan assays to verify imputation quality, evaluated as the concordance rate between imputed and genotyped data (percentage of individuals correctly classified by imputation).', {'entities': [(153, 163, 'imputation')]}),
 (' Before imputation, genetic homogeneity was assessed in each sample using multi-dimensional scaling (MDS) analysis ().', {'entities': [(8, 18, 'imputation')]}),
 (' Imputation was performed as described previously (; ).', {'entities': [(1, 11, 'imputation')]}),
 (' Hence, imputation quality criteria varied slightly among studies, and low-confidence imputed SNPs were omitted in the meta-analysis for individual studies.', {'entities': [(8, 18, 'imputation')]}),
 (' A custom-modified HumanCoreExome array by Illumina was used to obtain the genotypes followed by imputation with the 1000 Genomes Project reference panel (Phase I).', {'entities': [(97, 107, 'imputation')]}),
 (' This procedure yielded a total of 780,650 high-quality genotyped or imputed SNPs, which were used for all analyses.', {'entities': [(69, 76, 'imputation')]}),
 (' In\norder to have a common set of single-nucleotide polymorphisms (SNPs) available\nfor meta-analysis and after selecting individuals and genotyped SNPs on the\nbasis of call rates, minor allele frequency and Hardy–Weinberg\nequilibrium test thresholds, SNPs were imputed in each study using the Hapmap 2\nrelease 22 CEU population as a reference panel (see  for\nprecise filters used).', {'entities': [(261, 268, 'imputation')]}),
 (' Imputation was performed using either the MACH 1.', {'entities': [(1, 11, 'imputation'), (43, 47, 'imputation')]}),
 ('We used the algorithm GCTA (Genome-wide Complex Trait Analysis) to estimate the proportion of phenotypic variance explained by genome-wide and imputed SNPs ().', {'entities': [(143, 150, 'imputation')]}),
 (' For the imputed SNPs, we excluded SNPs that had imputation quality measures <0.', {'entities': [(9, 16, 'imputation')]}),
 (' Approximately, 66 % of the resulting target SNPs had MAF <1 % (dosage) or IMPUTE INFO score ≤0.', {'entities': [(75, 81, 'imputation')]}),
 (' To account for uncertainty, we used the mean of the distribution of imputed genotypes, which corresponds to an expected allelic or genotypic count (dosage) for each individual.', {'entities': [(69, 76, 'imputation')]}),
 (' Imputed genotypes were analyzed in a similar manner using SNP dosage data in PLINK 1.', {'entities': [(1, 8, 'imputation')]}),
 (' All individuals were treated independently while doing imputation.', {'entities': [(56, 66, 'imputation')]}),
 (' Sample exclusions before imputation are outlined in .', {'entities': [(26, 36, 'imputation')]}),
 ('org/) for poorly imputed SNPs (±500 kb), including only genotyped SNPs within the region.', {'entities': [(17, 24, 'imputation')]}),
 ('  N=1m∑i=1m1(2p(1−p)se2Rsq)′ N=1m∑i=1m1(2p(1−p)se2Rsq)′ N=1m∑i=1m1(2p(1−p)se2Rsq)′ N=1m∑i=1m1(2p(1−p)se2Rsq)′ N=1m∑i=1m1(2p(1−p)se2Rsq)′ N  = 1m 1m 1 1  m m     ∑i=1m ∑i=1m ∑ ∑  i=1 i=1 i = 1  m m  1(2p(1−p)se2Rsq)′ 1(2p(1−p)se2Rsq)′ 1 1  (2p(1−p)se2Rsq)′ (2p(1−p)se2Rsq)′ (2p(1−p)se2Rsq)′ (2p(1−p)se2Rsq) (2p(1−p)se2Rsq) ( 2 p ( 1 − p ) se2 se2 se se  2 2  Rsq )  ′ ′        To facilitate the meta-analysis, the imputation of unobserved genotypes from the HAPMAP II CEU Panel (Release 22, NCBI Build36, dbSNP b126) was conducted within each cohort.', {'entities': [(413, 423, 'imputation')]}),
 (' Four main association analyses were conducted using the HapMap3 imputed data for: BD and SCZ separately (new subjects), SCZ (full sample), and all SCZ and BD cases combined ().', {'entities': [(65, 72, 'imputation')]}),
 ('Genotyping, pre-imputation quality control, imputation and analysis methods are presented in Supplementary Material, Table S2.', {'entities': [(16, 26, 'imputation')]}),
 (' Within these groups, each SNP was modeled using additive dosages to account for imputation uncertainty, which works well in practice ().', {'entities': [(81, 91, 'imputation')]}),
 (' The quality control-passed control-case GWAS data were pre-phased to construct haplotypes of the autosomal chromosomes by SHAPEIT and subsequent imputation was performed by IMPUTE2 using the 1000 Genomes Project phase I reference panel.', {'entities': [(146, 156, 'imputation'), (174, 180, 'imputation')]}),
 (' All analyses were performed under an additive genetic model using allelic dosage (genotyped or imputed) at each SNP, adjusted for age, age-squared, sex and clinic site (if applicable), 4–10 principal components.', {'entities': [(96, 103, 'imputation')]}),
 (' SNP dosages were imputed in each study using MaCH ().', {'entities': [(18, 25, 'imputation'), (46, 50, 'imputation')]}),
 ('16) on every dataset to impute genotypes for all participants of European ancestry with haplotypes derived from initial low coverage sequencing of 112 European ancestry samples in the 1000 Genomes Project (as of August, 2009).', {'entities': [(24, 30, 'imputation')]}),
 (' Missing genotypes were imputed using a procedure specifically developed for extended pedigrees in MERLIN ().', {'entities': [(24, 31, 'imputation')]}),
 (' To test for epistasis between pairs of variants, imputed allele dosages of the two tested variants and a multiplicative dosage interaction term were included in the logistic regression model along with cohort and PCA covariates.', {'entities': [(50, 57, 'imputation')]}),
 (' Our final GWAS dataset (before IMPUTE2 imputation) was tested against the T1DGC, and only the SNPs in the HLA region were imputed.', {'entities': [(40, 50, 'imputation'), (32, 38, 'imputation')]}),
 (' Association analysis of the imputed genotypes, taking the imputation uncertainty into account, was conducted using the SNPTEST v2 package () missing data-likelihood score test.', {'entities': [(29, 36, 'imputation')]}),
 (' In JoCo and OAI separately, we imputed SNP dosages in all samples based on the 1000 genomes Caucasian and African American reference panel (June 2011 release).', {'entities': [(32, 39, 'imputation')]}),
 ('Of the 120 246 participants, 95 806 had imputed data on the X-chromosome.', {'entities': [(40, 47, 'imputation')]}),
 (' Imputation was undertaken using the HapMap2 reference data (release 22, build 36) using MaCH v1.', {'entities': [(1, 11, 'imputation'), (89, 93, 'imputation')]}),
 ('1 () software were used to impute up to 6 million SNPs.', {'entities': [(27, 33, 'imputation')]}),
 (' Prior to MA, SNPs with imputation quality <0.', {'entities': [(24, 34, 'imputation')]}),
 (' Genotypes for both cohorts were imputed to the 1000 genomes CEU reference panel (June 2011 release) using the Minimac software program (http://genome.', {'entities': [(33, 40, 'imputation')]}),
 (' To impute HLA antigens, we used a separate reference data set collected by the Type 1 Diabetes Genetics Consortium and the SNP2HLA software, as described by its developers ().', {'entities': [(4, 10, 'imputation')]}),
 ('To investigate the effect of genome-wide-significant SNVs on vitamin D insufficiency (defined as 25OHD levels below 50\xa0nmol/L), we used data from four cohorts: TUK imputed, TUK WGS, BPROOF, and MrOS (n = 8,711).', {'entities': [(164, 171, 'imputation')]}),
 (' The ratio of empirically observed to expected (binomial) dosage variance for these imputed SNPs was higher than 0.', {'entities': [(84, 91, 'imputation')]}),
 (' SNPs not on the Illumina array were imputed using minimac  () with reference CEU haplotypes from the  after having been prephased with BEAGLE  (http://faculty.', {'entities': [(37, 44, 'imputation'), (136, 142, 'imputation'), (6, 9, 'negation')]}),
 (' EUR analysis panel was used to impute the EA samples.', {'entities': [(32, 38, 'imputation')]}),
 ('000001 or minor allele frequency (MAF) < 1% were further removed prior to imputation for the current analysis.', {'entities': [(74, 84, 'imputation')]}),
 (' Imputed SNPs with an information score of <0.', {'entities': [(1, 8, 'imputation')]}),
 (' MetaXcan uses established predictive models and accepted association summary statistics as input; it then imputes the transcript expression levels and tests the association between these imputed transcript expression levels and the phenotype [].', {'entities': [(107, 114, 'imputation')]}),
 (' After QC filtering, approximately 4 million genotyped or imputed SNPs on 22 autosomes remained for analysis.', {'entities': [(58, 65, 'imputation')]}),
 (' Two studies (FINCAVAS and DIACORE) in stage 2 imputed genotypes with 1000 Genomes reference haplotypes on GRCh build 37.', {'entities': [(47, 54, 'imputation')]}),
 (' We imputed genotypes for all polymorphic 1000 Genomes Project SNPs using a hidden Markov model implemented in MACH (version 1.', {'entities': [(4, 11, 'imputation'), (111, 115, 'imputation')]}),
 (' We also excluded imputed SNPs with a minor allele frequency of <0.', {'entities': [(18, 25, 'imputation')]}),
 (' Imputation was performed using Beagle v.', {'entities': [(1, 11, 'imputation'), (32, 38, 'imputation')]}),
 (' A total of 578 568 SNPs passed QC (MAF ≥ 2%, call rate ≥ 95%, HWE ≥ 10–4) and were used for imputation.', {'entities': [(93, 103, 'imputation')]}),
 (' We imputed the genotype data to all of the 1000G reference panel (Phase 1) using the same imputation pipeline as described above and removed SNPs with HWE P  value < 1 × 10_−6  or IMPUTE-INFO < 0.', {'entities': [(4, 11, 'imputation'), (181, 187, 'imputation')]}),
 (' The thyroid cancer GWAS data set used in the current study comprises results from 222 individuals with thyroid cancer and 24,198 controls genotyped using Illumina Human Hap300, HapCNV370, Hap610, 1M, or Omni-1 Quad BeadChips (Illumina), as well as results from 627 individuals with thyroid cancer and 71,613 unaffected individuals with genotypes inferred using an imputation method making use of the Icelandic genealogy to propagate genotypic information into individuals for whom we have neither SNP chip nor sequence data, a process we refer to as genealogy-based imputation, the combined method of imputing sequence-derived data into Illumina chip–typed individuals and using genealogy-based imputation to infer the DNA sequence of ungenotyped individuals as two-way imputation (see ).', {'entities': [(365, 375, 'imputation')]}),
 ('  We evaluated associations between imputed genotypes and ovarian cancer risk using a version of the score test as described above but with the posterior genotype probabilities replacing the genotypes.', {'entities': [(36, 43, 'imputation')]}),
 (' After quality control, unobserved genotypes were imputed using the 1,000 Genomes Project Phase I release integrated polymorphisms and indels (March 2012) and BEAGLE software version 4 [].', {'entities': [(50, 57, 'imputation'), (159, 165, 'imputation')]}),
 (' After quality control, 529128 SNPs remained available for association and imputation analyses.', {'entities': [(75, 85, 'imputation')]}),
 ('After individual sample collection and study-specific quality control (webappendix pp 1–7), we used a Markov Chain based haplotyper (MACH; version 1.', {'entities': [(133, 137, 'imputation')]}),
 ('html MACH, http://www.', {'entities': [(5, 9, 'imputation')]}),
 (' In the CLHNS mothers, ∼350,000 markers were directly genotyped, and imputation was performed for all markers based on the 1000 Genomes Project; we used the imputed genotypes for all markers ().', {'entities': [(69, 79, 'imputation')]}),
 (' Directly genotyped or imputed SNPs are plotted with their association P- values (on a -log_10  scale) as a function of genomic position (NCBI Build 37).', {'entities': [(23, 30, 'imputation')]}),
 (' However, at the lowest combinations of minor allele frequency and use of TCAs, the variability of the standard errors was poorly estimated, requiring exclusion of SNPs where 2*(number of exposed participants)*MAF*imputation quality < 10, as described previously [].', {'entities': [(214, 224, 'imputation')]}),
 (' We verified the integrity of imputed data, where possible, by crosschecking the concordance of imputed genotypes with that of available Illumina SNP genotype data.', {'entities': [(30, 37, 'imputation')]}),
 (' The USA cohort was subsequently imputed to the Haplotype Reference Consortium panel (version r1.', {'entities': [(33, 40, 'imputation')]}),
 (' EVGC, rs62132295 (from European Vasculitis Genetics\nConsortium); VCRCi,\nrs138303849 and VCRCt, rs62132293 (most significant imputed and genotyped\nvariants, respectively, from Vasculitis Clinical Research Consortium).', {'entities': [(125, 132, 'imputation')]}),
 (' For SNPs not interrogated on the arrays, imputation was performed using the 1000 Genomes Project (http://www.', {'entities': [(42, 52, 'imputation'), (10, 13, 'negation')]}),
 (' Three of the participating cohorts were imputed with the HRC panel (n = 5,717).', {'entities': [(41, 48, 'imputation')]}),
 ('3 in any imputation batch, or failed a test for imputation batch effect (testing imputation dosage with imputation batch; P  < 10_−50 ).', {'entities': [(9, 19, 'imputation')]}),
 ('To replicate association findings in Hispanic/Latino samples, we used 1000 Genomes imputed GWAS data available in three additional Hispanics/Latinos samples, including 3,454 from the Women’s Health Initiative (WHI) SNP Health Association Resource (SHARe) project, 782 from the Multi-Ethnic Study of Atherosclerosis (MESA) cohort,_,   and 2,854 from Mount Sinai BioMe Biobank.', {'entities': [(83, 90, 'imputation')]}),
 (' Following imputation, 8.', {'entities': [(11, 21, 'imputation')]}),
 ('To ensure high data quality, the datasets from the primary study were subjected to per-SNP and per-sample quality control (QC) before and after imputation.', {'entities': [(144, 154, 'imputation')]}),
 (' We imputed genotypes for ~70 million SNPs for all samples by using the October 2014 (Phase 3) release of the 1KGP data as the reference panel.', {'entities': [(4, 11, 'imputation')]}),
 ('7 million SNPs with a minor allele frequency ≥5% and an imputation accuracy R \n_2  > 0.', {'entities': [(56, 66, 'imputation')]}),
 (' For imputed genotypes, we used dosage information (i.', {'entities': [(5, 12, 'imputation')]}),
 (' The phased data were then imputed with Minimac (17072013) to the 1000 Genomes phase1 release v3 20101123 SNPs INDELS SVS ALL panel as a reference set.', {'entities': [(27, 34, 'imputation')]}),
 (' This resulted in a total of ~2,261,000 SNPs that were either genotyped or imputed with high confidence in all three samples.', {'entities': [(75, 82, 'imputation')]}),
 (' The same regression model was used to test the imputed allelic dosage at each SNP, via MACH2QTL.', {'entities': [(48, 55, 'imputation'), (88, 93, 'imputation')]}),
 (' The\xa0number of SNPs that entered the imputation process were 525,752, 795,240, and 532,149 for GOCHA, GERFHS, and ESs, respectively.', {'entities': [(37, 47, 'imputation')]}),
 (' In order to impute the HLA alleles with 2-digit coding (i.', {'entities': [(13, 19, 'imputation')]}),
 (' Both platforms were imputed using IMPUTE2 and the 1000 Genomes reference panel [].', {'entities': [(21, 28, 'imputation'), (35, 41, 'imputation')]}),
 ('3; IMPUTE: proper information <0.', {'entities': [(3, 9, 'imputation')]}),
 (' These analyses were performed using the same quality control and imputation exclusions, and meta-analysis was performed using METAL.', {'entities': [(66, 76, 'imputation')]}),
 ('\nA summary of INFO scores and imputation cross-validation are presented in \nfor each chromosome and  for each associated locus.', {'entities': [(30, 40, 'imputation')]}),
 (' We excluded SNPs with an imputation quality R _2  score less than 0.', {'entities': [(26, 36, 'imputation')]}),
 ('01 and imputation quality scores\u2009<0.', {'entities': [(7, 17, 'imputation')]}),
 (' The distribution of imputed dosage is shown in .', {'entities': [(21, 28, 'imputation')]}),
 (' All newly identified loci were imputed with imputation qualities >0.', {'entities': [(32, 39, 'imputation')]}),
 (' SNPs imputed by all studies (n  = 1 167 113) were excluded from further presentation or discussion.', {'entities': [(6, 13, 'imputation')]}),
 ('Each cohort individually performed GWA using an additive model accounting for genotype imputation uncertainty for all autosomes by linear regression, adjusting for population substructure (the first principal components) if necessary and age at measurement (in years, to the nearest month, if available).', {'entities': [(87, 97, 'imputation')]}),
 (' Imputation of over 2.', {'entities': [(1, 11, 'imputation')]}),
 (' Genotypes were analyzed using an additive model for typed markers, and additive dosages for imputed markers, which has been shown to be efficient ().', {'entities': [(93, 100, 'imputation')]}),
 (' Imputation to the HapMap-II reference panel (CEU population release 22, NCBI build 36) was performed in MACH (,) in two stages.', {'entities': [(1, 11, 'imputation'), (105, 109, 'imputation')]}),
 (' Given the use of a common genotyping platform (Illumina Human660W-Quad v1 DNA Analysis BeadChips) and genotyping lab (Mayo Clinic), many common pitfalls in GWAS meta-analysis were avoided, including strand orientation mismatches, imputation reference sample heterogeneity, variable QC criteria, etc.', {'entities': [(231, 241, 'imputation')]}),
 (' Imputed allele dosage values of SNPs with imputation quality score (Rsq) greater than or equal to 0.', {'entities': [(43, 53, 'imputation'), (1, 8, 'imputation')]}),
 ('0 genotypes and the imputed genotypes was 99.', {'entities': [(20, 27, 'imputation')]}),
 (' Recommended protocols for association were provided to the studies based on those used in mach2qtl software (see ENIGMA protocols).', {'entities': [(91, 96, 'imputation')]}),
 (' SNPs were excluded if the Hardy-Weinberg equilibrium (HWE) P  value was <1 × 10_−6  or based on cohort-specific criteria, minor allele frequency (MAF) was <1%; imputation information score was <0.', {'entities': [(161, 171, 'imputation')]}),
 (' Samples from all batches were joined prior to performing pre-imputation QC steps.', {'entities': [(62, 72, 'imputation')]}),
 (' Imputation was conducted by using IMPUTE2 software version 2.', {'entities': [(1, 11, 'imputation'), (35, 41, 'imputation')]}),
 ('After quality-control procedures and principal component analysis, imputation was performed separately in GOCHA, GERFHS, and ESs via IMPUTE2 v.', {'entities': [(67, 77, 'imputation'), (133, 139, 'imputation')]}),
 (' For each of the three datasets we used MACH (v.', {'entities': [(40, 44, 'imputation')]}),
 (' Briefly, 20,776 samples were genotyped with Illumina (550K, 610K, 660K or OmniExpress) arrays, and standard quality control (QC) filters were applied before imputation.', {'entities': [(158, 168, 'imputation')]}),
 (' SNP imputation was performed in batches dividing the cohorts\naccording to genotyping platforms.', {'entities': [(5, 15, 'imputation')]}),
 (' Imputation was performed using Beagle v3.', {'entities': [(1, 11, 'imputation'), (32, 38, 'imputation')]}),
 (' To generate a common set of SNPs between EGEA and Hutterites for meta-analysis, imputations were conducted in EGEA using MACH software (http://www.', {'entities': [(81, 92, 'imputation'), (122, 126, 'imputation')]}),
 (' Genotypes not directly genotyped with single SNP genotyping or with the Affymetrix chip were treated as missing, but the imputed genotypes were included in the analysis and used to provide partial information on the missing genotypes.', {'entities': [(122, 129, 'imputation'), (11, 14, 'negation')]}),
 ('We used minimac  to impute into the European phase1 version 3 (20101123) panel SNPs and indels reference panel.', {'entities': [(20, 26, 'imputation')]}),
 (' We determined all the most significantly associated SNPs (or an appropriate surrogate) in the GWAS results from METASTROKE, a study of 12,389 individuals with ischemic stroke and 62,004 controls with imputation to the Hapmap2 reference panel.', {'entities': [(201, 211, 'imputation')]}),
 (' A UGT2B10 splice variant, rs116294140, common in African Americans () was successfully imputed (imputation scores ≥ 0.', {'entities': [(88, 95, 'imputation')]}),
 ('3 or proper_info from IMPUTE/SNPTEST > 0.', {'entities': [(22, 28, 'imputation')]}),
 (' Regions with more than one SNP associated with IgE levels at p ≤5x10_−6  underwent in silico  fine mapping using genotype imputation.', {'entities': [(123, 133, 'imputation')]}),
 (' Cohorts uploaded results imputed using the HapMap 2 CEU (r22.', {'entities': [(26, 33, 'imputation')]}),
 (' Imputation was performed by using a 1000 Genomes Phase 1 V3 reference set and the University of Michigan Imputation Server (https://imputationserver.', {'entities': [(133, 149, 'imputation'), (1, 11, 'imputation')]}),
 ('Each study performed genotyping and imputation to the 1000 Genomes Project Phase 1 reference panel (March 2012 release).', {'entities': [(36, 46, 'imputation')]}),
 (' Results for variants with imputation quality () below 0.', {'entities': [(27, 37, 'imputation')]}),
 (' For unrelated samples, association was examined by the linear regression model with MACH2QTL [], in which allele dosage was taken as the predictor for the phenotype.', {'entities': [(85, 90, 'imputation')]}),
 ('The imputation of genome wide SNP information in HEBCS and POSH GWS was performed based on 1000 Genomes Project phase 1 and release version 3 European reference haplotypes.', {'entities': [(4, 14, 'imputation')]}),
 (' () Genome-wide genotype imputation of SNPs and insertion/deletion polymorphisms (indels) was conducted separately by ancestry group using IMPUTE2 () with reference to all 1000 Genomes haplotype panels (see ).', {'entities': [(25, 35, 'imputation'), (139, 145, 'imputation')]}),
 (' Hologic DEXA machines were further divided by the use of pencil-beam or fan-beam measurements.', {'entities': [(14, 18, 'imputation')]}),
 (' After quality control, imputation and filtering, 8,224,478 markers were included in the subsequent association analyses of 245 patients.', {'entities': [(24, 34, 'imputation')]}),
 (' The RPGEH imputed >25 million SNPs not covered in the original genotyping arrays, as well as HLA major histocompatibility complex (MHC) serotypes.', {'entities': [(11, 18, 'imputation'), (36, 39, 'negation')]}),
 (' Prior to discovery meta-analyses, SNPs were excluded if imputation quality metrics (equivalent to the squared correlation between proximal imputed and genotyped SNPs) were <0.', {'entities': [(57, 67, 'imputation')]}),
 (' Association analysis in imputed genotypes was assessed with probabilistic genotypes, correcting for population stratification with the first five principal components as covariates, using logistic regression as implemented in mach2dat.', {'entities': [(25, 32, 'imputation'), (227, 232, 'imputation')]}),
 ('We computed SNP genotype imputation across the genome using the 1000Genomes reference panel to localize the top statistical associations.', {'entities': [(25, 35, 'imputation')]}),
 (' Genotypes were imputed to the 1000 Genome Phase I Integrated Release Version 3 reference panel ().', {'entities': [(16, 23, 'imputation')]}),
 ('Genotype imputation was conducted by each center but followed a similar protocol as detailed below.', {'entities': [(9, 19, 'imputation')]}),
 (' The final data set includes 8\u2009974\u2009355 SNPs (265\u2009096 genotyped and 8\u2009709\u2009259 imputed SNPs).', {'entities': [(77, 84, 'imputation')]}),
 (' PCA was performed using 13,012 LD-pruned SNPs with allele frequency >5% and IMPUTE2 info score >0.', {'entities': [(77, 83, 'imputation')]}),
 (' Imputation was performed as described before ().', {'entities': [(1, 11, 'imputation')]}),
 (' The protocols used for testing association with mach2qtl (ref.', {'entities': [(49, 54, 'imputation')]}),
 (' Plasmid was linearised with SpeI restriction enzyme (New englan Biolabs, UK) and cRNA synthesised in vitro using the T7 mMachine in vitro transcription system (Ambion, Applied Biosystems, Warrington, UK).', {'entities': [(122, 126, 'imputation')]}),
 ('\nAfter imputation and further quality control (filtering SNPs with imputation\ncertainty score (Info)<0.', {'entities': [(7, 17, 'imputation')]}),
 (' We selected only the highest quality imputed SNPs based on a plink imputation quality score (INFO) between 0.', {'entities': [(38, 45, 'imputation')]}),
 (' Quality control for the imputed SNPs included removal of variants with an imputation certainty (info score) <0.', {'entities': [(25, 32, 'imputation')]}),
 ('org) to impute missing genotypes across the three data sets and obtain a concordant set of probes in the total data set.', {'entities': [(8, 14, 'imputation')]}),
 (' These cleaned genotypes formed the basis for imputing additional genomic variants, using the IMPUTE2 software, considering the reference genomes from the 1000 Genomes Project (Phase I integrated variant set release from March 2012, Includes 93 Finnish individuals), and outlined as in the National Center for Biotechnology Information (NCBI) human genome assembly 37 (GRCh37).', {'entities': [(46, 54, 'imputation'), (94, 100, 'imputation')]}),
 (' Individuals of ambiguous imputed sex or of imputed sex inconsistent with reported sex were removed.', {'entities': [(26, 33, 'imputation')]}),
 (' Genotype imputation clouds (ie, the full genotype probability values, not single point estimates) from IMPUTE2 were directly used to assess association using SNPTEST 2.', {'entities': [(10, 20, 'imputation'), (104, 110, 'imputation'), (71, 74, 'negation')]}),
 (' Variants with an imputed MAF ≥ 2% were used in association analyses, for a final analyzed SNP count of 2,193,082.', {'entities': [(18, 25, 'imputation')]}),
 (' First, we Taqman genotyped (Life Technologies) 352 individuals who were also genotyped on our EUR array and imputed with our EUR individuals.', {'entities': [(109, 116, 'imputation')]}),
 (' Allelic dosage data from the imputed SNPs were analyzed for association with asthma status using logistic regression under an additive model; genotypes were coded to measure the effect of the minor allele as previously described.', {'entities': [(30, 37, 'imputation')]}),
 (' The imputation reference was HapMap3 CEU (Utah residents with Northern and Western European ancestry) for subjects of European ancestry.', {'entities': [(5, 15, 'imputation')]}),
 (' Uncertainty of the imputed genotypes was taken into account.', {'entities': [(20, 27, 'imputation')]}),
 (' Thus, the imputed result is a 29 Mb region (140.', {'entities': [(11, 18, 'imputation')]}),
 ('2, rs10489202 ± 350kb and 8p12, rs16887244 ± 350kb) for imputation.', {'entities': [(56, 66, 'imputation')]}),
 ('Within each discovery study, we estimated the association between genotyped or imputed SNPs and the risk of gallstone disease by calculating beta coefficients and their standard errors using logistic regression models adjusted for age, sex and additional study specific covariates, assuming log-additive genetic effects.', {'entities': [(79, 86, 'imputation')]}),
 (' Genotype quality control prior to imputation was conducted separately for four strata: subjects in the San Diego cohort with the Illumina 550 array genotyping data; subjects in the San Diego cohort with the Illumina 650 array genotyping data; subjects in the US cohort with the Omni 2.', {'entities': [(35, 45, 'imputation')]}),
 (' For ARIC, B58C and PLCO, the polymorphic SNPs from the HapMap2 European CEU population were imputed using MACH ().', {'entities': [(93, 100, 'imputation'), (107, 111, 'imputation')]}),
 (' In addition, imputation of 4-digit HLA alleles was performed with HLA*IMP:02 ().', {'entities': [(14, 24, 'imputation')]}),
 (' For African-Americans, SNP data were imputed based on a panel of reference haplotypes using HapMap CEU and YRI samples.', {'entities': [(38, 45, 'imputation')]}),
 (' Detailed cohort descriptions, information about cohort-level genotyping and imputation procedures, cohort-level measures, and quality control filters are shown in  and discussed in the .', {'entities': [(77, 87, 'imputation')]}),
 (' SNPs in each sample were checked for minor allele frequency, Hardy-Weinberg equilibrium and if imputed, for imputation quality.', {'entities': [(96, 103, 'imputation')]}),
 ('05, imputation quality ratio >0.', {'entities': [(4, 14, 'imputation')]}),
 (' Because samples were genotyped in a variety of arrays, we selected only variants that intersected between all arrays to be included in the imputation stage.', {'entities': [(140, 150, 'imputation')]}),
 ('01; (2) an imputation information score or r _2  value of less than 0.', {'entities': [(11, 21, 'imputation')]}),
 (' Further quality control procedures were applied after imputation, yielding a total of 8,268,322 SNPs for further analyses.', {'entities': [(55, 65, 'imputation')]}),
 (' The GWAS data were first pre-phased in SHAPEIT2 , then imputed in IMPUTE2_,   with the 1000 Genomes Project (phase1_release_v3.', {'entities': [(56, 63, 'imputation'), (67, 73, 'imputation')]}),
 (' Imputed SNPs that passed a quality threshold of r _2 \u2009>\u20090.', {'entities': [(1, 8, 'imputation')]}),
 ('” The imputation reference panel was derived from the 2012-02-14 release of the 1000 Genomes Project, which included 246 Africans/African Americans, 379 Europeans, 181 Americans, and 286 Asians, using minimac with default parameter\xa0settings.', {'entities': [(6, 16, 'imputation')]}),
 (' Both populations analysed together with a number of ancestral populations are shown in (c)We performed imputation in MACH 1.', {'entities': [(104, 114, 'imputation'), (118, 122, 'imputation')]}),
 (' After imputation, we removed monomorphic SNPs, SNPs with HWE P  value < 1 × 10_−6 , SNPs with IMPUTE-INFO < 0.', {'entities': [(7, 17, 'imputation'), (95, 101, 'imputation')]}),
 ('05) different when comparing association results from meta-analysis of imputed and assayed genotypes.', {'entities': [(71, 78, 'imputation')]}),
 (' Genotypes were prephased using SHAPEIT2 and imputed using IMPUTE2 into the 1000 Genomes Phase 1 reference panel.', {'entities': [(45, 52, 'imputation'), (59, 65, 'imputation')]}),
 (' We used reference data from the European popultaion in the August 2010 release of the 1000 Genomes Project provided with the Beagle release for our European American sample.', {'entities': [(126, 132, 'imputation')]}),
 (' Genotype data were imputed using Impute2 v2.', {'entities': [(20, 27, 'imputation'), (34, 41, 'imputation')]}),
 ('0 chip, and imputation was performed with MaCH ().', {'entities': [(12, 22, 'imputation'), (42, 46, 'imputation')]}),
 ('Prior to imputation of unobserved genetic polymorphisms, SNPs passing quality filters were “pre-phased” to create haplotypes using SHAPEIT2.', {'entities': [(9, 19, 'imputation')]}),
 (' Cluster plots for associated SNPs were visually inspected to verify genotype calls and, if imputed, were directly genotyped to confirm the result (TaqMan SNP Genotyping Assay, ).', {'entities': [(92, 99, 'imputation')]}),
 (' Imputed genotype dosages were used to take into account uncertainty in the imputation.', {'entities': [(76, 86, 'imputation'), (1, 8, 'imputation')]}),
 (' The GENEVA Coordinating Center also imputed genotypes for SNPs that were observed in the 1000 Genomes Project that did not occur on the SNP array.', {'entities': [(37, 44, 'imputation'), (120, 123, 'negation')]}),
 ('Imputed SNPs in the MHC region were tested for association and for tagging of HLA-B*27 .', {'entities': [(0, 7, 'imputation')]}),
 (' The imputed genotypes were analyzed using logistic regression under an additive model adjusting for the first two principal components and sex.', {'entities': [(5, 12, 'imputation')]}),
 (' In either approach, we obtained very similar imputed genotypes.', {'entities': [(46, 53, 'imputation')]}),
 ('5 million SNPs of high imputation quality (information measure ≥0.', {'entities': [(23, 33, 'imputation')]}),
 (' Imputation was performed using the HapMap2 reference data (release 22, build 36) using MaCH (Li et al.', {'entities': [(1, 11, 'imputation'), (88, 92, 'imputation')]}),
 (' To minimize imputation errors, we additionally excluded SNPs with a MAF <1% and a call rate <98% in any study, SNPs that could not be linked to the 1KGP reference, those with MAF for Europeans that differed from that for the 1KGP, and a further 16,526 SNPs for which the cluster plot was judged to be not ideal.', {'entities': [(13, 23, 'imputation'), (128, 131, 'negation')]}),
 (' Imputation was performed with FISH [], a fast and accurate diploid genotype imputation algorithm that we previously developed.', {'entities': [(77, 87, 'imputation'), (1, 11, 'imputation')]}),
 (' Prior to performing imputation, SNPs were excluded if there were: (i) improper mapping to Genome Reference Consortium GRCh37; (ii) a minor allele frequency (MAF) <0.', {'entities': [(21, 31, 'imputation')]}),
 (' Genotype imputation was performed using MaCH () and minimac ()\nusing 1,000 Genomes () Phase I v3 European\n(EUR) and cosmopolitan reference panels for the NHW and AA subjects.', {'entities': [(10, 20, 'imputation'), (41, 45, 'imputation')]}),
 (' Imputation was conducted with MACH using the HapMap CEU reference sample [].', {'entities': [(1, 11, 'imputation'), (31, 35, 'imputation')]}),
 (' Allele dosage was imputed using the software indicated.', {'entities': [(19, 26, 'imputation')]}),
 (' Genotypes were imputed in both samples to the HapMap CEU panel using MACH algorithm.', {'entities': [(16, 23, 'imputation'), (70, 74, 'imputation')]}),
 (' SNPTEST was used to analyze the posterior SNP dosages from IMPUTE2, adjusting for study center, as described above ().', {'entities': [(60, 66, 'imputation')]}),
 ('Imputation of SNPs was conducted proximal to any SNPs with genome-wide\nsignificance from the trio, case-control or trio-case-control samples.', {'entities': [(0, 10, 'imputation')]}),
 (' Non-genotyped SNPs were imputed for all stage 1 samples using the 1000 Genomes Project data as a reference panel.', {'entities': [(25, 32, 'imputation'), (1, 5, 'negation')]}),
 (' Imputed SNPs with Information<0.', {'entities': [(1, 8, 'imputation')]}),
 (' For each imputed SNP, a reliability of imputation was estimated as the ratio of the empirically observed dosage variance to the expected binomial dosage variance (O/E ratio).', {'entities': [(10, 17, 'imputation')]}),
 ('html) was used to impute untyped SNPs by the LD information from the HapMap phase II database (CHB+JPT was used as reference set, released July 17, 2006; 17).', {'entities': [(18, 24, 'imputation')]}),
 (' As the ImmunoChip genotyping was performed before the imputation, these genotypes were mainly utilized to account for population stratification and relatedness in the later replication analyses.', {'entities': [(55, 65, 'imputation')]}),
 (' Before imputation, 452,154 SNPs for 3,772 individuals (1,208 cases and 2,564 controls) were in the German dataset, and 494,760 SNPs for 3,134 individuals (1,118 cases and 2,016 controls) were in the Dutch dataset.', {'entities': [(8, 18, 'imputation')]}),
 (' QQ and Manhattan plots of genome-wide association studies for loneliness in EA-only subjects using the imputed SNPs, calculated by mixed regression models with adjustments for age, gender, and marital status.', {'entities': [(104, 111, 'imputation')]}),
 (' We performed the association analysis using EMMAX () for the imputed data and GCTA () for the resequenced data, as both employ mixed model approaches and readily support different data formats.', {'entities': [(62, 69, 'imputation')]}),
 (' Imputed variants with an info score\u2009<0.', {'entities': [(1, 8, 'imputation')]}),
 (' After the imputation, a further stringent cleaning procedure was applied thereby removing any imputed SNP with a certainty score below 0.', {'entities': [(11, 21, 'imputation')]}),
 (' Second, we subsetted the 1000 Genomes Project data to the SNPs on the EUR array, and imputed the rs4646284 indel in a leave-one-out manner as described in (), using the 1000 Genomes Project data as a reference.', {'entities': [(86, 93, 'imputation')]}),
 (' The UK biobank array is a high-density custom designed array with 7,348 SNPs across the HLA region (~24,000 high-quality imputed SNPs) and over 830,115 established SNPs across the genome (~4 million high-quality imputed SNPs).', {'entities': [(122, 129, 'imputation')]}),
 (' These genotypes were used to evaluate the imputation accuracy by examining the correlation between array genotypes and imputed dosages.', {'entities': [(43, 53, 'imputation')]}),
 (' Details of genotyping, imputation, and calculation of principal components of ancestry in the UK biobank interim dataset can be found on the UK biobank website (http://www.', {'entities': [(24, 34, 'imputation')]}),
 (' Imputed HLA alleles or amino acid dosages were tested for association using a logistic regression model with covariates to correct for population substructure and genotyping batch.', {'entities': [(1, 8, 'imputation')]}),
 (' To prevent the undue influence of rare variants and/or of poorly imputed SNPs, we included variants with a minor allele count >10 and imputation quality >0.', {'entities': [(66, 73, 'imputation')]}),
 (' Only genotypes with genotype imputation probability (GP) ≥0.', {'entities': [(30, 40, 'imputation')]}),
 ('_,  The association of SNPs, in or near (±20 kb) the top RNA predictor genes, with ΔTG was tested in all HERITAGE white participants using imputed SNPs.', {'entities': [(139, 146, 'imputation')]}),
 (' This method uses a computationally efficient implementation of the Markov chain-based haplotyper (MaCH) algorithm with prephasing using SHAPEIT () as previously described ().', {'entities': [(99, 103, 'imputation')]}),
 (' Imputation results are summarized as an allele dosage\ndefined as the expected number of copies of the minor allele at that SNP (a\nfractional value between 0.', {'entities': [(1, 11, 'imputation')]}),
 (' In total, 161,689 SNPs with poor imputation quality (info score\u2009<\u20090.', {'entities': [(34, 44, 'imputation')]}),
 ('0 array, and ancestry estimation and imputation for this data set were conducted as described for TCGA.', {'entities': [(37, 47, 'imputation')]}),
 ('_,  QCTOOL was used to remove imputed genotypes with a MAF <0.', {'entities': [(30, 37, 'imputation')]}),
 (' GWAS data in the WHI AAs were prephased via MaCH, with options “–states 200” and “–rounds 50.', {'entities': [(45, 49, 'imputation')]}),
 (' Perfect concordance was observed between genotyped and imputed SNPs (100% concordance rate for 144 genotypes).', {'entities': [(56, 63, 'imputation')]}),
 (' All samples genotyped on the Axiom array that passed quality review (n=4,060) were imputed together using the 1000Genomes haplotypes (n=1092) as the phased reference panel.', {'entities': [(84, 91, 'imputation')]}),
 (' Imputation of the combined case–control dataset with the same settings as outlined above resulted in 8.', {'entities': [(1, 11, 'imputation')]}),
 (' We then separately imputed the studies\n(using IMPUTE) with 1KG reference data\n(phase 1 integrated set, March 2012, build 37).', {'entities': [(20, 27, 'imputation'), (47, 53, 'imputation')]}),
 (' Untyped HapMap2 SNPs were imputed using the IMPUTE software package (v2).', {'entities': [(27, 34, 'imputation'), (45, 51, 'imputation')]}),
 ('GWAS samples were imputed by the 1000 genomes project phase 3 sequence variants (as of May, 2013) [].', {'entities': [(18, 25, 'imputation')]}),
 (' We performed downstream association analyses only on observed variants passing quality filters and all imputed variants (a total of 27,887,661 variants), but we filtered the results on the basis of imputation quality (oevar > 0.', {'entities': [(104, 111, 'imputation')]}),
 ('The HLA serotype imputation method used in our study was originally developed and described in detail by Jia et al [].', {'entities': [(17, 27, 'imputation')]}),
 ('Genotypes were phased using SHAPEIT and imputed with IMPUTE2 using reference files from the “1000 Genomes haplotypes–Phase I integrated variant set release (v3) in NCBI build 37 (hg19) coordinates.', {'entities': [(40, 47, 'imputation'), (53, 59, 'imputation')]}),
 (' The effective allele count was defined as twice the product of the MAF, imputation accuracy (r _2 , info score or oevar_imp), and number of cases.', {'entities': [(73, 83, 'imputation')]}),
 (' Many of the imputed SNPs were removed from further analyses because of low call rate and deviation from HWE, probably owing to low LD between genotyped and imputed SNPs.', {'entities': [(13, 20, 'imputation')]}),
 (' The MAAS study imputed to the combined 1000 Genomes (1000G) Pilot + HapMap 3 (release June 2010/Feb 2009) panel.', {'entities': [(16, 23, 'imputation')]}),
 (' Imputation was\nperformed within each study in batches of 300 individuals.', {'entities': [(1, 11, 'imputation')]}),
 (' Quality control of SNPs for inclusion was the same as that for SNP-based analyses: imputation accuracy r _2  > 0.', {'entities': [(84, 94, 'imputation')]}),
 ('3, if using the 24 imputation algorithm MACH, or proper info <0.', {'entities': [(19, 29, 'imputation'), (40, 44, 'imputation')]}),
 (' For GECCO, Rsq was used as the imputation quality measure for imputed SNPs, and SNPs were excluded at different Rsq thresholds based on their MAF; for SNPs with MAF>0.', {'entities': [(32, 42, 'imputation')]}),
 ('3 using SNPTEST software to account for uncertainty in imputation ().', {'entities': [(55, 65, 'imputation')]}),
 (' The association for the imputed variants with SHR was performed by a linear regression with either PLINK (v.', {'entities': [(25, 32, 'imputation')]}),
 (' We genotyped all subjects on Illumina platforms and imputed genotypes using MaCH and minimac () with 1,000 Genomes Phase I v3 reference panels.', {'entities': [(53, 60, 'imputation'), (77, 81, 'imputation')]}),
 ('We used two approaches to validate that we correctly imputed the rs4646284 variant.', {'entities': [(53, 60, 'imputation')]}),
 (' The imputed genotypes were analyzed by PCA-determined ethnicity controlling for the first two principal components and HIV status, and then meta-analyzed in the same way as the original analysis.', {'entities': [(5, 12, 'imputation')]}),
 ('gov/downloads/phasing/2007-08_rel22/phased/) using MACH (version 1.', {'entities': [(51, 55, 'imputation')]}),
 ('Additional SNPs were imputed using IMPUTE2 () and 1000 Genome phase 3 () Asian reference panels\n(504 EAS and 489 SAS).', {'entities': [(21, 28, 'imputation'), (35, 41, 'imputation')]}),
 (' We observe high imputation accuracy (as captured by the INFO score) across a range of minor allele frequencies ().', {'entities': [(17, 27, 'imputation')]}),
 (' Details of data cleaning and genotype imputation have been described by Ferreira et al.', {'entities': [(39, 49, 'imputation')]}),
 (' Then the SNP genotyping data were aligned to the forward strand by checking them against 1000 Genomes Phase I V2 Northern Europeans from Utah (CEU) data using Beagle’s utility programs (http://www.', {'entities': [(160, 166, 'imputation')]}),
 ('Genotype imputation was performed using the prephasing/imputation strategy () by SHAPEIT2 () and IMPUTE2 () for both autosomes and the X chromosome.', {'entities': [(9, 19, 'imputation'), (97, 103, 'imputation')]}),
 (' To improve accuracy of the downstream imputation analysis, cleaned, genotyped SNPs were first aligned to hg19 coordinates and phased by estimation of the samples’ haplotype structures according to the 1000 Genomes Project reference (phase 1, version 3, NCBI build 37, hg19 coordinates, August 2012) using Shapeit2 software ().', {'entities': [(39, 49, 'imputation')]}),
 (' SNPs not on the Illumina array were imputed using minimac  () with reference CEU haplotypes from 1000 Genomes (2/2012) after having been prephased with BEAGLE  ().', {'entities': [(37, 44, 'imputation'), (153, 159, 'imputation'), (6, 9, 'negation')]}),
 (' We imputed against the 1000 Genome reference panel using IMPUTE2 () (first dividing the genome into approximately 5 Mb regions) resulting in (expected) genotypic values for ∼40 M SNPs.', {'entities': [(4, 11, 'imputation'), (58, 64, 'imputation')]}),
 (' For quality, we checked the concordance between the most likely imputed genotype and genotyped results for rs2814778 in the 1,373 overlapping individuals (typed on 1 M and AA subjects who we imputed), which was 99.', {'entities': [(65, 72, 'imputation')]}),
 ('01), were poorly imputed (INFO score\u2009≤\u20090.', {'entities': [(17, 24, 'imputation')]}),
 (' The identical quality control criteria were applied for the imputed SNPs as in the genotyped SNPs.', {'entities': [(61, 68, 'imputation')]}),
 (' Pathway size was determined by the total number of genes in the pathway to which SNPs in the imputed GWAS dataset could be mapped.', {'entities': [(94, 101, 'imputation')]}),
 (' Additionally, we analysed two GWAS (from the Netherlands and Iceland) after the meta-analysis and included these in the replication stage by the same imputation procedure.', {'entities': [(151, 161, 'imputation')]}),
 (' After imputation, we performed quality control (see below).', {'entities': [(7, 17, 'imputation')]}),
 (' Imputation was then performed using IMPUTE2 with reference to the 1000 Genome Project multi-ancestry reference panel (Phase I Integrated, June 2014 haplotypes) (,).', {'entities': [(1, 11, 'imputation'), (37, 43, 'imputation')]}),
 (' Data were phased with SHAPEIT2 and imputed using IMPUTE2 to the 1000 Genomes Phase 3 release (September 2014) reference panel.', {'entities': [(36, 43, 'imputation'), (50, 56, 'imputation')]}),
 (' aureus  infections) and secondary outcome (community-acquired SSTIs), testing the association with each genotyped and each imputed SNP separately.', {'entities': [(124, 131, 'imputation')]}),
 (' As the individual imputation of each case/control set could lead to stratification, imputed data were also subjected to rigorous quality filters in PLINK, including removal of SNPs with call rates < 0.', {'entities': [(19, 29, 'imputation')]}),
 (' Mendelian errors in the imputed SNPs were reviewed and resolved as described in Wetherill et al.', {'entities': [(25, 32, 'imputation')]}),
 (' Imputed SNPs were modeled using the probability of genotypes.', {'entities': [(1, 8, 'imputation')]}),
 (' Genotype imputation was performed using the IMPUTE2 software () in conjunction with the 1000GP Phase 3 reference panel, which has been shown to capture\u2009>99% of SNPs with a frequency\u2009>0.', {'entities': [(10, 20, 'imputation'), (45, 51, 'imputation')]}),
 (' Before imputation, we used PLINK v1.', {'entities': [(8, 18, 'imputation')]}),
 (' For analysis, we imputed the genotypes for all 1000 Genomes SNPs using the Markov chain haplotyping software (MACH) and retained those with pairwise linkage disequilibrium ( >0.', {'entities': [(18, 25, 'imputation'), (111, 115, 'imputation')]}),
 (' In order to infer the untyped genotypes, imputation was performed with Impute2 () using haplotype reference panels from HapMap (CEU+CHB+JPT+YRI) with NCBI Build 36.', {'entities': [(42, 52, 'imputation'), (72, 79, 'imputation')]}),
 (' All models were adjusted for ancestry using STRUCTURE Mach2dat and PLINK, version 1.', {'entities': [(55, 60, 'imputation')]}),
 (' Imputation was performed in 5-Mb non-overlapping intervals.', {'entities': [(1, 11, 'imputation'), (34, 38, 'negation')]}),
 (' Single-nucleotide variants with an imputation accuracy of 0.', {'entities': [(36, 46, 'imputation')]}),
 (' The information content for rs75932628 in the imputed data was 0.', {'entities': [(47, 54, 'imputation')]}),
 (' We imputed for additional autosomal SNPs with IMPUTE v2 (Marchini et al.', {'entities': [(4, 11, 'imputation'), (47, 53, 'imputation')]}),
 (' Approximately 34 million markers (SNPs and insertion–deletion polymorphisms), including the 191,777 functional variants identified through whole-genome sequencing, were imputed in the Icelandic cases and controls.', {'entities': [(170, 177, 'imputation')]}),
 (' After quality control, genotypes were imputed with HapMap Phase II, using a 1 : 1 mixture of the CEU and YRI reference populations.', {'entities': [(39, 46, 'imputation')]}),
 (' The assay for rs150207780 failed; genotyping was not reat-tempted because this SNP showed no residual association signal in the analyses of the imputed data with conditioning on the missense variant rs373863828 ().', {'entities': [(145, 152, 'imputation'), (91, 93, 'negation'), (50, 53, 'negation')]}),
 (' The machines were calibrated daily.', {'entities': [(5, 9, 'imputation')]}),
 ('9 to remove questionable imputed SNPs which then added 565808 (AC), 2181130 (NE), 2651672 (MA) and 2877419 (TH) imputed SNPs.', {'entities': [(25, 32, 'imputation')]}),
 ('Imputation and phasing were performed by MaCH software, using the East\nAsian panel and European panel in the 1000 Genomes Project, as references for\nJapanese and French populations, respectively.', {'entities': [(0, 10, 'imputation'), (41, 45, 'imputation')]}),
 ('3 for MACH http://www.', {'entities': [(6, 10, 'imputation')]}),
 (' Within each study, stringent quality control of the GWAS genotype scaffold was undertaken, prior to imputation ().', {'entities': [(101, 111, 'imputation')]}),
 (' Imputed SNPs with deviations from Hardy-Weinberg equilibrium were filtered out of downstream analyses.', {'entities': [(1, 8, 'imputation')]}),
 (' When we excluded imputation data to confirm the results by\navoiding batch effects derived from different genotyping methods, German cases were combined with French cohorts because\nimputation data were used for all German controls.', {'entities': [(18, 28, 'imputation')]}),
 (' Mayo Clinic, UCSF and Mayo Clinic Biobank SNP data were each phased and imputed using the Michigan Imputation Server with the Haplotype Reference Consortium (release 1; http://www.', {'entities': [(73, 80, 'imputation'), (100, 110, 'imputation')]}),
 ('After applying the QC filters, whole-genome SNP genotype imputation was carried out with IMPUTE v.', {'entities': [(57, 67, 'imputation'), (89, 95, 'imputation')]}),
 ('01 were used to impute the approximately 2.', {'entities': [(16, 22, 'imputation')]}),
 (' Imputation was performed with IMPUTE2 using the 1000 Genomes project (phase 1 v.', {'entities': [(1, 11, 'imputation'), (31, 37, 'imputation')]}),
 (' For the imputed data for AMD-MMAP, allele dosage scores were used in association tests.', {'entities': [(9, 16, 'imputation')]}),
 (' Imputed variants with R_2  ≤ 0.', {'entities': [(1, 8, 'imputation')]}),
 ('Genotyping platforms and imputation methods for each participating study are described in .', {'entities': [(25, 35, 'imputation')]}),
 (' The UGT2B10 missense SNP, rs61750900, was successfully imputed (with imputation scores from 0.', {'entities': [(56, 63, 'imputation')]}),
 (' For each of these loci, we then re-assessed the amount of association signals through fixed-effects inverse variance meta-analysis of the two cohorts for all 37,000 available traits using imputed SNPs relative to HapMap2 data (see Online Methods for details).', {'entities': [(189, 196, 'imputation')]}),
 (' Under imputation R_2 >0.', {'entities': [(7, 17, 'imputation')]}),
 (' Outlying metabolite concentration values (data points) and outlying samples were also removed, and the missing data points were imputed with the ‘R’ package ‘mice’.', {'entities': [(129, 136, 'imputation')]}),
 (' Finally, aligned and prephased genotyped SNP data were imputed genome wide using the IMPUTE2 toolset with 1000 Genomes phase 1 as the reference panel.', {'entities': [(56, 63, 'imputation'), (86, 92, 'imputation')]}),
 (' After quality control of imputation data, 2,731,086 SNPs in PanScan and 2,307,550 SNPs in ChinaPC were available for analysis.', {'entities': [(26, 36, 'imputation')]}),
 ('_,  For SNPs that were only genotyped in set 1 subjects and were imputed in set 2 subjects, association tests results were combined by meta-analysis using PLINK.', {'entities': [(65, 72, 'imputation')]}),
 (' After imputation, a total of 6 812 394 SNPs were included in the initial GWAS step and the meta-analysis of the three GWAS.', {'entities': [(7, 17, 'imputation')]}),
 ('0 for pre-phasing with the –X chromosome flag (no reference panel) in the entire cohort and IMPUTE2 with the Phase 3 1KG Project reference panel for imputation using the –chrX flag on 500kb chunks in randomly assigned subsets of 30,000 individuals.', {'entities': [(149, 159, 'imputation'), (92, 98, 'imputation'), (47, 49, 'negation')]}),
 ('07 () on imputed dosages.', {'entities': [(9, 16, 'imputation')]}),
 (' Genotypes were imputed for SNPs not present in/on arrays or for those where genotyping had failed to meet the QC criteria.', {'entities': [(16, 23, 'imputation'), (33, 36, 'negation')]}),
 (' In the CHARGE cohorts, genotype quality control and imputation were conducted in each study separately.', {'entities': [(53, 63, 'imputation')]}),
 (' Details of the genotype imputation procedure have been described previously (,).', {'entities': [(25, 35, 'imputation')]}),
 (' Imputation was performed using MACH 1.', {'entities': [(1, 11, 'imputation'), (32, 36, 'imputation')]}),
 (' For the KORA S4 replication sample, SNP genotypes were imputed against the 1,000 g phase1 integrated haplotypes reference set.', {'entities': [(56, 63, 'imputation')]}),
 ('org/) following the Enhancing Neuroimaging Genetics through Meta-Analysis 2 (ENIGMA 2) imputation protocol (http://enigma.', {'entities': [(87, 97, 'imputation')]}),
 (' Prior to genetic association testing, variants were filtered in each\nsubcohort separately using the following exclusion criteria: (1) imputation\nquality (INFO) score <0.', {'entities': [(135, 145, 'imputation')]}),
 ('Logistic regression was used to test for association between SNPs and disease, treating disease status as the response and expected genotype counts from imputation or allele counts from direct genotyping as covariates.', {'entities': [(153, 163, 'imputation')]}),
 (' To control for difference in allele frequency caused by genotyping or imputation artifacts, we performed a control–control analysis using the MLMA-LOCO method as described above to test for allele frequency (AF) difference between TP-Han (n  = 373) and WZ-Han + GERA-EAS (n  = 6,911) and removed SNPs at P  < 1 × 10_−6 .', {'entities': [(71, 81, 'imputation')]}),
 ('Following uniform quality control and imputation using the 1000 Genomes Project (phase 3) () in the anorexia nervosa case-control cohorts, we performed association analysis using an additive model using the dosage data for each cohort.', {'entities': [(38, 48, 'imputation')]}),
 (' To refine these admixture mapping regions and in an effort to reveal genes or variants that contribute to population-level trait differences, we performed conditional analyses with all typed and imputed SNPs in each region.', {'entities': [(196, 203, 'imputation')]}),
 ('_,  We analysed imputed SNP dosages from 1 250 922 autosomal SNPs.', {'entities': [(16, 23, 'imputation')]}),
 (' To enable us to combine data from all studies for our GWA\nmeta-analysis we used information on SNP genotypes in our samples and HapMap\nII data to statistically predict (impute) all SNP genotypes for all\nindividuals.', {'entities': [(170, 176, 'imputation')]}),
 ('We performed genotype imputation separately in each of the four QC cleaned and filtered genotyping sets using BEAGLE () and a HapMap 3 reference panel ().', {'entities': [(22, 32, 'imputation'), (110, 116, 'imputation')]}),
 ('To estimate the effect of using pre- instead of post-bronchodilator lung\nfunction on our results, we examined the top set of genome-wide significant\nresults in our largest cohorts with both pre- and post-bronchodilator data and\ndensely imputed genotypes (COPDGene NHW and AA, ECLIPSE, NETT-NAS, and\nNorway/GenKOLS).', {'entities': [(236, 243, 'imputation')]}),
 (' The genomic control parameter λ for bacteremia\xa0overall and pneumococcal bacteremia after imputation and QC\xa0were 1.', {'entities': [(90, 100, 'imputation')]}),
 (' Imputation was performed chunk-wise with 5-Mbp sequences in each chunk.', {'entities': [(1, 11, 'imputation')]}),
 ('6% and MACH r _2  0.', {'entities': [(7, 11, 'imputation')]}),
 (' All studies imputed approximately 2.', {'entities': [(13, 20, 'imputation')]}),
 ('Imputation for non-genotyped autosomal SNPs was carried out using MACH version 1.', {'entities': [(0, 10, 'imputation'), (66, 70, 'imputation'), (15, 19, 'negation')]}),
 ('We selected variants with high imputation accuracy (mean r_2 >0·80) yielding an association at p<5 × 10_−6  significance level with all stroke, ischaemic stroke, cardioembolic ischaemic stroke, or non-cardioembolic ischaemic stroke.', {'entities': [(31, 41, 'imputation'), (197, 201, 'negation')]}),
 ('5 million HapMap SNPs by using either MACH  (ARIC, InCHIANTI), BEAGLE  (CARDIA), BIMBAM  (CHS), or IMPUTE  (MESA).', {'entities': [(99, 105, 'imputation'), (63, 69, 'imputation'), (38, 42, 'imputation')]}),
 (' Genome-wide imputation of the pediatric samples was performed with the IMPUTE2 package (B.', {'entities': [(13, 23, 'imputation'), (72, 78, 'imputation')]}),
 (' An additive effect of a SNP was included in the model as a quantitative estimate between 0 and 2 representing the probability score of the effect allele to incorporate the uncertainty of the imputation estimates.', {'entities': [(192, 202, 'imputation')]}),
 (' Imputation was performed using SHAPEIT and IMPUTE2 to a reference panel from the 1000 Genomes Project (1KGP; March, 2012) (,).', {'entities': [(1, 11, 'imputation'), (44, 50, 'imputation')]}),
 ('_,   The association of SNPs, in or near (±20 kb) the top RNA predictor genes, with ΔTG was tested in all HERITAGE white participants using imputed SNPs.', {'entities': [(140, 147, 'imputation')]}),
 (' Only SNPs that had an imputation quality above 0.', {'entities': [(23, 33, 'imputation')]}),
 (' Imputation of missing SNPs was performed using IMPUTE 2 () on build 36 and release 22 of HapMap.', {'entities': [(1, 11, 'imputation'), (48, 54, 'imputation')]}),
 (' Imputed genotype data was analyzed using an additive genetic model.', {'entities': [(1, 8, 'imputation')]}),
 (' Moreover, to take into account the uncertainty of imputation, we have done the same association in PLINK1.', {'entities': [(51, 61, 'imputation')]}),
 (' We used logistic regression based on imputed dosages to assess the association between each SNP and any of the FTD subtypes, adjusting for eigenvectors 1 and 2 from principal components analysis as covariates.', {'entities': [(38, 45, 'imputation')]}),
 (' For the 22 autosomes, analysis was performed using genotyped and imputed SNPs.', {'entities': [(66, 73, 'imputation')]}),
 ('05/45) based on the number of genotyped SNPs with VIF <2 in the imputed region (139.', {'entities': [(64, 71, 'imputation')]}),
 (' We used the program BEAGLE version 3.', {'entities': [(21, 27, 'imputation')]}),
 (' For iCOGS and OncoArray, we included data for all SNPs with imputation r _2  >0.', {'entities': [(61, 71, 'imputation')]}),
 ('() Each cohort was cleaned, imputed, and analyzed separately to avoid batch effects.', {'entities': [(28, 35, 'imputation')]}),
 (' For imputation of genotypes to the HapMap set of 2.', {'entities': [(5, 15, 'imputation')]}),
 (' All analyses were performed using an additive genetic model (ie, genotyped SNPs were coded 0, 1, or 2 based on the number of minor alleles [with 0 being homozygous for the reference allele, 1 being heterozygous, and 2 being homozygous for the minor allele], and imputed SNPs were coded based on the posterior probability of the minor allele [0–2]).', {'entities': [(263, 270, 'imputation')]}),
 (' The deCODE analysis included a referent set derived from Icelandic individuals who have been sequenced; it therefore provides more accurate imputation for rare variants than imputation analysis used by other sites.', {'entities': [(141, 151, 'imputation')]}),
 (' Standard quality control filters were applied to the genotyping, restricting the imputation to samples and SNPs with high data quality.', {'entities': [(82, 92, 'imputation')]}),
 (' MACH (see URLs) was used for imputation in the Dutch and Australian cohorts.', {'entities': [(30, 40, 'imputation'), (1, 5, 'imputation')]}),
 (' For each trait, we filtered the summary statistics to the subset of HapMap 3 SNPs to decrease the potential for bias due to poor imputation quality.', {'entities': [(130, 140, 'imputation')]}),
 (' IMPUTE version 2.', {'entities': [(1, 7, 'imputation')]}),
 ('Imputation was performed for all autosomes using IMPUTE2 (https://mathgen.', {'entities': [(0, 10, 'imputation'), (49, 55, 'imputation')]}),
 (' Genotypes in all four GWAS were imputed for ~2.', {'entities': [(33, 40, 'imputation')]}),
 (' Quality control filters applied for exclusions of SNPs from the meta-analysis were: imputation quality score of <0.', {'entities': [(85, 95, 'imputation')]}),
 (' We then imputed the cleaned genotype data to 1000G reference panels (phase 1) () using IMPUTE2 ().', {'entities': [(9, 16, 'imputation'), (88, 94, 'imputation')]}),
 (' IMPUTE software (version 2) was used for haplo type-based inference (ie, imputation) of missing genotypes in regions for which genotype information was not covered by the SNP array, with data from the 1000 Genomes Project as a reference.', {'entities': [(74, 84, 'imputation'), (1, 7, 'imputation'), (153, 156, 'negation')]}),
 (' Finally, we ran PCA for 100,000 randomly selected imputed sites across all individuals as well as for the maximum number of unrelated individuals to test whether the primary source of aggregated imputed variation arose from technical artifacts or population/familial structure.', {'entities': [(51, 58, 'imputation')]}),
 ('5 million autosomal SNPs by using a hidden Markov model algorithm implemented in MACH for FOS and Health ABC and IMPUTE2 for MESA ().', {'entities': [(113, 119, 'imputation'), (81, 85, 'imputation')]}),
 ('To meta-analyze genotype data generated from multiple platforms and to increase the coverage of variation that is measurable across the genome, imputation of genotypes was performed for both autosomal (all consortia) and X chromosome (excluding GECCO consortium) markers.', {'entities': [(144, 154, 'imputation')]}),
 ('50, 1,695,815 genotyped or imputed SNPs remained for meta-analyses.', {'entities': [(27, 34, 'imputation')]}),
 ('3, we selected 31 imputed SNPs and successfully genotyped 22 out of the 31 SNPs.', {'entities': [(18, 25, 'imputation')]}),
 (' A global reference panel was used to increase imputation accuracy by allowing the software to create a unique reference panel for each individual.', {'entities': [(47, 57, 'imputation')]}),
 (' The imputation reference panel was HapMap 3 release 2.', {'entities': [(5, 15, 'imputation')]}),
 ('edu/wiki/Mach2dat:_Association_with_MACH_output last accessed on March, 2016.', {'entities': [(9, 14, 'imputation')]}),
 ('To replicate association findings in Hispanic/Latino samples, we used 1000 Genomes imputed GWAS data available in three additional Hispanics/Latinos samples, including up to 3\xa0454 from the WHI SHARe project (); 782 from the MESA cohort (,) and 2\xa0854 from Mount Sinai BioMe Biobank ().', {'entities': [(83, 90, 'imputation')]}),
 (' This pipeline was used for the GWAS of single serum and urinary metabolite concentrations and the FEs, using filtered imputed data of genotype dosages and assuming an additive genetic model.', {'entities': [(119, 126, 'imputation')]}),
 ('org/) database as the reference genome, leveraging linkage disequilibrium (LD) within racial ethnic groups (Northern European ancestry, West African ancestry, and other) with MaCH-Admix software (University of North Carolina) for the COG AALL0232 and SJ Total XV cohorts, and IMPUTE2 (University of Oxford, United Kingdom) for the Vanderbilt cohort.', {'entities': [(276, 282, 'imputation'), (175, 179, 'imputation')]}),
 ('Associations between phenotypes and SNPs (both genotyped and imputed) were tested under an additive mode of inheritance.', {'entities': [(61, 68, 'imputation')]}),
 ('Genotyping and imputation were conducted as described in Supplemental Table 2.', {'entities': [(15, 25, 'imputation')]}),
 ('01and imputation R_2  > 0.', {'entities': [(6, 16, 'imputation')]}),
 (' Similarly, IMPUTE v2 (, ) was used in the imputation of MESA samples.', {'entities': [(43, 53, 'imputation'), (12, 18, 'imputation')]}),
 ('uk/impute) ().', {'entities': [(3, 9, 'imputation')]}),
 (', biomarker levels or vascular disease) in the VISP sample using SNPs that were genotyped, imputed, or had appropriate surrogate SNP data by linkage disequilibrium (LD) r _2  > 0.', {'entities': [(91, 98, 'imputation')]}),
 (' Performance of software for imputation is generally similar between the most used methods_,  for common variants (MACH, IMPUTE and BEAGLE); the protocols provided included use of the MACH tool.', {'entities': [(29, 39, 'imputation'), (121, 127, 'imputation'), (132, 138, 'imputation'), (115, 119, 'imputation')]}),
 ('gov/1000genomes/ftp/release/20110521))_,  helps improve imputation accuracy of low-frequency variants.', {'entities': [(56, 66, 'imputation')]}),
 (' Imputation was carried out using IMPUTE2 version 2.', {'entities': [(1, 11, 'imputation'), (34, 40, 'imputation')]}),
 (' Genome-wide imputation was performed with the full, cosmopolitan 1000 Genomes Project phase 1 reference panel (); associations for novel loci were confirmed with 1000 Genome phase 3 imputation panel.', {'entities': [(13, 23, 'imputation')]}),
 ('Full details of the genotyping, imputation and QC procedures are given in the Supplementary Material.', {'entities': [(32, 42, 'imputation')]}),
 (' Regional association plots (Supplemental Figure 3) were created using imputed and meta-analyzed data.', {'entities': [(71, 78, 'imputation')]}),
 (' Imputation of the CHOP cohort was conducted at the Center for Applied Genomics.', {'entities': [(1, 11, 'imputation')]}),
 (' To further protect against potential errors misleading the imputation and phasing, we checked that each genotype conformed to local patterns of linkage disequilibrium in HapMap by using a leave-one-out imputation strategy.', {'entities': [(60, 70, 'imputation')]}),
 (' We imputed the WTCCC genotyped data for 5667 subjects into the phase I version 3 reference panels from the 1000 Genomes Project using IMPUTE.', {'entities': [(4, 11, 'imputation'), (135, 141, 'imputation')]}),
 (' SNP imputation to the 1000 Genomes Project is described in the .', {'entities': [(5, 15, 'imputation')]}),
 (' Genotypes of SNPs that were not genotyped were imputed by IMPUTE 2.', {'entities': [(48, 55, 'imputation'), (59, 65, 'imputation'), (29, 32, 'negation')]}),
 ('uk) and resulted in 87,696,888\nimputed variants.', {'entities': [(31, 38, 'imputation')]}),
 (' Imputation was conducted using IMPUTE4, a modified version of IMPUTE2, and the 1000 Genomes Project (phase 3), UK10K and Haplotype Reference Consortium reference panels, resulting in 92\u2009693\u2009895 autosomal SNPs, short indels and large structural variants.', {'entities': [(1, 11, 'imputation'), (32, 38, 'imputation')]}),
 (' Imputation was based on the HapMap II CEU population and resulted in approximately 2.', {'entities': [(1, 11, 'imputation')]}),
 (' For each SNP, the z-statistic, derived from the P-value and direction of effect, was weighted by the effective sample size, which is the product of the sample size and the product of the sample size and the ratio of the empirically observed dosage variance to the expected binomial dosage variance for imputed SNPs.', {'entities': [(303, 310, 'imputation')]}),
 (' In the primary GWAS data set, 44 644 SNPs on the microarray and 135 individuals with call rates <98% were excluded, and 62 076 additional SNPs were removed before imputation because of minor allele frequencies (MAF) <1%.', {'entities': [(164, 174, 'imputation')]}),
 (' Association testing for typed or imputed SNPs was performed by linear regression of log-transformed WBC count adjusted for age, sex and PCs.', {'entities': [(34, 41, 'imputation')]}),
 (' Second, genotype imputations of ∼2.', {'entities': [(18, 29, 'imputation')]}),
 ('Imputation of chromosome 15 in the LSC was conducted using BEAGLE (version 3.', {'entities': [(0, 10, 'imputation'), (59, 65, 'imputation')]}),
 (' Imputation of classical HLA alleles at the HLA-A , HLA-B , and the HLA-C  loci were conducted using HLA*IMP ().', {'entities': [(1, 11, 'imputation')]}),
 (' Imputed SNPs having a reported r _2  score of <0.', {'entities': [(1, 8, 'imputation')]}),
 (' Imputation was performed on the Michigan Imputation Server (https://imputationserver.', {'entities': [(69, 85, 'imputation'), (1, 11, 'imputation')]}),
 (' Imputation was performed using 1000 Genomes Project data (June 2011 Data Release)() as the reference panel using IMPUTE v2.', {'entities': [(1, 11, 'imputation'), (114, 120, 'imputation')]}),
 (' Imputation results were summarized as an “allele dosage” (a fractional value between 0 and 2), defined as the expected number of copies of the minor allele at that SNP.', {'entities': [(1, 11, 'imputation')]}),
 (' The “most likely” genotypes were used in the QLSw test; therefore, imputed SNPs were treated the same as genotyped SNPs.', {'entities': [(68, 75, 'imputation')]}),
 ('0 were used to perform imputation.', {'entities': [(23, 33, 'imputation')]}),
 (' However, we chose not to test all imputed markers at the beginning of the study based on a power consideration.', {'entities': [(35, 42, 'imputation'), (19, 22, 'negation')]}),
 (' We transformed the SNP information of imputed genotypes on NCBI build 35 or GRCh build 37 to NCBI build 36 to match the data with HapMap-imputed genotypes of the other studies.', {'entities': [(39, 46, 'imputation')]}),
 (' From the imputed SNP genotype data for the KORA S4 target sample, the SNPs corresponding with the remaining clump index SNPs were selected.', {'entities': [(10, 17, 'imputation')]}),
 ('Within each cohort, association analyses were performed by linear regression using an additive model across genotyped and imputed SNPs (dosages), for males and females separately.', {'entities': [(122, 129, 'imputation')]}),
 (' In a first pre-phasing step, we used MaCH  to estimate haplotypes for the IHPS study samples.', {'entities': [(38, 42, 'imputation')]}),
 ('5 milion SNPs using MACH.', {'entities': [(20, 24, 'imputation')]}),
 (' Overlaps were counted for the all SNPs against which genotypes were imputed in 1000 genomes for each H3K27Ac dataset.', {'entities': [(69, 76, 'imputation')]}),
 ('Details on genotyping methods, quality control, imputation, and software are provided in detail in .', {'entities': [(48, 58, 'imputation')]}),
 (' Imputed variants with a MAF <1% or INFO score <0.', {'entities': [(1, 8, 'imputation')]}),
 ('SNP Imputation was conducted to increase the density of untyped markers around significant and suggestive association signals using the statistical program IMPUTE2 using a multi-ethnic reference panel from four continents (Africa, North and South America, Asia, and Europe) as part of the 1000 Genomes Project.', {'entities': [(4, 14, 'imputation'), (156, 162, 'imputation')]}),
 ('7 (as estimated by MACH) were removed.', {'entities': [(19, 23, 'imputation')]}),
 (' The imputation was done using IMPUTE v2.', {'entities': [(5, 15, 'imputation'), (31, 37, 'imputation')]}),
 (' All studies used their genotype data to impute to the 2.', {'entities': [(41, 47, 'imputation')]}),
 (' The Multiple Imputation effect estimation was calculated as follows: \n β¯MI=1m∑j=1mβj  The variance was calculated as the sum of within-replicate and between-replicate variances σMI2=1mσ⌢j2+1m-1∑j=1m(β¯MI-βj)2 Confidence intervals were retrieved using the 95% quantile of a Student distribution with a number of degrees of freedom, which is a function of the two components of the variance.', {'entities': [(14, 24, 'imputation')]}),
 (' Imputed SNPs were excluded for exhibiting an information score of < .', {'entities': [(1, 8, 'imputation')]}),
 (' First, we assessed the homozygous reference, heterozygous, and homozygous non-reference concordance between the imputed output and two low-pass genome sequences from individuals SA1000 and SA1025 at sites that passed variant call filters and with > 5 reads.', {'entities': [(113, 120, 'imputation'), (75, 79, 'negation')]}),
 ('Because the top signal from the cross-disorder GWAS was primarily imputed, we selected 6 SNPs for confirmation genotyping in the linkage disequilibrium block identified by the imputed dataset.', {'entities': [(66, 73, 'imputation')]}),
 (' The number of\nvariants imputed at R _2  greater than 0.', {'entities': [(24, 31, 'imputation')]}),
 (' SNPs genotyped or imputed in at least 40% of Alzheimer’s disease cases and 40% of control samples were included in the meta-analysis.', {'entities': [(19, 26, 'imputation')]}),
 (' Tables and figures specify whether each result derives from a SNP that was genotyped in all subjects, imputed in all subjects, or represents a combination of genotyped and imputed data using the meta-analysis approach described.', {'entities': [(103, 110, 'imputation')]}),
 (' PGS were calculated for all individuals of the NTR and NESDA target set by taking a set of most significant SNPs from the analysis in the discovery set and by multiplying the individual’s genotypic score (0, 1 or 2 for genotyped SNPs, or any value in between 0 and 2 for imputed SNPs) by the effect size of a particular SNP (unstandardized regression coefficient based on the meta-analysis), and summing this over SNPs.', {'entities': [(272, 279, 'imputation')]}),
 (' A total of 704,409 and 706,040 SNPs passed quality control in the NHS and HPFS sets, respectively, and were used to impute the genotypes of other SNPs by means of MACH.', {'entities': [(117, 123, 'imputation'), (164, 168, 'imputation')]}),
 (' After filtering we had 437,652 SNPs that were used for imputation.', {'entities': [(56, 66, 'imputation')]}),
 ('After QC and imputation, 16,851 cases and 32,473 controls across 15 ancestry-specific groups were available for genome-wide testing (, ).', {'entities': [(13, 23, 'imputation')]}),
 (' For meta-analysis of stepwise regression results and generation of association meta-p-values needed for construction of 95% Bayesian credible sets, the analyses for a region were restricted to those discovery studies with good coverage in the region, and only those markers well imputed in all included studies were tested.', {'entities': [(280, 287, 'imputation')]}),
 (' UK Biobank-CMC used a newer imputation reference panel than the other studies, and where a requested variant was not available, a proxy was used (next most significant P  value with LD r _2 >0.', {'entities': [(29, 39, 'imputation'), (114, 117, 'negation')]}),
 (' Each study performed a genome-wide association analysis for tHcy concentrations by using either MACH2QTL (www.', {'entities': [(97, 102, 'imputation')]}),
 ('edu/csg/abecasis/MACH/), minimac () (http://genome.', {'entities': [(17, 21, 'imputation')]}),
 (' 334,631 SNPs remained for\nimputation.', {'entities': [(27, 37, 'imputation')]}),
 (' For each SNP, the Z  statistic was weighted by the effective sample size (product of the sample size and the ratio of the empirically observed dosage variance to the expected binomial dosage variance for imputed SNPs).', {'entities': [(205, 212, 'imputation')]}),
 ('8% of the reference SNPs used by HiBAG were missing genotype data, we repeated the HLA imputation after filling-in missing genotype data with the “best guess” imputed SNP data from the 1000 genomes imputation described above.', {'entities': [(87, 97, 'imputation')]}),
 (' We considered the top imputed lead SNP for each locus and, in addition, any of its near-perfect proxies (defined as r _2  > 0.', {'entities': [(23, 30, 'imputation')]}),
 (' We were able to accurately impute (see below) many SNPs removed by the QC steps.', {'entities': [(28, 34, 'imputation')]}),
 ('5 million autosomal imputed SNPs data are made available on these 2226 individuals.', {'entities': [(20, 27, 'imputation')]}),
 (' In each fragment, haplotypes of the individual GWA study were phased by a MArkov Chain Haplotyping algorithm (MACH) (,).', {'entities': [(111, 115, 'imputation')]}),
 ('3 (for IMPUTE) in each cohort.', {'entities': [(7, 13, 'imputation')]}),
 (' Imputation results are summarized as an ‘allele dosage’ (a fractional value between 0 and 2), defined as the expected number of copies of the minor allele at that SNP.', {'entities': [(1, 11, 'imputation')]}),
 ('6 as cut-offs to ensure high imputation data quality.', {'entities': [(29, 39, 'imputation')]}),
 (' There was high concordance between directly genotyped variants with imputed dosages of the same variants after masking ().', {'entities': [(69, 76, 'imputation')]}),
 ('IMPUTE2, a genotype imputation method, was applied to impute the European ancestry dataset to the 1000 Genomes Project Phase 3 integrated autosomal reference panel.', {'entities': [(20, 30, 'imputation'), (0, 6, 'imputation')]}),
 ('edu/wiki/Minimac) and mach2dat (http://genome.', {'entities': [(22, 27, 'imputation')]}),
 (' The reference set for imputation was the Utah residents with ancestry from northern and western Europe available via  the HapMap.', {'entities': [(23, 33, 'imputation')]}),
 (' The ∼280K SNPs passing QC in all batches were used as input to the imputation process that involved standalone phasing without reference panel of the ∼280K SNPs using MACH v.', {'entities': [(68, 78, 'imputation'), (168, 172, 'imputation')]}),
 ('9 with 97 percent having imputation r > 0.', {'entities': [(25, 35, 'imputation')]}),
 ('Fine-scale imputation at CACNA1A  was performed using all 1,484 XFS cases and 1,188 controls passing the standard GWAS QC checks.', {'entities': [(11, 21, 'imputation')]}),
 (' The total number of SNPs that were imputed was 21764463 (See  for additional details).', {'entities': [(36, 43, 'imputation')]}),
 ('16 with the HapMap3 CEU and TSI populations as an reference, which was further extended with a population specific sample set of 81 Finns (imputation methods and reference samples previously described by Surakka et al ).', {'entities': [(139, 149, 'imputation')]}),
 (' _–  Genotypes were imputed to the ~2.', {'entities': [(20, 27, 'imputation')]}),
 ('5 between imputed and the nearest genotyped SNPs, MAF <5%, and HWE p  < 1 × 10_−6 .', {'entities': [(10, 17, 'imputation')]}),
 (' SNPs with call rates >90%, minor allele frequencies >3%, and that had genotype distributions that did not deviate from the expected by Hardy-Weinberg equilibrium (in controls; P>10_−6 ) were retained for imputation using IMPUTE2.', {'entities': [(205, 215, 'imputation'), (222, 228, 'imputation'), (103, 106, 'negation')]}),
 (' We performed imputations in two stages: pre-phasing using the MACH software/library and imputation using Minimac software (Abecasis Lab, Ann Arbor, MI) [, ].', {'entities': [(14, 25, 'imputation'), (63, 67, 'imputation')]}),
 ('edu/wiki/Minimac), resulting in a total of 8,248,570 and 8,349,255 imputed SNPs in the OAI and JoCo, respectively, available for analyses after removal of SNPs with low minor allele frequencies (<1%) and poor imputation quality scores (<0.', {'entities': [(67, 74, 'imputation')]}),
 (' All but one study used imputed genotypes based on the 1000GpIv3 “All” reference panel ().', {'entities': [(24, 31, 'imputation')]}),
 (' The imputation of 11,572,501 autosomal SNPs was conducted using the MACH (http://www.', {'entities': [(5, 15, 'imputation'), (69, 73, 'imputation')]}),
 ('005 in reference panels were excluded from imputation.', {'entities': [(43, 53, 'imputation')]}),
 ('3,\ndepending on the imputation software used) were excluded (see  for number of\nSNPs removed during filtering).', {'entities': [(20, 30, 'imputation')]}),
 (' Association study of genome-wide imputed genotypes was performed with SNPTEST v2.', {'entities': [(34, 41, 'imputation')]}),
 ('5M arrays for the CHOP imputation and the 1M and 2.', {'entities': [(23, 33, 'imputation')]}),
 ('0 () (details in )In order to determine the quality of imputation, we performed targeted deep sequencing of the 300kb region (chr8: 75,400,000–75,700,000) surrounding the chromosome 8 GWAS signal in a total of 997 patients (249 with and 748 without a breast event).', {'entities': [(55, 65, 'imputation')]}),
 (' Two scores were calculated, both including the 57 risk SNPs and either including or excluding alleles imputed as above for the four HLA effects (HLA-DRB1*15:01, DRB1*03:01, DRB1*13:03 and HLA–A*02:01) established in our previous genome-wide association study on susceptibility including this data set ().', {'entities': [(103, 110, 'imputation')]}),
 (' Likewise, data from PCGC CTD and LVOTD trios were imputed together.', {'entities': [(51, 58, 'imputation')]}),
 (' Haplotypes of bi-allelic variants, including SNPs and bi-allelic insertions/deletions, were extracted to form reference panels for imputation.', {'entities': [(132, 142, 'imputation')]}),
 (' APOE  genotype data were merged with the imputed genotype dataset.', {'entities': [(42, 49, 'imputation')]}),
 ('Imputation was conducted using BEAGLE.', {'entities': [(0, 10, 'imputation'), (31, 37, 'imputation')]}),
 (' To evaluate the performance of the imputation, we randomly masked 5% of the markers (n =1,046) directly genotyped on chromosome 12 and compared the imputed genotypes with the Affymetrix genome-wide Human SNP array 5.', {'entities': [(36, 46, 'imputation')]}),
 (' Genotypes were imputed into the 1000 Genomes October 2014 (Phase 3, version 5)  European reference panel for both data sets.', {'entities': [(16, 23, 'imputation')]}),
 (' This left 254,457 autosomal SNPs for imputation.', {'entities': [(38, 48, 'imputation')]}),
 (' Control individuals for which the imputed genotypes were more than 4.', {'entities': [(35, 42, 'imputation')]}),
 (' IMPUTEv2_,  was used and the reference panel consisted of 120 European samples from HapMap release #24 (NCBI build36, Nov 2008).', {'entities': [(1, 7, 'imputation')]}),
 ('05, imputation INFO > 0.', {'entities': [(4, 14, 'imputation')]}),
 (' Additional single-nucleotide variants (SNVs) were imputed using Minimac3 implemented in Michigan Imputation Server (https://imputationserver.', {'entities': [(51, 58, 'imputation'), (98, 108, 'imputation')]}),
 (' Genome-wide imputation in HCHS/SOL was carried out using the full, cosmopolitan 1000 Genomes Project phase 1 reference panel (n \u2009=\u20091\xa0092) (), as previously described ().', {'entities': [(13, 23, 'imputation')]}),
 (' In brief, samples from 19 observational studies genotyped with high-density SNP arrays and imputed to the 1,000 Genomes Project March 2012 reference panel contributed to the discovery meta-analysis.', {'entities': [(92, 99, 'imputation')]}),
 (' Imputed SNPs were restricted based on MAF (≥1%) and imputation accuracy (R_2  > 0.', {'entities': [(53, 63, 'imputation'), (1, 8, 'imputation')]}),
 ('00, indicating an excellent imputation quality] for the Harvard cohort.', {'entities': [(28, 38, 'imputation')]}),
 ('05 in Europeans) was carried out using IMPUTE v2 (ref.', {'entities': [(39, 45, 'imputation')]}),
 (' Most of the imputed SNPs were common [for all five cohorts, >98% SNPs have a minor allele frequency (MAF) > 0.', {'entities': [(13, 20, 'imputation')]}),
 (' Imputation of the HLA classical alleles in the genes HLA-A, -B, -C, -DPB1, -DQA1, -DQB1, and -DRB1 was done using the program HiBAG() and the Asian reference panel.', {'entities': [(1, 11, 'imputation')]}),
 ('01 or with low imputation quality scores (MACH’s Rsq<0.', {'entities': [(15, 25, 'imputation'), (42, 46, 'imputation')]}),
 (' SNPs were excluded on a cohort basis if the imputation score, assessed using r2.', {'entities': [(45, 55, 'imputation')]}),
 ('5% or an observed:expected variance ratio (imputation quality) less than 0.', {'entities': [(43, 53, 'imputation')]}),
 ('8) within a gene or within 1MB of the gene transcription start or end site and normalized expression values were performed with the GenABEL/ProbABEL packages using the polygenic linear model incorporating a kinship matrix in GenABEL followed by the ProbABEL mmscore score test with imputed genotypes.', {'entities': [(282, 289, 'imputation')]}),
 (' Fixed-effects meta-analysis was used to combine individual association estimates from four imputed GWAS scans as well as each replication data set.', {'entities': [(92, 99, 'imputation')]}),
 (' After imputation and quality control, the final genetic dataset consisted of 758 samples (n=461 white, n=297 African American).', {'entities': [(7, 17, 'imputation')]}),
 (' To increase genome coverage, genotypes were imputed for un-typed SNPs and in-dels using the 1kG multi-ethnic reference panel, yielding a total of 6,378,483 variants, and of these 5,904,251 with MAF≥ 5% were analyzed in the current investigation.', {'entities': [(45, 52, 'imputation'), (57, 60, 'negation')]}),
 (' Imputation of HapMap haplotypes (CHB + JPT for all samples except CLHNS which used CHB + JPT + CEU) of ∼2 million SNPs was carried out for each study using IMPUTE or MACH.', {'entities': [(1, 11, 'imputation'), (157, 163, 'imputation'), (167, 171, 'imputation')]}),
 (' Imputation in the LLFS: Imputations were performed based on the cosmopolitan phased haplotypes of 1000 Human Genome (1000HG, version 2010–11 data freeze, 2012-03-04 haplotypes).', {'entities': [(1, 11, 'imputation')]}),
 (' Imputation was done separately for each study.', {'entities': [(1, 11, 'imputation')]}),
 (' _– ) for imputation in our region of interest centered on rs12513649 with the December 2013 1000 Genomes Project Phase I integrated variant set release haplotype reference panel.', {'entities': [(10, 20, 'imputation')]}),
 (' Prediction of untyped or partly genotyped SNPs was performed with BEAGLE 3.', {'entities': [(67, 73, 'imputation')]}),
 (' The reference panel used is a multi-reference panel specifically developed for imputation of nonwhite populations and shown to impute genotypes in African Americans with high accuracy.', {'entities': [(80, 90, 'imputation')]}),
 (' MACH v1.', {'entities': [(1, 5, 'imputation')]}),
 (' Imputed SNPs with confidence < .', {'entities': [(1, 8, 'imputation')]}),
 (' To ensure comparability between samples, raw genotype and phenotype data for each study were uploaded to a central server and processed through the same quality control, imputation, and analysis process ().', {'entities': [(171, 181, 'imputation')]}),
 ('5 array to produce a reduced set of genotypes for imputing to the HapMap.', {'entities': [(50, 58, 'imputation')]}),
 (' We then used IMPUTE2_;   to impute the SNP genotypes for the HumanOmni1-Quad with the 1000 Genomes Phase 1 integrated reference panel and the previously imputed HumanOmni2.', {'entities': [(29, 35, 'imputation'), (14, 20, 'imputation')]}),
 (' The 1000 Genomes phase 1 reference panel () containing phased haplotypes for 1092 individuals was used for imputation.', {'entities': [(108, 118, 'imputation')]}),
 (' Imputed SNPs with ‘INFO’ scores >0.', {'entities': [(1, 8, 'imputation')]}),
 (' Participating studies separately genotyped samples and imputed them to WGS-based reference panels.', {'entities': [(56, 63, 'imputation')]}),
 ('42 [], including the no-mean-imputation option to ensure scores would not be imputed for missing genetic data.', {'entities': [(29, 39, 'imputation'), (21, 23, 'negation'), (70, 73, 'negation')]}),
 (' The information content of the imputed data associated with the additive test was 0.', {'entities': [(32, 39, 'imputation')]}),
 (' The imputed data were highly consistent with the genotype data from Sequenom for the two SNPs identified in this study (Supplementary Material, Table S8, squared correlation coefficient (r _2 )_\u2009 =\u20090.', {'entities': [(5, 12, 'imputation')]}),
 ('Associations between SNPs and CRC risk were evaluated on the basis of the log-additive model using mach2dat, PLINK version 1.', {'entities': [(99, 104, 'imputation')]}),
 (' Associations between SNPs and CRC risk were evaluated based on the log-additive model using mach2dat.', {'entities': [(93, 98, 'imputation')]}),
 (' We used a cutoff of N  × MAF > 3 to exclude the extremely rare variants present in only one or two samples that might be due to genotyping/imputation errors or private mutations.', {'entities': [(140, 150, 'imputation')]}),
 (' We imputed additional SNPs within 1 Mb on either side of the implicated SNPs using IMPUTE2 software and the reference data from both the 1000 Genomes project (March 2012 release; []) and the DCEG Imputation Reference Set version 1 ().', {'entities': [(4, 11, 'imputation'), (197, 207, 'imputation'), (84, 90, 'imputation')]}),
 (' For imputation, the RS used overlapping fragments each of 2000 markers with 100 markers of overlap to improve imputation quality.', {'entities': [(5, 15, 'imputation')]}),
 (' Only SNPs with an imputation quality score (R2) greater than 0.', {'entities': [(19, 29, 'imputation')]}),
 ('HLA alleles and amino acids were imputed by SNP2HLA.', {'entities': [(33, 40, 'imputation')]}),
 (' The larger decrease in coverage with higher r_2  values for East Asians may reflect having designed the array with only a greedy SNP selection as opposed to the hybrid greedy/imputation-based approach of the AFR and LAT arrays.', {'entities': [(176, 186, 'imputation')]}),
 ('Classical human leukocyte antigen (HLA ) alleles and corresponding amino acid sequences were imputed using SNP2HLA.', {'entities': [(93, 100, 'imputation')]}),
 ('01 or imputation quality scores\n<0.', {'entities': [(6, 16, 'imputation')]}),
 (' Imputed genotypes were used, where directly assayed genotypes were unavailable.', {'entities': [(1, 8, 'imputation')]}),
 (' With 1000 Genomes (phase I; March 2012) as a reference panel, SNP data were imputed using IMPUTE2 v2.', {'entities': [(77, 84, 'imputation'), (91, 97, 'imputation')]}),
 (' SNPs with a minor allele frequency ≥1% and imputation quality≥0.', {'entities': [(44, 54, 'imputation')]}),
 (' We performed imputation separately for set 1 and set 2 genotypes.', {'entities': [(14, 24, 'imputation')]}),
 ('7Mb (NCBI build 36) that include 4810 imputed variants (dosage R_2  is ≥ 0.', {'entities': [(38, 45, 'imputation')]}),
 (' The exclusion criteria were: poorly imputed (an imputation informativeness INFO statistic from IMPUTE software < 0.', {'entities': [(37, 44, 'imputation'), (96, 102, 'imputation')]}),
 (' These CNPs were in linkage disequilibrium with 40 767 SNPs present in the HapMap3-imputed results for our full SCZ sample and were cross-referenced with these results.', {'entities': [(83, 90, 'imputation')]}),
 (' Genotype imputation\non the COPDGene cohorts was performed using MaCH and minimac_,  using 1000 Genomes Phase I v3 European (EUR) and cosmopolitan reference panels\nfor the non-Hispanic whites and African-Americans, respectively.', {'entities': [(10, 20, 'imputation'), (65, 69, 'imputation'), (172, 176, 'negation')]}),
 (' Most studies with European ancestry samples performed imputation with the HRC reference v1.', {'entities': [(55, 65, 'imputation')]}),
 (' The average imputation accuracy, which is calculated by masking known probes and comparing the imputed genotype against the true genotype, was 98.', {'entities': [(13, 23, 'imputation')]}),
 (' The genotyping array, preimputation quality control filters, imputation software, and association testing software used by each study are listed in Table S4.', {'entities': [(26, 36, 'imputation')]}),
 (' Only SNPs with an imputation score of R _2  > 0.', {'entities': [(19, 29, 'imputation')]}),
 ('3 in MACH, proper_info ≤ 0.', {'entities': [(5, 9, 'imputation')]}),
 (' A total of 2,232,944 SNPs passed filters for both quality and informativeness (polymorphic and unduplicated) and became candidates for imputation and association testing.', {'entities': [(136, 146, 'imputation')]}),
 (' Comparison of the GWAS imputation with SNPs on a candidate gene array indicates an allelic concordance rate of ~95.', {'entities': [(24, 34, 'imputation')]}),
 (' After quality control of sample and SNP data, imputation of HapMap2 SNP genotypes was performed using SNPs common to these platforms; these procedures were as previously described ().', {'entities': [(47, 57, 'imputation')]}),
 ('To analyze genotype data generated from four different platforms that measure different genetic variants and to increase the coverage of variation that is measurable across the genome, imputation of genotypes was performed for both autosomal and X chromosome markers.', {'entities': [(185, 195, 'imputation')]}),
 (' Genotype imputation reference panels of 503 individuals of European ancestry, of 504 individuals of East Asian ancestry, of 661 of African ancestry, and of 347 of admixed American ancestry, were downloaded from the project website.', {'entities': [(10, 20, 'imputation')]}),
 (' MACH2QTL () was used to perform the association analysis.', {'entities': [(1, 6, 'imputation')]}),
 (' Blue dots are imputed variants.', {'entities': [(15, 22, 'imputation')]}),
 ('SNP imputation was performed in each cohort to facilitate the\ncombination of results from different genotyping platforms and to increase\ngenotype coverage.', {'entities': [(4, 14, 'imputation')]}),
 (' The Korean GWAS was imputed using the 1000 Genomes Project Phase 1 as the reference.', {'entities': [(21, 28, 'imputation')]}),
 (' We imputed genotypes into the reference panel from the 1000 Genomes Project (v3 October 2014).', {'entities': [(4, 11, 'imputation')]}),
 (' We first identified principal components (PCs) representing axes of ancestral variation to adjust for population stratification () and imputed untyped SNPs using the HapMap3 data.', {'entities': [(136, 143, 'imputation')]}),
 (' Genotyping in CAMP was performed using the Illumina HumanHap550v3 BeadChip, and imputation was performed based on the 1,000 Human Genomes Project as previously described.', {'entities': [(81, 91, 'imputation')]}),
 (' Ten data sets were created where each uncertain genotype was replaced by a value simulated under the probability distribution obtained through genetic imputation (IMPUTE output consisting of P (AA), P (AB) and P (BB)).', {'entities': [(152, 162, 'imputation'), (164, 170, 'imputation')]}),
 (' The resulting dataset, containing 370,404 SNPs for 3,307 individuals, was subsequently imputed across ∼2.', {'entities': [(88, 95, 'imputation')]}),
 ('5 million autosomal CEU (Centre d’Etude du Polymorphisme Humain collection from Utah; Northern and Western European ancestry) HapMap SNPs which were measured directly (approximately 550,000) or imputed (approximately 2 million) as previously reported [].', {'entities': [(194, 201, 'imputation')]}),
 ('05) have an imputation r imputation accuracy > 0.', {'entities': [(12, 22, 'imputation')]}),
 (' Each study performed genotype imputation with reference to HapMap Phase II of the corresponding population.', {'entities': [(31, 41, 'imputation')]}),
 (' Study Design Abbreviations are as follows: CCMA, case control meta-analysis; MANTRA, meta-analysis of trans-ethnic association studies; BFD, Bayesian false discovery; PO, prior odds; _∗ conditional analysis for the MHC was also carried out with imputed classical HLA-allele (detailed in the Subjects and Methods).', {'entities': [(246, 253, 'imputation')]}),
 ('95, imputation quality score<0.', {'entities': [(4, 14, 'imputation')]}),
 (' After imputation, SNPs with an imputation accuracy score <0.', {'entities': [(7, 17, 'imputation')]}),
 (' In each fragment, haplotypes of individual GWAS were phased by a Markov Chain Haplotyping algorithm (MACH) ().', {'entities': [(102, 106, 'imputation')]}),
 ('0 chip and were imputed to ≈ 2.', {'entities': [(16, 23, 'imputation')]}),
 ('02 M SNPs were imputed.', {'entities': [(15, 22, 'imputation')]}),
 (' After QC analysis, genotype data in each study were used to impute to the 1000 Genomes  reference panel (version available in ).', {'entities': [(61, 67, 'imputation')]}),
 (' In total 137,532 SNPs with an estimate of the squared correlation between imputed and true genotypes, ≤0.', {'entities': [(75, 82, 'imputation')]}),
 (' We performed downstream association analyses on observed variants passing quality filters and all imputed variants (a total of 27\xa0887\xa0661 variants).', {'entities': [(99, 106, 'imputation')]}),
 (' Imputed genotypes were stored as continuous allele dosage data, which are continuous numerical values indicating the estimated number of minor alleles (ranging from 0 to 2), thus incorporating a measure of imputation uncertainty.', {'entities': [(207, 217, 'imputation'), (1, 8, 'imputation')]}),
 (' A total of 2,090,256 SNPs with a minor allele frequency ≥1% and directly genotyped or imputed with sufficient quality (see  Supplementary Table 3 under “Supplemental data” in the online issue) were included in the meta-analysis.', {'entities': [(87, 94, 'imputation')]}),
 (' Genotype imputation in the filtered sample was performed using MACH v1.', {'entities': [(10, 20, 'imputation'), (64, 68, 'imputation')]}),
 (' In previous studies conducted in the ACCC, imputation was conducted using the CHB and JPT HapMap 2 panel as the reference.', {'entities': [(44, 54, 'imputation')]}),
 (' All imputations were done on the forward (+)-strand using 562,554 genotyped SNPS that had passed quality control filters.', {'entities': [(5, 16, 'imputation')]}),
 (' 2 939 993 SNPs were imputed using MACH () and Minimac () software based on combined reference haplotype data from HapMap Phase 2 CEU + YRI samples that includes monomorphic SNPs in either of the two constituent populations (release 22, build 36.', {'entities': [(21, 28, 'imputation'), (35, 39, 'imputation')]}),
 (' One of the SNPs, rs7186831, was not\nwell-imputed; a proxy, rs11865296 in modest linkage disequilibrium\n(r_2  = 0.', {'entities': [(42, 49, 'imputation'), (33, 36, 'negation')]}),
 ('1 software in order to incorporate the imputation uncertainties in the regression models described above.', {'entities': [(39, 49, 'imputation')]}),
 (' SNPs with imputation r _2  > 0.', {'entities': [(11, 21, 'imputation')]}),
 (' Genotyped and imputed German samples were analyzed separately, and results were then combined by fixed-effects meta-analysis using the inverse variance approach as implemented in METAL.', {'entities': [(15, 22, 'imputation')]}),
 (' Imputation was based on the entire multi-ethnic 1000 genomes reference panel of 28.', {'entities': [(1, 11, 'imputation')]}),
 (' After quality control, 214,705 SNPs were pre-phased with SHAPEIT v2 (r790), and genotypes were imputed with a publicly available reference panel (https://imputation.', {'entities': [(96, 103, 'imputation')]}),
 (' Imputation was performed by comparing the respective panel with the closest ancestry.', {'entities': [(1, 11, 'imputation')]}),
 ('  All SNPs with an imputation information score <0.', {'entities': [(19, 29, 'imputation')]}),
 (' Since individual imputation data for the French GWAS were not fully available due to restriction of data sharing policy in\nthe control samples, we performed conditional analysis and HLA imputation using all of the case samples and a part of the control\nsamples whose genotyping data were available.', {'entities': [(18, 28, 'imputation'), (59, 62, 'negation')]}),
 (' Eighteen imputed SNPs were available in this region for association analysis.', {'entities': [(10, 17, 'imputation')]}),
 (' For both sample sets, raw data were imputed to approximately 1.', {'entities': [(37, 44, 'imputation')]}),
 (' We also implemented the following QC exclusion criteria for SNPs post-imputation: (i) MAF <0.', {'entities': [(71, 81, 'imputation')]}),
 ('9 () using the logistic regression analysis at each imputed marker and including study site assignment.', {'entities': [(52, 59, 'imputation')]}),
 ('3, which provides results identical to those generated with dosage data using Mach2dat and Rvtests.', {'entities': [(78, 83, 'imputation')]}),
 (' Imputation was performed with all cases and controls combined.', {'entities': [(1, 11, 'imputation')]}),
 (' SNPs with RSQR quality estimates of less than 0·30 as indicated by MACH were excluded from analyses of the datasets, because imputed genotypes below this threshold are probably of poor quality.', {'entities': [(126, 133, 'imputation'), (68, 72, 'imputation')]}),
 (' Two Japanese studies were imputed slightly differently.', {'entities': [(27, 34, 'imputation')]}),
 ('The 1000 genome data (June 2011 release) and the Beagle software were used to impute up to 6 million SNPs.', {'entities': [(78, 84, 'imputation'), (49, 55, 'imputation')]}),
 (' Overall imputation quality was assessed by calculating ‘oevar’ (the ratio of the observed variance of imputed dosages to the expected binomial variance) using the MaCH imputation software () and by examination of the distribution of imputation quality metrics from the IMPUTE2 internal masking experiments.', {'entities': [(9, 19, 'imputation'), (270, 276, 'imputation'), (164, 168, 'imputation')]}),
 (' Genotypes of the Haplotype Reference Consortium were imputed into the phased Michigan Genomics Initiative genotypes, resulting in dense mapping of over 7.', {'entities': [(54, 61, 'imputation')]}),
 ('0) to perform imputation of the phased data.', {'entities': [(14, 24, 'imputation')]}),
 (' GWAS data from the seven studies were imputed to >10 million SNPs with IMPUTE2 (v2.', {'entities': [(39, 46, 'imputation'), (72, 78, 'imputation')]}),
 (' For this analysis, imputed genotypes with probabilities <0.', {'entities': [(20, 27, 'imputation')]}),
 (' Association tests were performed using maximum-likelihood estimated dosages for imputed SNPs and observed integer dosages for genotyped SNPs.', {'entities': [(81, 88, 'imputation')]}),
 (' For each eligible SNP in both cohorts, the ratio of the observed versus expected variance of the dosage served as a measure of imputation quality.', {'entities': [(128, 138, 'imputation')]}),
 ('044 for individual studies based on all SNPs including both directly genotyped and imputed, indicating there is little evidence of residual population substructure, cryptic relatedness, or differential genotyping between cases and controls.', {'entities': [(83, 90, 'imputation')]}),
 ('9) were applied between directly measured and imputed genotypes after masking input genotypes (for genotyped markers only) to enter the analysis phase.', {'entities': [(46, 53, 'imputation')]}),
 (' Since the initial imputation of the datasets used here, a number of more comprehensive reference panels have been released including the latest HapMap release and the samples available through the 1000 Genomes Project.', {'entities': [(19, 29, 'imputation')]}),
 ('5 million HapMap SNPs using MACH (ARIC, InCHIANTI), BIMBAM (CHS), BEAGLE (CARDIA) or IMPUTE2.', {'entities': [(85, 91, 'imputation'), (66, 72, 'imputation'), (28, 32, 'imputation')]}),
 (' Imputation based on the 1000 Genomes Project () and quality control is described in the online supplement.', {'entities': [(1, 11, 'imputation')]}),
 (' Imputation of autosomal SNPs was performed to a merged reference panel of the Phase 3 1000 Genome Project and the UK10K using IMPUTE2.', {'entities': [(1, 11, 'imputation'), (127, 133, 'imputation')]}),
 (' The final imputed data set consisted of 8340 individuals, each with 2 594 390 imputed markers.', {'entities': [(11, 18, 'imputation')]}),
 ('edu/wiki/Minimac: 1000_Genomes_Imputation_Cookbook).', {'entities': [(31, 41, 'imputation')]}),
 (' From all HapMap 3 SNPs that were either genotyped or imputed (with information content >0.', {'entities': [(54, 61, 'imputation')]}),
 (' Before imputation, SNPs were\nfiltered based on sample and SNP call rates, minor allele frequencies (MAF),\nand Hardy-Weinberg equilibrium p-values.', {'entities': [(8, 18, 'imputation')]}),
 (', imputation quality) scores for CYP2A6  were compared to those of EIF3K  and TGFβ1 , located outside of this region of high homology (~2,222kb 5’ and ~480kb 3’ of CYP2A6 , respectively).', {'entities': [(2, 12, 'imputation')]}),
 (' Missing genotypes were imputed on the 1000\nGenomes Project data (interim 20101123 phase 1) against all-population reference panel\nusing either MiniMac () (RISC, EUGENE2, Stanford)\nor IMPUTE (ULSAM).', {'entities': [(24, 31, 'imputation'), (184, 190, 'imputation')]}),
 (' To maximize the overlap between the genotyped SNPs from the discovery cohort and the SNPs included in the target cohorts, the imputed SNPs with imputation quality score > 0.', {'entities': [(127, 134, 'imputation')]}),
 (' Data was imputed with the 1000-Genomes reference panel (phase 1, version 3) using MACH version 1.', {'entities': [(10, 17, 'imputation'), (83, 87, 'imputation')]}),
 (') The combined set 1 and 2 case (532) and control (2,128) imputed genotypes (6,175,472) were used as the data set for initial analyses.', {'entities': [(58, 65, 'imputation')]}),
 (' Imputed genotypes were included if posterior probabilities exceeded 0.', {'entities': [(1, 8, 'imputation')]}),
 (' From 1,411,821 SNPs after imputation, 165,433 SNPs were dropped due to QC reasons.', {'entities': [(27, 37, 'imputation')]}),
 (' The raw genotypes were imputed with IMPUTE2 ().', {'entities': [(24, 31, 'imputation'), (37, 43, 'imputation')]}),
 ('Each replication cohort performed genome-wide genotyping, quality control and imputation as part of its own primary study.', {'entities': [(78, 88, 'imputation')]}),
 (' Imputation quality by locus and cohort are available in .', {'entities': [(1, 11, 'imputation')]}),
 ('EAS samples from the 1000 Genomes Project (phase 1 version 3) were used for imputation reference.', {'entities': [(76, 86, 'imputation')]}),
 (' Individual genotyped and imputed SNPs were tested for association using multivariable linear regression models in PLINK () and MACH2QTL v.', {'entities': [(26, 33, 'imputation'), (128, 133, 'imputation')]}),
 (' Additional un-genotyped autosomal SNPs and sporadic missing data of genotyped autosomal SNPs were imputed for COHRA and IFS1 samples using BEAGLE software [] and the HapMap Phase III reference panel.', {'entities': [(99, 106, 'imputation'), (140, 146, 'imputation'), (12, 15, 'negation')]}),
 ('4) was employed for phasing and imputation of sporadic missing genotypes in the HCHS/SOL and reference-panel datasets.', {'entities': [(32, 42, 'imputation')]}),
 (' For five of the GWAS sets (BC_NHS, T2D_NHS, T2D_HPFS, CHD_NHS and CHD_HPFS), we used the MACH program () to impute 8 221 074 autosomal SNPs based on haplotypes from the 1000 Genomes Project (using the August 2009 release of the Sanger Institute SNP calls based on the pilot 1 project).', {'entities': [(109, 115, 'imputation'), (90, 94, 'imputation')]}),
 (' Details about genotyping, imputation, and quality control are provided elsewhere.', {'entities': [(27, 37, 'imputation')]}),
 (' This parameter is related to both the sample size and the quality of imputation (2*N*MAF*quality of imputation).', {'entities': [(70, 80, 'imputation')]}),
 ('html (), IMPUTE http://mathgen.', {'entities': [(9, 15, 'imputation')]}),
 ('  Genotype data were imputed using Impute2 v2.', {'entities': [(21, 28, 'imputation'), (35, 42, 'imputation')]}),
 ('01 and (ii) SNP imputation score <0.', {'entities': [(16, 26, 'imputation')]}),
 (' For each study, we excluded SNPs with poor imputation quality scores (r _2 .', {'entities': [(44, 54, 'imputation')]}),
 (' Stage 2 is the actual imputation stage and uses the model parameters estimated in stage 1 to speed up the imputation of the genotypes.', {'entities': [(23, 33, 'imputation')]}),
 (' For each subject in our analysis, we inferred local ancestry, which defines the proportion of European and African ancestry at each genotyped and imputed SNP.', {'entities': [(147, 154, 'imputation')]}),
 (' Price, Department of Genetics, Harvard Medical School, Boston, MA) () on the genotyping data in the pediatric samples and the imputed data in the adults (using 35,324 SNPs common to all Illumina and Affymetrix genotyping platforms).', {'entities': [(127, 134, 'imputation')]}),
 ('In the PGC samples, (), individual genotypes were assembled, processed through a central quality control pipeline and imputed using the CEU and TSI HapMap3 reference panels.', {'entities': [(118, 125, 'imputation')]}),
 (' In stage 1, 20 studies each imputed approximately 2.', {'entities': [(29, 36, 'imputation')]}),
 ('We prephased the targeted sequencing sample using SHAPEIT_–  and then imputed into our discovery sample using IMPUTE2 (refs.', {'entities': [(70, 77, 'imputation'), (110, 116, 'imputation')]}),
 (' The imputed data was filtered by the criteria of MAF>1%, Maximum probability≥0.', {'entities': [(5, 12, 'imputation')]}),
 (' This test has correct type 1\nerror with imputed data.', {'entities': [(41, 48, 'imputation')]}),
 ('Genotype imputation for the ROOT consortium was conducted by the University of Washington Genetics Coordinating Center (GCC) using the IMPUTE2  software ().', {'entities': [(9, 19, 'imputation'), (135, 141, 'imputation')]}),
 (' For the conditional analysis, we included the imputed dosages of the sentinel SNP as a covariate in the linear mixed model.', {'entities': [(47, 54, 'imputation')]}),
 ('Genotypes were imputed for all polymorphic SNPs based on HapMap CEU (haplotype map for people living in Utah with ancestry from northern and western Europe) phase II data (release 22, build 36) oriented to the positive strand.', {'entities': [(15, 22, 'imputation')]}),
 ('_–  For the meta-analysis of GWAS, we included only high quality imputed genotypes (INFO >0.', {'entities': [(65, 72, 'imputation')]}),
 (' Variants with poor imputation accuracy (R_2 <0.', {'entities': [(20, 30, 'imputation')]}),
 (' Classical HLA  alleles, variant amino acids within HLA proteins, and additional SNPs in the MHC were imputed using the SNP2HLA pipeline, with a reference panel consisting of 5,225 individuals of European ancestry from the Type 1 Diabetes Genetics Consortium ().', {'entities': [(102, 109, 'imputation')]}),
 (' Imputed data were analyzed using SNPTESTv2.', {'entities': [(1, 8, 'imputation')]}),
 (' After imputation, 85 per cent of common variants including both single nucleotide variants and small indels (MAF>0.', {'entities': [(7, 17, 'imputation')]}),
 (' EZimputer () (http://www.', {'entities': [(3, 10, 'imputation')]}),
 (' These SNPs were all very well imputed in both studies.', {'entities': [(31, 38, 'imputation')]}),
 (' Imputation was performed using MACH (), IMPUTE (,) or BEAGLE () for ∼2.', {'entities': [(1, 11, 'imputation'), (41, 47, 'imputation'), (55, 61, 'imputation'), (32, 36, 'imputation')]}),
 ('01, and with low imputation quality (Rsq < 0.', {'entities': [(17, 27, 'imputation')]}),
 (' The INFO metric is based on the ratio of empirical and expected variance in dosage where better imputation quality is expected for values closer to 1.', {'entities': [(97, 107, 'imputation')]}),
 (' Genotype imputation was performed using the combined UK10K/1000GP Phase 1 reference panels as described previously ().', {'entities': [(10, 20, 'imputation')]}),
 ('Within each discovery study, DNA samples were genotyped with high-density SNP arrays and were imputed for SNPs available in the 1000 Genomes reference dataset.', {'entities': [(94, 101, 'imputation')]}),
 (' Programs used for imputation were MACH (version 1.', {'entities': [(19, 29, 'imputation'), (35, 39, 'imputation')]}),
 ('  In order to infer the untyped genotypes, imputation was performed with Impute2 () using haplotype reference panels from HapMap (CEU+CHB+JPT+YRI) with NCBI Build 36.', {'entities': [(43, 53, 'imputation'), (73, 80, 'imputation')]}),
 ('  The MHC region on chromosome 6 (chr6:25092012-35092011) was extracted from the post-QC dataset and used to impute 199 classical HLA alleles using HLA*IMP:02.', {'entities': [(109, 115, 'imputation')]}),
 (' ] with the CEU+TSI HapMap3 data as reference (410\nphased haplotypes) to impute\n1 235 109 autosomal SNP allele dosages.', {'entities': [(73, 79, 'imputation')]}),
 ('1 () to impute SNPs on autosomes and X chromosome that were not genotyped on the Illumina Omni Express array.', {'entities': [(8, 14, 'imputation'), (60, 63, 'negation')]}),
 (' To restrict the analysis to well-imputed SNPs, the SNPs were filtered to HapMap3 SNPs (), and were required to have a MAF above 1%.', {'entities': [(34, 41, 'imputation')]}),
 (' Following the elimination of duplicated SNPs, a second alignment step was performed, followed by pre-phasing and imputation, according to previously established protocols (-).', {'entities': [(114, 124, 'imputation')]}),
 (' Imputation for both studies was conducted using Minimac (http://genome.', {'entities': [(1, 11, 'imputation')]}),
 (' Quality control and filtering pipeline for MECC discovery samples before imputation.', {'entities': [(74, 84, 'imputation')]}),
 (' Second, we imputed MHC Class 1 and 2 SNP and amino acid variants.', {'entities': [(12, 19, 'imputation')]}),
 (' In the imputation analysis, pairwise r _2  values were calculated using the R Bioconductor package snpMatrix (version 1.', {'entities': [(8, 18, 'imputation')]}),
 (' After the HLA imputations, we removed samples with cumulative dosage of >2.', {'entities': [(15, 26, 'imputation')]}),
 (' The number of well-imputed SNPs (INFO score>0.', {'entities': [(20, 27, 'imputation')]}),
 (' A total of 390 additional variants were imputed in ATG5  (autophagy-related 5 [MIM 604261]), 541 in the SCHIP1  (schwannomin-interacting protein 1[MIM 612008])-IL12A  (interleukin 12A [MIM 161560]) locus, and 628 in DNASE1L3  (deoxyribonuclease 1-like 3 [MIM 602244]).', {'entities': [(41, 48, 'imputation')]}),
 (' MixABEL was used for running the linear regressions between the estimated residuals and all the imputed SNPs.', {'entities': [(97, 104, 'imputation')]}),
 ('We used markers of highest quality to impute with Minimac [] approximately 2.', {'entities': [(38, 44, 'imputation')]}),
 (' Imputation was performed using IMPUTE2 software and association between imputed genotype and TGCT was tested using SNPTEST , under a frequentist model of association.', {'entities': [(73, 80, 'imputation'), (1, 11, 'imputation'), (32, 38, 'imputation')]}),
 (' Imputation was performed with MACH (), with the 1KG European reference panel (as of August 2010).', {'entities': [(1, 11, 'imputation'), (31, 35, 'imputation')]}),
 (' SNPs with low imputation quality (r _2  < 0.', {'entities': [(15, 25, 'imputation')]}),
 ('01 and imputation quality (INFO)\u2009>0.', {'entities': [(7, 17, 'imputation')]}),
 ('3 1000 Genomes Project March 2012 release with imputation as previously described [].', {'entities': [(47, 57, 'imputation')]}),
 (' The FTO  region was imputed and analysed in the GenoMEL Phase 2 data in the same way.', {'entities': [(21, 28, 'imputation')]}),
 ('nz/~browning/beagle/strand_switching/strand_switching.', {'entities': [(13, 19, 'imputation')]}),
 (' Imputation was performed using IMPUTE software (https://mathgen.', {'entities': [(1, 11, 'imputation'), (32, 38, 'imputation')]}),
 ('r644, c2011-2012) to derive phased genotypes from the array SNPs and IMPUTE2 (version 2.', {'entities': [(69, 75, 'imputation')]}),
 (' Genotyping, quality control and imputation are presented are presented in the online supplemental materials.', {'entities': [(33, 43, 'imputation')]}),
 (' We did not impute genotypes in these three studies given the low-density coverage of the genome by these common variants.', {'entities': [(12, 18, 'imputation'), (8, 11, 'negation')]}),
 ('3 million imputed SNPs available for analysis.', {'entities': [(10, 17, 'imputation')]}),
 (' Detailed information about the genotyping platforms, genotype cleaning procedures, imputation process, and association analysis modeling is described in the  and .', {'entities': [(84, 94, 'imputation')]}),
 (' In stage 2, one study (the LifeLines Cohort Study) contributed association statistics on the basis of genotypes imputed with HapMap CEU release 24 haplotypes on NCBI build 36.', {'entities': [(113, 120, 'imputation')]}),
 (' In addition, because our top hit with 18:2ct replicated in Chinese and Hispanics but not in African Americans, we explored the full loci of 2 genes in this region [fatty acid desaturase (FADS ) 1/2 region: 61566604–61635303, ∼70 kb, in Human Genome build 37; 61323180–61391879 in build 36] in African Americans by using fine mapping (1000 Genomes imputation data) to assess whether absence of top hit association might be due to differences in genetic architecture between races.', {'entities': [(348, 358, 'imputation'), (86, 89, 'negation')]}),
 (' 1000 Genome imputed dosage data were tested for association with breastfeeding using the additive family-based association test in Merlin-off line ().', {'entities': [(13, 20, 'imputation')]}),
 ('As different genotyping platforms were used across studies, we imputed to ~2.', {'entities': [(63, 70, 'imputation')]}),
 ('4 million genotyped SNPs and 7 million imputed SNPs available for analysis.', {'entities': [(39, 46, 'imputation')]}),
 (' We assessed overall imputation quality both by looking at the distribution of imputed quality metrics across the MAF spectrum and by examining results from the IMPUTE2 internal masking experiments.', {'entities': [(21, 31, 'imputation'), (161, 167, 'imputation')]}),
 (' An additive model was applied to the genotype dosages generated by IMPUTE2 including the proportion of missing data as a covariate.', {'entities': [(68, 74, 'imputation')]}),
 (' DeltaSVM scores were generated as previously published by training the gapped k-mer support vector machine (gkmSVM) on cell type specific DHSs, computing weights for all possible 10-mers of the genome based on the SVM classifier, and calculating the difference in weights of 10-mers encompassing the reference and effect alleles for the variant of interest .', {'entities': [(100, 104, 'imputation')]}),
 (' Of these, 16,147,413 have passed the imputation quality filter (imputation score\u2009>0.', {'entities': [(38, 48, 'imputation')]}),
 (' Rs73371737 is imputed in National Cancer Institute (dosage R_2  = 0.', {'entities': [(15, 22, 'imputation')]}),
 ('For familial samples (FHS and IFS), 200 unrelated founder individuals were randomly selected to estimate model parameters, which were then used to impute all family members.', {'entities': [(147, 153, 'imputation')]}),
 (' After quality control, which consisted of Mendelian error checks, Hardy-Weinberg equilibrium (p>1E-06 included), and minor allele frequency (>1% included), a total of 369,241 SNPs remained for use in the imputation to the HapMap population (release 22, build36, CEU, http://hapmap.', {'entities': [(205, 215, 'imputation')]}),
 (' Once matched, imputation was conducted on GWAS genotype data for each GWAS collection separately, using the IMPUTE software and haplotype-phased HapMap Phase 2 European CEU founders as a reference panel.', {'entities': [(15, 25, 'imputation'), (109, 115, 'imputation')]}),
 (' Detailed information on study design, participant characteristics, genotyping and imputation for all contributing studies are provided in the  and .', {'entities': [(83, 93, 'imputation')]}),
 (' Imputation was then performed on the same chunks using IMPUTE2 (59).', {'entities': [(1, 11, 'imputation'), (56, 62, 'imputation')]}),
 (' Genotype data for a total of 34,985,077 SNPs were available after imputation, including both fully imputed SNPs as well as genotyped SNPs for which sporadic missingness was imputed.', {'entities': [(67, 77, 'imputation')]}),
 (' These genome-wide imputation analyses were conducted in each\nstudy independently using either IMPUTE or MACH  ().', {'entities': [(19, 29, 'imputation'), (95, 101, 'imputation'), (105, 109, 'imputation')]}),
 (' Both genotyped and imputed SNPs were examined as continuous variables (i.', {'entities': [(20, 27, 'imputation')]}),
 (' The reference panel of imputation was based on the 1000 Genomes Phase 3 and UK10K haplotype panels.', {'entities': [(24, 34, 'imputation')]}),
 (' This resulted in 711,589 SNPs used for imputation in European-American subjects and 806,416 in African-American subjects.', {'entities': [(40, 50, 'imputation')]}),
 ('6 million SNPs with the HapMap version 2 CEU panel (Utah residents of Northern and Western European ancestry) as a reference, using the program MaCH v1.', {'entities': [(144, 148, 'imputation')]}),
 (' To determine whether additional SNPs in the GC  region not included on the initial Illumina HumanHap500/550/610 array may be associated with serum DBP, we used the software program IMPUTE2 () to impute additional SNPs 500 kb upstream and downstream of the GC  region.', {'entities': [(196, 202, 'imputation'), (182, 188, 'imputation'), (56, 59, 'negation')]}),
 (' To increase genome coverage, genotypes were imputed for un-typed SNPs and in-dels using the 1kG multi-ethnic reference panel, yielding a total of 6,378,483 variants, and of these 5,904,251 with MAF≥ 5% were analyzed in the current investigation for association analysis.', {'entities': [(45, 52, 'imputation'), (57, 60, 'negation')]}),
 (' In the  and  results are presented using only genotyped data for comparison with the imputed results.', {'entities': [(86, 93, 'imputation')]}),
 ('9 following\nimputation or set to missing otherwise) in the merged genetic data set, and only\nvariants also passing the univariable genome-wide threshold (P \n< 1.', {'entities': [(12, 22, 'imputation')]}),
 (' Based on our GWAS results, we conducted region-specific imputation analysis of flanking SNPS, namely, 1 Mb region on either side of the strongest SNP using the IMPUTE2 software and the reference data from the 1000 Genomes project (Phase 3 genotype data).', {'entities': [(57, 67, 'imputation'), (161, 167, 'imputation')]}),
 (' Post imputation, we included SNPs with an IMPUTE2 info score of ≥0.', {'entities': [(6, 16, 'imputation'), (43, 49, 'imputation')]}),
 (' Each study performed SNP association analyses with heart rate using an additive genetic model implemented in MACH2QTL, Merlin, SNPTEST, ProbAbel, GenABEL, LME in R, MMAP, Matlab or PLINK ().', {'entities': [(110, 115, 'imputation')]}),
 (' IMPUTE2 was used with the option -buffer 2000  to leverage on a genomic window of 5Mb (1Mb analysed region plus 2 Mb buffer regions on either side).', {'entities': [(1, 7, 'imputation')]}),
 (' A consensus set of 6,036,699 high quality SNPs from each imputed dataset was analyzed by PLINK using a generalized linear model controlling for the genotyping platform and genetic ancestry based on principal component analysis by EIGENSOFT.', {'entities': [(58, 65, 'imputation')]}),
 ('5 for IMPUTE or Rsq < 0.', {'entities': [(6, 12, 'imputation')]}),
 (' IMPUTE v2.', {'entities': [(1, 7, 'imputation')]}),
 (' Prior to imputation, a consistency test of allele frequency between GWAS and reference samples was examined with the chi-square test.', {'entities': [(10, 20, 'imputation')]}),
 (' Post-imputation filters further excluded SNPs from association analyses having minor allele frequency (MAF)<1% or imputation quality score (INFO)<0.', {'entities': [(6, 16, 'imputation')]}),
 ('9) was used to perform association tests on imputed SNP dosage with logistic regression adjusted for the top 10 within-population principal components.', {'entities': [(44, 51, 'imputation')]}),
 ('0 × 10_−4  for Hardy–Weinberg violation, (iii) SNPs with a concordance rate <95% among the duplicated QC samples, (iv) SNPs with MAF < 1%, (v) low imputation quality (for imputed SNPs; r -hat < 0.', {'entities': [(147, 157, 'imputation')]}),
 (' The imputation process was performed with Beagle software according to a previously described method.', {'entities': [(5, 15, 'imputation'), (43, 49, 'imputation')]}),
 (' Specifically, we ran IMPUTE on each of the study samples in turn, both cases and controls, re-imputing known genotypes.', {'entities': [(95, 103, 'imputation'), (22, 28, 'imputation')]}),
 (' After imputation, we included SNPs with minor allele frequency >5% and high imputation quality (certainty>0.', {'entities': [(7, 17, 'imputation')]}),
 (' In brief, the GEFOS-seq study performed whole-genome sequencing in 2882 subjects from 2 cohorts in the UK10K project, whole-exome sequencing in 3549 subjects from 5 cohorts, and genome-wide genotype imputation in 26,534 subjects.', {'entities': [(200, 210, 'imputation')]}),
 (' Genotype imputation on the INGI cohorts and SR was conducted after standard QC using SHAPEIT2 for the phasing step and IMPUTE2 for the imputation using the 1000 Genomes phase I v3 reference set.', {'entities': [(10, 20, 'imputation'), (120, 126, 'imputation')]}),
 (' Genetic imputations in the replication cohorts were performed using MACH, IMPUTE, minimac or BimBam ().', {'entities': [(9, 20, 'imputation'), (75, 81, 'imputation'), (69, 73, 'imputation')]}),
 (' Imputed SNPs were combined with SNPs extracted from the 1000 Genomes Project data set under the IMPUTE format.', {'entities': [(1, 8, 'imputation'), (97, 103, 'imputation')]}),
 (' SNPs with MAF ≥ 1%, call rate ≥ 97% and HWE-p  ≥ 1e–6 were used for imputation.', {'entities': [(69, 79, 'imputation')]}),
 (' After stringent quality control, 1 085 772 genotyped and imputed SNPs were available for 21 953 subjects of European descent (11 185 cases and 10 768 controls).', {'entities': [(58, 65, 'imputation')]}),
 (' Mendelian errors in the imputed data were removed.', {'entities': [(25, 32, 'imputation')]}),
 (" Association tests was carried out in PLINK, using the post-imputation genotype dosage data and using 10, 7 or 15 principal components for Crohn's disease, ulcerative colitis or IBD respectively as covariates, chosen from the first 20 principal components.", {'entities': [(60, 70, 'imputation')]}),
 (' Genotyped SNPs with Hardy-Weinberg equilibrium P-values <10_−5  were set to missing and imputed genotypes were used instead.', {'entities': [(89, 96, 'imputation')]}),
 (' Imputation was performed using the IMPUTE software package (v2)  using two reference panels, P0 (HapMap2, rel 22, combined CEU+YRI+ASN panels) and P1 (610k+, including the combined HumanHap610k and 1M reduced to 610k SNP content).', {'entities': [(1, 11, 'imputation'), (36, 42, 'imputation')]}),
 (' Each European GWAS data (BRASS, CANADA, NARAC2 and WTCCC) independent of the Immunochip data was pre-phased and imputed by MaCH and Minimac using the high-density phased reference data from the 1000 Genome Project instead of the reference phase of the HapMap2 data used in the previous study.', {'entities': [(113, 120, 'imputation'), (124, 128, 'imputation')]}),
 (' For the analyses of the HLA region, we used logistic regression to test for allelic association between the imputed variant and disease status.', {'entities': [(109, 116, 'imputation')]}),
 ('Genome-wide imputation was performed for all GWAS datasets.', {'entities': [(12, 22, 'imputation')]}),
 ('Cohorts performed quality control (QC) and imputed their SNP genotype data using the March 2012 release of the 1000 Genomes reference set that includes all ethnicities.', {'entities': [(43, 50, 'imputation')]}),
 (' We then conducted imputation using the MACH Markov Chain Haplotyping software with CEU individuals from phase 2 of the HapMap project as a reference set (release 22).', {'entities': [(19, 29, 'imputation'), (40, 44, 'imputation')]}),
 (' The association of each imputed SNP with i/fPAH was tested by logistic regression analysis in which allele dosage (from 0 to 2 copies of the minor allele) for imputed SNPs was assessed.', {'entities': [(25, 32, 'imputation')]}),
 (' Genome-wide association testing was performed using PROBABEL (), GWAS software for use with probabilistically imputed genotype dosages.', {'entities': [(111, 118, 'imputation')]}),
 (' Genotype imputation was also performed by each study using MACH http://www.', {'entities': [(10, 20, 'imputation'), (60, 64, 'imputation')]}),
 (' Imputation was phased by modified version of SHAPEIT2 and imputed by IMPUTE2, using a combined panel of UK10K haplotype and 1000G phase 3 as the reference panel.', {'entities': [(59, 66, 'imputation'), (1, 11, 'imputation'), (70, 76, 'imputation')]}),
 ('4 (IMPUTE2, SNPTEST).', {'entities': [(3, 9, 'imputation')]}),
 (' Heritability calculations were performed with the BOLT-REML software, and genotyped SNPs were used for calculation given decreased computational demands while providing minimal deflation in heritability estimates compared to analyses with imputed data.', {'entities': [(240, 247, 'imputation')]}),
 (' Using hard-call genotypes to analyze imputed GWAS genotypes has been reported previously ().', {'entities': [(38, 45, 'imputation')]}),
 ('6 million SNPs) was constructed from a reference panel of 2120 Sardinians who underwent whole-genome sequencing and was then propagated (“imputed”) to all genotyped persons.', {'entities': [(138, 145, 'imputation')]}),
 ('2)), recoding all negative logOR into positive logOR on the basis of the risk allele; 2) SNPs observed or imputed with high quality (Rsq > 0.', {'entities': [(106, 113, 'imputation')]}),
 (' SHAPEIT2 was used for prephasing (), and imputation to the 1000 Genomes full, cosmopolitan phase 1 version 1 reference panel was completed using IMPUTE2 ().', {'entities': [(42, 52, 'imputation'), (146, 152, 'imputation')]}),
 (' Because the single SNP rs445925 that reached genome-wide significance in the GWAS meta-analysis was a low frequency variant with low imputation quality in some cohorts, we replicated the association of this SNP and of SNPs in the same region using directly genotyped SNPs from exome chip data from each of the same four cohorts.', {'entities': [(134, 144, 'imputation')]}),
 (' Conditional logistic regression was used to fit models with the binary pesticide exposure variable and the SNP genotype coded as the minor allele count (0,1,2 for observed SNPs or the imputed “dosage”), with and without the interaction term between these two variables.', {'entities': [(185, 192, 'imputation')]}),
 (' Full siblings and offspring of individuals who had been identified as ancestry outliers were excluded from the reference set used in Mach stage 1.', {'entities': [(134, 138, 'imputation')]}),
 (' Prediction of the untyped SNPs was carried out using IMPUTEv2, based on 1000genomes Phase 1 integrated version 3 reference data.', {'entities': [(54, 60, 'imputation')]}),
 (' For those studies that used IMPUTE software to impute missing genotype data, association analyses were conducted in SNPtest, taking the uncertainty of the imputed genotypes into account.', {'entities': [(48, 54, 'imputation'), (29, 35, 'imputation')]}),
 (' Reference haplotypes representing 283 individuals with European ancestry, 193 with Asian ancestry, and 174 with African ancestry were downloaded from MACH () download website.', {'entities': [(151, 155, 'imputation')]}),
 (' Genotyped SNPs are in dark grey, 1000 genomes imputed SNPs are in light grey.', {'entities': [(47, 54, 'imputation')]}),
 (' We estimated the genetic relationship matrix (GRM) including imputed genotypes filtered by MAF >0.', {'entities': [(62, 69, 'imputation')]}),
 ('0 BeadChip array and imputed to the 1000 Genomes Project phase 1 reference panel with IMPUTE2.', {'entities': [(21, 28, 'imputation'), (86, 92, 'imputation')]}),
 (' Imputation yielded posterior genotype probabilities as well as imputation quality scores at SNPs not genotyped with a minor allele frequency >=1% in HapMap CEU.', {'entities': [(64, 74, 'imputation'), (1, 11, 'imputation'), (98, 101, 'negation')]}),
 (' SNPs were excluded from Phase 1 analysis if the effective count of the minor allele was <30 or imputation quality was poor (RSQ ≤0.', {'entities': [(96, 106, 'imputation')]}),
 (' The imputation genotype error rate was 1.', {'entities': [(5, 15, 'imputation')]}),
 (' For additional studies in IMAS, MAP and ROS, identical procedures were used to impute the specific SNPs required for analysis (; ).', {'entities': [(80, 86, 'imputation')]}),
 (' After one-step imputation of the genotypes in the regions of interest we used genotype dosages in a single logistic regression model with adjustment for each genotyping project/study combination and nineteen principal components.', {'entities': [(16, 26, 'imputation')]}),
 ('uk/) and an imputation info score cut-off of 0.', {'entities': [(12, 22, 'imputation')]}),
 (' SNPs with a call rate <95% or a BEAGLE r_2  ≤0.', {'entities': [(33, 39, 'imputation')]}),
 (' All variants not present on the Illumina Omni1M array were masked, and the SNVs on chromosome 20 were subsequently imputed back using four different reference panels (1000 Genomes Project, GoNL, custom panel and merged panel).', {'entities': [(116, 123, 'imputation'), (14, 17, 'negation')]}),
 ('(–) Imputation used all population subsets from 1000G Phase 3 v5 as reference panel; haplotype phasing was performed using SHAPEIT.', {'entities': [(4, 14, 'imputation')]}),
 ('Whole genome imputations for the MD Anderson Cancer Center (MDACC), deCODE, Samuel Lunenfeld Research Institute (SLRI) Study, Environmental and Genetics in Lung Cancer Etiology (EAGLE), and Prostate, Lung, Colon, and Ovary (PLCO) screening studies in TRICL-ILCCO consortium were conducted using IMPUTE2 v2.', {'entities': [(13, 24, 'imputation'), (295, 301, 'imputation')]}),
 ('0_,  (unless stated otherwise) with 1000 Genomes June 2011 imputation reference panel with 2,188 haplotypes (www.', {'entities': [(59, 69, 'imputation')]}),
 (' Association analyses were performed using a count of DSM-IV  CAD criteria (0–7) as the outcome variable and the imputed minor allele dosage (adjusted for sex, age, and the first 3 ancestry principal components) as a predictor variable.', {'entities': [(113, 120, 'imputation')]}),
 (' Prior to imputation, the observed genotypes were pre-phased using SHAPEIT v2  to estimate haplotypes.', {'entities': [(10, 20, 'imputation')]}),
 (' We used linkage disequilibrium (LD)-based clumping  of SNPs in PLINK in order to cluster multiple genotyped and imputed SNPs within a region of strong LD, thus determining independent loci.', {'entities': [(113, 120, 'imputation')]}),
 (' Estimated allele dosages were used rather than the most likely genotypes in order to account for the uncertainty arising from the imputation process.', {'entities': [(131, 141, 'imputation')]}),
 (' In each study, SNPs were restricted based on MAF>20/# samples and imputation accuracy (Rsq>0.', {'entities': [(67, 77, 'imputation')]}),
 (' We performed imputation using the most recent reference panels provided by the Haplotype Reference Consortium (version 1.', {'entities': [(14, 24, 'imputation')]}),
 (' The genotype data were phased using SHAPEIT [] to infer haplotypes and improve imputation accuracy\nusing the 1000 Genomes haplotypes.', {'entities': [(80, 90, 'imputation')]}),
 (' We first imputed all relevant untyped SNPs using the HapMap CEU as a reference population and carried out tests for association with a likelihood-ratio test.', {'entities': [(10, 17, 'imputation')]}),
 (' Imputation to the Phase 1 or 2 1000 Genomes panel was conducted using either MACH, IMPUTE, or BIMBAM with quality control metrics as shown in Supplemental Table 2.', {'entities': [(1, 11, 'imputation'), (84, 90, 'imputation'), (78, 82, 'imputation')]}),
 (' These data show, as expected, that imputed SNPs tend to show very similar results as SNPs that were directly genotyped if the correlation is high between SNPs.', {'entities': [(36, 43, 'imputation')]}),
 ('[] Subsequently, we imputed variants from the 1000 Genomes Project[] as a cosmopolitan reference panel with Impute2 v2.', {'entities': [(20, 27, 'imputation'), (108, 115, 'imputation')]}),
 (' Imputation of 2,416,663 SNPs from the HapMap release 22 build 36 Chinese Han of Beijing and Japanese of Tokyo (CHB+JPT) reference panel was conducted using MACH software (version 1.', {'entities': [(1, 11, 'imputation'), (157, 161, 'imputation')]}),
 ('0 (see URLs) for auto-somal markers and IMPUTE v1 (ref.', {'entities': [(40, 46, 'imputation')]}),
 (' Imputation analyses of untyped SNPs were performed using BEAGLE version 3.', {'entities': [(1, 11, 'imputation'), (58, 64, 'imputation')]}),
 (' EUR samples were imputed using a merged reference panel comprised of the 1000 Genomes Project (1KG) Phase I and the Genome of the Netherlands; AFR and HIS samples were imputed using the 1KG Phase I reference panel only.', {'entities': [(18, 25, 'imputation')]}),
 (' Each GWAS sample was imputed by the 1000 genomes project phase 3 sequence variants (as of May 2013) [].', {'entities': [(22, 29, 'imputation')]}),
 (' After quality control, SNP imputation was conducted to infer unobserved\ngenotypes.', {'entities': [(28, 38, 'imputation')]}),
 (' Additional details on genotyping and imputation per cohort are provided in Supplementary Table 1.', {'entities': [(38, 48, 'imputation')]}),
 (' The imputation was performed in 5-Mb nonoverlapping intervals.', {'entities': [(5, 15, 'imputation')]}),
 ('\xa0To ensure quality of imputed SNPs, the most likely call was used for merging genotypes, but only if the most likely call exceeded a probability threshold of 0.', {'entities': [(22, 29, 'imputation')]}),
 (' We used BEAGLE, Version 3.', {'entities': [(9, 15, 'imputation')]}),
 (' Imputation was performed using MaCH on the basis of the HapMap 3 Gujarati Indians in Houston (GIH) population (Build 36).', {'entities': [(1, 11, 'imputation'), (32, 36, 'imputation')]}),
 (' HLA types for French controls were obtained using six tagging SNPs from the imputed Illumina Human 660W-Quad BeadChip array as described previously [], and the HLA SNPs for the Dutch GoNL controls in the replication study (NL2) were extracted from the whole-genome sequencing data.', {'entities': [(77, 84, 'imputation')]}),
 (' To refine association signals, an additional 9\u2009217\u2009535 SNPs imputed from the 1000 Genomes Project were analyzed as additive dosages.', {'entities': [(61, 68, 'imputation')]}),
 ('html; MACH, http://www.', {'entities': [(6, 10, 'imputation')]}),
 (' SNPs with imputation r _2 >0.', {'entities': [(11, 21, 'imputation')]}),
 (' At each study visit, for those taking anti-hypertensive medication, blood pressure was imputed by adding 10 mmHg and 5 mmHg to SBP and DBP, respectively.', {'entities': [(88, 95, 'imputation')]}),
 ('edu/wiki/Mach2dat:_Association_with_MACH_output METAL: http://csg.', {'entities': [(9, 14, 'imputation')]}),
 (' Genotype imputation was conducted using IMPUTE2, with the Chinese panels (CHB and CHD in phase 2 and phase 3) in the HapMap project as reference population.', {'entities': [(10, 20, 'imputation'), (41, 47, 'imputation')]}),
 (' The imputed SNPs were cleaned using the same methods as genotyped SNPs.', {'entities': [(5, 12, 'imputation')]}),
 ('6) available in Metabochip with 1000G imputation in the fine-mapping regions, the stage 1 result was followed up in EPIC-InterAct and GERA (N _eff  = 40,637), both imputed to 1000G variant density (Supplementary Material).', {'entities': [(38, 48, 'imputation')]}),
 (' In the case of twin pairs, only one twin was included, either randomly or based on genotyping or imputation quality.', {'entities': [(98, 108, 'imputation')]}),
 ('01 for MACH, proper information ≤0.', {'entities': [(7, 11, 'imputation')]}),
 (' Subsequently, genotype imputation was performed according to standard protocols [] separately for each group using SHAPEIT v2.', {'entities': [(24, 34, 'imputation')]}),
 (' After standard QC, genotype data were imputed to the 1000 Genome reference panel (http://www.', {'entities': [(39, 46, 'imputation')]}),
 (' Imputation was performed using EZimputer () across the three cohorts separately.', {'entities': [(34, 41, 'imputation'), (1, 11, 'imputation')]}),
 ('edu/csg/abecasis/mach/).', {'entities': [(17, 21, 'imputation')]}),
 ('html), we utilized the IMPUTE2 package [,] to conduct imputation of the TAOK3  region.', {'entities': [(54, 64, 'imputation'), (23, 29, 'imputation')]}),
 (' Additional classical HLA-DQA1 , HLA-DQB1 , and HLA-DRB1  alleles were imputed in each case-control cohort with the exception of the Irish samples, in which there were insufficient informative SNPs.', {'entities': [(71, 78, 'imputation')]}),
 (' Third, we reran the replication including only the HapMap-imputed and unimputed studies (TEDS, TEENAGE and BREATHE).', {'entities': [(59, 66, 'imputation'), (71, 80, 'NO imputation')]}),
 (' We used as a reference panel for the imputation (1) 2,767 European-descent individuals with four-digit typing of human leukocyte antigen (HLA) class I and II molecules and (2) the genotypes of more than 7,500 common SNPs and indel polymorphisms across the extended MHC (xMHC).', {'entities': [(38, 48, 'imputation')]}),
 ('6 or MACH  < 0.', {'entities': [(5, 9, 'imputation')]}),
 (' Imputed variants were tested using a linear regression model in the statistical programming language, R, where  is the dosage score computed from the posterior probabilities for genotypes  and  ().', {'entities': [(1, 8, 'imputation')]}),
 ('We performed whole-genome imputation using the 1000 Genomes Phase I data as a reference panel.', {'entities': [(26, 36, 'imputation')]}),
 (' Using the 50 most significant associations in the imputed dataset, we identified the closest genes using bedtools with gencode v19 gene annotations.', {'entities': [(51, 58, 'imputation')]}),
 (' As imputation is sensitive to both missingness and SNP distribution, to avoid introducing bias, a set of SNPs common to the nine Illumina subsamples available was used (N=269,840).', {'entities': [(4, 14, 'imputation')]}),
 (' Imputation was executed using IMPUTE version 2 and the 1000 Genomes Project Phase III reference panel (October 2014 version) [; ].', {'entities': [(1, 11, 'imputation'), (31, 37, 'imputation')]}),
 ('[-]We used the quality control r [] info metric from Impute2, which estimates the correlation of the true genotype to the imputed genotype,[]and set a cutoff filter to eliminate SNPs with an r [] < 0.', {'entities': [(122, 129, 'imputation'), (53, 60, 'imputation')]}),
 (' The data were then phased using SHAPEIT [] and imputed via IMPUTE2.', {'entities': [(48, 55, 'imputation'), (60, 66, 'imputation')]}),
 (' To test for the associations between the imputed HLA classical alleles and B2M, we coded each allele with frequency > 1% as biallelic and conducted linear regression using log(B2M) as outcome controlling for age, gender, and center.', {'entities': [(42, 49, 'imputation')]}),
 ('Since the validation data set was genotyped on a different platform with a smaller number of SNPs (558,183), we imputed missing SNPs in the validation data set using the program IMPUTE [] and the phased CEU HapMap data set as a reference [; accessed February 2009].', {'entities': [(112, 119, 'imputation'), (178, 184, 'imputation')]}),
 (' Individuals were imputed in 10 separate sets that were composed of randomly selected individuals from each study.', {'entities': [(18, 25, 'imputation')]}),
 (' Untyped SNPs were\nimputed using a 1:1 ratio of CEU/YRI HapMap reference haplotypes based on\nconsistency across other CARe-COGENT studies.', {'entities': [(19, 26, 'imputation')]}),
 (' Imputation was performed separately for\nmales and females using MINIMAC with haplotypes from 381 European samples from\nthe 1000 Genomes Project as reference (1.', {'entities': [(1, 11, 'imputation')]}),
 (' All mixed model association analyses with the imputed GWAS data were performed with EMMAX.', {'entities': [(47, 54, 'imputation')]}),
 (' Imputed HLA alleles for both cohorts were combined into a single dataset and univariate logistic regression was performed without covariates.', {'entities': [(1, 8, 'imputation')]}),
 ('3 as estimated by Minimac were considered of low imputation accuracy.', {'entities': [(49, 59, 'imputation')]}),
 ('3) combined panel (7,562 haplotypes from the UK10K project and 2,184 haplotypes from the 1000 Genomes Project) and the Haplotype Reference Consortium (HRC) panel (64,976 haplotypes), enabled more accurate imputation of low-frequency variants than the UK10K or 1000 Genomes reference panel alone.', {'entities': [(205, 215, 'imputation')]}),
 (' Finally, for both genotyped and imputed SNPs, we excluded SNPs with <30 copies of the minor allele from our interaction analysis.', {'entities': [(33, 40, 'imputation')]}),
 (' The meta-analysis of imputed genotypes included all studies.', {'entities': [(22, 29, 'imputation')]}),
 ('b of MaCH was used to pre-phase haplotypes based on genotype data for each of the six discovery studies.', {'entities': [(5, 9, 'imputation')]}),
 (' Before imputation, SNPs with <95% call rate, concordance <95% with 1,000 Genomes in samples genotyped for QC, or Hardy-Weinberg equilibrium P <10_−4  in controls were excluded.', {'entities': [(8, 18, 'imputation')]}),
 ('30 as reported by MACH or BEAGLE.', {'entities': [(26, 32, 'imputation'), (18, 22, 'imputation')]}),
 (' To distribute imputation computation to multiple parallel CPUs, chromosomes were split into non-overlapping fragments each of 10 Mega base-pair length.', {'entities': [(15, 25, 'imputation'), (93, 97, 'negation')]}),
 (' In particular, among the total analyzed SNPs, 149,817 were genotyped, and the remaining SNPs were imputed based on their LD with the observed SNPs and are thus not independent.', {'entities': [(99, 106, 'imputation'), (161, 164, 'negation')]}),
 (' Genotypes were determined using Illumina chips; methods, QC steps and imputation of untyped HapMap 2 SNPs were as previously described ().', {'entities': [(71, 81, 'imputation')]}),
 (' Conservative quality control measures were imposed on each data set before imputation (as described previously).', {'entities': [(76, 86, 'imputation')]}),
 (' We excluded markers in any study that had low imputation quality scores (IMPUTE2 INFO  < 0.', {'entities': [(47, 57, 'imputation'), (74, 80, 'imputation')]}),
 ('05) different MAF for imputed and experimental genotypes, (2) empirical imputation quality substantially (≥0.', {'entities': [(22, 29, 'imputation')]}),
 (' rs3217810, rs10911251, rs59336 and rs11903757 showed strong correlation between imputation and sequencing with r _2  of 1.', {'entities': [(81, 91, 'imputation')]}),
 (' Furthermore, we performed an imputation experiment using the 2,504 1KGP Phase 3 samples.', {'entities': [(30, 40, 'imputation')]}),
 (' Data were imputed separately for these studies.', {'entities': [(11, 18, 'imputation')]}),
 (' Due to the unique ancestral populations of Latinos, we used the AMR\u2009+\u2009CEU\u2009+\u2009YRI reference panels (a combination of Colombian, Mexican, Puerto Rican, CEPH, and Yoruba haplotypes), which we have previously shown to have the highest genotype imputation accuracy for Latinos ().', {'entities': [(240, 250, 'imputation')]}),
 (' SNPs with imputation qualities <0.', {'entities': [(11, 21, 'imputation')]}),
 (' For both studies, additional genotypes were imputed using the 1,000 Genomes Reference panel ().', {'entities': [(45, 52, 'imputation')]}),
 ('8 were removed from further analysis; for imputed loci, MAF was estimated based on allelic dosage.', {'entities': [(42, 49, 'imputation')]}),
 (' These association tests, including those for imputed genotypes, were performed assuming an additive inheritance model (homozygote major allele vs heterozygote vs homozygote minor allele).', {'entities': [(46, 53, 'imputation')]}),
 (' Quality of imputed data was assessed following the Electronic Medical Records and Genomics (eMERGE) protocol [].', {'entities': [(12, 19, 'imputation')]}),
 ('  We preferred SNVs associated with oestrogen receptor α -positive (ER+) BC risk (often higher than for all BC) and close to coding sequences, to maximise the use of genotyped data without imputations of allelic variant status.', {'entities': [(189, 200, 'imputation')]}),
 ('An imputed dataset, including >92 million variants, referenced to the UK10K haplotype, 1000 Genomes Phase 3, and Haplotype Reference Consortium (HRC) panels was available in UK Biobank.', {'entities': [(3, 10, 'imputation')]}),
 (' The following criteria were used to flag markers with poor imputation despite passing our predicted imputation quality threshold (r_2  ≥ 0.', {'entities': [(60, 70, 'imputation')]}),
 (' MaCH-Admix () was used in Costa Rican samples to perform imputation of an additional approximately 2 million SNPs in each race/ethnic group for inclusion in GWAS analyses, using HapMap Phase I\u2009+\u2009II reference panels with individuals of European (CEU), West African (YRI), Chinese (CHB), and Japanese (JPT) descent.', {'entities': [(58, 68, 'imputation'), (1, 5, 'imputation')]}),
 ('() MaCH-Admix (http://www.', {'entities': [(3, 7, 'imputation')]}),
 ('1 () to impute SNPs that were not genotyped on the Illumina Omni Express array.', {'entities': [(8, 14, 'imputation'), (30, 33, 'negation')]}),
 (' In total, 894 HapMap SNPs were successfully imputed in the interval between 130,051,729 bp and 131,225,253 bp using available SNP genotype data from GWA scans (225 SNPs).', {'entities': [(45, 52, 'imputation')]}),
 ('SNP2HLA was used to perform imputation of classical HLA alleles and their corresponding amino acids from SNP genotyping data.', {'entities': [(28, 38, 'imputation')]}),
 (' We used BEAGLE ver 3.', {'entities': [(9, 15, 'imputation')]}),
 (' Phased genotypes were then imputed to one of the three WGS reference panels (UK10K alone or UK10K+1000GP or 1000GP+Genomes of the Netherland (GoNL)) as detailed in .', {'entities': [(28, 35, 'imputation')]}),
 ('5% or an observed to expected variance ratio (imputation quality) less than .', {'entities': [(46, 56, 'imputation')]}),
 (' The overlapping set of SNPs was used to minimize differences in imputation accuracy across the cohorts that could arise if imputations were based on different SNPs for each cohort.', {'entities': [(65, 75, 'imputation')]}),
 ('GWAS analysis was performed in either PLINK (ARIC, BHS, CHS, JHS, WHI),\nR (HANDLS, Health ABC, MESA), ProbA-BEL (WHI), or MERLIN (BLSA) using linear\nregression with an additive genetic model based on allelic dosages accounting\nfor imputation uncertainty.', {'entities': [(231, 241, 'imputation')]}),
 ('8 in Beagle), low minor allele count (n  × MAF ≤ 3) and/or extreme effect size (β  > ±50 bpm per effect allele, that is, ~5 times the standard deviation of heart rate as typically observed in the contributing studies) in each sex- and case-specific stratum.', {'entities': [(5, 11, 'imputation')]}),
 ('Genome-wide associations between 4,313,801 imputed autosomal single nucleotide polymorphisms (SNPs) (with minor allele frequency (MAF) >5%, imputation information >0.', {'entities': [(43, 50, 'imputation')]}),
 (' For the International Agency for Research on Cancer (IARC) study imputation was performed using minimac (version 2012.', {'entities': [(66, 76, 'imputation')]}),
 ('Genotyping of the FinnDiane patients was performed using the Illumina 610Quad chip; genotype calling, quality control, and imputation procedures have been described earlier.', {'entities': [(123, 133, 'imputation')]}),
 (' An imputation was conducted based on the genotyped SNPs and haplotype information in the HapMap phase II data build 35 (CEU) ().', {'entities': [(4, 14, 'imputation')]}),
 (' For that, genotyped SNPs were phased using SHAPE-IT followed by imputation using IMPUTE2 considering all populations from the 1000 Genomes Project Phase I v3 as a reference.', {'entities': [(65, 75, 'imputation'), (82, 88, 'imputation')]}),
 ('The genotypes of the three SNPs tested in replication were imputed using IMPUTE software for 806 D.', {'entities': [(59, 66, 'imputation'), (73, 79, 'imputation')]}),
 ('The association of imputed and genotyped SNPs with CAD was tested with\nmultiple logistic regression analysis in an additive genetic model (with 1\ndegree of freedom) after adjusting for age (onset of the first event for cases\nor time of recruitment for controls) and sex.', {'entities': [(19, 26, 'imputation')]}),
 (' From the top SNPs for EFS (genotyped or imputed), we selected 76 SNPs for evaluation along with 12 additional potentially functional SNPs based on a bioinformatics analysis of top regions (Data Supplement).', {'entities': [(41, 48, 'imputation')]}),
 (' Association analyses of dosage data for imputed SNPs in each stage I study were analysed using the Mach2dat for SeBCS1 and Rvtests for SBCGS and BBJ1 (see URLs).', {'entities': [(41, 48, 'imputation'), (100, 105, 'imputation')]}),
 (' Quality control of genotype data and subsequent imputation using IMPUTE software was conducted on separate sets, and on the full set of all genotyped individuals within the NTR.', {'entities': [(49, 59, 'imputation'), (66, 72, 'imputation')]}),
 (' The squared correlation (r _2 ) for the allelic dosage between the imputed genotypes and the genotypes measured by TaqMan was calculated.', {'entities': [(68, 75, 'imputation')]}),
 ('4% of imputed genotypes with probabilities higher than 0.', {'entities': [(6, 13, 'imputation')]}),
 (' Chromosome X imputation was conducted\nfor subjects passing QC for the autosomal analysis and with SNP call rates >\n0.', {'entities': [(14, 24, 'imputation')]}),
 (' On both resulting imputed datasets, post-imputation quality controls were similarly conducted in order to account for imputation uncertainty.', {'entities': [(19, 26, 'imputation')]}),
 (' Genotype data were phased with MACH, and genotypes were imputed with Minimac.', {'entities': [(57, 64, 'imputation'), (32, 36, 'imputation')]}),
 (' Before the meta-analysis, additional checks were imposed on the SNPs, including for MAF (MAF > 1%) and imputation quality (R _2  from MACH > 0.', {'entities': [(104, 114, 'imputation'), (135, 139, 'imputation')]}),
 (' Given differences in the timing of the availability of data from CHOP and PCGC, data from these two sources were imputed separately.', {'entities': [(114, 121, 'imputation')]}),
 (' Our total list of individuals with goiter consists of 691 individuals, of whom 217 have been genotyped using the Illumina SNP chip platform and 329 have their genotypes imputed using two-way imputation based on first- or second-degree SNP chip–genotyped relatives.', {'entities': [(170, 177, 'imputation')]}),
 (' For one of these (rs8018217), we substituted a marker that was more reliably imputed in the discovery analysis (rs3168891), which is in near-perfect LD (r_2  = 0.', {'entities': [(78, 85, 'imputation')]}),
 (' Directly genotyped (GWAS and Metabochip) and imputed variants (GWAS only) were then tested for association with the inverse normally transformed BMI residuals using linear regression assuming an additive genetic model.', {'entities': [(46, 53, 'imputation')]}),
 (' Long-range phasing and imputation of variants from 2,636 sequenced Icelanders was carried out with in-house software using the IMPUTE model.', {'entities': [(24, 34, 'imputation'), (128, 134, 'imputation')]}),
 (' An overview of the pre-imputation QC metrics and imputation methods applied in each cohort is provided in , available online.', {'entities': [(24, 34, 'imputation')]}),
 (' Imputation quality was confirmed by genotyping 3,694 of the previously-imputed samples from GenoMEL Phase 1 at rs16953002.', {'entities': [(72, 79, 'imputation'), (1, 11, 'imputation')]}),
 (' All SNPs with poor imputation quality (r_2  hat <0.', {'entities': [(20, 30, 'imputation')]}),
 (' We selected the highest-ranked single-nucleotide polymorphisms (SNPs), which had the smallest P  values in Cox regression analysis, high imputation quality scores (≥0.', {'entities': [(138, 148, 'imputation')]}),
 (' Studies of African American ancestry were imputed to the HRC reference v1.', {'entities': [(43, 50, 'imputation')]}),
 ('4 (for MaCH) or >0.', {'entities': [(7, 11, 'imputation')]}),
 ('Imputation was performed using a cosmopolitan reference panel of all of the individuals of all races/ethnicities from the 1000 Genomes March 2012 interim release (http://1000genomes.', {'entities': [(0, 10, 'imputation')]}),
 ('8 and minor allele frequency (MAF) ≥1% led to 9,281,895 high-quality imputed markers that were subsequently used for GWAS.', {'entities': [(69, 76, 'imputation')]}),
 (' Imputation of non-genotyped single nucleotide polymorphisms (SNPs) was performed with IMPUTE2, using data from the Phase I (November 2010 release) of the 1000 Human Genomes Project as the reference panel.', {'entities': [(1, 11, 'imputation'), (87, 93, 'imputation'), (15, 19, 'negation')]}),
 (' Association analyses were performed using the mach2dat (v 1.', {'entities': [(47, 52, 'imputation')]}),
 (' Following pre-phasing using MACH 1.', {'entities': [(29, 33, 'imputation')]}),
 (' Genotyping was performed by the UK Biobank, and genotyping, quality control, and imputation procedures are described in detail at the UK Biobank website (http://biobank.', {'entities': [(82, 92, 'imputation')]}),
 (' In the CLHNS mothers, we applied MACH2QTL to perform the GWA analyses, adjusting for age, age_2 , household assets (a score that counts the possession of land and house and household amenities, such as a TV or refrigerator) (), natural ln household income, and the first seven PCs.', {'entities': [(34, 39, 'imputation')]}),
 (' The array contains 659,253 SNPs, including tag SNPs for imputation, as well as SNPs related to phenotypes from previously reported GWAS and pharmacogenomics studies.', {'entities': [(57, 67, 'imputation')]}),
 (' As a standard approach for facilitating meta-analyses, all studies used their genotype data to impute unmeasured, autosomal SNPs using either the CEU data from HapMap (release 22 or 24, build 36) or the 1000 Genomes project.', {'entities': [(96, 102, 'imputation')]}),
 (' The imputation reference set consisted of 2,186 phased haplotypes from the full 1000 Genomes Project dataset (August 2012, 30,069,288 variants, release “v3.', {'entities': [(5, 15, 'imputation')]}),
 (' One of them only had non-imputed data (BREATHE), two (TEENAGE and TEDS) had data imputed to HapMap release 22, one cohort (PANIC) used exome chip data and the other nine performed imputation to 1000G.', {'entities': [(26, 33, 'imputation'), (22, 26, 'negation')]}),
 (' Initial imputation yielded genotypes for 81,698,995 variants.', {'entities': [(9, 19, 'imputation')]}),
 (' We filtered out SNPs that were either not present in the GWAS or failed imputation (INFO < 0.', {'entities': [(73, 83, 'imputation'), (39, 42, 'negation')]}),
 (' In all, 520 SNPs in a 630-kb interval that includes DAB2IP  and 200 kb upstream and downstream of the gene were imputed for both the Icelandic and the Dutch sample sets.', {'entities': [(113, 120, 'imputation')]}),
 ('1_B BeadChip, genetic data were phased using SHAPEIT, and imputation was performed with IMPUTE2 software to the 1000 Genomes Phase 1 release (June 2011) reference panel.', {'entities': [(58, 68, 'imputation'), (88, 94, 'imputation')]}),
 ('We aggregated HapMap-imputed GWAS results from 71,638 individuals represented in 23 cohorts embedded in the CHARGE Consortium (40,258 individuals of EUR ancestry), the RIKEN/BioBank Japan Project and AGEN cohorts (15,252 individuals of EAS ancestry), and the COGENT Consortium (16,128 individuals of AFR ancestry).', {'entities': [(21, 28, 'imputation')]}),
 (' The MACH 1.', {'entities': [(5, 9, 'imputation')]}),
 (' Comparison of the imputations made using the four SNPs to those made from the full GWAS data show 1.', {'entities': [(19, 30, 'imputation')]}),
 ('edu/research/departments-divisions/department-health-sciences-research/division-biomedical-statistics-informatics/software/bioinformatics-software-packages) imputes both un-genotyped SNPs and missing SNPs on a given platform.', {'entities': [(157, 164, 'imputation'), (170, 173, 'negation')]}),
 (' SNPs rs710446 and rs780094 were genotyped in ASAP on the Illumina 1M chip, while rs4253417, rs76438938 and rs4253421 were imputed to 1000G.', {'entities': [(123, 130, 'imputation')]}),
 ('3 (MACH) or if the quality information was >0.', {'entities': [(3, 7, 'imputation')]}),
 ('16) to impute untyped SNPs using Human Genome Build 36, CEU population, as the reference [,].', {'entities': [(7, 13, 'imputation')]}),
 (' PTSD diagnosis was assigned using multiple imputation methods that relied on PCL and CIDI-SC data; our clinical reappraisal study found satisfactory concordance with independent clinical diagnoses based on blinded Structured Clinical Interviews for DSM-IV (AUC = 0.', {'entities': [(44, 54, 'imputation')]}),
 (' Phasing was also done at the server prior to imputation with SHAPEIT2 v2.', {'entities': [(46, 56, 'imputation')]}),
 (' At the conclusion of the QC pipeline and imputation, 203 ROS and 171 MAP subjects with AD diagnosis, longitudinal cognitive data (2 or greater evaluations), and quality-controlled genotyping were available for the replication analysis.', {'entities': [(42, 52, 'imputation')]}),
 ('5% of SNPs remained after imputation.', {'entities': [(26, 36, 'imputation')]}),
 (' Of the imputed genotypes, 85.', {'entities': [(8, 15, 'imputation')]}),
 (' (Note: testing of strongly suggestive associated SNPs (P  values <10_−7 ) with genotypes that met lower r _2  thresholds in one or both sets showed P  values >5 × 10_−5  after regional imputation and testing.', {'entities': [(186, 196, 'imputation')]}),
 ('Before imputation all cohorts (see  for cohort information) went through a quality control (QC) pipeline with the following criteria: samples with genotype call rate < 95%, sex discrepancies, excess heterozygosity and cryptic relatedness were removed.', {'entities': [(7, 17, 'imputation')]}),
 ('Pre-imputation QC filtering of samples and variants was conducted based on recommended guidelines as described in .', {'entities': [(4, 14, 'imputation')]}),
 (' Imputation to nonmonomorphic, autosomal single nucleotide polymorphisms (SNPs) from the HapMap CEU (Utah residents with Northern and Western European ancestry from the CEPH collection) panel was performed with standard quality control filters (Section 4, ).', {'entities': [(1, 11, 'imputation')]}),
 ('Association of LOAD with genotyped and imputed SNPs (allele dosages) that had passed quality control was assessed using logistic regression methods for case-control data sets and logistic generalized estimating equations for family data sets as implemented in PLINK.', {'entities': [(39, 46, 'imputation')]}),
 (' SNP imputation was carried out using Mach/1.', {'entities': [(5, 15, 'imputation'), (38, 42, 'imputation')]}),
 (' Imputed SNPs with an INFO score <0.', {'entities': [(1, 8, 'imputation')]}),
 (' Genotypes that were imputed were coded as allelic dosages (estimated counts ranging from 0 to 2).', {'entities': [(21, 28, 'imputation')]}),
 (' A total of 28,032,917 SNPs were successfully imputed (i.', {'entities': [(46, 53, 'imputation')]}),
 (' We conducted the imputation using either BEAGLE, IMPUTE or MACH.', {'entities': [(18, 28, 'imputation'), (50, 56, 'imputation'), (42, 48, 'imputation'), (60, 64, 'imputation')]}),
 ('5 million SNP markers was performed with 669,450 high-quality genotyped SNPs and the MACH program (version 1.', {'entities': [(85, 89, 'imputation')]}),
 (' Analysis of these unrelated individuals was performed under an additive genetic model, using a score test accounting for imputed genotype probabilities as implemented in SNPTEST v2.', {'entities': [(122, 129, 'imputation')]}),
 (' Subsequently, strata were imputed up to the merged reference panel in 5-Mb chunks using IMPUTE2.', {'entities': [(27, 34, 'imputation'), (89, 95, 'imputation')]}),
 (' Although not on the Illumina array, these two SNPs could be imputed relatively accurately with reference to haplotypes in the 1000 Genomes reference panel, with imputation r_2  values of .', {'entities': [(61, 68, 'imputation'), (10, 13, 'negation')]}),
 ('edu/csg/abecasis/mach/) and minimac softwares (http://genome.', {'entities': [(17, 21, 'imputation')]}),
 (' We used IMPUTE2 with the 1000 Genomes Phase 1 integrated reference panel to impute the SNP genotypes for the HumanOmni2.', {'entities': [(77, 83, 'imputation'), (9, 15, 'imputation')]}),
 (' Each scaffold was then pre-phased and imputed_,  up to reference panels from the 1000G or 1000G and UK10K Project ().', {'entities': [(39, 46, 'imputation')]}),
 (' Imputed variants with MAF < 1% and/or INFO score < 0.', {'entities': [(1, 8, 'imputation')]}),
 (' Each study performed genotyping using genome-wide SNP arrays, and\nconducted QC and imputation of the data to ~2.', {'entities': [(84, 94, 'imputation')]}),
 (' We used HapMap JPT and CHB data as an approximate reference to identify proxies for the variants that were not genotyped or imputed in any of the Asian populations.', {'entities': [(125, 132, 'imputation'), (108, 111, 'negation')]}),
 (' IMPUTE2 info (i.', {'entities': [(1, 7, 'imputation')]}),
 (' An association study of imputed SNP allelic dosages in the region surrounding rs13064411 on chromosome 3 with delta log PCSK9 was conducted using mach2qtl [] with the third genome-wide ancestry axis as a covariate, and association results were filtered to exclude markers with an imputation R_2 <0.', {'entities': [(25, 32, 'imputation'), (147, 152, 'imputation')]}),
 ('4%) or low IMPUTE2 info score (<0.', {'entities': [(11, 17, 'imputation')]}),
 (' Imputation was conducted using phased genotype data of European (EUR) populations from the 1000 Genomes project.', {'entities': [(1, 11, 'imputation')]}),
 (' Chromosome 3 genotypes were then imputed using minimac with 5 rounds and 200 states [].', {'entities': [(34, 41, 'imputation')]}),
 (' Phasing and imputation was performed separately for each of the 15 datasets using a common set of single nucleotide polymorphisms (SNPs) passing QC () using the program Impute2 v2.', {'entities': [(13, 23, 'imputation'), (170, 177, 'imputation')]}),
 ('We used additive genetic models with a count of variant alleles (0, 1, or 2) for each genotyped SNP or allelic dose for imputed SNPs.', {'entities': [(120, 127, 'imputation')]}),
 (' After imputation, monomorphic SNPs or SNPs with HWE P  < 1 × 10_−6  or IMPUTE-INFO score < 0.', {'entities': [(7, 17, 'imputation'), (72, 78, 'imputation')]}),
 (' PLINK and R software were used to analyze the imputed SNP and imputed HLA serotype data.', {'entities': [(47, 54, 'imputation')]}),
 ('To technically validate our imputation findings, we optimized three TaqMan assays (Applied Biosystems) for rs72658409, rs11610143 and rs7741164, respectively.', {'entities': [(28, 38, 'imputation')]}),
 (' The genotypes of the SNPs which passed QC in the UK1 dataset were extracted and used for imputation of each sample.', {'entities': [(90, 100, 'imputation')]}),
 (' Estimated per-allele log odds ratios (OR) and standard errors were calculated using unconditional logistic regression of the allele counts (dosage for imputed data).', {'entities': [(152, 159, 'imputation')]}),
 ('   Prior to imputation, additional variant filtering steps were performed\nto establish a high-quality imputation scaffold.', {'entities': [(12, 22, 'imputation')]}),
 ("Investigators representing four published GWAS  formed a consortium with the predetermined goal to discover new loci associated with Parkinson's disease by a prospective meta-analysis of imputed sequence variants (discovery stage).", {'entities': [(187, 194, 'imputation')]}),
 (' For selection of the best associated SNP in a meta-analysis of KORA and TwinsUK within a region we used genotyped as well dosages of imputed SNPs.', {'entities': [(134, 141, 'imputation')]}),
 ('_,  Imputed and directly genotyped SNPs were used to examine the association between genetic loci and the presence of valvular calcium.', {'entities': [(4, 11, 'imputation')]}),
 ('html) software applying strict prephasing, preimputation filtering, and variant position and strand alignment control.', {'entities': [(46, 56, 'imputation')]}),
 (' Because this SNP has a low minor allele frequency and is hard to impute, this SNP was directly genotyped in the SAGE and COGA datasets ().', {'entities': [(66, 72, 'imputation')]}),
 (' This was completed\nusing the 1000 Genomes Project via IMPUTE2, and haplotypes from the 1,092 individuals in a 1000 Genomes Data\nRelease as a reference dataset.', {'entities': [(55, 61, 'imputation')]}),
 (' Filters before imputing were: removing markers that had MAF < 1%, HWE-p  < 1e–6, if LLFS SNPs alleles mismatched with those of 1000HG, and absent in the 1000HG panel, as well as flipping any SNP when appropriate to the forward strand.', {'entities': [(16, 24, 'imputation')]}),
 (' Following standard definitions for human leukocyte antigen (HLA) allele sequences from the EMBL-EBI Immunogenetics HLA Database, we imputed against the 2767 unrelated founder individuals of European descent, with high-resolution MHC genotyping data for 263 HLA alleles, 3852 SNPs and 372 amino acid positions.', {'entities': [(133, 140, 'imputation')]}),
 (' See  for full details and for additional pre-imputation SNP QC.', {'entities': [(46, 56, 'imputation')]}),
 (' To combine genotypes across the different platforms, we imputed genotypes using the 1000 Genomes cosmopolitan samples as a reference, using SHAPEIT [] to phase the data and IMPUTE2 [] to complete the imputation.', {'entities': [(57, 64, 'imputation'), (174, 180, 'imputation')]}),
 ('com/AudeDN/ALS_GWAS_1000G_mach2dat_2017).', {'entities': [(26, 31, 'imputation')]}),
 (' To increase the number and type of genetic polymorphisms examined, genome-wide imputation of SNPs and insertion/deletion polymorphisms (indels) was performed.', {'entities': [(80, 90, 'imputation')]}),
 (' The WZ-Han and GERA-EAS subjects were genotyped and imputed separately from the TP subjects, and the GERA-EAS subjects were genotyped on a different type of SNP array (the GERA-EAS subjects were genotyped on Affymetrix Axiom arrays, and all of the other subjects were genotyped on Illumina CoreExome arrays).', {'entities': [(53, 60, 'imputation')]}),
 (' The Biobank array has more than 650,000 variants, including 265,000 exome coding snps and indels, 70,000 novel loss-of-function SNPs and indels, 23,000 eQTLs, 2000 markers of pharmacogenomic relevance and 246,000 genome-wide association markers designed to ensure good genome-wide coverage in major populations, which make it possible to carry out imputation in order to increase the number of markers in the statistical analyses.', {'entities': [(349, 359, 'imputation')]}),
 (' After excluding imputed SNPs with imputation quality\nscores below a threshold (R_2  < 0.', {'entities': [(17, 24, 'imputation')]}),
 ('Additional Methods in the  describe (1) SNP imputation; (2) estimation of the variance explained; (3) LD analysis; (4) gene-expression analysis; (6) oral fat tolerance test; and (7) ancestry analyses.', {'entities': [(44, 54, 'imputation')]}),
 (' For imputed SNPs, we used the expected number of copies of the variant allele which provides unbiased test statistics.', {'entities': [(5, 12, 'imputation')]}),
 (' 76% of the 9,412,474 SNPs with MAF>1% frequency was imputed at RSQ>0.', {'entities': [(53, 60, 'imputation')]}),
 (' To increase genome coverage, imputation was performed using IMPUTE2 with the reference panel of 1092 worldwide subjects from 1000 Genomes Project Phase I integrated variant set (March 2012 release) in NCBI Build 37 (hg19) coordinates.', {'entities': [(30, 40, 'imputation'), (61, 67, 'imputation')]}),
 ('We performed a meta-analysis on directly genotyped and imputed SNPs from individuals of European ancestry in 27 studies, with a total of 37,382 individuals.', {'entities': [(55, 62, 'imputation')]}),
 (' For dedicated imputation of the HLA region we used SNP2HLA  and imputed into the T1DGC reference panel of 5,224 individuals that have had classical HLA alleles typed as well as SNPs and indels by the immunochip.', {'entities': [(15, 25, 'imputation')]}),
 ('For the GWA data from the two initial study samples, we analyzed the imputed allele dosage data with the SNPTEST software (version 2.', {'entities': [(69, 76, 'imputation')]}),
 (' Unobserved genotypes were imputed in the family-based study leading to 7,467,568 combined genotyped and imputed SNPs across autosomes, and 5,390,648 autosomal SNPs retained after quality control filtering ().', {'entities': [(27, 34, 'imputation')]}),
 ('99 in CHS were used to do the imputation, and allele dosage information was summarized in the imputation results.', {'entities': [(30, 40, 'imputation')]}),
 ('  Using the 50 most significant associations in the imputed dataset, we identified the closest genes using bedtools with gencode v19 gene annotations.', {'entities': [(52, 59, 'imputation')]}),
 (' Imputation was performed using a cosmopolitan panel from the 1000 Genomes Project (March 2012) to increase the genetic coverage.', {'entities': [(1, 11, 'imputation')]}),
 (' We tested for association between imputed SNPs and SLE status using IMPUTE2’s companion program SNPTEST; SNPTEST explicitly accounts for estimated imputation uncertainty (i.', {'entities': [(35, 42, 'imputation'), (69, 75, 'imputation')]}),
 (' In addition, imputation may be used to infer SNPs not directly genotyped in a given sample, but genotyped in a reference dataset.', {'entities': [(14, 24, 'imputation'), (51, 54, 'negation')]}),
 (' The genotyping, imputation and quality control protocols are described elsewhere ().', {'entities': [(17, 27, 'imputation')]}),
 (' A fixed-effects model () based on the inverse-variance-weighted effect size was used to combine the results (log-odds ratio and standard error) from typed GWAS and two imputation GWASs (imputation based on both the data from HapMap 3 and the 1000 Genomes Project, including the non-pseudoautosomal region (nonPAR) and two pseudoautosomal regions (PAR1 and PAR2) of X chromosome) from the SAC and WTCCC-TB results (SAC-TB and Davila et al .', {'entities': [(169, 179, 'imputation'), (279, 283, 'negation')]}),
 (' After combining imputed genotypes from both cohorts, the final data set contained ∼5.', {'entities': [(17, 24, 'imputation')]}),
 (' Filtering for imputation quality (info) value of >0.', {'entities': [(15, 25, 'imputation')]}),
 (' We used IMPUTE2 to predict (impute) unmeasured genotypes, using phased haplotypes from the whole-genome sequencing of 168 Indian Asians as a reference panel.', {'entities': [(29, 35, 'imputation'), (9, 15, 'imputation')]}),
 ('edu/csg/abecasis/MaCH/).', {'entities': [(17, 21, 'imputation')]}),
 ('5 million SNPs using MACH v1.', {'entities': [(21, 25, 'imputation')]}),
 (' Variants were then imputed from the 1000 Genomes Project October 2014 release with 2,504 samples with singletons removed (which impute terribly) and as a cosmopolitan reference panel with Impute2 v2.', {'entities': [(20, 27, 'imputation'), (189, 196, 'imputation')]}),
 (' Genotypes were pre-phased using SHAPEIT2 and imputed using IMPUTE2_,  with the 1000 Genomes Phase 3 cosmopolitan (“ALL”) reference panel, resulting in 49 million imputed variants.', {'entities': [(46, 53, 'imputation'), (60, 66, 'imputation')]}),
 (' Imputation used the Michigan Imputation Server implementing Minimac3.', {'entities': [(1, 11, 'imputation')]}),
 (' Chromosomes 23 through 26 were not imputed.', {'entities': [(36, 43, 'imputation'), (32, 35, 'negation')]}),
 (' As a subset of these samples had also been genotyped as part of stage 1, we examined the imputation quality for critical variants by comparing imputed genotypes to those directly genotyped by the exome array; overall concordance was >99%, while concordance among alternate allele genotypes (heterozygotes and alternate allele homozygotes) was >88.', {'entities': [(90, 100, 'imputation')]}),
 (' In the AABC GWAS, we analysed genotyped SNPs and imputed SNPs with imputation score\u2009>0.', {'entities': [(50, 57, 'imputation')]}),
 (' In order to perform a meta-analysis, we imputed the SNPs for both datasets.', {'entities': [(41, 48, 'imputation')]}),
 ('0) [] using the Positional Burrows–Wheeler Transform algorithm [] available on the imputation server at the Wellcome Trust Sanger Institute (https://imputation.', {'entities': [(83, 93, 'imputation')]}),
 (' We used the Markov Chain Haplotyping (MACH) package version 1.', {'entities': [(39, 43, 'imputation')]}),
 ('3, as indicated by MaCH or IMPUTE2, respectively (with these two quality estimates described to be equivalent), were excluded from analyses.', {'entities': [(27, 33, 'imputation'), (19, 23, 'imputation')]}),
 (' One RCDII SNP (rs1402582) did not pass the quality control parameters and was imputed as described previously [].', {'entities': [(79, 86, 'imputation'), (31, 34, 'negation')]}),
 (' Briefly, genotyping was performed using the Illumina HumanOmniExpress, with imputation based on the 1,000 Genomes Phase I v3 reference panel.', {'entities': [(77, 87, 'imputation')]}),
 (' The target panel was phased using Beagle (GECCO) or SHAPE-IT (CORECT, MECC1 and CFR1) and the phased target panel was imputed to the 1,000 Genomes reference panel using either Minimac (GECCO) or IMPUTE2 (CORECT, MECC1 and CFR1).', {'entities': [(119, 126, 'imputation'), (196, 202, 'imputation'), (35, 41, 'imputation')]}),
 (' Haplotypes were phased using the MaCH program () before running minimac for genotype\nimputation (,), using the recommended parameters (20 iterations of the\nMarkov sampler and 200 states).', {'entities': [(86, 96, 'imputation'), (34, 38, 'imputation')]}),
 (' Imputation was carried out on the forward (+) strand using the University of Michigan Imputation Server (https://imputationserver.', {'entities': [(114, 130, 'imputation'), (1, 11, 'imputation')]}),
 (' We compared the genotype concordance of all pAID GWAS imputed SNPs that were directly genotyped on the Immunochip after performing sample and marker QC as described above.', {'entities': [(55, 62, 'imputation')]}),
 ('edu/csg/abecasis/MaCH/download/1000G.', {'entities': [(17, 21, 'imputation')]}),
 ('05 and imputation quality scores <0.', {'entities': [(7, 17, 'imputation')]}),
 (' Moreover, after imputation, stringent QC was applied: (1) individuals who generated genotypes at <90% loci were not considered in the analysis, (2) markers with call rates ≤ 95% were excluded, (3) markers with allele distributions deviated from HWE in controls (p < 1\xa0× 10_−3 ) were discarded, and (4) variants with MAF < 0.', {'entities': [(17, 27, 'imputation'), (113, 116, 'negation')]}),
 ('Individual study association analyses were implemented using logistic regression with an additive model on the imputed dosage of the effect allele.', {'entities': [(111, 118, 'imputation')]}),
 (' SNPs with minor allele frequency (MAF) <3% and/or imputation quality r_2  <0.', {'entities': [(51, 61, 'imputation')]}),
 (' The imputation process uses information on the haplotype structure in the human genome from the HapMap project (Release22 Build36) to impute non-genotyped SNPs in the sample.', {'entities': [(5, 15, 'imputation'), (142, 146, 'negation')]}),
 (' Since the most significantly associated SNPs showed LD heterogeneity, and the method can be applied to imputed GWAS data, we used the LD- and MAF-stratified genomic-REML (GREML-LDMS) method [] in GCTA to estimate  for each LD quartile and calculate a total  estimate ().', {'entities': [(104, 111, 'imputation')]}),
 (' Imputation for the BPC3 study used MACH 1.', {'entities': [(1, 11, 'imputation'), (36, 40, 'imputation')]}),
 (' For novel PrCa associations for which the variant was imputed in the OncoArray study sample series and had an imputed quality score <0.', {'entities': [(55, 62, 'imputation')]}),
 (' In total, 12,106,458 SNPs passed quality control (minor allele count [MAC]\n>5 in individual cohorts; imputation quality >0.', {'entities': [(102, 112, 'imputation')]}),
 ('07, and R using lm  for imputed variants, under an additive genetic model.', {'entities': [(24, 31, 'imputation')]}),
 ('  includes the LD plots for three of the poorly imputed SNPs.', {'entities': [(48, 55, 'imputation')]}),
 ('() For SNPs not interrogated on the arrays, imputation was performed using the 1000 Genomes Project (http://www.', {'entities': [(44, 54, 'imputation'), (12, 15, 'negation')]}),
 (' The phased haplotypes from SHAPEIT were input directly into the IMPUTE2 program.', {'entities': [(65, 71, 'imputation')]}),
 (' Studies of Japanese ancestry or Hispanic ethnicity were imputed to the 1000G Phase 1 integrated v3 panel (March 2012).', {'entities': [(57, 64, 'imputation')]}),
 ('  To estimate IBD, we phased intersected genotypes for the ‡Khomani and Nama populations both separately (number of SNPs = 300,370 in ‡Khomani, 525,934 in Nama) and jointly (number of SNPs = 241,929) using Beagle (v4.', {'entities': [(206, 212, 'imputation')]}),
 ('uk/impute/ALL_1000G_phase1integrated_v3_impute.', {'entities': [(3, 9, 'imputation')]}),
 (' Empirical assessments show that MACH2QTL provides an effective means of evaluating evidence for association at untyped markers ().', {'entities': [(33, 38, 'imputation')]}),
 (' Imputation with the Mach software has been shown to perform slightly better, but differences tend to be small.', {'entities': [(1, 11, 'imputation'), (21, 25, 'imputation')]}),
 (' Additionally, to investigate whether a SNP had a role in machineries of gene regulation, we used available datasets from ENCODE (the Encyclopedia of DNA Elements) and the National Institutes of Health Roadmap Epigenomics Mapping Consortium.', {'entities': [(58, 62, 'imputation')]}),
 ('Untyped genotypes were imputed in the GWAS samples using IMPUTE2 (version 2.', {'entities': [(23, 30, 'imputation'), (57, 63, 'imputation')]}),
 (' Most of the study sites have imputed data available (with the HapMap phase 2 CEU population set as the reference).', {'entities': [(30, 37, 'imputation')]}),
 (') were removed, and SNPs with genotyping call rate <95%, departures from Hardy-Weinberg equilibrium (P <10_−7 ) or minor allele frequency (MAF) <5% were excluded using the software PLINK before association testing or imputation.', {'entities': [(217, 227, 'imputation')]}),
 (" Each GWAS sample was imputed by relevant population's reference haplotypes.", {'entities': [(22, 29, 'imputation')]}),
 (' In addition, two SNPs from the imputed locus on chromosome 18q22.', {'entities': [(32, 39, 'imputation')]}),
 (' Meta-analysis of GWA results obtained in the cohorts participating in stage 1 was performed as follows: the expected minor allele count (eMAC) was computed at the cohort level for each SNP as\n \nwhere N  is the study sample size, MAF is the minor allele frequency and I _A   is the SNP genotype imputation quality measure.', {'entities': [(295, 305, 'imputation')]}),
 (' After imputation, genotype probabilities ≥ 0.', {'entities': [(7, 17, 'imputation')]}),
 (' The 1000 Genomes cosmopolitan samples (African, AFR; AMR; Asian, ASN; European, EUR) were used as a reference for imputation and were based on Build 37.', {'entities': [(115, 125, 'imputation')]}),
 (' Imputation was carried out using IMPUTE V2 using standard settings .', {'entities': [(1, 11, 'imputation'), (34, 40, 'imputation')]}),
 (' Sample Characteristics for Measure of FertilityEach participating cohort performed participant-level genotyping of SNPs that included standard quality-control measures for genotyping and imputation ().', {'entities': [(188, 198, 'imputation')]}),
 (' A total of 2,072,428 SNPs were imputed, with 2,028,122 high-confidence SNPs remaining after removal of SNPs with low imputation quality (r _2\u2009 <0.', {'entities': [(32, 39, 'imputation')]}),
 (' Moreover, we compared the genetic scores obtained with genotyped versus imputed SNPs for 49 individuals who were genotyped on Axiom Genome-Wide CEU 1 arrays and imputed with the European replication population and observed high correlation between methods ().', {'entities': [(73, 80, 'imputation')]}),
 (' The quality of imputed SNPs depends on the strength of the linkage between hard genotyped SNPs and the imputed SNPs.', {'entities': [(16, 23, 'imputation')]}),
 (' Individual genotypes imputed with probability <0.', {'entities': [(22, 29, 'imputation')]}),
 (' Programs used to perform the GWA analyses were MACH2QTL (,), QUICKTEST (), SnpTest (), Plink () and ProbABEL ().', {'entities': [(48, 53, 'imputation')]}),
 (' Imputation was performed with the GIANT ALL data panel from the 1,000 Genomes Project phase1 release v3 as the reference using program MACH v1.', {'entities': [(1, 11, 'imputation'), (136, 140, 'imputation')]}),
 (' Because these selected SNPs were all based on imputed data, results were validated by regenotyping stage one samples with the iPLEX Gold Platform.', {'entities': [(47, 54, 'imputation')]}),
 (' Analyses were adjusted for the first four principal components and were performed using the mach2dat (v 1.', {'entities': [(93, 98, 'imputation')]}),
 (' Imputation was conducted separately for each scan.', {'entities': [(1, 11, 'imputation')]}),
 ('In the discovery stage, imputation was performed for each GWA study using 1000G sequence variants as a reference panel (as of August 2010).', {'entities': [(24, 34, 'imputation')]}),
 (' We computed the correlation with the imputed genotype, and a bias-corrected and accelerated bootstrap CI (99,999 iterations).', {'entities': [(38, 45, 'imputation')]}),
 (' Genotypes were determined using Illumina chips; methods, quality control steps and imputation of untyped HapMap 2 SNPs were as previously described ().', {'entities': [(84, 94, 'imputation')]}),
 ('2 [] were used for phasing and imputation.', {'entities': [(31, 41, 'imputation')]}),
 (' All cohorts were whole genome genotyped before imputation using the HapMap CEU panel as reference (Supplemental Tables 6 and 7).', {'entities': [(48, 58, 'imputation')]}),
 (' Detailed genotyping and imputation information for each study is provided ().', {'entities': [(25, 35, 'imputation')]}),
 ('For all imputed and genotyped SNPs with a P  value of less than 1×10_−5  (N=75) in the NFIB  locus genomic annotation of SNP markers was conducted using the Encyclopedia of DNA Elements (ENCODE) () tool HaploReg (), RegulomeDB () and LDlink ().', {'entities': [(8, 15, 'imputation')]}),
 (' Prior to imputation, all genotype data underwent QC procedures that have been described extensively elsewhere_, .', {'entities': [(10, 20, 'imputation')]}),
 (' Imputation of genotypes not directly measured was performed using pooled haplotypes from the CEU, YRI and CHB/JPT HapMap2 reference panel, and the IMPUTE2 software package, as previously described.', {'entities': [(1, 11, 'imputation'), (148, 154, 'imputation'), (25, 28, 'negation')]}),
 ('SNPs with p < 1\xa0× 10_−5  in the additive model or p < 5\xa0× 10_−7  in the genotypic model were directly genotyped in the discovery set to confirm imputation accuracy and in the replication sample set to confirm the associations using two Sequenom iPLEX assays.', {'entities': [(144, 154, 'imputation')]}),
 ('3 (provided a higher threshold for\nimputation quality was not already implemented), a minor allele count (MAC) of\n< 20 using the effective sample size or the number of cases and adjusted\nfor imputation quality where applicable, were set to missing.', {'entities': [(35, 45, 'imputation'), (58, 61, 'negation')]}),
 ('727 and genotypes for additional variants were imputed using Impute 2 v2.', {'entities': [(47, 54, 'imputation'), (61, 67, 'imputation')]}),
 (' The INFO score is a measure of imputation reliability.', {'entities': [(32, 42, 'imputation')]}),
 (' The imputation was performed using\nMACH [; ] in ARIC, RSI, RSII,\nand WGHS, and BIMBAM [] in CHS and HVH.', {'entities': [(5, 15, 'imputation'), (36, 40, 'imputation')]}),
 (' Odds ratio estimates were derived using MACH for the BCFR GWAS, ProbABEL was used for the BPC3 GWAS, SNPTEST (see URLs) was used for the remaining GWAS and purpose-written software was applied for the iCOGS and OncoArray data sets.', {'entities': [(41, 45, 'imputation')]}),
 (' For quality control of imputed data, imputed SNPs with minor allele frequency (MAF) <0.', {'entities': [(24, 31, 'imputation')]}),
 (' Logistic regression was performed per batch using mach2dat\nsoftware (version 1.', {'entities': [(51, 56, 'imputation')]}),
 (' The first SNP-based analysis consisted of SNP-specific logistic regressions for each of the 1,265,548 typed or imputed HapMap3 SNPs using BEAGLE ().', {'entities': [(112, 119, 'imputation'), (139, 145, 'imputation')]}),
 ('Ungenotyped markers 50 kb upstream and downstream from borderline significant regions from the TDT GWAS (chromosomes 3, 7, 8, 15 and 22) were imputed for the discovery sample using a trio design as implemented in BEAGLE v3.', {'entities': [(142, 149, 'imputation'), (213, 219, 'imputation')]}),
 (' Detailed information about genotype calling and imputation was described previously in ().', {'entities': [(49, 59, 'imputation')]}),
 (' Genotyping, imputation, and preliminary quality control were performed by 23andMe.', {'entities': [(13, 23, 'imputation')]}),
 (' Phased haplotypes for 90 CHB+JPT subjects (180 haplotypes) were used as the reference for imputing genotypes.', {'entities': [(91, 99, 'imputation')]}),
 (' HLA-haplotypes were imputed using HLA*IMP:02 with default parameters ().', {'entities': [(21, 28, 'imputation')]}),
 ('_,   Post-imputation quality control procedures included removing variants that were: indels, poorly imputed (r_2 < 0.', {'entities': [(10, 20, 'imputation')]}),
 (' Details of the COPDGene genotyping, imputation, and quality control have been previously described ().', {'entities': [(37, 47, 'imputation')]}),
 ('Asn484Ser GRHL3 were shuttled into CS2+ vector and the corresponding capped mRNAs were generated in\xa0vitro with mMESSAGE mMACHINE SP6 kit (Ambion) and purified with RNeasy mini kit (QIAGEN).', {'entities': [(121, 125, 'imputation')]}),
 ('9 and 58 per cent have an imputation r_2 > 0.', {'entities': [(26, 36, 'imputation')]}),
 (' Post-imputation quality control included: removing\nduplicates, variants with low imputation accuracy (Rsq<0.', {'entities': [(6, 16, 'imputation')]}),
 (' After imputation, principal\ncomponents were calculated using PLINK software after removing known\nhypervariable regions and the 1 MB surrounding the\nC9orf72  region.', {'entities': [(7, 17, 'imputation')]}),
 (' The LD structure was based on SNPs with a p-value < 1 × 10-3  that were extracted from the imputed genotypes.', {'entities': [(92, 99, 'imputation')]}),
 (' Imputation was performed using the IMPUTE2 [] based on HapMap2, release 22.', {'entities': [(1, 11, 'imputation'), (36, 42, 'imputation')]}),
 (' After excluding the unqualified samples and SNPs in the preimputation process, our final dataset included 734 cases, 3651 controls, and 746,272 autosomal SNPs.', {'entities': [(60, 70, 'imputation')]}),
 (' For imputed SNPs, X  could be non-integer, equal to the expected allele count provided by the imputation; however, it is advised to perform the analysis using the expected values rather than replace them with, say, the most likely genotype value ().', {'entities': [(5, 12, 'imputation'), (31, 35, 'negation')]}),
 ('We imputed genotypes for ~70 million SNPs for all samples by using the October 2014 (Phase 3) release of the 1KGP data as the reference panel.', {'entities': [(3, 10, 'imputation')]}),
 (' Novel SNPs with an IMPUTE2 r _2  <0.', {'entities': [(20, 26, 'imputation')]}),
 (' For the samples contributing to the stage 1 (discovery) meta-analysis, imputation was conducted with reference to HapMap phase 2 build 36 release 22 or 24 CEU (Utah residents of Northern and Western European ancestry) phased genotypes.', {'entities': [(72, 82, 'imputation')]}),
 ('We imputed additional SNPs in the 1,962 samples that passed quality control standards in the GWAS, using Impute 2 version 2.', {'entities': [(3, 10, 'imputation'), (105, 111, 'imputation')]}),
 (' Related subjects that passed all other quality-control thresholds were retained during subsequent phasing and imputation.', {'entities': [(111, 121, 'imputation')]}),
 (' Therefore, to facilitate meta-analysis of all samples, we used MaCH () to impute all variants reported in the HapMap Phase 2, release 21, reference panel.', {'entities': [(75, 81, 'imputation'), (64, 68, 'imputation')]}),
 (' All five SNPs analyzed in SMHS were imputed from phased haplotypes of HapMap (R22 CHB + JPT), with imputation quality (MACH_Rsq) >0.', {'entities': [(37, 44, 'imputation'), (120, 124, 'imputation')]}),
 (' First, chromosomal segments of no more than 10,000 genotyped SNPs, with overlaps of 200 SNPs, were phased using Beagle (version 3.', {'entities': [(113, 119, 'imputation'), (32, 34, 'negation')]}),
 (' Customized imputation settings included an effect size of 20,000, allowance of large-region imputation and a random seed of 12345.', {'entities': [(12, 22, 'imputation')]}),
 (' Data from DS2 were analyzed using the genotyped data from ARIC, along with both genotyped and imputed data from the samples genotyped on the Axiom array using the SNPTEST version 2 software.', {'entities': [(95, 102, 'imputation')]}),
 (' ) for imputation.', {'entities': [(7, 17, 'imputation')]}),
 ('18 software (), 38 million SNPs, excluding SNPs monomorphic in CEU/YRI, were imputed using minimac () based on 1000 Genome Project phase I reference samples (November 2010, Version 3).', {'entities': [(77, 84, 'imputation')]}),
 (' Imputation concordance scores for cases and controls were compared to assess biases in imputation accuracy ().', {'entities': [(88, 98, 'imputation'), (1, 11, 'imputation')]}),
 (' Association analysis of imputed data was performed using the single.', {'entities': [(25, 32, 'imputation')]}),
 (' Imputation quality scores were reviewed for the top SNPs reported to ensure good imputation quality (proper-info of IMPUTE or R_2  of MACH > 0.', {'entities': [(82, 92, 'imputation'), (1, 11, 'imputation'), (117, 123, 'imputation'), (135, 139, 'imputation')]}),
 ('95 was used to remove SNPs with poor imputation quality.', {'entities': [(37, 47, 'imputation')]}),
 (' We decided to impute SNPs by splitting each chromosome into 5 Mb regions for analysis by IMPUTE2.', {'entities': [(15, 21, 'imputation'), (90, 96, 'imputation')]}),
 (' We set thresholds for imputation quality to retain potential risk variants with MAF > 0.', {'entities': [(23, 33, 'imputation')]}),
 ('In the ADNI sample, we tested each SNP dosage value for association with the lentiform nucleus volume, assuming, by default, an additive model - each SNP dosage value was recorded as the number of minor alleles, with an implicit correction for the accuracy of imputation at that SNP.', {'entities': [(260, 270, 'imputation')]}),
 (' Analysis of imputed genotypes used either the dosage information from MACH or the genotype probabilities from IMPUTE.', {'entities': [(13, 20, 'imputation'), (111, 117, 'imputation'), (71, 75, 'imputation')]}),
 ('1 region used genotyped data and maximum-likelihood genotypes for SNPs imputed with high reliability (r _2  > 0.', {'entities': [(71, 78, 'imputation')]}),
 ('uk/~wrayner/tools/) prior to imputation.', {'entities': [(29, 39, 'imputation')]}),
 (' After removal of low quality imputed SNPs, 6,844,888 imputed SNPs remained for further analysis.', {'entities': [(30, 37, 'imputation')]}),
 (' Detailed information about the pre-imputation quality control pipeline is available in our published AD GWAS [].', {'entities': [(36, 46, 'imputation')]}),
 (' Genome-wide association analyses were conducted using the imputed allele dosage as predictor adjusted for age, gender, center, and principal components associated with the outcome at p-value < 0.', {'entities': [(59, 66, 'imputation')]}),
 (' Only SNPs with minor allele frequency (MAF) > 5% and a high imputation quality (R_2  > 0.', {'entities': [(61, 71, 'imputation')]}),
 ('0 was used for imputation.', {'entities': [(15, 25, 'imputation')]}),
 (' Imputation was independently conducted for each study with reference to HapMap phase 2 or 3 CEU genotypes, and association analysis was performed using logistic regression models based on an expected allelic dosage model for SNPs, adjusting for ancestry-informative principal components as necessary.', {'entities': [(1, 11, 'imputation')]}),
 (' Specifically, we used Illumina SNP arrays to genotype 3523 EOBC cases and 2702 control women and to impute their genotypes for the HaMap3 SNPs (hereafter called the discovery set ).', {'entities': [(101, 107, 'imputation')]}),
 (' Genotype uncertainty, generated by the calling algorithm or by imputation, was factored into the association test using the -method score  option in SNPTEST.', {'entities': [(64, 74, 'imputation')]}),
 (' Genome-wide genotype imputation was performed using Beagle v.', {'entities': [(22, 32, 'imputation'), (53, 59, 'imputation')]}),
 (' Individual genotypes were all imputed up to the CEU (Utah Residents with Northern and Western European Ancestry) and TSI (Toscani in Italy) HapMap3 reference panel.', {'entities': [(31, 38, 'imputation')]}),
 (' Similar to GenSalt, we imputed BP for participants taking antihypertensive medication by adding 10 and 5 mm Hg to SBP and DBP, respectively.', {'entities': [(24, 31, 'imputation')]}),
 (' Imputation quality was assessed on the basis of IMPUTE2 imputation r _2  in the OncoArray dataset ().', {'entities': [(57, 67, 'imputation'), (1, 11, 'imputation'), (49, 55, 'imputation')]}),
 (' Detailed descriptions, including genotyping quality control, genotyping imputation, and quantitative imaging, have been previously published (, , –).', {'entities': [(73, 83, 'imputation')]}),
 (' Using genotype information generated on these platforms, all cohorts imputed genotypes for a common set of ∼2.', {'entities': [(70, 77, 'imputation')]}),
 (' To ensure the appropriateness of the reference panel, only study subjects of European ancestry defined via principal components analysis were included for imputation.', {'entities': [(156, 166, 'imputation')]}),
 (' Imputation used the Michigan Imputation Server implementing Minimac3 (, ; “Minimac3,” n.', {'entities': [(1, 11, 'imputation')]}),
 (' We conducted imputation with IMPUTE2 using 5MB non-overlapping intervals.', {'entities': [(14, 24, 'imputation'), (30, 36, 'imputation'), (48, 52, 'negation')]}),
 (' We note that genome-wide imputation to 1000 Genomes Project data is in fact available for WHI-SHARe.', {'entities': [(26, 36, 'imputation')]}),
 (' Association between all SNPs (MAF>5%, IMPUTE info >0.', {'entities': [(39, 45, 'imputation')]}),
 (' The\nchip-typed individuals were long range phased (), and variants from\nwhole-genome sequencing of Icelanders (n  = 15,220) were imputed\ninto the chip-typed individuals as well as 282,894 close relatives ().', {'entities': [(130, 137, 'imputation')]}),
 (' Haplotypes were estimated from the targeted sequencing data to identify the presence of other rare or novel variants that might not be present in the imputed markers.', {'entities': [(151, 158, 'imputation'), (129, 132, 'negation')]}),
 (' Results were then filtered on the basis of imputation quality (oevar\u2009>\u20090.', {'entities': [(44, 54, 'imputation')]}),
 ('  We initially used an effcient two-step procedure, which involved pre-phasing using SHAPEIT  followed by imputation of the phased data using IMPUTE2 .', {'entities': [(106, 116, 'imputation'), (142, 148, 'imputation')]}),
 ('() To circumvent this potential bias, imputation was conducted using the common set of genotyped SNPs available across all EAs (344,736 SNPs) or AAs (336,412 SNPs) as the input genotypes.', {'entities': [(38, 48, 'imputation')]}),
 (' Imputations were carried out using a two-step strategy: 1/prephasing using the program SHAPEIT [] and 2/Imputation from the reference panel into the estimated haplotypes with IMPUTE v2 [,].', {'entities': [(1, 12, 'imputation'), (176, 182, 'imputation')]}),
 (' (A) QQ plot of RTL GWAS of the Sikh discovery cohort after quality control of directly genotyped (474,231), and (B) imputed variants 5,904,251 (MAF≥5%) from the 1kG reference panel of 1092 world-wide subjects In addition to analysis of directly genotyped SNPs, we performed imputation using the Impute 2 program_– .', {'entities': [(117, 124, 'imputation'), (296, 302, 'imputation')]}),
 (" eQTLs were mapped using Spearman's rank correlation, using imputation dosage values as genotypes.", {'entities': [(60, 70, 'imputation')]}),
 (' The 1000 Genomes Project reference panel and Impute2 _–  were used to impute the top methadone dose GWAS SNP.', {'entities': [(71, 77, 'imputation'), (46, 53, 'imputation')]}),
 (' ) for imputation to the 1KGP-RP (https://mathgen.', {'entities': [(7, 17, 'imputation')]}),
 (' We applied logistic regression assuming an additive model to test for association between case/control status and either genotypes or imputed dosages (for imputed SNPs).', {'entities': [(135, 142, 'imputation')]}),
 (' After applying genomic control at the individual cohort level, two independent analysts carried out additive model fixed-effects meta-analysis of association data for imputed autosomal SNPs, using two different software packages (METAL and GWAMA).', {'entities': [(168, 175, 'imputation')]}),
 ('We imputed unobserved genotypes using phased haplotypes from the integrated Phase I release of the 1000 Genomes Project.', {'entities': [(3, 10, 'imputation')]}),
 ('() For each imputed SNP and indel, a dosage value (a fractional value between 0 and 2 indicating the expected number of minor allele copies) and an “info” metric (a fractional value typically between 0 and 1 with higher values indicating SNPs imputed with higher certainty) were generated.', {'entities': [(12, 19, 'imputation')]}),
 (' Imputations were performed in chunks with 5,000 SNPs blocks and 1,000 SNPs overlap from our data.', {'entities': [(1, 12, 'imputation')]}),
 (' The Yale-Penn 2 sample was genotyped using the HumanCore Exome array (Illumina) containing approximately 266\u2009000 exomic SNPs and approximately 240\u2009000 tagging SNPs for genome-wide imputation.', {'entities': [(181, 191, 'imputation')]}),
 ('3 was implemented in the program to identify and discard low-quality imputations.', {'entities': [(69, 80, 'imputation')]}),
 (' The imputation was run in two stages using Mach.', {'entities': [(5, 15, 'imputation'), (44, 48, 'imputation')]}),
 (' To remove poorly imputed SNPs from analysis, we filtered the data to include SNPs with an IMPUTE2 info score cutoff of ≥ 0.', {'entities': [(18, 25, 'imputation'), (91, 97, 'imputation')]}),
 (' SNPs were coded on the forward strand to facilitate the imputation process.', {'entities': [(57, 67, 'imputation')]}),
 (', lower resolution) for HLA-A, -C, -B, and -DRB1  in the genotyped myositis cases and controls, we collapsed the 4-digit coding of T1DGC HLA data for these 4 genes to 82 alleles with 2-digit coding and included them in the reference panel for imputation.', {'entities': [(243, 253, 'imputation')]}),
 (' We supplemented the quality control performed by the individual studies by excluding (1) genotyped SNPs called in fewer than 90% of participants or with Hardy-Weinberg p < 10_−6  and (2) imputed SNPs with r_2  < 0.', {'entities': [(188, 195, 'imputation')]}),
 ('Details on genotyping and imputation in each cohort are provided in the .', {'entities': [(26, 36, 'imputation')]}),
 (' Approximately 8 million SNPs were imputed using reference populations from the 2010 release of the 1000 Genomes Project.', {'entities': [(35, 42, 'imputation')]}),
 (' Additional information regarding the merging of set 1 and set 2, imputation, and quality control can be found in the .', {'entities': [(66, 76, 'imputation')]}),
 (' In the second stage, data were imputed for all individuals using the HapMap data (release 22, build 36) as the reference panel and the recombination and error files generated in stage 1 were used to customize the imputation.', {'entities': [(32, 39, 'imputation')]}),
 (' After imputation and quality control (QC), a total of 2,708,280 SNPs were used in the meta-analysis of GECCO studies and CCFR.', {'entities': [(7, 17, 'imputation')]}),
 (' R was used to create complete data sets from IMPUTE output.', {'entities': [(46, 52, 'imputation')]}),
 (' In the CHARGE GWAMA, a linear regression analysis was applied to test the association of depressive symptom score on imputed SNP dosages in the contributing studies adjusting for age and sex.', {'entities': [(118, 125, 'imputation')]}),
 ('01) () and tested for association (allowing for potential ambiguity in statistically-inferred haplotype phase and imputed genotype).', {'entities': [(114, 121, 'imputation')]}),
 (' Genome-wide SNP imputation using inferred haplotypes was performed with IMPUTE2, generating data for 9,237,809 SNPs ().', {'entities': [(17, 27, 'imputation'), (73, 79, 'imputation')]}),
 (' Genotype data were phased with EAGLE2 and imputed with PBWT.', {'entities': [(43, 50, 'imputation')]}),
 ('_,  Prephasing and imputation were both performed using 30 rounds and 200 states, with regions divided into 1 Mb segments with 500-kb flanks.', {'entities': [(19, 29, 'imputation')]}),
 ('Genotyped and imputed SNPs were analyzed according to logistic regression assuming an additive model for allelic effects, including covariates for age, gender and the top five principal components to account for residual population structure.', {'entities': [(14, 21, 'imputation')]}),
 ('-  For the imputation, reference groups for imputing SNPs in patients classified as white (see below) were as follows: the European individuals in 1000 Genomes, for patients classified as black were the 1000 Genomes Africans, and the remaining patients were all individuals in the 1000 Genomes database.', {'entities': [(11, 21, 'imputation')]}),
 (' Each GWAS sample was imputed by respective reference panel with the closest ancestry.', {'entities': [(22, 29, 'imputation')]}),
 (' The imputed index SNP was included in the plot to determine the strength of LD with nearby signals and to assess a pattern of association.', {'entities': [(5, 12, 'imputation')]}),
 ('8), preferentially\nretaining both an imputed and genotyped top SNP at each locus.', {'entities': [(37, 44, 'imputation')]}),
 ('Within each cohort (and within the breast cancer cases and controls separately in AABC), we tested associations between the imputed and genotyped SNPs with age at menarche using an additive genetic model.', {'entities': [(124, 131, 'imputation')]}),
 (' Imputation of untyped SNPs was performed using Minimac ().', {'entities': [(1, 11, 'imputation')]}),
 (' Monomorphic variants and variants with imputation quality <0.', {'entities': [(40, 50, 'imputation')]}),
 (' analysis of GWA data imputed with missing genotypes from the HapMap2 reference panel (total 2,646,472 SNPs).', {'entities': [(22, 29, 'imputation')]}),
 (' All genotype data were imputed to HapMap CEU II (build 36, version 22), and standard quality control procedures were applied.', {'entities': [(24, 31, 'imputation')]}),
 ('A logistic regression analysis was conducted to evaluate the association of each imputed SNP with diabetic nephropathy under an additive genetic model (allele dosage used as covariate for characterizing the tested SNP).', {'entities': [(81, 88, 'imputation')]}),
 (' SNPs with an IMPUTE2 information score < 0.', {'entities': [(14, 20, 'imputation')]}),
 (' Only SNPs that passed post imputation quality control were used for the association analysis.', {'entities': [(28, 38, 'imputation')]}),
 (', absolute beta estimates or standard\xa0errors > 10, association p values > 1 or < 0, imputation quality < 0, infinite beta estimates or standard errors), minor allele frequency (MAF) less than 0.', {'entities': [(84, 94, 'imputation')]}),
 (' Imputation used MaCH () and minimac2 (), and the same version of 1000 Genomes as reference set, but only included Asian individuals (n  = 286; including JPT, CHB and CHS).', {'entities': [(1, 11, 'imputation'), (17, 21, 'imputation')]}),
 (' Dosage r_2  and quality scores were used to measure imputation quality.', {'entities': [(53, 63, 'imputation')]}),
 (' SNPs with MAF <2% were not used in the genotype imputation (141,000).', {'entities': [(49, 59, 'imputation'), (24, 27, 'negation')]}),
 ('01 were removed, resulting in 1,829,586 genotyped or imputed markers for analyses.', {'entities': [(53, 60, 'imputation')]}),
 (' To allow for the combination of data derived from different genotyping platforms and to improve coverage of the genome, genotype imputation was performed by each participating study using MACH http://www.', {'entities': [(130, 140, 'imputation'), (189, 193, 'imputation')]}),
 ('We performed a meta-analysis on directly genotyped and imputed SNPs to the 1000 Genomes reference panel.', {'entities': [(55, 62, 'imputation')]}),
 (' Gene dosages for all markers with an imputation INFO_\u2009 ≥\u20090.', {'entities': [(38, 48, 'imputation')]}),
 (' Only genotyped SNPs that were also contained in the HapMap reference data and imputed SNPs were included in case-only analyses.', {'entities': [(79, 86, 'imputation')]}),
 (' We further performed fine mapping using imputation to the 1,000 genomes () for genetic loci reported at genome-wide significance.', {'entities': [(41, 51, 'imputation')]}),
 (' For each Yale-Penn cohort, genotypes from EAs and AAs were imputed together with Minimac3 implemented in Michigan Imputation Server (https://imputationserver.', {'entities': [(60, 67, 'imputation'), (115, 125, 'imputation')]}),
 ('4310_−6  respectively) were from the genome-wide imputation but all subsequent analyses are based on the FTO-regional imputation.', {'entities': [(49, 59, 'imputation')]}),
 (' In 3 of the replication studies, the index SNPs were imputed from genome-wide genotype data (see ).', {'entities': [(54, 61, 'imputation')]}),
 ('_,   For the analyses presented here, data for all cohorts were imputed (or re-imputed) using data from the 1,000 Genomes Project reference data.', {'entities': [(64, 71, 'imputation')]}),
 (' Genotype imputation was done using the Markov-chain Monte Carlo method implemented in MACH1.', {'entities': [(10, 20, 'imputation'), (87, 92, 'imputation')]}),
 (' A standardized population template from HapMap 3 representing those sampled was selected for imputation.', {'entities': [(94, 104, 'imputation')]}),
 (' No mismatches resulted from a comparison of genotypes determined through imputation and Centaurus genotyping of 964 participants, including 30 participants who were predicted to be heterozygous for the rare allele and 2 who were predicted to be homozygous for the rare allele.', {'entities': [(74, 84, 'imputation'), (1, 3, 'negation')]}),
 ('org/1998/Math/MathML" id="M1" overflow="scroll"><mi>N</mi><mo>=</mo><mfrac><mn>1</mn><mi>m</mi></mfrac><munderover><mtext>∑</mtext><mrow><mi>i</mi><mo>=</mo><mn>1</mn></mrow><mi>m</mi></munderover><mfrac><mn>1</mn><msup><mrow><mo stretchy="false">(</mo><mn>2</mn><mi>p</mi><mo stretchy="false">(</mo><mn>1</mn><mo>−</mo><mi>p</mi><mo stretchy="false">)</mo><msup><mtext mathvariant="italic">se</mtext><mn>2</mn></msup><mtext mathvariant="italic">Rsq</mtext><mo stretchy="false">)</mo></mrow><mo>′</mo></msup></mfrac></math> where m  is the number of SNPs and Rsq  is the imputation quality score.', {'entities': [(571, 581, 'imputation')]}),
 (' After the imputation, we created a hybrid dataset that included 2 543 887 SNPs, of which 584 029 were initially genotyped in the GOLDN population.', {'entities': [(11, 21, 'imputation')]}),
 (' After quality control, an imputation to 2.', {'entities': [(27, 37, 'imputation')]}),
 (' X-chromosome data were imputed separately, using Eagle 2.', {'entities': [(24, 31, 'imputation')]}),
 (' Genotyping, quality control, and imputation procedures have been described (, ).', {'entities': [(34, 44, 'imputation')]}),
 (' In the PGC GWAMA, a logistic regression analysis was used to test the association between MDD and imputed SNP dosages under an additive model and adjusting for study indicators and five principal components ().', {'entities': [(99, 106, 'imputation')]}),
 (' Given this strong confirmation of the quality of the imputation, unless otherwise stated we present the result using the imputed Phase 1 results, rather than interleaving imputed and genotyped data indiscriminately.', {'entities': [(54, 64, 'imputation')]}),
 (' Subsequent validation analyses based on this genotyping found that 7 of the 23 follow-up markers had questionable imputation quality.', {'entities': [(115, 125, 'imputation')]}),
 (' The first stage generated error and crossover maps as parameter estimates for imputation on a random subset of 200 samples per study over 100 iterations of the initial statistical model.', {'entities': [(79, 89, 'imputation')]}),
 (' For imputed variants for which we had experimental genotypes, the imputation quality was high: the first (Q_1 ) and third (Q_3 ) quartiles of r_2  scores were 0.', {'entities': [(5, 12, 'imputation')]}),
 (' Genotypes of 39,164 chromosome 3 SNPs that were not monomorphic in the CAP Caucasians or triallelic in dbSNP and were not A/T or C/G SNPs were used for imputation using the 1000G PhaseIv3 EUR haplotypes [] as a reference.', {'entities': [(153, 163, 'imputation'), (49, 52, 'negation')]}),
 (' Genotypes from genome-wide, high-density SNP genotyping arrays for 16,175 AD cases and 17,176 cognitive-normal individuals were imputed.', {'entities': [(129, 136, 'imputation')]}),
 (' Study-specific GWA analyses were conducted for circulating phylloquinone with a linear model adjusted for covariates to relate the outcome to genotyped and imputed SNP dosages by assuming an additive genetic model.', {'entities': [(157, 164, 'imputation')]}),
 (' The main analysis was linear regression of each fatty acid on single-SNP allele dosage from imputation, including covariates to account for age, sex, site of recruitment when appropriate (InCHIANTI, CARDIA, CHS and MESA), as well as the top 2 (MESA) or top 10 (CARDIA, CHS) principal components to adjust for potential population structure.', {'entities': [(93, 103, 'imputation')]}),
 (' For each case–control data set, genotype imputation was performed in Ricopili (Rapid Imputation Consortium Pipeline, https://sites.', {'entities': [(42, 52, 'imputation'), (86, 96, 'imputation')]}),
 (' Untyped variants were imputed using the 1000 Genomes Project phase 1 cosmopolitan reference panel.', {'entities': [(23, 30, 'imputation')]}),
 (' 23andMe participant genotype data were imputed using the 1000 Genomes Project phase 1 version 3 reference panel.', {'entities': [(40, 47, 'imputation')]}),
 (' First, as with the PGC-SCZ data, we imputed our genotypes against autosomal genotype data from HapMap3 and retained only SNP dosages imputed with very high confidence (Info >0.', {'entities': [(37, 44, 'imputation')]}),
 (' Imputed genotypes were analysed as expected genotype counts based on the posterior probabilities (gene dosage) using SNPTEST2 assuming an additive model with geographic region as a covariate.', {'entities': [(1, 8, 'imputation')]}),
 (' All studies used logistic regression with an additive genetic model adjusted for age and sex to conduct analyses of all directly genotyped and imputed SNPs and their association with dichotomous VWF:Ag measures.', {'entities': [(144, 151, 'imputation')]}),
 (' Variants with MAF<1% were then excluded and\nimputation was performed using the Michigan Imputation Server (https://imputationserver.', {'entities': [(45, 55, 'imputation'), (89, 99, 'imputation')]}),
 ('  DeltaSVM scores were generated as previously published by training the gapped k-mer support vector machine (gkmSVM) on cell type specific DHSs, computing weights for all possible 10-mers of the genome based on the SVM classifier, and calculating the difference in weights of 10-mers encompassing the reference and effect alleles for the variant of interest .', {'entities': [(101, 105, 'imputation')]}),
 (' The best-guess imputed genotype for any untyped SNP per sample was chosen as the genotype with the highest imputation probability (imputation score).', {'entities': [(16, 23, 'imputation')]}),
 (' (We were unable to impute one SNP that was not polymorphic in the HapMap3 data.', {'entities': [(20, 26, 'imputation'), (44, 47, 'negation')]}),
 ('05) and well-imputed (r_2 >=0.', {'entities': [(13, 20, 'imputation')]}),
 ('0 and MACH, respectively.', {'entities': [(6, 10, 'imputation')]}),
 (' The data set was split in groups of thousand individuals, imputed separately and then merged, resulting in 2 585 290 reference SNPs.', {'entities': [(59, 66, 'imputation')]}),
 ('edu/~purcell/plink/) and MACH (http://www.', {'entities': [(25, 29, 'imputation')]}),
 (' Linkage disequilibrium (LD)-aware variant calls were calculated in a multistage process that initially creates genotype-likelihood files for single samples using samtools-hybrid, then builds initial haplotypes using BEAGLE [], and then runs Thunder [] using the BEAGLE haplotypes as input [].', {'entities': [(217, 223, 'imputation')]}),
 (' Quality control measures applied to imputed data included excluding SNPs with HWE P  value < 1 × 10_−6 , MAF < 5%, and imputed genotype call rate ≤90% and individuals call rate ≤90%.', {'entities': [(37, 44, 'imputation')]}),
 ('1%), or imputed with low accuracy (defined by an imputation info score <0.', {'entities': [(8, 15, 'imputation')]}),
 (' Analyses were limited to the ∼17 million imputed SNPs with estimated imputation quality of r _2  >0.', {'entities': [(42, 49, 'imputation')]}),
 (' Singleton variants—variants appearing only once in the whole data set—were not included in the imputation reference panel as the imputation quality is generally lower and we lack power to detect association for such low frequency variants.', {'entities': [(96, 106, 'imputation'), (76, 79, 'negation')]}),
 (' To verify the imputation accuracy, we validated randomly selected SNPs that reached a nominally significant P  value after imputation.', {'entities': [(15, 25, 'imputation')]}),
 (' Additional association analyses based on imputation results on chromosome 15 did not identify new variants having association with risk for gene methylation stronger than that seen for rs73371737 and rs7179575 ().', {'entities': [(42, 52, 'imputation'), (82, 85, 'negation')]}),
 ("02 or low imputation quality scores, defined as BEAGLE's allelic r _2  or MACH's r _2  < 0.", {'entities': [(10, 20, 'imputation'), (48, 54, 'imputation'), (74, 78, 'imputation')]}),
 (' Ungenotyped SNPs in Afro-Caribbean subjects, subjects of European descent from HAPO and Caucasian subjects from SOPHIA, and Hispanic subjects were imputed and tested in PLINK using HapMap 3 female founders of African ancestry in Southwest USA (ASW), Northern and Western European ancestry from Utah (CEU), and Mexican ancestry in Los Angeles, CA (MEX), respectively (http://www.', {'entities': [(148, 155, 'imputation')]}),
 (' With the exception of the screening imputed genotypes, genotype probabilities (and a minimum information score of 0.', {'entities': [(37, 44, 'imputation')]}),
 (' We used genomic control to obtain optimal and unbiased results and applied the inverse variance method of each effect size estimated for both autosomal SNPs that were genotyped and imputed in both cohorts.', {'entities': [(182, 189, 'imputation')]}),
 (' Finally, DNA samples from 391 additional CeAD cases and 162 controls, recruited in the same centers as other individuals included in the discovery or follow-up analyses, were genotyped for the top 5 genotyped loci and the top imputed locus (1–2 SNPs per locus) using KASPAR technology.', {'entities': [(227, 234, 'imputation')]}),
 (' For MESA, IMPUTE version 2.', {'entities': [(11, 17, 'imputation')]}),
 (' The haplotypes were examined in the European collections that were successfully genotyped or imputed for all three SNPs.', {'entities': [(94, 101, 'imputation')]}),
 (' Beagle imputed all missing SNPs, classical HLA alleles, and amino acid polymorphisms.', {'entities': [(8, 15, 'imputation'), (1, 7, 'imputation')]}),
 ('988); imputation was very good for rs150207780 and rs373863828 (IMPUTE2 info metric = 0.', {'entities': [(6, 16, 'imputation'), (64, 70, 'imputation')]}),
 (' Imputation was performed on the genotypes for the 1Mb regions flanking the two loci using Minimac2 and SHAPEIT with the 1000 Genomes Project Phase 3 as the reference data.', {'entities': [(1, 11, 'imputation')]}),
 (' Imputation and genotyping quality metrics are given in Supplemental Table 10.', {'entities': [(1, 11, 'imputation')]}),
 (' The HapMap imputed data of T2D_HPFS and CHD_HPFS were used for eye color GWASs to be combined with KS_HPFS.', {'entities': [(12, 19, 'imputation')]}),
 (' Each study performed SNP imputation with the genotype data, together with the HapMap Phase II ethnically matched reference panels (CEU, JPT+CHB, or the four HapMap populations) on the basis of HapMap build 36 databases (release 22 or 24).', {'entities': [(26, 36, 'imputation')]}),
 ('3 in MACH or BimBam or proper info <0.', {'entities': [(5, 9, 'imputation')]}),
 (' Imputed SNPs were analyzed by PLINK software and genotype imputation uncertainty was accounted for by using allelic dosage in PLINK.', {'entities': [(59, 69, 'imputation'), (1, 8, 'imputation')]}),
 ('3 (proper-info of IMPUTE) or R2 ≥ 0.', {'entities': [(18, 24, 'imputation')]}),
 (' A two-step imputation process was performed using SHAPEIT for haplotype phasing and IMPUTE2 for imputation, yielding a total of 39,345,920 imputed SNPs.', {'entities': [(12, 22, 'imputation'), (85, 91, 'imputation')]}),
 (' Missing genotypes were then imputed into these haplotypes using the program IMPUTE2 and a mixed-population 1000 Genomes Project reference panel (March 2012, phase I, v3 release or later).', {'entities': [(29, 36, 'imputation'), (77, 83, 'imputation')]}),
 (' Since our sample was European American, we used as a reference set the genotypic data from the EUR in the August 2010 release of the 1000 Genomes Project, provided with the Beagle 3.', {'entities': [(174, 180, 'imputation')]}),
 (' SNPs with imputation r_2  < 0.', {'entities': [(11, 21, 'imputation')]}),
 (' This likely has slightly decreased the final imputation quality of each cohort, as prior SNP filtering does not improve the imputation quality, since losing genotyped SNPs only makes the imputation worse.', {'entities': [(46, 56, 'imputation'), (109, 112, 'negation')]}),
 ('01 and with a quality of imputation\u2009≥\u20090.', {'entities': [(25, 35, 'imputation')]}),
 ('gov/) using the Markov Chain Haplotyping (MACH) algorithm.', {'entities': [(42, 46, 'imputation')]}),
 ('16) was used to impute SNPs on chromosome 1–22 with NCBI build 36 of Phase II HapMap CEU data (release 22) as the reference panel.', {'entities': [(16, 22, 'imputation')]}),
 (' SNPs for which testing Hardy Weinberg equilibrium resulted in p<10_−5  were excluded from imputation.', {'entities': [(91, 101, 'imputation')]}),
 ('  Fine mapping of significant admixture mapping peaks was performed using allelic association testing using both genotyped and imputed SNPs.', {'entities': [(127, 134, 'imputation')]}),
 (' To address this issue, HLA imputation was repeated after filling in the missing genotype data with the “best guess” imputed SNP data from the 1000 Genomes imputation described above.', {'entities': [(28, 38, 'imputation')]}),
 (' Each study applied stringent quality control procedures for imputation ().', {'entities': [(61, 71, 'imputation')]}),
 (' Details on the study-specific quality control procedures for genotyping and imputation are found in Supplementary Table 1.', {'entities': [(77, 87, 'imputation')]}),
 (' A reference panel of haplotypes was constructed using 1000 Genomes Phase 3 CEU and YRI data and imputed SNP genotypes using all Illumina SNPs that passed the previously described QC.', {'entities': [(97, 104, 'imputation')]}),
 (' Poorly imputed variants (“info” score ≤0.', {'entities': [(8, 15, 'imputation')]}),
 ('4, if using the IMPUTE imputation algorithm) were excluded.', {'entities': [(23, 33, 'imputation'), (16, 22, 'imputation')]}),
 ('3 or IMPUTE imputation quality<0.', {'entities': [(12, 22, 'imputation'), (5, 11, 'imputation')]}),
 ('We prioritized directly genotyped and imputed SNPs for replication based on statistical significance (P  < 10-4 ), robust QC metrics, and vicinity to plausible candidate genes.', {'entities': [(38, 45, 'imputation')]}),
 ('\nPost-imputation QC and allelic dosage analysis were conducted in PLINK (see ).', {'entities': [(6, 16, 'imputation')]}),
 ('Imputation was performed on 5942 cases and 10 861 control samples from NCI-GWAS2 and NCI-GWAS1 for the four newly identified bladder cancer susceptibility regions at 3q26.', {'entities': [(0, 10, 'imputation')]}),
 (' We excluded the imputed SNPs with MAF < 0.', {'entities': [(17, 24, 'imputation')]}),
 (' Heritability analysis was conducted with the GCTA software package () using common variants (MAF of >1%), which were accurately imputed in at least 99% of samples, pruned based on LD (r _2  < 0.', {'entities': [(129, 136, 'imputation')]}),
 (' MAF was calculated by summing the imputed genotypes for each SNP and dividing by twice the number of individuals in the study.', {'entities': [(35, 42, 'imputation')]}),
 (' Samples were genotyped using Affymetrix and Illumina genome-wide genotyping arrays ( and ) and were imputed for polymorphic HapMap Phase 2 European CEU SNPs using MACH, IMPUTE, BIMBAM or Beagle ().', {'entities': [(101, 108, 'imputation'), (170, 176, 'imputation'), (188, 194, 'imputation'), (164, 168, 'imputation')]}),
 ('  We used a linear mixed-effects model to account for cryptic population structure and relatedness to model the association between genotyped variants (when available for a particular position) or imputed variants (dosages) and AF, as implemented in BOLT-LMM.', {'entities': [(197, 204, 'imputation')]}),
 ('21 locus were estimated from imputed genotypes at 8q24.', {'entities': [(29, 36, 'imputation')]}),
 ('Genotype imputation was performed using IMPUTE2 after estimating haplotypes with SHAPEIT2 and the UK10K reference panel.', {'entities': [(9, 19, 'imputation'), (40, 46, 'imputation')]}),
 ('Genotypes for ~21 million SNPs were imputed for all samples using the October 2014 (Phase 3) release of the 1000 Genomes Project data as the reference panel and based on 800 haplotypes.', {'entities': [(36, 43, 'imputation')]}),
 (' Non-autosomal SNPs were excluded, as well as SNPs with an imputation quality score less than 0.', {'entities': [(59, 69, 'imputation'), (1, 5, 'negation')]}),
 (' The replication samples of the STRIP and Leipzig studies only contributed 20 and 21 imputed SNPs, respectively, as the unimputed SNPs were part of the discovery analysis.', {'entities': [(85, 92, 'imputation'), (120, 129, 'NO imputation')]}),
 ('\xa0html Beagle, http://faculty.', {'entities': [(6, 12, 'imputation')]}),
 (' Imputation of SNPs not represented on the array was conducted using minimac with reference data from the 1000 Genomes Project (RELEASE STAMP 2012-10-09)_,  .', {'entities': [(1, 11, 'imputation'), (20, 23, 'negation')]}),
 (' In our region of interest on chromosome 15, there were 2,818 SNPs available for imputation.', {'entities': [(81, 91, 'imputation')]}),
 (' In an independent analysis, we masked 100 markers on chromosomes 4, 9, 16 and 20 from the inference files used for imputation and compared the imputed genotypes with the original genotypes obtained with the Affymetrix 5.', {'entities': [(116, 126, 'imputation')]}),
 ('Imputation, which determines probable genotypes for SNPs that were not on the array, was conducted for chromosomes 6 and 19.', {'entities': [(0, 10, 'imputation'), (67, 70, 'negation')]}),
 (' MACH () (http://www.', {'entities': [(1, 5, 'imputation')]}),
 (' SNPs with poor imputation quality (proper info <0.', {'entities': [(16, 26, 'imputation')]}),
 (' To find supporting evidence for the 12 associated SNPs, we performed imputation analysis for untyped SNPs within ±500 kb of these SNPs.', {'entities': [(70, 80, 'imputation')]}),
 (' After data cleaning and quality control, 5,697 individuals and 889,659 SNPs remained for imputation.', {'entities': [(90, 100, 'imputation')]}),
 (' The expression-trait association was evaluated using the imputed expression data.', {'entities': [(58, 65, 'imputation')]}),
 ('To determine whether stronger associations may exist with SNPs that were not genotyped, we imputed non-genotyped SNPs and repeated the analyses in the imputed data.', {'entities': [(91, 98, 'imputation'), (73, 76, 'negation'), (99, 103, 'negation')]}),
 (' The programming code used to analyze the GWAS data including the\nimputation with SHAPEIT and Minimac3, individual-based association analysis\nusing Mach2dat and a meta-analysis using METAL is freely available on\nGitHub: https://github.', {'entities': [(66, 76, 'imputation'), (148, 153, 'imputation')]}),
 (' Quality control and filtering pipeline for MECC replication samples before imputation.', {'entities': [(76, 86, 'imputation')]}),
 (' Subsequent quality control excluded imputed SNPs with minor allele frequency of <0.', {'entities': [(37, 44, 'imputation')]}),
 (' In the discovery stage, we used the imputed genotype data based on Hapmap phase II data build 35 (CEU) for the analyses.', {'entities': [(37, 44, 'imputation')]}),
 (' Genotypes were imputed to approximately 2.', {'entities': [(16, 23, 'imputation')]}),
 (' Estimated per-allele ORs and standard errors were generated from the imputed genotypes using ProbABEL.', {'entities': [(70, 77, 'imputation')]}),
 (' Quality control filters were applied (see ) which resulted in 18,485,882 imputed SNPs for analysis in 329,821 individuals.', {'entities': [(74, 81, 'imputation')]}),
 (' Only imputed SNPs with high genotype information content (proper info ≥0.', {'entities': [(6, 13, 'imputation')]}),
 (' When available, results from directly genotyped SNP data were used in preference over those from imputed SNP data.', {'entities': [(98, 105, 'imputation')]}),
 (' There were 58, 19, 75, 37, and 30 genotyped SNPs and 1074, 234, 613, 276, and 431 imputed variants on chromosomes 3, 7, 8, 15, and 22 respectively.', {'entities': [(83, 90, 'imputation')]}),
 (' Genome-wide association analyses were performed using mach2qtl () which accepts imputed dosages or posterior probabilities from MaCH-Admix output.', {'entities': [(81, 88, 'imputation'), (55, 60, 'imputation')]}),
 (' The study samples were imputed in a two-stage procedure using SHAPEIT2 (version 2.', {'entities': [(24, 31, 'imputation')]}),
 (' The IMPUTE2 program was used to impute a 1 Mb region centered on the index SNP for each of the three regions, using recommended default settings.', {'entities': [(33, 39, 'imputation'), (5, 11, 'imputation')]}),
 (' [] SNPs with an imputation dosage allele r_2  of at least 0.', {'entities': [(17, 27, 'imputation')]}),
 (' Concordance between Stage 3 imputed genotypes and exome chip genotypes for replicated SNPs is reported in .', {'entities': [(29, 36, 'imputation')]}),
 (' We estimated haplotypes using SHAPEIT [] and then imputed allele dosages for each dataset separately using IMPUTE2 [] and 1000 Genomes reference haplotypes (March 2012).', {'entities': [(51, 58, 'imputation'), (108, 114, 'imputation')]}),
 ('  Genotyping was an expansion and re-imputation of the dataset used in Medland et\xa0al.', {'entities': [(37, 47, 'imputation')]}),
 (' The details of genotyping, QC and imputation have been reported previously.', {'entities': [(35, 45, 'imputation')]}),
 (' Results were obtained for 10,641,224 single nucleotide polymorphisms (SNPs) and insertion-deletion variants with minor allele frequency > 1% and imputation quality scores > 0.', {'entities': [(146, 156, 'imputation')]}),
 ('For the Icelandic data, we performed case–control association testing of imputed genotypes using methods that were described previously.', {'entities': [(73, 80, 'imputation')]}),
 (' Adding SNPs typed but not used for imputation purposes resulted in a total of 2,587,527 genotyped or imputed SNPs available for association analyses.', {'entities': [(36, 46, 'imputation'), (23, 26, 'negation')]}),
 ('90 was applied to call genotypes during imputation and the same QC procedure for excluding genotyped SNPs was applied to imputed SNPs.', {'entities': [(40, 50, 'imputation')]}),
 ('Through imputation based on reference panels from the 1000 Genomes Project, we were able to test 4.', {'entities': [(8, 18, 'imputation')]}),
 ('01 exclusion, and Hardy-Weinberg equilibrium p-value <1E-06 exclusion, a total of 584,060 genotyped autosomal SNPs remained for use in the imputation.', {'entities': [(139, 149, 'imputation')]}),
 ('\xa0html University of Michigan Imputation Server, https://imputationserver.', {'entities': [(56, 72, 'imputation'), (29, 39, 'imputation')]}),
 (' For the remaining seven replication\nstudies (), genotypes were available in-silico \nusing data from genome-wide SNP chips or imputation analyses ().', {'entities': [(126, 136, 'imputation')]}),
 (' After conversion of genomic coordinates to GRCh37/hg19, exclusion of SNPs with duplicates, call rates < 97%, MAFs < 1%, and without chromosome and base pair position, and exclusion of 44 subjects with genotype call rates < 90%, 642,766 were available for imputation in 2,972 participants.', {'entities': [(256, 266, 'imputation')]}),
 ('Information on genotyping in each cohort, the particular platforms used to perform genotyping and the methods of imputation can be found in more detail in .', {'entities': [(113, 123, 'imputation')]}),
 (' Imputation uncertainty was accounted for by using posterior means or allele dosage in logistic regression ().', {'entities': [(1, 11, 'imputation')]}),
 ('In each study of the discovery GWAS, genotyping was performed on genome-wide chips, and imputation was conducted using HapMap 2 data as the reference.', {'entities': [(88, 98, 'imputation')]}),
 (' In the imputed datasets, the association between PG and EN status and each single SNP were evaluated using logistic regression with SNPTEST(http://mathgen.', {'entities': [(8, 15, 'imputation')]}),
 ('02 or IMPUTE2 information score <0.', {'entities': [(6, 12, 'imputation')]}),
 (' Poorly imputed SNPs defined by an RSQR< 0.', {'entities': [(8, 15, 'imputation')]}),
 ('5 million SNPs in HapMap2 (Build 35) using IMPUTE.', {'entities': [(43, 49, 'imputation')]}),
 (' eQTLs were mapped using Spearman’s rank correlation, using the imputation dosage values as genotypes.', {'entities': [(64, 74, 'imputation')]}),
 (' We applied minor allele frequency threshold of 5% and imputation quality threshold of proper info > .', {'entities': [(55, 65, 'imputation')]}),
 ('Particulars of genotyping in each cohort, particular platforms used to generate genotyping and methods of imputation can be found in more detail in the .', {'entities': [(106, 116, 'imputation')]}),
 (' Before meta-analysis, we excluded variants with MACH imputation quality<0.', {'entities': [(54, 64, 'imputation'), (49, 53, 'imputation')]}),
 ('4 (Impute, BEAGLE).', {'entities': [(3, 9, 'imputation'), (11, 17, 'imputation')]}),
 (' Genotypes for the Scottish control replication dataset were SNPs genotyped on the Illumina OmniExpressExome array (only SNPs that genotyped were included, imputed data were not used).', {'entities': [(156, 163, 'imputation'), (174, 177, 'negation')]}),
 (' After quality control, imputation, and filtering, 7,481,872 markers were included in the subsequent association analyses of 123 samples.', {'entities': [(24, 34, 'imputation')]}),
 ('5 in the output of MaCH for the subsequent analyses (see ).', {'entities': [(19, 23, 'imputation')]}),
 (' We coded 0, 1, or 2 copies of the effect alleles as dosage for genotyped SNPs and used the expected number of copies of the effect alleles as dosage score for imputed SNPs to account for imputation uncertainty ().', {'entities': [(160, 167, 'imputation')]}),
 (' 27 SNPs (including rs75764599G>A; IGFBP1  locus) demonstrated modest evidence of association in cohort 2 (P < 5 x 10-5 ) but could not be imputed in cohort 1.', {'entities': [(139, 146, 'imputation'), (132, 135, 'negation')]}),
 (' Efficient Mixed-Model Association eXpedited (EMMAX) [] software was used to assess associations for smoking phenotypes using genotyped and imputed SNP data.', {'entities': [(140, 147, 'imputation')]}),
 (' GWAS variants with a MAF > 1% were phased with SHAPEIT2, and IMPUTE2 was used for imputing to the 1000 Genomes Project cosmopolitan dataset (June 2014 version).', {'entities': [(83, 91, 'imputation'), (62, 68, 'imputation')]}),
 ('5 million autosomal SNPs were imputed cohorts using the HapMap II Caucasian (CEU, Centre d’Etude du Polymorphisme Humain) sample as reference panel for the European-ancestry cohorts, a combined CEU+YRI reference panel for the African-American cohorts, and a combined CEU+YRI+CHB+JPT reference panel for the Hispanic sample.', {'entities': [(30, 37, 'imputation')]}),
 (' Owing to the highly correlated nature of the results from imputed data because of linkage disequilibrium (LD) between the SNPs, some regions will have many SNPs with similar p-values.', {'entities': [(59, 66, 'imputation')]}),
 (' Individual studies performed genotype imputation using reference haplotypes that consisted of either a mixture of phased haplotype data from HapMap 2 YRI and CEU in a 1:1 ratio or a combination of HapMap 2 YRI and CEU in a 1:1 ratio and HapMap 3 YRI, CEU, and ASW in a 1:1:1 ratio (Supplementary Material, Table S1).', {'entities': [(39, 49, 'imputation')]}),
 (' Association tests were carried out on\nallelic dosages to account for imputation uncertainty (‘-method\nexpected’ option) using SNPTEST v2.', {'entities': [(70, 80, 'imputation')]}),
 (' Imputation was based on the 1000 Genomes phase 1 reference panel.', {'entities': [(1, 11, 'imputation')]}),
 ('  After the cohort-specific association was performed, results were filtered based on imputation quality (PROPER INFO <0.', {'entities': [(86, 96, 'imputation')]}),
 (' All of the SNPs, showed a concordance rate between imputed and directly genotyped calls greater than 97.', {'entities': [(52, 59, 'imputation')]}),
 ('Before undertaking targeted sequencing, we first used SHAPEIT_–  and IMPUTE2 (refs.', {'entities': [(69, 75, 'imputation')]}),
 (' Prior to meta-analysis, SNPs with a minor allele frequency <1% and poorly-imputed SNPs (proper_info ≤0.', {'entities': [(75, 82, 'imputation')]}),
 (' Because of their limited sample sizes, data from the four European studies (ESs) were analyzed together for the purposes of quality control, imputation, and association testing.', {'entities': [(142, 152, 'imputation')]}),
 ('edu/csg/abecasis/MaCH/; date last accessed December 12, 2016).', {'entities': [(17, 21, 'imputation')]}),
 (' For the GWAS of UACR, we examined UACR as a log-transformed variable and used additive genetic models, filtering by variants with an MAF≥1% and imputation quality rsq ≥0.', {'entities': [(145, 155, 'imputation')]}),
 (' Imputation using the HapMap2 reference did not yield additional significant results (data not shown).', {'entities': [(1, 11, 'imputation'), (44, 47, 'negation')]}),
 (" We used non-integer allele numbers as a primary predictor of Parkinson's disease in logistic regression models to account for imputation uncertainty.", {'entities': [(127, 137, 'imputation'), (9, 13, 'negation')]}),
 ('Each GWAS sample from Stage 1 was imputed by the 1KG sequence variants (as of August, 2010).', {'entities': [(34, 41, 'imputation')]}),
 (' MDD cases and controls used in PGC study [] were European ancestry and genotype data were imputed with Beagle (v3.', {'entities': [(91, 98, 'imputation'), (104, 110, 'imputation')]}),
 ('8 for IMPUTE-based imputations.', {'entities': [(19, 30, 'imputation'), (6, 12, 'imputation')]}),
 ('Imputation analysis was performed using IMPUTE against all of the HapMap Asian (JPT (Japanese in Tokyo) + CHB (Han Chinese in Beijing)) population (release 22/NCBI, build 36, and dbSNP build 126) for a total of 1 573 409 SNPs.', {'entities': [(0, 10, 'imputation'), (40, 46, 'imputation')]}),
 (' Exploring the advantage of the model in IMPUTE2, we combined all available reference-phased haplotype data from both release 2 of the HapMap 3 dataset (NCBI Build 36) (includes Utah residents (CEPH) with Northern and Western European ancestry (CEU), Japanese in Toyko (JPT), Chinese in Denver, Maasai in Kinyawa, Toscani in Italia (TSI), GIH, African Ancestry in Southwest (ASW), Luhya in Webuye (LWK), Mexican Ancestry in Los Angeles (MEX), Han Chinese in Beijing (CHB) and Yoruba in Ibadan (YRI); and 1000 Genomes Project () includes CEU, YRI, British from England and Scotland (GBR), Finnish from Finland (FIN), Han Chinese South (CHS), Puerto Rican (PUR), Chinese in Denver (CHB), JPT, LWK, MXL, ASW, TSI, Colombian in Medellin (CLM) and Iberian populations in Spain (IBS).', {'entities': [(41, 47, 'imputation')]}),
 (' Finally, two cohorts were imputed to the 1000 Genomes panel (n = 7,536), and one cohort was imputed to the UK10K panel (n = 863) ().', {'entities': [(27, 34, 'imputation')]}),
 (' In addition, SNPs not directly genotyped in the top region(s) of interest were imputed using all populations from the 1,000 Genomes Project (phase I v3) as reference for phasing and imputation with SHAPE-IT and IMPUTE2, respectively.', {'entities': [(80, 87, 'imputation'), (212, 218, 'imputation'), (19, 22, 'negation')]}),
 (' BEAGLE (v.', {'entities': [(1, 7, 'imputation')]}),
 (' Measured SNPs, along with HapMap (release 22, build 36, CEU reference panel) [] was used to impute the remaining 2 million SNPs using MaCH [].', {'entities': [(93, 99, 'imputation'), (135, 139, 'imputation')]}),
 ('We imputed unobserved genotypes in the three confirmed regions using phased haplotypes from the Interim Phase I release of the 1000 Genomes Project .', {'entities': [(3, 10, 'imputation')]}),
 ('9 or imputation quality of <0.', {'entities': [(5, 15, 'imputation')]}),
 ('5 for IMPUTE and Rsq ≥0.', {'entities': [(6, 12, 'imputation')]}),
 ('After imputing a common set of SNPs and combining cases and controls into a single dataset, EIGENSTRAT () was used to compute principal components based on the genotyped markers.', {'entities': [(6, 14, 'imputation')]}),
 (' We selected imputed SNPs that showed P _GC <1.', {'entities': [(13, 20, 'imputation')]}),
 (' Because PanScan II and PanC4 used different genotyping platforms, imputation was conducted to generate a common dataset for both studies.', {'entities': [(67, 77, 'imputation')]}),
 ('Fine-scale imputation at the three loci reaching genome-wide significance was performed using all 1,854 PACG cases and 9,608 controls that passed stage 1 quality control filters.', {'entities': [(11, 21, 'imputation')]}),
 (' The goal of imputation is to increase the resolution of genetic markers in these regions in an attempt to narrow down the possible causal locations by finding stronger signals().', {'entities': [(13, 23, 'imputation')]}),
 ('05, imputation quality score <0.', {'entities': [(4, 14, 'imputation')]}),
 (' Genotype data of GPC-1 were then imputed using HapMap phase II CEU as a reference panel including ~2.', {'entities': [(34, 41, 'imputation')]}),
 (' Imputation runs were conducted separately in the mothers and offspring within each of the four HAPO cohorts.', {'entities': [(1, 11, 'imputation')]}),
 ('imputed function (ie, GEE model including a main effect (SNP) and the effect of the interaction term (the product of allelic dosage and a covariate for interaction)) from the GWAF package to test the interaction between the imputed allele dosage and DSM-IV AD diagnosis for the RSB score, after adjusting for DSM-IV CD, OD, and ND diagnoses, age, and the first three ancestry PCs.', {'entities': [(0, 7, 'imputation')]}),
 ('Genotyping, single nucleotide polymorphism (SNP) imputation, and association testing procedures for each of the 4 GWASs (Australian Asthma Genetics Consortium [AAGC], 23andMe, ALSPAC, and Raine) are described in detail in the Methods section in this article’s  at www.', {'entities': [(49, 59, 'imputation')]}),
 ('7 million imputed SNPs were tested for association with TC, HDL-C, LDL-C, and TGs.', {'entities': [(10, 17, 'imputation')]}),
 (' Subjects in each individual GWAS had their specific standard genotyping platform and quality control criteria, which were summarized elsewhere []; all subjects were imputed using the 1000 Genomes Project [] reference panel (Phase I, v3 release or later).', {'entities': [(166, 173, 'imputation')]}),
 (' We excluded imputed single-nucleotide polymorphisms (SNPs) with an imputation quality estimate of R _2  ≤0.', {'entities': [(13, 20, 'imputation')]}),
 ('\nAdditional information is provided in the , including\ncohort-specific genotype and imputation quality control methods (see ).', {'entities': [(84, 94, 'imputation')]}),
 (' Imputed SNPs with a minor allele frequency (MAF) < 1% were excluded.', {'entities': [(1, 8, 'imputation')]}),
 (' After quality control, genotypes were imputed using MACH 1.', {'entities': [(39, 46, 'imputation'), (53, 57, 'imputation')]}),
 (' Each participating study imputed genotypes based on the 1000 Genomes Project Phase 1 integrated release version 3 (March 2012) all ancestry reference panel.', {'entities': [(26, 33, 'imputation')]}),
 ('IMPUTE2, http://mathgen.', {'entities': [(0, 6, 'imputation')]}),
 ('edu/csg/abecasis/MACH/inde\xa0x.', {'entities': [(17, 21, 'imputation')]}),
 (' Quality control parameters were applied to filter out low quality imputed SNPs, i.', {'entities': [(67, 74, 'imputation')]}),
 (' Genotypes for untyped SNPs were imputed using haplotypes from the 1000 Genomes project (Europeans in the 1000G release on 4 August 2010), the observed genotypes were phased using the ‘MACH’ program followed by imputation using the ‘minimac’ program.', {'entities': [(33, 40, 'imputation'), (185, 189, 'imputation')]}),
 (' Imputation and association analyses in KoGES were performed with IMPUTE2 () and Plink ().', {'entities': [(1, 11, 'imputation'), (66, 72, 'imputation')]}),
 (' After removal of the 64,908 SNPs with MAF<1%, 654,634 SNPs were available for imputation.', {'entities': [(79, 89, 'imputation')]}),
 ('99, in Hardy-Weinberg equilibrium (P  > 1×10_−6 )) comprised the input set of SNPs for imputation, which was performed on the University of Michigan Imputation Server () with the following parameters: 1000G Phase 1 v3 ShapeIt2 (no singletons) reference panel, SHAPEIT phasing and the EUR (European) population.', {'entities': [(87, 97, 'imputation'), (149, 159, 'imputation'), (228, 230, 'negation')]}),
 (' After the quality control, 305,811 autosomal SNPs available on 2226 individuals (1046 singletons and 590 DZs) were available and used for imputation.', {'entities': [(139, 149, 'imputation')]}),
 (' Imputation of SNPs in the HapMap CEU population was performed using IMPUTE  for use in the regional association plots.', {'entities': [(1, 11, 'imputation'), (69, 75, 'imputation')]}),
 (' The natriuretic peptide residuals were then standardized within sex (mean=0 and variance=1) and tested for association with imputed SNPs using an additive genetic model.', {'entities': [(125, 132, 'imputation')]}),
 (' To facilitate meta-analysis, each group performed genotype imputation with IMPUTE or MACH software using genotypes from the HapMap Phase II release 22, NCBI build 36 (CEU or CHB/JPT as appropriate) as reference panels.', {'entities': [(60, 70, 'imputation'), (76, 82, 'imputation'), (86, 90, 'imputation')]}),
 (' SNPs in this candidate set that were not on the Illumina array were imputed.', {'entities': [(69, 76, 'imputation'), (38, 41, 'negation')]}),
 (' They were excluded from the initial GWAS of NHW but included in the meta-analysis using imputed genotypes.', {'entities': [(89, 96, 'imputation')]}),
 (' The\nassociations between genotype and residual gene expression were evaluated using linear\nregression models by the mach2qtl program (,).', {'entities': [(117, 122, 'imputation')]}),
 (' After excluding monomorphic SNPs and SNPs with Hardy-Weinberg Equilibrium P<1×10_−6 , missing rate>25% or MAF<1%, a total of 820,017 genotyped SNPs remained for genotype imputation.', {'entities': [(171, 181, 'imputation')]}),
 (' When the SNPs were available as both genotyped SNPs and imputed SNPs, we used genotyped SNPs.', {'entities': [(57, 64, 'imputation')]}),
 (' The SNP content was designed based on SNP associations from analysis of GWA data, including imputed data.', {'entities': [(93, 100, 'imputation')]}),
 (' Marchini, Department of Statistics, University of Oxford, Oxford, UK) () to take into account the genotype uncertainty introduced by the imputation.', {'entities': [(138, 148, 'imputation')]}),
 (' Each study independently imputed its genotype data to the ≈2.', {'entities': [(26, 33, 'imputation')]}),
 (' We then used the 382 935 genotyped SNPs to impute all autosomal SNPs on HapMap (∼2.', {'entities': [(44, 50, 'imputation')]}),
 ('html The programming code used to analyze the GWAS data including the\nimputation with SHAPEIT and Minimac3, individual-based association analysis\nusing Mach2dat and a meta-analysis using METAL is freely available on\nGitHub: https://github.', {'entities': [(70, 80, 'imputation'), (152, 157, 'imputation')]}),
 (' The single-step imputation used IMPUTE2 without pre-phasing with some of the default parameters modified.', {'entities': [(17, 27, 'imputation'), (33, 39, 'imputation')]}),
 (' Participants and SNPs passing basic quality control thresholds were imputed to >2.', {'entities': [(69, 76, 'imputation')]}),
 ('  We performed whole-genome association testing using post-imputation genotype probabilities with the software SNPTEST (v2.', {'entities': [(59, 69, 'imputation')]}),
 ('In the ROOT GWAS, we analysed genotyped SNPs and imputed SNPs with imputation score\u2009>0.', {'entities': [(49, 56, 'imputation')]}),
 (' Because we used allele calls rather than allele probabilities in our analyses, imputed probes with certainty < 90% were zeroed out for specific individuals and were subsequently removed from the entire data set if the call rate was < 97% in all samples.', {'entities': [(80, 87, 'imputation')]}),
 (' For imputed data sets, SNPs were considered to be of low imputation quality if their info score was <0.', {'entities': [(5, 12, 'imputation')]}),
 (' Following phasing using SHAPEIT (), imputation was performed on the phased data with Impute2.', {'entities': [(37, 47, 'imputation'), (86, 93, 'imputation')]}),
 (' For the Asian colorectal cancer follow-up study, genotyped SNPs and dosage data of imputed SNPs were analyzed using the program mach2dat (available at: http://www.', {'entities': [(84, 91, 'imputation'), (129, 134, 'imputation')]}),
 (' Association analysis was conducted separately on subjects in each race/ethnicity group (NHW, East Asian, Latino, and African American) using all typed and imputed SNPs and using the same covariates as the original analysis with the appropriate principal components for that ethnic group.', {'entities': [(156, 163, 'imputation')]}),
 (' After meta-analysis, variants with a weighted minor allele frequency of <1% or N effective (product of study sample size and imputation quality summed across contributing studies) <60% were then excluded and meta-analysis genomic control lambda calculated and used to adjust the meta-analysis results.', {'entities': [(126, 136, 'imputation')]}),
 (' After removing the singletons and monomorphic sites and merging the typed and imputed data, 27,449,496 variants on 821 participants were available for the genome-wide association study.', {'entities': [(79, 86, 'imputation')]}),
 (' Within each dataset, genome-wide association analyses were conducted using more than 7 million imputed SNPs in the total sample, as well as in subgroups of subjects with and without the APOE  ε4 allele, using regression models including age, sex, the first three PCs.', {'entities': [(96, 103, 'imputation')]}),
 ('8 (the latter an imputation quality score calculated by the IMPUTE2 algorithm); 6 923 995 SNPs passed these criteria in both cohorts.', {'entities': [(17, 27, 'imputation'), (60, 66, 'imputation')]}),
 ('3% and MACH r _2  0.', {'entities': [(7, 11, 'imputation')]}),
 (' Because of the different genotyping arrays and data sources, stringent data cleaning was performed prior to imputation, removing SNPs with minor allele frequency (MAF) <1%, Hardy–Weinberg equilibrium (HWE) P-value <0.', {'entities': [(109, 119, 'imputation')]}),
 (' Imputed genotypes that were not consistent with Mendelian inheritance in a family were set to missing.', {'entities': [(1, 8, 'imputation'), (29, 32, 'negation')]}),
 ('GWAS analyses were conducted in each ancestry group to test the imputed SNP and indel genotype dosages for association with drug abuse using logistic regression models in ProbABEL().', {'entities': [(64, 71, 'imputation')]}),
 (' The scaffold was then imputed up to the phase 1 integrated (March 2012 release) multi-ethnic reference panel from the 1000 Genomes Project via\xa0IMPUTE2_,   or MaCH/Minimac ().', {'entities': [(23, 30, 'imputation'), (144, 150, 'imputation'), (159, 163, 'imputation')]}),
 ('_,   Post-imputation filters were applied to remove SNPs with INFO scores < 0.', {'entities': [(10, 20, 'imputation')]}),
 ('edu/csg/abecasis/MACH/download/1000G.', {'entities': [(17, 21, 'imputation')]}),
 (' MACH and 1000 Genomes Project data (build 37, hg19) as a reference panel were used for imputation.', {'entities': [(88, 98, 'imputation'), (1, 5, 'imputation')]}),
 (' Eleven of these were cohort studies: 574 children from the Copenhagen Studies on Asthma in Childhood 2010 birth cohort (COPSAC2010), 676 additional children from the DNBC, 386 additional children from LISA + GINI, 3152 children from the TEDS Study, 1955 children from the Prevention and Incidence of Asthma and Mite Allergy birth cohort study (PIAMA), 1665 children from the BREATHE Study, 447 children from the Bone Mineral Density in Childhood Study (BMDCS), 200 children from the TEENs of Attica: Genes and Environment (TEENAGE) study, additional imputed data on 857 children from the Leipzig Study, 480 additional children from PANIC and additional imputed data for 569 children from STRIP.', {'entities': [(551, 558, 'imputation')]}),
 (' Genotype imputation of the FFES data to the HapMap-II reference panel (CEU population release 22, NCBI build 36) was carried out in a two-step process using the Markov Chain Haplotyping (MACH version 1.', {'entities': [(10, 20, 'imputation'), (188, 192, 'imputation')]}),
 ('01 and imputation quality scores ≥0.', {'entities': [(7, 17, 'imputation')]}),
 ('Single-nucleotide polymorphisms with a minor allele frequency below\n1% or bad imputation quality (info score<0.', {'entities': [(78, 88, 'imputation')]}),
 ('uk/impute/impute_v.', {'entities': [(3, 9, 'imputation')]}),
 (' Imputed genotypes with information score <90%, MAF <3% or missing >10% were excluded.', {'entities': [(1, 8, 'imputation')]}),
 ('Additional SNPs at the 9q33 loci, not genotyped on the Illumina SNP bead-chips, were imputed with the IMPUTE software using the HapMap CEU data set (version 22) as training set.', {'entities': [(85, 92, 'imputation'), (102, 108, 'imputation'), (34, 37, 'negation')]}),
 (' Imputation was performed using IMPUTE (http://mathgen.', {'entities': [(1, 11, 'imputation'), (32, 38, 'imputation')]}),
 (' Prior to imputation, we excluded individuals with incorrect sex assignments or whose sex could not be determined by genotype, and individuals with missing rate per person >5%.', {'entities': [(10, 20, 'imputation'), (96, 99, 'negation')]}),
 (' We then performed imputation using Minimac with data from the 1000 Genomes Project used as the reference panel (RELEASE STAMP 2012-10-09), resulting in 23\u2009675\u2009718 high-quality variants.', {'entities': [(19, 29, 'imputation')]}),
 (' Related subjects that passed all other QC thresholds were retained during subsequent phasing and imputation, but then one from each pair of putatively related individuals were excluded from all genetic association analyses.', {'entities': [(98, 108, 'imputation')]}),
 (' Both sets of imputations (i.', {'entities': [(14, 25, 'imputation')]}),
 (' SNPs for which IMPUTE was confident of the imputation call but for which the genotyped data was discordant (and therefore indicative of genotyping error) were also removed if the difference between the measure of information and error rate was greater than 0.', {'entities': [(44, 54, 'imputation'), (16, 22, 'imputation')]}),
 (' SNP genotyping and imputation in SMHS (n  = 230) were carried out using Affymetrix 6.', {'entities': [(20, 30, 'imputation')]}),
 (' SNPs with a Beagle R_2  of 0.', {'entities': [(13, 19, 'imputation')]}),
 (' Genotype imputation was performed with IMPUTE2 software (V.', {'entities': [(10, 20, 'imputation'), (40, 46, 'imputation')]}),
 ('edu/csg/abecasis/mach/) [, ] to impute genotype data for untyped SNPs using the CEU Human Genome release 22, build 36 as the reference.', {'entities': [(32, 38, 'imputation'), (17, 21, 'imputation')]}),
 ('Because of the use of many different genotyping platforms, and a relatively small number of markers with genotypes in all strata, we used genome-wide SNP imputation to extend genome-wide coverage and to increase comparability.', {'entities': [(154, 164, 'imputation')]}),
 ('sg/agen/ IMPUTE, http://mathgen.', {'entities': [(9, 15, 'imputation')]}),
 (' A set of SNPs common to the nine subsamples was used for imputation in order to remove bias from the imputed data (for more details see ).', {'entities': [(58, 68, 'imputation')]}),
 (' The same rigorous quality control process used for genotyped SNPs was also applied to imputed SNPs.', {'entities': [(87, 94, 'imputation')]}),
 (' Genotypes were prephased with mach v1 () and imputed using minimac ().', {'entities': [(46, 53, 'imputation'), (31, 35, 'imputation')]}),
 (' We excluded SNPs with MAF <5%, imputation quality <0.', {'entities': [(32, 42, 'imputation')]}),
 (' The imputation data for Yale-Penn 1-3 were generated in dosage format separately.', {'entities': [(5, 15, 'imputation')]}),
 (' A total of 65,014 iChip markers were extracted from the imputed data ().', {'entities': [(57, 64, 'imputation')]}),
 ('3, we selected 38 imputed SNPs and successfully genotyped 33 out of the 38 SNPs.', {'entities': [(18, 25, 'imputation')]}),
 (' Test of association between imputed SNPs and glioma was performed using SNPTEST (v2.', {'entities': [(29, 36, 'imputation')]}),
 (' As recommended, all of the available reference panels in Phase 3 of the 1000 genomes project were used to infer genotypes, and imputation was implemented in non-overlapping 5 Mb windows (with 250 kb buffer) across the genome using the recommended default parameters.', {'entities': [(128, 138, 'imputation'), (158, 162, 'negation')]}),
 ('For WTCCC2 data, genotypes were imputed using IMPUTE2 (), which adopts a two-stage approach using both haploid and diploid reference panels.', {'entities': [(32, 39, 'imputation'), (46, 52, 'imputation')]}),
 ('We used SHAPEIT () and IMPUTE2 () to extend our genotype analysis by imputing all SNPs appearing in the thousand genomes project () as of the March 2012 release.', {'entities': [(69, 77, 'imputation'), (23, 29, 'imputation')]}),
 (' For the studies that used MACH to impute their data, either MACH QTL or Merlin was used for association analyses.', {'entities': [(35, 41, 'imputation'), (27, 31, 'imputation')]}),
 (' The imputation of the datasets was performed using IMPUTE v2.', {'entities': [(5, 15, 'imputation'), (52, 58, 'imputation')]}),
 (' We observed high imputation quality in each cohort’s imputation.', {'entities': [(18, 28, 'imputation')]}),
 (' Beagle software [] was used to phase genotype data into individual haplotypes, taking into account familial relationships.', {'entities': [(1, 7, 'imputation')]}),
 (' Secondly, we interrogated all common genotyped and imputed SNPs (MAF > 0.', {'entities': [(52, 59, 'imputation')]}),
 (' Specifically, we used these data to identify which haplotypes in our haplotype analyses were expected to carry the minor allele for the top imputed SNPs that were identified in our individual SNP analyses.', {'entities': [(141, 148, 'imputation')]}),
 (' Only variants with imputation accuracy R_2  > 0.', {'entities': [(20, 30, 'imputation')]}),
 (' Imputed genotypes were only used where directly assayed genotypes were unavailable.', {'entities': [(1, 8, 'imputation')]}),
 (' Imputation on the COPDGene cohorts was performed using MaCH and minimac.', {'entities': [(1, 11, 'imputation'), (56, 60, 'imputation')]}),
 ('  The top associated imputed SNPs were validated by SNP genotyping in\nsubsets of iDILIC cases and in the overall DILIN cohort (see ).', {'entities': [(21, 28, 'imputation')]}),
 ('  regression of phenotype on the number of reference alleles, or equivalently the imputed dosage for imputed genotypes.', {'entities': [(82, 89, 'imputation')]}),
 (' Imputed SNPs with dosage r2 values <0.', {'entities': [(1, 8, 'imputation')]}),
 (' Within each GWAS set, logistic regression models included the above-stated principal components and accounted for the imputation uncertainty via  the posterior genotype probabilities.', {'entities': [(119, 129, 'imputation')]}),
 (' Samples were first pre-phased using SHAPEIT () and genotypes imputed using IMPUTE2 ().', {'entities': [(62, 69, 'imputation'), (76, 82, 'imputation')]}),
 (' The quality control and filtering criteria for all 2,462,060 imputed SNPs were the same as for the genotyped SNPs, and 1,672,517 imputed SNPs were retained for the GWAS analysis ().', {'entities': [(62, 69, 'imputation')]}),
 (' Thus, the inverse variance weighting scheme automatically incorporates imputation quality in the meta-analysis for imputed SNPs.', {'entities': [(72, 82, 'imputation')]}),
 (' Results were similar between imputed dosage (β  = 0.', {'entities': [(30, 37, 'imputation')]}),
 (' For both LS and non-LS, logistic regression analysis of genotyped and imputed single-nucleotide polymorphisms (SNPs) was performed with expected genotype count using the posterior probabilities.', {'entities': [(71, 78, 'imputation'), (17, 21, 'negation')]}),
 (' UK/Australia stages 1 and 2 and CGEMS were imputed using MACH 1.', {'entities': [(44, 51, 'imputation'), (58, 62, 'imputation')]}),
 (' Individuals from the 1000 Genomes Project data set were added for all SNPs either genotyped or imputed.', {'entities': [(96, 103, 'imputation')]}),
 (' For the SNPs used in this study, the SNPs rs12913832, rs12421680, rs12520016 and rs12203592 were directly genotyped, and the SNPs rs975739, rs3002288 and rs7173419 were imputed with imputation r _2  of 1.', {'entities': [(170, 177, 'imputation')]}),
 (' Genotyping was done on a custom Affymetrix Axiom array (UK BiLEVE array; Santa Clara, CA) and non-genotyped variants were imputed using a combined 1000 Genomes Project Phase and UK10K Project reference panel.', {'entities': [(123, 130, 'imputation'), (95, 99, 'negation')]}),
 (' Detailed descriptions including study populations, genotyping quality control, and genotyping imputation have been previously published ().', {'entities': [(95, 105, 'imputation')]}),
 (' Genotyping was performed on the Affymetrix 500K arrays, followed by quality control and imputation to Phase 1 1000 Genomes reference panel.', {'entities': [(89, 99, 'imputation')]}),
 (' Imputation results were removed at info score threshold of < 0.', {'entities': [(1, 11, 'imputation')]}),
 ('All studies imputed SNPs using HapMap II reference populations; SNPs with low imputation quality (r_2 <0.', {'entities': [(12, 19, 'imputation')]}),
 (' Imputation was performed using Minimac2 using the September 2013 release of the 1000 Genomes Phase 1 reference haplotypes phased using Beagle4 (V3.', {'entities': [(1, 11, 'imputation'), (136, 142, 'imputation')]}),
 (' For B58C, the genotypes were phased with MACH and imputed with Minimac.', {'entities': [(51, 58, 'imputation'), (42, 46, 'imputation')]}),
 (' After imputation, the mean of the 9 SBP and DBP measures were used in the current analysis.', {'entities': [(7, 17, 'imputation')]}),
 (' Imputation was done for each 5-Mb regional chunk across the genome, and data were subsequently merged for association testing.', {'entities': [(1, 11, 'imputation')]}),
 (' Details of the genotyping, quality control, imputation procedure in the replication set 3 are described elsewhere.', {'entities': [(45, 55, 'imputation')]}),
 ('edu/~yunmli/MaCH-Admix) was used to impute the remaining untyped SNPs using the 1000 Genomes Project (http://www.', {'entities': [(36, 42, 'imputation'), (12, 16, 'imputation')]}),
 (' Imputation was performed in the Discovery Stage samples based on either the 1000 Genomes Phase 1 interim reference panel or the Phase 1 integrated reference panel using IMPUTE2 software ().', {'entities': [(1, 11, 'imputation'), (170, 176, 'imputation')]}),
 (' SNPs that were imputed poorly were discarded (INFO < 0.', {'entities': [(16, 23, 'imputation')]}),
 (' Imputation of un-genotyped variants was performed in European (544,620 directly genotyped SNPs) and Indian Asian (541,497 SNPs) samples separately with IMPUTE2 v2.', {'entities': [(1, 11, 'imputation'), (153, 159, 'imputation'), (15, 18, 'negation')]}),
 ('  Imputed genotypes were examined in regions where at least one genotyped SNP achieved a p < 10_−6  and in regions showing ancestry association in WHI AAs (p < 7\xa0× 10_−6 ).', {'entities': [(2, 9, 'imputation')]}),
 (' Genetic data\nimputations were performed in each cohort using HapMap II CEPH (Utah residents with\nancestry from northern and western Europe) as the reference panel, with the exceptions of\nARIC and GENOA African-American cohorts that imputed their genetic data using both HapMap\nII CEPH and YRI (Yoruba in Ibadan) populations as a reference.', {'entities': [(14, 25, 'imputation')]}),
 (' CARDIoGRAM represents a GWAS meta-analysis of CVD comprising 60,801 cases and 123,504 controls from 48 studies, in which logistic regression was first used in each cohort to test for association with CVD using a log-additive model with adjustment for age and sex and taking into account the uncertainty of possibly imputed genotypes.', {'entities': [(316, 323, 'imputation')]}),
 (' The phasing and imputation were done separately for males and females for the X chromosome.', {'entities': [(17, 27, 'imputation')]}),
 (' For the initial six-study discovery analysis, all variants for which at least one study had good imputation quality (r_2  ≥ 0.', {'entities': [(98, 108, 'imputation')]}),
 (' In a second step, we imputed missing alleles for additional SNPs directly onto these phased haplotypes using Minimac .', {'entities': [(22, 29, 'imputation')]}),
 (' As a check, we then applied the imputation approach we used in the replication data to the GWAS samples.', {'entities': [(33, 43, 'imputation')]}),
 (' The imputation yielded, a genotype dataset consisting of 27.', {'entities': [(5, 15, 'imputation')]}),
 ('_,   To increase the coverage of genotypes in this study, we imputed genotypes for each of these five studies with data from the 1000 Genomes Project Phase I Release (Version 3) as the reference.', {'entities': [(61, 68, 'imputation')]}),
 ('We performed SNP genotype imputation of the identified SSc susceptibility loci (5 Mb regions centered in the lead SNP were considered).', {'entities': [(26, 36, 'imputation')]}),
 ('05) and were present in the imputed data set (imputation quality R _2 \u2009>\u20090.', {'entities': [(28, 35, 'imputation')]}),
 (' After phasing the data, IMPUTE2 was used for the imputation with the 1000 Genomes Phase I integrated reference panel().', {'entities': [(50, 60, 'imputation'), (25, 31, 'imputation')]}),
 (' We used these parameter estimates to generate maximum likelihood estimates of allele numbers per SNP on the basis of reference haplotypes for the datasets during the second stage of the imputation.', {'entities': [(187, 197, 'imputation')]}),
 ('Genotyping platforms, quality control and imputation are detailed in ESM method.', {'entities': [(42, 52, 'imputation')]}),
 (' In total, 73,355,677 SNPs, short indels and large structural variants were imputed.', {'entities': [(76, 83, 'imputation')]}),
 (' The VCF-QUERY tool was used to convert the new VCF files into phased haplotypes and legend files for IMPUTE V2 .', {'entities': [(102, 108, 'imputation')]}),
 (' Association analysis result files from the different studies were quality-controlled using the R package EasyQC () to harmonize any discrepancy in marker names between studies and to perform basic exclusions (incomplete and invalid data, monomorphic SNPs and SNPs with a sample size\u2009<\u200930, a minor allele count\u2009<\u20096, failed or low quality imputation, i.', {'entities': [(338, 348, 'imputation')]}),
 (' After checking strand and allele inconsistencies, both the 1000 Genomes Project reference panel (release 05-21-2011) and custom reference panel were imputed up to the union of their variants as described previously.', {'entities': [(150, 157, 'imputation')]}),
 (' Non-autosomal SNPs were excluded from imputation and association analysis.', {'entities': [(39, 49, 'imputation'), (1, 5, 'negation')]}),
 (' SNPs with potentially unreliable imputation were filtered out based on MAF (<2%), imputation info value (<0.', {'entities': [(34, 44, 'imputation')]}),
 (' Imputation was conducted using IMPUTE2 and phase 3 of the 1000 Genomes Project (comprising 2,504 individuals from 26 populations worldwide) as the reference panel.', {'entities': [(1, 11, 'imputation'), (32, 38, 'imputation')]}),
 (' Lastly, we used 6852 markers (SNPs or HLA alleles) of two alleles from 12,983 people as reference data in HLA imputation _– .', {'entities': [(111, 121, 'imputation')]}),
 ('edu/~purcell/plink/) for all genotyped and imputed markers.', {'entities': [(43, 50, 'imputation')]}),
 (' However, and as should be expected, we observed that the posterior probabilities for the HLA alleles were comparable for the two methods and we are reporting the HLA imputation based on the imputed data incorporating the imputation posterior probability.', {'entities': [(167, 177, 'imputation')]}),
 (' Details on the identification and replication cohorts concerning genotyping method, genotyping imputation software, and CMH and COPD definitions are given in .', {'entities': [(96, 106, 'imputation')]}),
 (' Our analysis included a total of 5,815,690 imputed and genotyped variants.', {'entities': [(44, 51, 'imputation')]}),
 (' The most recent imputation panels, such as the UK10K and 1000 Genomes Project (v.', {'entities': [(17, 27, 'imputation')]}),
 (' The imputed data was filtered using standard post-imputation quality control based on IMPUTE2 information scores >0.', {'entities': [(5, 12, 'imputation'), (87, 93, 'imputation')]}),
 ('3 in MACH or >0.', {'entities': [(5, 9, 'imputation')]}),
 ('1 array, and genotypes of the 1000 Genomes Project (phase 3 release 5; Minimac3) were imputed into their phased haplotypes (SHAPEIT2).', {'entities': [(86, 93, 'imputation')]}),
 (' Each study imputed the allele dosages for ∼2.', {'entities': [(12, 19, 'imputation')]}),
 (' In the remaining studies (CORECT, MECC1 and CFR1) stringent imputation quality and accuracy filters (info≥0.', {'entities': [(61, 71, 'imputation')]}),
 ('5M SNPs and, alternatively, a reference panel from 1000 Genomes Project phase 1 version 3 was used to impute the genotype data of GPC-2.', {'entities': [(102, 108, 'imputation')]}),
 ('The SNP rs138042437 (referred to as kgp28696802 in the imputed data set), which had a high OR in the GWAS, was followed up to assess the segregation of the rare allele with prostate cancer.', {'entities': [(55, 62, 'imputation')]}),
 (' Association testing for typed or imputed SNPs was performed by linear regression of square-root-transformed PLT adjusted for age, sex, and PCs.', {'entities': [(34, 41, 'imputation')]}),
 ('\nWe used Beagle 3.', {'entities': [(9, 15, 'imputation')]}),
 ('0 array, and either direct or imputed genotypes were available for all the 19 variants.', {'entities': [(30, 37, 'imputation')]}),
 (' The most likely imputed alleles were used as input for testing of association of common HLA alleles with CSF phenotypes using the same regression approach as described for SNPs above.', {'entities': [(17, 24, 'imputation')]}),
 (' Imputed SNPs located within one megabase of internally validated Affymetrix Array SNPs were then tested for associations with obesity using the same approach.', {'entities': [(1, 8, 'imputation')]}),
 (' Further details concerning genotyping, quality control, and imputation are posted on the COPDGene Web site (www.', {'entities': [(61, 71, 'imputation')]}),
 ('3 (IMPUTE).', {'entities': [(3, 9, 'imputation')]}),
 (' A framework map for imputation was defined by choosing SNPs on all platforms, and restricting to those with minor allele frequency between 1% and 50%, and excluding SNPs with significant (p< 1.', {'entities': [(21, 31, 'imputation')]}),
 (' In the small\nnumber of cases in which imputed variants had the same genomic position (GRCh37)\nand alleles, the variant with the lowest INFO score was removed.', {'entities': [(39, 46, 'imputation')]}),
 (' MetaboChip SNPs were imputed in WHI-SHARE participants using genome-wide genotype data (Affymetrix 6.', {'entities': [(22, 29, 'imputation')]}),
 (' Imputation of 6.', {'entities': [(1, 11, 'imputation')]}),
 (' This was likely due to the inclusion of one study (MAAS) that had imputed to the combined HapMap + 1000G panel, whereas all other studies with imputed data had imputed to HapMap.', {'entities': [(67, 74, 'imputation')]}),
 (' Prior to meta-analysis, SNPs were filtered out within each cohort if they had a poor imputation quality (Rsq > 0.', {'entities': [(86, 96, 'imputation')]}),
 (' We performed whole-genome association testing using post-imputation genotype probabilities with the software SNPTEST (v2.', {'entities': [(58, 68, 'imputation')]}),
 ('43 × 10_−31 ) and collapsed imputed dosage (β  = 0.', {'entities': [(28, 35, 'imputation')]}),
 (' In this case, we provided the same HapMap dataset that was used for imputation (i.', {'entities': [(69, 79, 'imputation')]}),
 (' A weighted linear kappa statistic was calculated to determine the correlation of the imputation with the true genotypes.', {'entities': [(86, 96, 'imputation')]}),
 (' Summary level results were filtered, keeping variants with imputation quality >0.', {'entities': [(60, 70, 'imputation')]}),
 (' A minority of contributing studies used alternative programs for phasing and imputation; BEAGLE, MACH, MINIMAC, or in-house custom software.', {'entities': [(78, 88, 'imputation'), (90, 96, 'imputation'), (98, 102, 'imputation')]}),
 (' All studies performed genotype imputation to HapMap Project Phase II reference panel (JPT\u2009+\u2009CHB for all studies except CLHNS, which used JPT\u2009+\u2009CHB\u2009+\u2009CEU, and SiMES, which used JPT\u2009+\u2009CHB\u2009+\u2009CEU\u2009+\u2009YRI) of ∼2.', {'entities': [(32, 42, 'imputation')]}),
 (' Imputation was carried out by minimac (ver.', {'entities': [(1, 11, 'imputation')]}),
 (' The chip-genotype imputation was based on chip genotypes from 95,085 persons.', {'entities': [(19, 29, 'imputation')]}),
 (' The CAPS study used IMPUTE v1.', {'entities': [(21, 27, 'imputation')]}),
 ('Genome-wide imputation for samples in four Stage 1 studies was performed using program MACH 1.', {'entities': [(12, 22, 'imputation'), (87, 91, 'imputation')]}),
 ('2 was used to impute missing genotypes for study samples based on the cosmopolitan panel of reference haplotypes from Phase I of the 1000 Genomes Project (1000GP; March 2012 release; n  = 1092) (,).', {'entities': [(14, 20, 'imputation')]}),
 ('  We used the program BEAGLE version 3.', {'entities': [(22, 28, 'imputation')]}),
 (' Imputed genotypes were examined in regions where at least one genotyped SNP achieved a p < 10_−6  and in regions showing ancestry association in WHI AAs (p < 7\xa0× 10_−6 ).', {'entities': [(1, 8, 'imputation')]}),
 (' For individual-level genotype data, we retained genotypes having a probability ≥80% (from the gprob metric in Beagle); all other genotypes were set to missing.', {'entities': [(111, 117, 'imputation')]}),
 (' Finally, to help interpret the relationship between the haplotype results and the unconditional and conditional association results from non-genotyped imputed SNPs, we downloaded genotype data from CEU HapMap samples and used the ‘haplo.', {'entities': [(152, 159, 'imputation'), (138, 142, 'negation')]}),
 (' Twenty-one out of the 22 SNPs (in main manuscript ) were genotyped or imputed in the three\ncohorts, i.', {'entities': [(71, 78, 'imputation')]}),
 (' The imputation yielded ~4 million high-quality SNPs across the entire genome after excluding INDELs and copy number variants (CNVs).', {'entities': [(5, 15, 'imputation')]}),
 (' Genotype imputation was performed using impute2 [] after using ShapeIt (v1.', {'entities': [(10, 20, 'imputation')]}),
 ('  Genotype imputation was performed using the pre-phasing/imputation stepwise approach implemented in IMPUTE2 / SHAPEIT (chunk size of 3 Mb and default parameters _,  .', {'entities': [(11, 21, 'imputation'), (102, 108, 'imputation')]}),
 (' Imputation was performed via combination with 3.', {'entities': [(1, 11, 'imputation')]}),
 ('1M SNPs remaining in Yale-Penn 1-3 respectively, which were subjected to imputation and downstream analysis.', {'entities': [(73, 83, 'imputation')]}),
 ('  After imputation, SNPs were excluded based on the following: MAF ≤1%, test of Hardy–Weinberg equilibrium P  < 10_−6 , SNP failure rate >10% and imputation quality (info) <0.', {'entities': [(8, 18, 'imputation')]}),
 (' Detailed information about the pre-imputation quality control pipeline is available in our published AD GWAS ().', {'entities': [(36, 46, 'imputation')]}),
 ('01 or less were filtered out post-imputation.', {'entities': [(34, 44, 'imputation')]}),
 (' Of the 533,631 SNPs which were manufactured on the array, 494,813 SNPs passed the initial QC and 470,825 SNPs were used for imputation.', {'entities': [(125, 135, 'imputation')]}),
 (' Imputation of genotypes was performed using IMPUTE2 v2.', {'entities': [(1, 11, 'imputation'), (45, 51, 'imputation')]}),
 ('org/plink2, \nMACH:\nhttp://csg.', {'entities': [(13, 17, 'imputation')]}),
 (' Summary descriptions of genotyping technologies, quality-control procedures, and imputation methods used for the discovery cohorts are shown in .', {'entities': [(82, 92, 'imputation')]}),
 ('_, Genotype data were imputed using Impute2 v2.', {'entities': [(22, 29, 'imputation'), (36, 43, 'imputation')]}),
 (' Imputed SNPs were filtered prior to meta-analysis to exclude poorly imputed SNPs (IMPUTE filter PROPER INFO <0.', {'entities': [(69, 76, 'imputation'), (1, 8, 'imputation'), (83, 89, 'imputation')]}),
 (' To estimate the percentage of the variance of log(B2M) explained by the GWAS SNPs independent of the imputed classical HLA alleles, we conducted linear regression analyses of the imputed classical HLA allele genotypes with and without the GWAS SNPs and calculate the difference in multiple R_2 .', {'entities': [(102, 109, 'imputation')]}),
 (' Genotypes were imputed to the 1000 Genome Phase I Integrated Release Version 3 reference panel.', {'entities': [(16, 23, 'imputation')]}),
 (' Principal component analysis using HapMap populations and SMARTPCA () revealed 713 genetic Europeans (), who underwent genotype imputation.', {'entities': [(129, 139, 'imputation')]}),
 (' Only SNPs that could be imputed with relatively high confidence (R _2  > 0.', {'entities': [(25, 32, 'imputation')]}),
 ('edu/csg/abecasis/MACH/download/).', {'entities': [(17, 21, 'imputation')]}),
 (' Prior to analysis with IMPUTE2, we applied standard quality control filters akin to those described above.', {'entities': [(24, 30, 'imputation')]}),
 (' Imputation of the X chromosome loci was only possible using IMPUTEv1 with HapMap Data Release 21 on NCBI Build 35.', {'entities': [(1, 11, 'imputation'), (61, 67, 'imputation')]}),
 (' Each study used MACH () or BEAGLE () to impute up to ∼ 2.', {'entities': [(41, 47, 'imputation'), (28, 34, 'imputation'), (17, 21, 'imputation')]}),
 (' Each imputation software estimates an overall imputation quality score for each SNP.', {'entities': [(6, 16, 'imputation')]}),
 (' In order to assess the accuracy of the imputation, we used partial data from previously genotyped HLA alleles from 490 individuals from the US and 466 individuals from Spain for HLA-A , HLA-B , HLA-C , HLA-DPA1 , HLA-DPB1 , HLA-DQA1 , HLA-DQB1 , and HLA-DRB1  at four digits, which were partially included in previous reports.', {'entities': [(40, 50, 'imputation')]}),
 (' The first model used the imputed minor allele dosage as the dependent variable and the DSM-IV symptom count for AD and the three other major SD diagnoses (cocaine, opioid and nicotine dependence: CD, OD and ND, respectively) as ordinal predictors (adjusted for sex, age and the first three ancestry PCs).', {'entities': [(26, 33, 'imputation')]}),
 (' For each trait, we filtered the summary statistics to the subset of HapMap 3 SNPs, as advised by the developers, to ensure that no bias was introduced due to poor imputation quality.', {'entities': [(164, 174, 'imputation'), (129, 131, 'negation')]}),
 (' Imputation was run separately on data from each genotyping platform.', {'entities': [(1, 11, 'imputation')]}),
 ('  Within each dataset, genome-wide association analyses were conducted using more than 7 million imputed SNPs in the total sample, as well as in subgroups of subjects with and without the APOE  ε4 allele, using regression models including age, sex, the first three PCs.', {'entities': [(97, 104, 'imputation')]}),
 (' The Breast and Prostate Cancer Cohort Consortium (BPC3) and Breast Cancer Family Registry (BCFR) GWAS performed imputation separately using MACH and Minimac_, .', {'entities': [(113, 123, 'imputation'), (141, 145, 'imputation')]}),
 ('4 (Impute2) or < 0.', {'entities': [(3, 10, 'imputation')]}),
 (' Detailed information regarding study populations, genotyping and imputation is found in () and ().', {'entities': [(66, 76, 'imputation')]}),
 (' After imputation analysis, genotype data of cases only were extracted from each cohort; in total, 4256 (72.', {'entities': [(7, 17, 'imputation')]}),
 (' The two newly available GWAS, CHNS and BES, were imputed to the 1000 Genomes Project Phase 3 reference panel () using the University of Michigan imputation server ().', {'entities': [(50, 57, 'imputation')]}),
 (' Untyped SNPs were imputed using the IMPUTE2 (), MACH1 () or minimac () software and HapMap Phase II, Phase III and/or 1000 Genome Project data release 2010-08 or 2010-06 reference genotypes.', {'entities': [(19, 26, 'imputation'), (37, 43, 'imputation'), (49, 54, 'imputation')]}),
 (' We examined the linear, multivariate, and case/control phenotype models using either directly genotyped or a combination of genotyped and imputed SNP data, adjusting for sex, age, and marital status (binary).', {'entities': [(139, 146, 'imputation')]}),
 ('edu/~purcell/plink/; IMPUTE, http://mathgen.', {'entities': [(21, 27, 'imputation')]}),
 (' As raw genotype data were not directly transferred to the meta-analysis site, a histogram of allele frequency differences between each contributing group and the HapMap 3 CEU population was generated for each group () to further examine genotyping and imputation quality.', {'entities': [(253, 263, 'imputation'), (27, 30, 'negation')]}),
 (' Variants with imputation quality <0.', {'entities': [(15, 25, 'imputation')]}),
 (' After imputation, SNPs with r_2 <0.', {'entities': [(7, 17, 'imputation')]}),
 (' Of the 11 cohorts, 6 directly genotyped rs556621, and 5 imputed allelic dosages for this SNP.', {'entities': [(57, 64, 'imputation')]}),
 ('4, MACH filter r _2  < 0.', {'entities': [(3, 7, 'imputation')]}),
 (' Each study imputed SNPs by combining their study’s\ngenotyped SNPs with HapMap Phase II CEU SNPs samples, preferably using release\n22 of HapMap, build 36.', {'entities': [(12, 19, 'imputation')]}),
 (' Hapmap SNPs in the 2 regions were imputed using MACH 1.', {'entities': [(35, 42, 'imputation'), (49, 53, 'imputation')]}),
 (' A total of 4,749,595 imputed variants in the NHW subjects with COPD from COPDGene, 4,753,821 imputed variants in ECLIPSE subjects with COPD, and 6,160,662 imputed variants in the AA subjects with COPD from COPDGene passed quality control.', {'entities': [(22, 29, 'imputation')]}),
 ('We imputed autosomal and X chromosome SNVs using the all-ancestries 1000G reference panel (1,092 individuals from Africa, Asia, Europe, and the Americas [March 2012 release]) using minimac () or IMPUTE2 ().', {'entities': [(3, 10, 'imputation'), (195, 201, 'imputation')]}),
 ('16 or BEAGLE.', {'entities': [(6, 12, 'imputation')]}),
 (' By limiting our initial analysis to the genotyped and imputed SNPs (N = 2070) within homozygous stretches whose frequency differed significantly between cases and controls, we focused our search for population-specific risk loci and reduced the statistical penalty for multiple tests.', {'entities': [(55, 62, 'imputation')]}),
 (' Genotyped data was phased with SHAPE-IT and imputation was performed with IMPUTE2, using all populations from 1000 Genomes Project Phase I v3 as reference.', {'entities': [(45, 55, 'imputation'), (75, 81, 'imputation')]}),
 ('The set of genotyped input SNPs used for imputation in each study was selected based on highest quality GWAS data.', {'entities': [(41, 51, 'imputation')]}),
 (' The imputation panel consists of approximately 22 million variants (SNPs and indels).', {'entities': [(5, 15, 'imputation')]}),
 ('5 million HapMap SNPs by using Beagle () (CARDIA), Bimbam () (for Caucasians) and Beagle () (for African Americans) (CHS), Impute () (MESA), or Mach () (GOLDN, HPFS, NHS, and WGHS).', {'entities': [(123, 129, 'imputation'), (31, 37, 'imputation'), (144, 148, 'imputation')]}),
 ('30, which resulted in 2,455,927 imputed SNPs.', {'entities': [(32, 39, 'imputation')]}),
 (' Imputation was performed using the program impute2, version 2.', {'entities': [(44, 51, 'imputation'), (1, 11, 'imputation')]}),
 (' The genotyped indel showed high agreement with the imputed indel (r_2 =0.', {'entities': [(52, 59, 'imputation')]}),
 (' Phase 3 of the 1000 Genomes Project data set (n\u2009=\u20092,504) was used as the reference panel for imputation.', {'entities': [(94, 104, 'imputation')]}),
 (' Following imputation and QC, 9 009 669, 8 304 060 and 9 177 523 SNPs and indels were available for analysis in the MECC discovery, CFR discovery and MECC replication, respectively.', {'entities': [(11, 21, 'imputation')]}),
 (' The remaining 339 affected individuals genotyped using the Centaurus platform are a subset of the 627 affected individuals contributing imputed genotypes to the initial thyroid cancer GWAS data set ().', {'entities': [(137, 144, 'imputation')]}),
 (' Finally, each stratum was prephased and imputed.', {'entities': [(41, 48, 'imputation')]}),
 ('4 and variants with effective minor allele count (minor allele count × imputation quality)<10.', {'entities': [(71, 81, 'imputation')]}),
 (' Then, whole-genome imputation was performed using the IMPUTE version 2 [] and the integrated haplotypes of the 1000 Genomes Project Phase III reference panel (October 2014 version) [].', {'entities': [(20, 30, 'imputation'), (55, 61, 'imputation')]}),
 ('Conditional analysis of imputed HLA  alleles was performed to test for multiple independent effects within the region.', {'entities': [(24, 31, 'imputation')]}),
 ('5M arrays for the PCGC imputation).', {'entities': [(23, 33, 'imputation')]}),
 (' Similarly, imputated data and genotype data were consistent for the remaining 26 SNPs (squared correlation coefficient (r _2 )_\u2009 >\u20090.', {'entities': [(12, 21, 'imputation')]}),
 (' For imputed SNPs, we calculated the imputation quality scores “info” and “oevar” (ratio of observed to expected variance of imputed dosage) for each SNP and excluded SNPs with oevar <0.', {'entities': [(5, 12, 'imputation')]}),
 (' Briefly the 1,000 genome data and BEAGLE v3.', {'entities': [(35, 41, 'imputation')]}),
 (' We performed genotype imputation to the non-monomorphic SNPs described in the HapMap 2 and 1000 Genomes Project (August 2010 release) CEU panels ().', {'entities': [(23, 33, 'imputation'), (41, 45, 'negation')]}),
 ('Imputation was also performed on an array-wise basis.', {'entities': [(0, 10, 'imputation')]}),
 ('Association analyses of imputed SNPs with VTE risk were performed separately in each study by using logistic or Cox-proportional regression analyses adjusted for study-specific covariates ().', {'entities': [(24, 31, 'imputation')]}),
 ('To begin to fine map newly identified regions, we imputed all the SNPs catalogued in the 1000 Genomes Project data, March 2012 release, and the DCEG Imputation Reference Set version 1.', {'entities': [(50, 57, 'imputation'), (149, 159, 'imputation')]}),
 (' After stringent quality control, there were 474,231 directly genotyped SNPs in 1616 subjects available for further analysis and used for the basis of imputation.', {'entities': [(151, 161, 'imputation')]}),
 (' We included SNPs with an IMPUTE2 info score of ≥0.', {'entities': [(26, 32, 'imputation')]}),
 (' Genotypes were imputed to ~2.', {'entities': [(16, 23, 'imputation')]}),
 (' To filter poorly imputed SNPs, as previously recommended, we excluded variants having overall information scores from SNPTESTv2.', {'entities': [(18, 25, 'imputation')]}),
 (' Variant calls for the\n301,019 variants imputed in the MA sample were extracted from the sequencing data to\ncreate a replication sample; 269,453 total variants were selected based on base pair\nlocation.', {'entities': [(40, 47, 'imputation')]}),
 (' The original Phase 1 release of 1000 Genomes reference panel used for imputation contained ~38 million single nucleotide variants (SNVs).', {'entities': [(71, 81, 'imputation')]}),
 (' The best model emerging from the application of this approach was then applied to the analyses of the imputed SNPs.', {'entities': [(103, 110, 'imputation')]}),
 (' Imputed genotypes were called with an impute probability threshold of 0.', {'entities': [(39, 45, 'imputation'), (1, 8, 'imputation')]}),
 (' Criteria\nfor imputation quality and genomic control parameters are outlined in .', {'entities': [(14, 24, 'imputation')]}),
 (' For the X chromosome, only the non-pseudo autosomal region was imputed.', {'entities': [(64, 71, 'imputation'), (32, 36, 'negation')]}),
 (' Imputation accuracy was satisfactory, with info scores of 0.', {'entities': [(1, 11, 'imputation')]}),
 (' Imputed genotypes were only used where directly-assayed genotypes were unavailable.', {'entities': [(1, 8, 'imputation')]}),
 (' Imputation of 2.', {'entities': [(1, 11, 'imputation')]}),
 ('3 were removed, leaving a total of 5,970,354 imputed and genotyped variants.', {'entities': [(45, 52, 'imputation')]}),
 ('01), we imputed with accuracy r_2 ≥0.', {'entities': [(8, 15, 'imputation')]}),
 (' We included only discovery-phase genotyped SNPs that passed QC in the imputation process.', {'entities': [(71, 81, 'imputation')]}),
 (' Genotyping platforms and imputation methods for each participating study are described in .', {'entities': [(26, 36, 'imputation')]}),
 ('Genome-wide imputation was carried out with the full, cosmopolitan 1000 Genomes Project phase 1 reference panel (n = 1,092).', {'entities': [(12, 22, 'imputation')]}),
 ('We imputed genotypes in candidate regions for the European and Asian cohorts using the EUR and ASN reference panels, respectively, from the 1000 Genomes Project (Phase 1, 2010–2011 data freeze).', {'entities': [(3, 10, 'imputation')]}),
 (' In our detailed result table (), we list for each SNP the number of studies with directly genotyped or imputed data and the mean imputation R_2 .', {'entities': [(104, 111, 'imputation')]}),
 (' Imputation for the Axiom samples was performed for all autosomes using IMPUTE2.', {'entities': [(1, 11, 'imputation'), (72, 78, 'imputation')]}),
 ('3 postimputation.', {'entities': [(6, 16, 'imputation')]}),
 ('5 million genotyped or imputed autosomal SNPs (HapMap II, Centre d’Etude du Polymorphisme Humain [CEU] reference), based on linear (cups/day, phenotype-1) or logistic (high vs.', {'entities': [(23, 30, 'imputation')]}),
 (' Meta-analysis was performed by combining results from DS1 and DS2 for the common set of 451 088 SNP genotyped or imputed in both samples.', {'entities': [(114, 121, 'imputation')]}),
 (' If the highest imputation score for an imputed SNP of a sample was < 90%, a missing imputed genotype was assigned.', {'entities': [(16, 26, 'imputation')]}),
 (' Imputation software, including MACH, BIMBAM or IMPUTE, were used to impute unmeasured genotypes with SNPs that passed quality control criteria based on phased haplotypes observed in HapMap.', {'entities': [(69, 75, 'imputation'), (1, 11, 'imputation'), (48, 54, 'imputation'), (32, 36, 'imputation')]}),
 (' Analysis of imputed genotype data accounted for uncertainty in each genotype prediction by using either the dosage information from MACH or BimBam or the genotype probabilities from IMPUTE.', {'entities': [(13, 20, 'imputation'), (183, 189, 'imputation'), (133, 137, 'imputation')]}),
 (' Genotyping in the GACRS was performed using the Illumina BeadStation 500G platform, and imputation was performed based on the 1,000 Human Genomes Project, using the same methodology as in CAMP.', {'entities': [(89, 99, 'imputation')]}),
 (' For each chromosomal chunk, a set of genetically matched panel individuals was selected, according to the last strategy used by IMPUTE.', {'entities': [(129, 135, 'imputation')]}),
 ('4 or MaCH/Minimac r _2  ≥ 0.', {'entities': [(5, 9, 'imputation')]}),
 (' Mach2dat, http://genome.', {'entities': [(1, 6, 'imputation')]}),
 (' The same threshold of 5\xa0× 10_−8  was used to declare genome-wide statistical significance for the imputed genotypes, although we note that the significant regions identified remained the same when a more stringent threshold of 2.', {'entities': [(99, 106, 'imputation')]}),
 (' After imputation SNPs with a MAF < 0.', {'entities': [(7, 17, 'imputation')]}),
 (' One variant, rs7701094, was excluded due to failure of imputation and was replaced by rs6890814 (r _2 =0.', {'entities': [(56, 66, 'imputation')]}),
 (' Data were imputed for all scans for ~2.', {'entities': [(11, 18, 'imputation')]}),
 (' We used SHAPEIT, IMPUTE2, and SNPTEST software for imputation and association testing.', {'entities': [(52, 62, 'imputation'), (18, 24, 'imputation')]}),
 (' After the initial genome-wide imputation had identified the FTO region as a candidate region, further imputation of this region (1Mb either side of rs16953002, Chr16: 53,114,824–55,114,824) was conducted based on the 1000 Genomes Phase 1 integrated variant set (March 2012 release, excluding SNPs with MAF<0.', {'entities': [(31, 41, 'imputation')]}),
 (' In addition, 125 samples were genotyped for classical HLA A, B, C, DRB1, DQA1, DQB1 alleles using the LUMINEX system and data used to evaluate the performance of the imputation of classical HLA alleles (see below).', {'entities': [(167, 177, 'imputation')]}),
 (' Therefore, we excluded markers with imputation quality info score less than 0.', {'entities': [(37, 47, 'imputation')]}),
 ('GWAS data access was coordinated through ADGC, providing quality-controlled genotypes using imputation to the Phase I v.', {'entities': [(92, 102, 'imputation')]}),
 ('5 and imputed using 1000 Genomes Project Phase I data (1,092 individuals).', {'entities': [(6, 13, 'imputation')]}),
 ('_,   Imputation inaccuracy was assessed with missing data likelihood score test.', {'entities': [(5, 15, 'imputation')]}),
 ('5 million directly typed and imputed markers (info >0.', {'entities': [(29, 36, 'imputation')]}),
 (' A total of 2,416,663 SNPs from the HapMap release 22 build 36 CHB+JPT samples were imputed using MACH software.', {'entities': [(84, 91, 'imputation'), (98, 102, 'imputation')]}),
 ('We evaluated the association between genotype and disease using the imputed genotype dosage in a logistic regression model.', {'entities': [(68, 75, 'imputation')]}),
 (' To assess the quality of imputation, we tested the non-reference discordance rate for the low-frequency genome-wide-significant SNVs and found this to be 0% ().', {'entities': [(26, 36, 'imputation'), (52, 56, 'negation')]}),
 (' This provided us with 10,011,985 imputed autosomal markers, including 9,170,060 markers with Rsq > 0.', {'entities': [(34, 41, 'imputation')]}),
 (' This value, which generally ranges from 0 to 1 (ie, poor to excellent), reflects imputation quality.', {'entities': [(82, 92, 'imputation')]}),
 (' For each sample, we performed imputation with MaCH, which uses the Markov Chain Monte Carlo method to infer missing genotypes and SNPs robustly and accurately ().', {'entities': [(31, 41, 'imputation'), (47, 51, 'imputation')]}),
 ('Imputation of SNPs on chromosomes 1 and 20 was implemented for the case–control data set using a subset of SNPs with MAF >0.', {'entities': [(0, 10, 'imputation')]}),
 (' In order to incorporate the uncertainty of the imputation process, expected allelic dosage data were used for the analysis.', {'entities': [(48, 58, 'imputation')]}),
 ('02) imputed and genotyped autosomal variants.', {'entities': [(4, 11, 'imputation')]}),
 (' We observed a drop in imputation accuracy when we used a mixture of CEU (Caucasians) and Yoruban YRI (Africans) populations as reference haplotypes.', {'entities': [(23, 33, 'imputation')]}),
 ('0001 and imputation Rsq scores < 0.', {'entities': [(9, 19, 'imputation')]}),
 (' On the basis of this experience, as well as what we would expect given the unique population history of Samoans, we believe that the best way to perform accurate imputation in Samoans is by using a Samoan-specific reference panel.', {'entities': [(163, 173, 'imputation')]}),
 (' Imputed SNPs with INFO < 0.', {'entities': [(1, 8, 'imputation')]}),
 ('edu/csg/abecasis/MACH) using the HapMap Phase II (release 22) CEU reference panel from International HapMap Project (http://hapmap.', {'entities': [(17, 21, 'imputation')]}),
 (' SNPs with poor imputation quality (dosage R _2 <0.', {'entities': [(16, 26, 'imputation')]}),
 (' Imputation was performed using IMPUTE (v2) () using two reference panels, P0 (HapMap2, rel 22, combined CEU+YRI+ASN panels) and P1 (610k+, including the combined HumanHap610k and 1\u2009M reduced to 610k SNP content).', {'entities': [(1, 11, 'imputation'), (32, 38, 'imputation')]}),
 (' Assuming a single causal variant for each locus and that the true causal variant is either genotyped or well imputed, the probability that the 99% credible set contains the causal variant would be ∼0.', {'entities': [(110, 117, 'imputation')]}),
 (' Imputed SNPs were dropped for imputation scores < 0.', {'entities': [(31, 41, 'imputation'), (1, 8, 'imputation')]}),
 (' We then performed imputation based on the 1000 Genomes Project release version 3 reference haplotypes using IMPUTE version 2.', {'entities': [(19, 29, 'imputation'), (109, 115, 'imputation')]}),
 (' Quality control was performed before imputation by checking pedigree relationships (using GRR software), and excluding SNPs with low call rates (< 98%).', {'entities': [(38, 48, 'imputation')]}),
 ('edu/sguy/beagle/strand_switching/strand_switching.', {'entities': [(9, 15, 'imputation')]}),
 (' Samples from each cohort were pre-phased and imputed in a single batch, to avoid batch effects attributable to the imputation process.', {'entities': [(46, 53, 'imputation')]}),
 ('org/) was performed using SHAPEIT () and IMPUTE2 () using a cosmopolitan reference panel (all groups included).', {'entities': [(41, 47, 'imputation')]}),
 ('54 million SNPs using the Markov Chain haplotyping (MaCH) software (http://www.', {'entities': [(52, 56, 'imputation')]}),
 ('r644 [] and IMPUTE2 v2.', {'entities': [(12, 18, 'imputation')]}),
 ('  To prepare for whole-genome imputation across the entire study cohort, we combined case samples across the 10 pAIDs with the shared control samples.', {'entities': [(30, 40, 'imputation')]}),
 (' Participants were excluded based on: 1) completion rates lower than 94-96% as per the QC groups (n=420 samples); 2) abnormal heterozygosity values of less than 25% or greater than 35% (n=45) – some samples were excluded for both low completion rates and abnormal heterozygosity, and the total number of unique samples excluded for either criteria was 438; 3) unexpected duplicates (n=8 forming 4 pairs), and one sample that also failed due to low completion rate; 4) sex discordance between self reported and the imputed gender by X chromosome heterozygosity (n=9); 5) one sample from each unexpected inter-study duplicates (n=20) and 6) phenotype exclusions (due to ineligibility or incomplete information) (n=27).', {'entities': [(514, 521, 'imputation')]}),
 (' More details of the imputation methods and QC can be found in the online only .', {'entities': [(21, 31, 'imputation')]}),
 (' The inflation factor λ _GC  was calculated before and after imputation by dividing the mean of the lower 90% of the test statistics by the mean of the lower 90% of the expected values from a χ _2  distribution with 1 d.', {'entities': [(61, 71, 'imputation')]}),
 (' For OGP-Talana, using the phase II CEU HapMap individuals (release 22, NCBI build 36) as reference panel for imputation, genotypes were imputed for nearly 2.', {'entities': [(110, 120, 'imputation')]}),
 (' It should be noted that this genome-wide significant threshold, although being the most commonly used for GWAS, is on the liberal end of the spectrum for deeply imputed genotype data.', {'entities': [(162, 169, 'imputation')]}),
 (' SNPs with a low quality of imputation (r _2 <0.', {'entities': [(28, 38, 'imputation')]}),
 (' All samples used in stage 3 were imputed to the HRC haplotype reference panel_, , which includes 64,976 haplotypes with 39,235,157 SNPs that allows imputation down to an unprecedented MAF=0.', {'entities': [(34, 41, 'imputation')]}),
 (' To estimate imputation accuracy, imputed genotype calls at 99,124 SNPs were compared with direct genotyping data in 880 cases (Illumina Immunochip).', {'entities': [(13, 23, 'imputation')]}),
 (' Then, each phased segment was imputed against all-ethnicity 1000 Genomes Project haplotypes (excluding monomorphic and singleton sites) using a high-performance version of Minimac for 5 rounds and 200 states to estimate parameters.', {'entities': [(31, 38, 'imputation')]}),
 (' SNPs with low imputation quality (with a posterior probability score of < 0.', {'entities': [(15, 25, 'imputation')]}),
 (' Duplicates were removed but related individuals were retained for genotype imputation.', {'entities': [(76, 86, 'imputation')]}),
 (' After evidence of replication on chromosome 2, we investigated imputed data in the chromosome 2 region (chr2: 174286992–174307309) using the same imputation methods already described.', {'entities': [(64, 71, 'imputation')]}),
 ('Single nucleotide polymorphism (SNP) genotyping and imputation for Stage I have been described in detail elsewhere and in the Supplementary Methods.', {'entities': [(52, 62, 'imputation')]}),
 ('3 (proper-info of IMPUTE) or R _2 \u2009<\u20090.', {'entities': [(18, 24, 'imputation')]}),
 (' Genotypes were pre-phased using SHAPEIT before imputation with IMPUTE2.', {'entities': [(48, 58, 'imputation'), (64, 70, 'imputation')]}),
 (' After imputation and filtering to remove SNPs with minor allele frequencies of <0.', {'entities': [(7, 17, 'imputation')]}),
 (' SNPs mapped to the same genomic position due to differences in the version of 1000G Phase I reference panel used for imputation) were excluded from analysis.', {'entities': [(118, 128, 'imputation')]}),
 ('0 chip, and imputation was performed with IMPUTE2 (,) in 1000 Genomes phase 1 data (March 2012 v.', {'entities': [(12, 22, 'imputation'), (42, 48, 'imputation')]}),
 (' The PNAT2 AA and KIS3 AA genotypes were then phased using SHAPEIT () and imputed using IMPUTE2 ().', {'entities': [(74, 81, 'imputation'), (88, 94, 'imputation')]}),
 (' We evaluated four SNPs whose IMPUTE2 r _2  was <0.', {'entities': [(30, 36, 'imputation')]}),
 (' As input for the approximate conditional analysis, we used the discovery phase GWA meta-analysis results and the imputed SNP genotype data from the NTR cohort as a reference for LD structure.', {'entities': [(114, 121, 'imputation')]}),
 (' This also exhibited high agreement between the actual and imputed indel genotypes (r_2 =0.', {'entities': [(59, 66, 'imputation')]}),
 (' Postimputation SNVs with low imputation quality (info score < 0.', {'entities': [(5, 15, 'imputation')]}),
 (' To facilitate comparison of results among the three studies, and to better assess the effects of unmeasured variants, we first identified stretches of haplotype shared between individuals in our sample and those in the HapMap CEU sample and then used these shared stretches to impute missing genotypes.', {'entities': [(278, 284, 'imputation')]}),
 ('edu/csg/abecasis/MACH/index.', {'entities': [(17, 21, 'imputation')]}),
 (' We used the SNP2HLA program to impute individual amino acid–changing polymorphisms and classical 4-digit haplotypes at class I and II loci.', {'entities': [(32, 38, 'imputation')]}),
 (' After regression on age and sex and inverse normal transformation of the residuals, we carried out association analyses with genotypes or imputed genotype dosages.', {'entities': [(139, 146, 'imputation')]}),
 (' SNP-specific quality controls included filters for call rate, minor allele frequency Hardy-Weinberg equilibrium, differential missingness by outcome or genotype, and imputation quality.', {'entities': [(167, 177, 'imputation')]}),
 ('90 were considered for these imputed association analyses.', {'entities': [(29, 36, 'imputation')]}),
 (' The genetic trait analyzed was the imputed allele dosage, a fractional value between 0 and 2, reflecting the estimated number of allele copies of an SNP for each subject.', {'entities': [(36, 43, 'imputation')]}),
 ('  We used SHAPEIT for whole-chromosome prephasing and IMPUTE2 (ref.', {'entities': [(54, 60, 'imputation')]}),
 (' Based on phased haplotypes, untyped genotypes were then imputed by a computationally efficient imputing algorithm Minimac ().', {'entities': [(57, 64, 'imputation')]}),
 (' Linear regression was used, with SNPs represented by an additive genetic model and with imputed SNPs represented by expected allele dosage.', {'entities': [(89, 96, 'imputation')]}),
 (' All three studies successfully imputed the rs4646284 indel for the eQTL analyses (Mayo r_allelic _2 =0.', {'entities': [(32, 39, 'imputation')]}),
 (' In addition to the study-specific quality control filters, we included SNP results of a study in our meta-analysis only if the SNP imputation quality score was >0.', {'entities': [(132, 142, 'imputation')]}),
 (' Using these data and those from 120 phased chromosomes from the HapMap CEU samples (HapMap r22 release, NCBI build 36), genotypes were imputed for untyped autosomal SNPs across the genome using MACH 1.', {'entities': [(136, 143, 'imputation'), (195, 199, 'imputation')]}),
 (' Data from the TASC discovery sets were imputed with Markov Chain Haplotyping software (MACH) using phased data from CEU individuals from release 22 of the HapMap project as the reference set of haplotypes.', {'entities': [(40, 47, 'imputation'), (88, 92, 'imputation')]}),
 (' We applied QC filters on the post-imputed data sets: SNPs with imputation information < 30%, MAF < 1% or HWE P-value in controls < 1.', {'entities': [(35, 42, 'imputation')]}),
 (' Imputations of non-genotyped SNPs in the HapMap CEU v21a or v22 were carried out within each study using MACH  or IMPUTE .', {'entities': [(1, 12, 'imputation'), (115, 121, 'imputation'), (106, 110, 'imputation'), (16, 20, 'negation')]}),
 ('Genotyping, imputation and quality control has been previously reported.', {'entities': [(12, 22, 'imputation')]}),
 (' The final data sets of high-quality SNVs were prephased with SHAPEIT and subsequently used to perform imputation with IMPUTE2, the 1000 Genomes reference panel (integrated variant set, release March 2012).', {'entities': [(103, 113, 'imputation'), (119, 125, 'imputation')]}),
 (' To produce consistent datasets and enable a meta-analysis of studies across different genotyping platforms, the studies performed genomic imputation on available HapMap Phase 2 genotypes with MACH [] or IMPUTE [], using the appropriate ancestry groups as templates.', {'entities': [(139, 149, 'imputation'), (204, 210, 'imputation'), (193, 197, 'imputation')]}),
 (' We were able to impute the remaining 33 based on HapMap II CEU using the Markov Chain based haplotyper (MACH) program ().', {'entities': [(17, 23, 'imputation'), (105, 109, 'imputation')]}),
 (' We used the MACH program () to impute 2,543,887 autosomal SNPs based on haplotypes from the HapMap () database phase II data build 35 (CEU) in all of the four component sets, including T2D_NHS, T2D_HPFS, CHD_NHS and CHD_HPFS ().', {'entities': [(32, 38, 'imputation'), (13, 17, 'imputation')]}),
 (' IMPUTE users excluded SNPs with a proper info <0.', {'entities': [(1, 7, 'imputation')]}),
 ('  To identify loci significantly associated with baseline skin pigmentation and tanning status, we associated high quality imputed and resequenced SNPs and indels with these pigmentation phenotypes using a linear mixed model, with a covariance matrix of relatedness as a random effect.', {'entities': [(123, 130, 'imputation')]}),
 (' For any SNP that showed suggestive association (P  < 10_−5 ) in the screening imputation (described above), we performed regional imputation using Impute2 (IMPUTE v2.', {'entities': [(79, 89, 'imputation'), (148, 155, 'imputation'), (157, 163, 'imputation')]}),
 (' After the cleaning of the genotype datasets, for comparison purpose, we imputed SNPs separately for each genotyping platform using IMPUTE2 (mathgen.', {'entities': [(73, 80, 'imputation'), (132, 138, 'imputation')]}),
 (' We validated the top imputed SNP, rs7034162, to confirm the imputed genotype using TaqMan assays in 89 cases with GWAS data from the discovery stage (16% of the total 541 cases).', {'entities': [(22, 29, 'imputation')]}),
 ('The genotyping platforms, SNP quality control filters, imputation software, and reference human genome used varied by study and are detailed in Tables S2, S5, and S7.', {'entities': [(55, 65, 'imputation')]}),
 (' We used allele dosages from imputation to account for uncertainty in imputed genotypes.', {'entities': [(29, 39, 'imputation')]}),
 (' Phased genotype data of the 186 ASN cell lines sequenced in the 1000 Genomes Project phase 1 version 3 () were downloaded from the BEAGLE website (http://faculty.', {'entities': [(132, 138, 'imputation')]}),
 ('SNPs (genotyped or imputed) with association P < 1 × 10_−5  in Stage 1 were genotyped in Staged 2.', {'entities': [(19, 26, 'imputation')]}),
 ('11, 11p13, 15q24) we performed conditional analysis using the summary statistics from the meta-analysis to test for the association of each SNP while conditioning on the top SNPs, with correlations between SNPs due to linkage disequilibrium (LD) estimated from the imputed genotype data from the Atherosclerosis Risk in Communities cohort, a large and representative cohort of men and women of European ancestry.', {'entities': [(265, 272, 'imputation')]}),
 (' This resulted in 26,226 individuals (3,143 cases and 23,083 controls), 402,748 genotyped SNPs, and 2,184,083 imputed SNPs with r_info _2 ≥0.', {'entities': [(110, 117, 'imputation')]}),
 (' For each typed or imputed SNP using ProbABEL (), we combined the SNP-specific regression coefficients obtained for the discovery and replication sets using the commonly-deemed inverse-weighted summary statistic proposed by Cochran ().', {'entities': [(19, 26, 'imputation')]}),
 (' After imputation, SNPs were excluded based on the following: MAF ≤1%, test of Hardy–Weinberg equilibrium P  < 10_−6 , SNP failure rate >10% and imputation quality (info) <0.', {'entities': [(7, 17, 'imputation')]}),
 ('edu/csg/abecasis/MACH/), with reference haplotype panels from HapMap Phase 2 CEU subjects.', {'entities': [(17, 21, 'imputation')]}),
 (' QC was performed on the imputed SNPs; excluding those with INFO score < 0.', {'entities': [(25, 32, 'imputation')]}),
 ('  Genome-wide association testing was performed using PROBABEL (), GWAS software for use with probabilistically imputed genotype dosages.', {'entities': [(112, 119, 'imputation')]}),
 ('4 for imputed variants.', {'entities': [(6, 13, 'imputation')]}),
 ('59 M imputed SNPs that passed quality control (> 0.', {'entities': [(5, 12, 'imputation')]}),
 (' Detailed\ndescriptions of the ECLIPSE, NETT/NAS, and Norway (GenKOLS) cohorts, including\ngenotyping quality control and imputation, have been previously published.', {'entities': [(120, 130, 'imputation')]}),
 (' We applied the algorithm with 250-kb buffers (in addition to the interval under examination) and without prephasing (standard IMPUTE2 MCMC algorithm) as recommended by the developers for more accurate, although less computationally efficient, imputation.', {'entities': [(244, 254, 'imputation'), (127, 133, 'imputation')]}),
 (' The genotyping and imputation methods for each study are given in .', {'entities': [(20, 30, 'imputation')]}),
 (' Genotype data had to be imputed with either the HapMap Phase 2[] or 1000 Genomes reference panel[].', {'entities': [(25, 32, 'imputation')]}),
 (' Imputed data were analysed using SNPTEST v2 to account for uncertainties in SNP prediction.', {'entities': [(1, 8, 'imputation')]}),
 (' Of the 5,009 samples in the study, 4,704 were successfully imputed and genotyped (or sequenced) for rs138715366.', {'entities': [(60, 67, 'imputation')]}),
 ('html) to impute missing genotypes, with the HapMap (CEU population, release 23, forward strand) as the reference panel.', {'entities': [(9, 15, 'imputation')]}),
 (' The criteria for SNPs included in imputation are: Hardy–Weinberg equilibrium P  value >1e−5; SNP missingness <5%; and minor allele frequency >0.', {'entities': [(35, 45, 'imputation')]}),
 ('5 million autosomal SNPs were imputed with MACH (http://www.', {'entities': [(30, 37, 'imputation'), (43, 47, 'imputation')]}),
 ('nz/~bbrowning/beagle/beagle.', {'entities': [(14, 20, 'imputation')]}),
 (' After quality control, genotypes were imputed using the CEU reference panel of the HapMap Phase II haplotype data.', {'entities': [(39, 46, 'imputation')]}),
 (' After imputation quality control, SNPs with minor allele frequency (MAF) > 5% and high imputation quality (certainty > 0.', {'entities': [(7, 17, 'imputation')]}),
 (' The Cox proportional hazards model was applied genome wide to filtered imputed data in each population with the following independent variables: SNP genotype under a log-additive model, the 4 principal components of ancestry, sex, and age at onset.', {'entities': [(72, 79, 'imputation')]}),
 ('4 in IMPUTE and BIMBAM, info ≤ 0.', {'entities': [(5, 11, 'imputation')]}),
 (' For imputed SNPs, ‘dosage’ was calculated on a scale from 0 to 2 based on imputation probabilities for each genotype ().', {'entities': [(5, 12, 'imputation')]}),
 (' Before imputation analysis QC of samples and markers was performed separately in the eight studies using the PLINK software package ().', {'entities': [(8, 18, 'imputation')]}),
 ('All SNPs genotyped in the genome-wide studies, which were also contained in the HapMap phase II release 24 data, were used for imputation of additional genotypes using the software MACH 1.', {'entities': [(127, 137, 'imputation'), (181, 185, 'imputation')]}),
 ('For each study, an allele-dosage regression model at each genotyped or imputed SNP was conducted to determine its association with AL as a quantitative trait as well as its association with SE.', {'entities': [(71, 78, 'imputation')]}),
 (' After quality control, 1,885 individuals who were genotyped at 739,284 SNPs were available for imputation.', {'entities': [(96, 106, 'imputation')]}),
 ('01), >1 Mendelian error detected in a set of duplicated samples, and a missing call rate ≥2 %, which led to the removal of approximately 45 % of markers (of which a large proportion was monomorphic), leaving 2,567,713 SNPs to serve as the imputation basis.', {'entities': [(239, 249, 'imputation')]}),
 ('p1) and imputed using the same 1000 Genomes reference panel as by KP.', {'entities': [(8, 15, 'imputation')]}),
 (' Imputation uses derived patterns of population-specific LD between SNPs to infer genotypes at sites that have not directly been genotyped.', {'entities': [(1, 11, 'imputation'), (111, 114, 'negation')]}),
 (' For the Italian SLAGEN cohort, in silico  genotypes were obtained from Illumina Human-660W Quad Beadchips for rs12546767, and rs13268726 genotypes were imputed using IMPUTE v2 and HapMap3 release 2 and 1000 Genomes pilot reference panels.', {'entities': [(153, 160, 'imputation'), (167, 173, 'imputation')]}),
 (' The top associated imputed SNPs were validated by SNP genotyping in\nsubsets of iDILIC cases and in the overall DILIN cohort (see ).', {'entities': [(20, 27, 'imputation')]}),
 ('4, and\nMaCH users excluded SNPs with an r _2  <0.', {'entities': [(7, 11, 'imputation')]}),
 (' Uncertainty of imputed SNPs was accounted for by using estimated genotype probabilities for imputed SNPs in the regression model.', {'entities': [(16, 23, 'imputation')]}),
 ('edu/browning/beagle_utilities/utilities.', {'entities': [(13, 19, 'imputation')]}),
 (' To maximize the number of SNPs that were available for analysis in the JHH population, we imputed all the known SNPs that are cataloged in HapMap Phase II (www.', {'entities': [(91, 98, 'imputation')]}),
 (' Genotypes were imputed from the low-pass sequencing data as previously described [].', {'entities': [(16, 23, 'imputation')]}),
 (' Predefined marker\nfilters were applied before imputation (Hardy–Weinberg equilibrium\n>10_–6 , MAF >0.', {'entities': [(47, 57, 'imputation')]}),
 (' Detailed information on genotyping, imputation, quality control measures prior and post imputation, and genomic control before meta-analysis according to AGEN studies are shown in .', {'entities': [(37, 47, 'imputation')]}),
 (' Subjects with missing on- or off-treatment measurements were excluded, with the exception of the GoDARTS study for which missing off-treatment HDL-C levels were estimated using imputation methods, as described previously.', {'entities': [(178, 188, 'imputation')]}),
 ('40 for IMPUTE, or r _2  ≥ 0.', {'entities': [(7, 13, 'imputation')]}),
 (' In the MDD replication cohorts (), imputation was performed using IMPUTE2 / SHAPEIT (chunk size of 3 Mb and default parameters).', {'entities': [(36, 46, 'imputation'), (67, 73, 'imputation')]}),
 (' In KORA F4 imputation was done using IMPUTE v0.', {'entities': [(12, 22, 'imputation'), (38, 44, 'imputation')]}),
 ('Details of subject recruitment and genotyping for individual case-control and family-based datasets, genotype imputation, quality control, population substructure, and statistical methods for association analyses were reported previously for Alzheimer’s Disease Genetics Consortium (ADGC) datasets containing EAs [], African Americans (AA) [], Japanese (JPN) [], and Israeli-Arab (IA) [].', {'entities': [(110, 120, 'imputation')]}),
 (' Our study included genotype data (both directly genotyped and imputed) obtained from dbGaP (accession number phs000428.', {'entities': [(63, 70, 'imputation')]}),
 ('01 and imputation r _2  >0.', {'entities': [(7, 17, 'imputation')]}),
 (' For each cohort, genotype data for each array were quality controlled separately and then merged and imputed.', {'entities': [(102, 109, 'imputation')]}),
 ('1) [], while the Finnish cohort was imputed to the 1000 Genomes reference panel [].', {'entities': [(36, 43, 'imputation')]}),
 ('All remaining discovery cohorts were genome-wide genotyped and imputed to the UK10K/1000 Genomes reference panel, as described in the .', {'entities': [(63, 70, 'imputation')]}),
 ('org/1998/Math/MathML" id="MM4" overflow="scroll"><mfenced open="‖" close="‖" separators="|"><mrow><mi>a</mi><mi>P</mi><mi>T</mi><mi>T</mi></mrow></mfenced><mo>=</mo><mo></mo><mfrac><mrow><mi>a</mi><mi>P</mi><mi>T</mi><mi>T</mi></mrow><mrow><mi>σ</mi></mrow></mfrac></math> aPTT=aPTTσ  For the discovery analysis, the ARIC, GHS1 and 2, GAIT2, Martha and PROCARDIS studies performed linear regression analyses using an additive model of inheritance between 1000 Genome-imputed SNPs and natural-logarithm-transformed FXI levels, with adjustments for age, sex, and accounting for population stratification and cryptic relatedness (adjustment for MDS or PCA components).', {'entities': [(467, 474, 'imputation')]}),
 ('edu/csg/abecasis/MACH/).', {'entities': [(17, 21, 'imputation')]}),
 ('\nPhasing was conducted using MACH in female subjects.', {'entities': [(29, 33, 'imputation')]}),
 ('  Imputation of missing SNPs was performed using IMPUTE 2 () on build 36 and release 22 of HapMap.', {'entities': [(2, 12, 'imputation'), (49, 55, 'imputation')]}),
 (' Imputation was conducted separately for each study, and in each the data were pruned to a common set of SNPs between cases and controls before imputation.', {'entities': [(144, 154, 'imputation'), (1, 11, 'imputation')]}),
 (' SNPs imputed with an r_2  > 0.', {'entities': [(6, 13, 'imputation')]}),
 (' We phased our genotypes using Shapeit2 and carried out genotype imputation using Minimac3 on the phased data.', {'entities': [(65, 75, 'imputation')]}),
 (' Details on genotyping, quality assurance/quality control, and imputation can be found in the  section.', {'entities': [(63, 73, 'imputation')]}),
 ('Despite this high concordance, we chose to estimate genotype score risk within the Multiple Imputation framework.', {'entities': [(92, 102, 'imputation')]}),
 (' Autosomal SNPs were imputed using IMPUTE v2.', {'entities': [(21, 28, 'imputation'), (35, 41, 'imputation')]}),
 (' Imputation of SNPs in the KCNJ6  region was performed using the program BEAGLE version 3.', {'entities': [(1, 11, 'imputation'), (73, 79, 'imputation')]}),
 (' Replication controls consisted of 2583 Ashkenazi schizophrenia cases and controls from the North Shore-Long Island Jewish Health System typed on Illumina HumanOmni1-Quad BeadChip, imputed using the same procedure and passing the same quality control and ancestry filtering as the discovery cohort.', {'entities': [(181, 188, 'imputation')]}),
 (' To confirm the accuracy of our imputation we genotyped 23 SNPs, included the most significant SNPs, using Sequenom.', {'entities': [(32, 42, 'imputation')]}),
 (' Each cohort applied stringent quality control procedures prior to the imputation, including minor allele frequency cutoffs, Hardy-Weinberg equilibrium (P  > 10_−7 ), genotypic success rate (>95%), Mendelian inconsistencies, exclusion of individuals with more than 5% shared ancestry (exception made for family-based cohorts in which due adjustment for family relationship was made) and removal of all individuals whose ancestry as determined through genetic analysis did not match the prevailing ancestry group of the own cohort.', {'entities': [(71, 81, 'imputation'), (472, 475, 'negation')]}),
 (' Prior to imputation, SNPs with a minor allele frequency (MAF) <1%, a call rate <95% and Hardy–Weinberg frequency of P  < 1 × 10_−6  were excluded.', {'entities': [(10, 20, 'imputation')]}),
 ('81), we applied MACH to impute genotypes based on phased reference haplotypes from the 1000 Genomes Project CEU+CHB+JPT samples (June 2010 release).', {'entities': [(24, 30, 'imputation'), (16, 20, 'imputation')]}),
 ('3 (MACH) or <0.', {'entities': [(3, 7, 'imputation')]}),
 (' The genotyped and imputed SNPs were tested for association with IA susceptibility using a logistic regression model.', {'entities': [(19, 26, 'imputation')]}),
 ('0 was used to do imputation and allele dosage information was summarized in the imputation results.', {'entities': [(17, 27, 'imputation')]}),
 (' To determine the percentage of log(B2M) variance explained by significant imputed HLA classical alleles, we constructed HLA genotype by grouping together all insignificant alleles as one variant and included the genotypes as categorical predictors in linear regression.', {'entities': [(75, 82, 'imputation')]}),
 (' Imputation results are summarized as “dosage” scores (fractional values ranging from 0 to 2, representing the expected number of copies of the coded allele at each SNP).', {'entities': [(1, 11, 'imputation')]}),
 ('  The association analysis was performed in each cohort using SNPtest V2 (–), mach2qtl (,) and QUICKTEST ().', {'entities': [(78, 83, 'imputation')]}),
 (' Although imputation is accurate (Li et al.', {'entities': [(10, 20, 'imputation')]}),
 ('Prior to imputation, SNPs were removed from the initial list of autosomal markers based on the following criteria: 1/Markers classified as CallRateBelowThreshold, OffTargetVariants or Other by the program SNPolisher, 2/minor allele frequency <1%, 3/Hardy–Weinberg p-values <10–5 in the low-dose or high-dose sample and 4/missing genotyping rate per SNP > 5%.', {'entities': [(9, 19, 'imputation')]}),
 ('0 (Illumina, CA, USA) (the Exome set; predominately low-frequency and rare coding variants); (3) GWAS Imputed data (the Imputed set) imputed from the 1000 Genomes Project SNPs using IMPUTE2 (http://mathgen.', {'entities': [(133, 140, 'imputation'), (102, 109, 'imputation'), (182, 188, 'imputation')]}),
 (' Imputing missing genotypes for study samples based on the cosmopolitan panel of reference haplotypes from Phase I of the 1,000 Genomes Project (March 2012 release; n =1,092; (ftp://ftp-trace.', {'entities': [(1, 9, 'imputation')]}),
 ('All discovery cohorts had genome-wide genotype information generated on a standard genotyping platform and include imputed genotypes based on HapMapII CEU build 36 as a reference.', {'entities': [(115, 122, 'imputation')]}),
 ('02 or with low imputation quality scores were removed prior to meta-analysis ().', {'entities': [(15, 25, 'imputation')]}),
 (' To increase homogeneity between cohorts with respect to the SNPs genotyped by the different platforms, as well as to increase coverage, summary results were based on SNPs from the HapMap Phase 2 (build 36) reference population[], given the uniform availability of HapMap2-imputed SNPs and the computational burdens associated with performing analyses for reference panels with much larger numbers of SNPs.', {'entities': [(273, 280, 'imputation')]}),
 (' On the other hand, for regions harboring very rare variants that are not tagged by any markers on the array, our sample size is probably underpowered even if we tested the imputed genotype.', {'entities': [(173, 180, 'imputation'), (70, 73, 'negation')]}),
 (' Minimac2 & SHAPEIT, https://imputationserver.', {'entities': [(29, 45, 'imputation')]}),
 (' Imputed variants were tested using a linear regression model in the statistical programming language, R, where =(Aa ) + 2(aa ) is the dosage score computed from the posterior probabilities for genotypes Aa  and aa .', {'entities': [(1, 8, 'imputation')]}),
 (' SNPs with MAF <1% and/or poor imputation quality (r_2  <0.', {'entities': [(31, 41, 'imputation')]}),
 (' For the latter, preimputation quality-control procedures, imputation, and postimputation filters were implemented as described for the discovery phase.', {'entities': [(20, 30, 'imputation')]}),
 (' We then imputed variants in 5 Mb windows for all 4 sets using the full 1000 Genomes phase 3 reference panel as well as 53 HGDP medium coverage genomes () with Impute2 (v2.', {'entities': [(9, 16, 'imputation'), (160, 167, 'imputation')]}),
 (' Association analysis\nfor both imputed and genotyped SNPs was done using SNPTEST (with the full posterior\nprobability genotype distribution) or MERLIN.', {'entities': [(31, 38, 'imputation')]}),
 (' IMPUTE2 was used to impute additional variants using the 1000 Genomes Phase I reference panel (5/21/2011 1000G data, December 2013 haplotype release in IMPUTE2 site).', {'entities': [(21, 27, 'imputation'), (1, 7, 'imputation')]}),
 (' For the X chromosome we used the specific options in SHAPEIT and IMPUTE2.', {'entities': [(66, 72, 'imputation')]}),
 ('To compare the imputation accuracy between different reference panels, 109 unrelated ALS cases of Dutch ancestry sequenced by Complete Genomics and 67 ALS cases from the UK sequenced by Illumina were selected as a test panel.', {'entities': [(15, 25, 'imputation')]}),
 (' These Asian samples were imputed using HapMap reference panels: the phase 2 JPT and CHB reference was used for the Chinese samples, and the phase 3 cosmopolitan panel (1,011 individuals from Africa, Asia, Europe and North America) were used for the Indian and Malay samples.', {'entities': [(26, 33, 'imputation')]}),
 (' Details of genotyping arrays and imputation are summarized in .', {'entities': [(34, 44, 'imputation')]}),
 ('Variants with imputation quality below 0.', {'entities': [(14, 24, 'imputation')]}),
 (' Effective count was defined as 2*MAF*(1-MAF)*n*oevar, where oevar measures imputation quality.', {'entities': [(76, 86, 'imputation')]}),
 (' The 1,000 Genomes imputed genotypes were filtered on imputation quality (R \n_2  < 0.', {'entities': [(19, 26, 'imputation')]}),
 ('_,  Only imputed SNP dosages with an imputation quality estimate of R _2  ≥ 0.', {'entities': [(9, 16, 'imputation')]}),
 ('16, for pre-phasing of LLFS data) and MINIMACH (version of May 2012) for performing imputations and ChunkChromosome script for splitting the LLFS data into smaller blocks to speed the process of imputation [–].', {'entities': [(84, 95, 'imputation'), (42, 46, 'imputation')]}),
 (' Genotype imputation was conducted for each cancer site using IMPUTE, BEAGLE, MACH and Minimac (imputation threshold of R_2  > 0.', {'entities': [(10, 20, 'imputation'), (62, 68, 'imputation'), (70, 76, 'imputation'), (78, 82, 'imputation')]}),
 (' Details of genotyping and imputation and principal component generation are reported in the Supplementary Methods section.', {'entities': [(27, 37, 'imputation')]}),
 ('2) for prephasing and minimac (v17072013) for imputation.', {'entities': [(46, 56, 'imputation')]}),
 (' Only samples and SNPs passing the QC were included for pre-phasing and imputation.', {'entities': [(72, 82, 'imputation')]}),
 ('3 (MACH) were included.', {'entities': [(3, 7, 'imputation')]}),
 (' In the GWAS, we phased haplotypes using MACH software.', {'entities': [(41, 45, 'imputation')]}),
 (' Significant SNPs from the discovery stage with satisfactory imputation qualities were assessed for replication in a Norwegian case-cohort study (CONOR()) comprising 1,496 prostate cancer cases of which 791 died due to prostate cancer during follow-up.', {'entities': [(61, 71, 'imputation')]}),
 (' All cohorts except for CFS performed a GWAS using PLINK, R, MACH2QTL, or Merlin (Supplementary Materials, Table S1 Table and Text S1).', {'entities': [(61, 66, 'imputation')]}),
 ('r644) was used for prephasing, followed by imputation with IMPUTE2 (v2.', {'entities': [(43, 53, 'imputation'), (59, 65, 'imputation')]}),
 (' As imputation of genotypes is standard practice in genetic association analysis, all autosomal SNPs of each study were imputed to the CEPH collection (CEU) population in HapMap II using IMPUTE (CCFR), BEAGLE (OFCCR) and MACH (all other studies).', {'entities': [(4, 14, 'imputation'), (187, 193, 'imputation'), (202, 208, 'imputation'), (221, 225, 'imputation')]}),
 ('We used BEAGLE version 3.', {'entities': [(8, 14, 'imputation')]}),
 ('5 million genotyped or imputed autosomal SNPs for subsequent association analysis.', {'entities': [(23, 30, 'imputation')]}),
 (' Genotype calls were based on HapMap East-Asian samples (CHB and JPT) and imputed SNPs with info score <0.', {'entities': [(74, 81, 'imputation')]}),
 (' Full details of quality control procedures and any deviations from the imputation protocol are given in .', {'entities': [(72, 82, 'imputation')]}),
 (' We therefore used a nonparametric imputation algorithm to adjust the CES-D score for treatment effect.', {'entities': [(35, 45, 'imputation')]}),
 (' After imputation, we used individual call posterior probability > 0.', {'entities': [(7, 17, 'imputation')]}),
 (' In order to evaluate pleiotropy with the ischemic stroke phenotype, we selected the variant with the lowest P-value at each independent novel atrial fibrillation locus and performed a lookup in the results from 1000 Genomes imputed GWAS meta-analyses from the Neurology Working Group of the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium (4348 stroke patients and 80,613 referents) and the METASTROKE consortium (10,307 ischemic stroke cases and 19,326 referents) of the International Stroke Genetics Consortium (ISGC).', {'entities': [(225, 232, 'imputation')]}),
 (' Squares are imputed variants.', {'entities': [(13, 20, 'imputation')]}),
 (' The imputation reference set consisted of 2,186 phased haplotypes from the 1000 Genomes Project.', {'entities': [(5, 15, 'imputation')]}),
 (' Genotype imputation was performed using MaCH (version 1.', {'entities': [(10, 20, 'imputation'), (41, 45, 'imputation')]}),
 (' Imputation methods are described in\ndetail in the .', {'entities': [(1, 11, 'imputation')]}),
 (' Detailed descriptions of the genotyping platforms, quality control and imputation procedures for each study are provided in the Supplementary Material, Table S4.', {'entities': [(72, 82, 'imputation')]}),
 ('r778) and performed imputation using Minimac3 (ver.', {'entities': [(20, 30, 'imputation')]}),
 (' An additional imputation protocol using shapeit v2 (, ) and impute2 () was also implemented with highly concordant results.', {'entities': [(15, 25, 'imputation')]}),
 (' These SNPs were then passed to the imputation phase.', {'entities': [(36, 46, 'imputation')]}),
 (" We observed high imputation quality in each cohort's imputation.", {'entities': [(18, 28, 'imputation')]}),
 (' Imputation and association testing was performed as described above for GALA I.', {'entities': [(1, 11, 'imputation')]}),
 (' We used all available HapMap3 populations for imputation as it was shown that the increase in the reference panel decreases error.', {'entities': [(47, 57, 'imputation')]}),
 (' Using this list we extracted the individual genotypic data for all participants in our ProtecT dataset, although two SNPs were neither genotyped nor imputed (rs7210100 and rs16902094).', {'entities': [(150, 157, 'imputation')]}),
 (' Subsequently, genotype imputation was carried out using Shapeit and Impute2 [, ].', {'entities': [(24, 34, 'imputation'), (69, 76, 'imputation')]}),
 (' When the imputed genotypes were compared with the TaqMan data generated for technical validation, the squared correlation of allelic dosage improved to 0.', {'entities': [(10, 17, 'imputation')]}),
 (' Following filters for genotype imputation, including no ambiguity in strand alignment and ability to be mapped to NCDB build 37, 2,018,833 SNPs were selected as the basis for imputation.', {'entities': [(32, 42, 'imputation'), (54, 56, 'negation')]}),
 (' Before imputation, SNPs with minor allele frequency of <1%, call rate <95% or Hardy–Weinberg equilibrium P <1 × 10_−6  were excluded.', {'entities': [(8, 18, 'imputation')]}),
 (' The African American and European American samples were imputed separately.', {'entities': [(57, 64, 'imputation')]}),
 ('We excluded SNPs from the association analysis if their imputation accuracy was r_2 <0.', {'entities': [(56, 66, 'imputation')]}),
 (' Genotypes were aligned to the positive strand in both imputation and genotyping.', {'entities': [(55, 65, 'imputation')]}),
 (' For single SNP association testing with imputed dosage, two additional filters were implemented - the MAF > 1% and the r _2  > 0.', {'entities': [(41, 48, 'imputation')]}),
 (' Genotyping for the validation populations was done using TaqMan allelic discrimination assay on an ABI 7900 system (Applied Biosystems), except one (rs3850370) by SNP chip (Illumina 610k Quad, Call rate: 100%), and one (rs41997) by imputation analysis using the LD information from the 1000 Genomes Project database [by MACH, the estimated squared correlation (r _2 ) between imputed and true underlying genotypes is 1.', {'entities': [(233, 243, 'imputation'), (321, 325, 'imputation')]}),
 (' Briefly, we performed imputation on the COPDGene cohorts using MaCH () and minimac () using 1,000 Genomes () Phase I v3 European and cosmopolitan reference panels for the NHWs and AAs, respectively ().', {'entities': [(23, 33, 'imputation'), (64, 68, 'imputation')]}),
 (' These weights (w ) accounted for sample size (N ), and the proportions of cases (v ) in each study, as well as allele frequency (p ) and the imputation accuracy (R _2 ) of each SNP within each study w=R22p(1−p)v(1−v)N(w=R22p(1−p)v(1−v)N−−−−−−−−−−−−−−−−−√)<math xmlns:mml="http://www.', {'entities': [(142, 152, 'imputation')]}),
 (' Shapeit imputes missing genotypes, which can result in array-specific technical artifacts.', {'entities': [(9, 16, 'imputation')]}),
 (' Studies from Brazil were imputed with the HRC reference v1.', {'entities': [(26, 33, 'imputation')]}),
 (' The program SNPTESTv2 was used to test for association of the imputed variants().', {'entities': [(63, 70, 'imputation')]}),
 (' Since rs62256378 was imputed in the GWAS step, the SNP was genotyped directly in GWAS patients for whom DNA was available using Sequenom (Bonn1CSF, n  = 112 and Bonn2CSF, n  = 152).', {'entities': [(22, 29, 'imputation')]}),
 ('3 was considered to be poor imputation quality, and these SNPs were removed from further analyses.', {'entities': [(28, 38, 'imputation')]}),
 ('70, we assessed the quality of the imputation by masking the variant in a subset of the 1KGP European sample and calculating the concordance after reimputation in the remaining 1KGP samples.', {'entities': [(35, 45, 'imputation')]}),
 (' IMPUTE Version 2 was used to impute all autosomal SNPs on HapMap, using the publicly-available phased haplotypes from HapMap2 (release 22, build 36, CEU population) as a reference panel ().', {'entities': [(30, 36, 'imputation'), (1, 7, 'imputation')]}),
 (' A part of the replication data in the European samples was obtained by imputation\nbased on GWAS (see  and ).', {'entities': [(72, 82, 'imputation')]}),
 (' Of the three SNPS rs9907432 was genotyped in most replication cohorts, whereas rs9900428 was imputed in all replication cohorts ().', {'entities': [(94, 101, 'imputation')]}),
 (' We further excluded SNPs with imputation r_2  < 0.', {'entities': [(31, 41, 'imputation')]}),
 (' After removing SNPs with low quality imputation, 13,519,496 SNPs were included in the discovery GWAS; and only the top 10,000 most significant SNPs (http://www.', {'entities': [(38, 48, 'imputation')]}),
 (' Genotype imputation in the adult cohort was performed as described (), using SHAPEIT () and IMPUTE2 () with the cosmopolitan reference panel from the 1,000 Genomes Project.', {'entities': [(10, 20, 'imputation'), (93, 99, 'imputation')]}),
 (' We also performed analysis using only\nthe 22 genome-wide significant loci and tested for enrichment of imputed\nchromatin marks from ROADMAP using HaploReg 4.', {'entities': [(104, 111, 'imputation')]}),
 (' Imputation of chromosome 15q12.', {'entities': [(1, 11, 'imputation')]}),
 (' Imputation resulted in a total of 11\u2009626\u2009570 SNPs.', {'entities': [(1, 11, 'imputation')]}),
 ('The genotype call probabilities from the filtered BEAGLE output were used in a linear regression model between each of the phenotypes and the genotype probabilities under an additive model adjusting for the set of model-specific covariates.', {'entities': [(50, 56, 'imputation')]}),
 (' Genotypes were prephased using SHAPE-IT (v2) () and imputed using IMPUTEv2 () against the March 2013 1000G version 1 reference panel using standard protocols and recommended settings.', {'entities': [(53, 60, 'imputation'), (67, 73, 'imputation')]}),
 (' The initial postimputation filtering (removing monomorphic SNPs and those with low IMPUTE info scores, <0.', {'entities': [(17, 27, 'imputation'), (84, 90, 'imputation')]}),
 ('01 and low imputation quality (Rsq/proper_info<0.', {'entities': [(11, 21, 'imputation')]}),
 (' Prior to the meta- analyses, study results were adjusted for genomic inflation factors, and SNPs with imputation quality<0.', {'entities': [(103, 113, 'imputation')]}),
 (' The genotypes were phased using MACH, then imputed (including the X chromosome), using Minimacbased on the 283 European reference individuals in the March 2013 release of phased haplotype from the 1000 Genomes project.', {'entities': [(44, 51, 'imputation'), (33, 37, 'imputation')]}),
 (' SNPs were filtered out if the minor allele frequency (MAF) was <5%, or if the imputation INFO score was <0.', {'entities': [(79, 89, 'imputation')]}),
 ('Full details of the genotyping, quality control and imputation have been previously reported.', {'entities': [(52, 62, 'imputation')]}),
 ('1 are treated as missing), SNP imputation quality threshold of 0.', {'entities': [(31, 41, 'imputation')]}),
 (' Postimputation filters excluded imputed SNPs with\xa0MAF <0.', {'entities': [(5, 15, 'imputation')]}),
 (' The common sets of SNPs were then used for imputation using minimac and the 1000 Genomes Asian reference panel.', {'entities': [(44, 54, 'imputation')]}),
 (' For the imputation, we additionally excluded SNPs with a MAF<1% and a call rate <98% and SNPs that could not be linked to the 1000 genomes reference or differed significantly in frequency from the 1000 genomes (European frequency) and a further 1,128 SNPs where the cluster plot was judged to be inadequate.', {'entities': [(9, 19, 'imputation'), (106, 109, 'negation')]}),
 (' Imputation to HapMap Phase II and III (CEU reference samples) was performed using MaCH 2.', {'entities': [(1, 11, 'imputation'), (83, 87, 'imputation')]}),
 (' Genotype data were imputed using the 1000G phase 1 version 3 (build 37, hg19) reference panel with standard software packages such as IMPUTE, MACH or Minimac (see ).', {'entities': [(20, 27, 'imputation'), (135, 141, 'imputation'), (143, 147, 'imputation')]}),
 ('org) as the reference with MaCH-Admix software (University of North Carolina).', {'entities': [(27, 31, 'imputation')]}),
 (' SNPs for which testing Hardy Weinberg equilibrium resulted in p <10-5  (CHS, ARIC) or p <10-4  (CARDIA, InCHIANTI) were excluded from imputation.', {'entities': [(135, 145, 'imputation')]}),
 (' We performed whole-genome sequencing on samples obtained from 2261 Icelandic participants, followed by single-nucleotide-polymorphism (SNP) calling and genotype imputation, using methods that were described previously.', {'entities': [(162, 172, 'imputation')]}),
 (' Because only ~150,000 SNPs were shared between platforms, imputation (see below) was performed separately for each platform, and the data were combined and resubjected to the same QC metrics described above.', {'entities': [(59, 69, 'imputation')]}),
 (' Also, through the imputation process, a total of 449 polymorphic amino acid positions were obtained.', {'entities': [(19, 29, 'imputation')]}),
 ('3 [MACH2QTL]) were filtered.', {'entities': [(3, 8, 'imputation')]}),
 ('org/1998/Math/MathML" id="M6" overflow="scroll"><msub><mi>l</mi><mn>0</mn></msub><mo>·</mo><msup><mi>N</mi><mrow><mo>−</mo><mfrac><mrow><mo stretchy="false">|</mo><msub><mi>β</mi><mi>j</mi></msub><mo stretchy="false">|</mo></mrow><mn>2</mn></mfrac></mrow></msup><mo>·</mo><mfrac><mrow><mtext>Pr</mtext><mo stretchy="false">(</mo><msub><mi>A</mi><mi>j</mi></msub><mo stretchy="false">)</mo></mrow><mrow><mtext>Pr</mtext><mo stretchy="false">(</mo><mi>D</mi><mo stretchy="false">)</mo></mrow></mfrac></math> and the probability that variant j  is causal can be calculated using  β̂  l0·N−|βj|2·Pr(Aj)Pr(D)  Pr(Aj|D)∝exp(χj22),   which can be normalized across all variants as   Finally, the 99% credible set of variants is defined as the smallest set of models, with each model designating one causal variant, S = {}, such that   This credible set of variants has 99% probability of containing the causal variant, given the assumption that there is a true association and that all possible causal variants have been genotyped (both assumptions are likely to be valid in genome-wide significant regions of data that have been imputed to 1000 Genomes).', {'entities': [(1123, 1130, 'imputation')]}),
 (' Imputed data were not available for analysis.', {'entities': [(1, 8, 'imputation'), (19, 22, 'negation')]}),
 (' SNPs with minor allele frequency (MAF) ≤1% and imputation quality <0.', {'entities': [(48, 58, 'imputation')]}),
 ('9939, respectively, in the remaining 13,412,051 imputed SNPs.', {'entities': [(48, 55, 'imputation')]}),
 (' Briefly, each participant was assigned a score value, determined by summing up the number of copies (or imputed dosage) of each memory risk allele; each SNP in the score was weighted by the corresponding Z  score from the memory GWAS meta-analysis.', {'entities': [(105, 112, 'imputation')]}),
 (' Only SNPs with an imputation quality score of 0.', {'entities': [(19, 29, 'imputation')]}),
 ('05 and IMPUTE2 INFO criteria >0.', {'entities': [(7, 13, 'imputation')]}),
 (' Of the SNPs imputed, 49.', {'entities': [(13, 20, 'imputation')]}),
 (' A total of 11,892,802 SNPs/indels with a frequency >1% in any single ethnic population (1,131,426 genotyped and 10,761,376 imputed) were included in the analysis.', {'entities': [(124, 131, 'imputation')]}),
 (' Following additional quality control (SNP call rate < 95%, Hardy-Weinberg P  < 1 × 10_−6 ) and frequency filtering (MAF < 5%), 6 112 217 genotyped and imputed SNPs were available for analysis.', {'entities': [(152, 159, 'imputation')]}),
 ('3 (see URLs), which considered probabilistic genotypes out of imputation.', {'entities': [(62, 72, 'imputation')]}),
 (' The Beagle software package () was used for imputation in this data set (compatible with this software).', {'entities': [(45, 55, 'imputation'), (5, 11, 'imputation')]}),
 (' As a final prior step to imputation, SNPs with C/G and A/T allele combinations were removed if the MAF was between 0.', {'entities': [(26, 36, 'imputation')]}),
 (' Phasing of all samples and imputing cross-missing platform SNPs was done with MACH (1.', {'entities': [(28, 36, 'imputation'), (79, 83, 'imputation')]}),
 ('  In the imputed datasets, the association between PG and EN status and each single SNP were evaluated using logistic regression with SNPTEST(http://mathgen.', {'entities': [(9, 16, 'imputation')]}),
 (' The estimated QC r_info _2  metric given here is the info metric from Impute2, which estimates the correlation between the true and imputed genotype ().', {'entities': [(133, 140, 'imputation'), (71, 78, 'imputation')]}),
 ('30 were tested for association with IHPS in a logistic regression of disease status on imputed allele dosage (to account for imputation uncertainty) using mach2dat .', {'entities': [(87, 94, 'imputation'), (155, 160, 'imputation')]}),
 (' Imputed genotypes were analyzed as allele dosages adjusted by the quality of the imputation.', {'entities': [(82, 92, 'imputation'), (1, 8, 'imputation')]}),
 ('Genotype imputation within the GWAS data was performed using MACH.', {'entities': [(9, 19, 'imputation'), (61, 65, 'imputation')]}),
 (' For the imputation of X chromosome variants, we phased the haplotypes and performed imputation separately in males and females.', {'entities': [(9, 19, 'imputation')]}),
 ('Within our European ancestry meta-analysis, we evaluated SNPs that were previously found to have main effects on heart rate or QT in the GWAS of European ancestry as done with HapMap Phase II imputed reference panel imputation [–].', {'entities': [(192, 199, 'imputation')]}),
 ('54 million SNP loci by using MACH  () and HapMap2 CEU release 22 (60 unrelated individuals) () as the reference population.', {'entities': [(29, 33, 'imputation')]}),
 (' Detailed information about individual genotyping platforms, imputation methods, and analysis software is provided in .', {'entities': [(61, 71, 'imputation')]}),
 (' Quality control of the imputed genotype data was performed with the QCTOOL software package (http://www.', {'entities': [(24, 31, 'imputation')]}),
 (' In each cohort, each marker of interest (imputed genotype dosage) was tested for association with sex-specific height or BMI SDS for all age bins available, using linear regression assuming an additive model and adjusting for exact age at measurement (to the nearest month), along with optional correction for population stratification.', {'entities': [(42, 49, 'imputation')]}),
 (' Autosomal SNPs were imputed to the set of SNPs in HapMap II release 24 with MaCH (), using Utah residents with Northern and Western European Ancestry from the Centre d’etude du polymorphisme humain (CEPH) collection (CEU) as the reference population.', {'entities': [(21, 28, 'imputation'), (77, 81, 'imputation')]}),
 (' Genome-wide imputation was performed using IMPUTE2 software (see URLs) with the 1000 Genomes Project reference panel.', {'entities': [(13, 23, 'imputation'), (44, 50, 'imputation')]}),
 (' All genotypes were imputed to the positive strand of the 1000 Genomes Project v3,\nphase 1 dataset with either Minimac () or\nIMPUTE2 ().', {'entities': [(20, 27, 'imputation'), (125, 131, 'imputation')]}),
 (' For regions that met the statistical criteria of genome-wide association with prostate cancer risk, ungenotyped SNPs were imputed using IMPUTE software (see URLs) with 1000 Genomes Project CHB and JPT subjects serving as reference haplotype maps.', {'entities': [(123, 130, 'imputation'), (137, 143, 'imputation')]}),
 (' The probabilistic dosages rather than hard genotype calls were used in this investigation, to allow for imputation uncertainty at each locus.', {'entities': [(105, 115, 'imputation')]}),
 (' Post-association analysis required genotyped SNPs in LD with imputed variants to support the inferred alleles as true signals.', {'entities': [(62, 69, 'imputation')]}),
 (' Because of the complexity, detailed information on genotyping, quality control and imputation as well as on statistical analyses can be found in the ).', {'entities': [(84, 94, 'imputation')]}),
 (' The cohorts run on each array were cleaned, imputed, and analyzed separately to avoid batch effects.', {'entities': [(45, 52, 'imputation')]}),
 (' For genome-wide association analysis of global FA, each SNP dosage was coded as 0, 1 or 2, or for missing genotypes as the weighted value based on the imputation.', {'entities': [(152, 162, 'imputation')]}),
 (' Imputation of untyped variants included in the 1000 Genomes Project (http://www.', {'entities': [(1, 11, 'imputation')]}),
 (' Quality control and imputation using MACH () are described in the original reports (summarized in the  accompanying the online version of this article), yielding 1,922,309 single nucleotide polymorphisms (SNPs) in 3,117 subjects.', {'entities': [(21, 31, 'imputation'), (38, 42, 'imputation')]}),
 (' We used a combined reference panel of unrelated individuals from multiple HapMap Phase III populations for imputation, based on the PCA described above.', {'entities': [(108, 118, 'imputation')]}),
 ('2 million SNPs were imputed against the HapMap 3 cosmopolitan reference panel with Impute2.', {'entities': [(20, 27, 'imputation'), (83, 90, 'imputation')]}),
 (' Standard 12-lead\npositions were recorded at baseline in all cohort studies using a Marquette MAC\nPC, MAC6, or MAC1200 ECG machine system (GE Healthcare, Milwaukee, WI).', {'entities': [(123, 127, 'imputation')]}),
 (' Suspicious reads were locally realigned and the Illumina base calling quality scores were recalibrated to account for effects of sequencing technology and machine cycle.', {'entities': [(156, 160, 'imputation')]}),
 (' As secondary analyses, and to help fine-map the loci identified, we repeated the GWA analyses with after imputation of untyped SNPs from HapMap2.', {'entities': [(106, 116, 'imputation')]}),
 (' To assess\nuntyped SNPs, we imputed genotypes present in the 1000 Genomes dataset Phase 3v5 in the\nrisk locus region (±100 kb of the lead SNP, rs1740828) for SNPs that were not genotyped by\nthe Affymetrix 6.', {'entities': [(28, 35, 'imputation'), (173, 176, 'negation')]}),
 (' We performed a meta-analysis of the UCSF and Mayo Clinic results on a total of 6,026,834 SNPs in common from both GWAS that met the allele frequency and imputation quality thresholds.', {'entities': [(154, 164, 'imputation')]}),
 (' The eMERGE Coordinating Center (Pennsylvania State University) led the imputation of the adult dataset.', {'entities': [(72, 82, 'imputation')]}),
 (' Since the variance explained is estimated on the basis of imperfectly imputed dosages, we expect our estimates to be slightly lower than if they were based on measured genotypes.', {'entities': [(71, 78, 'imputation')]}),
 (' Post-imputation quality control included removal of SNPs with an information score of ≥0.', {'entities': [(6, 16, 'imputation')]}),
 (' In sensitivity analyses for the association between the sickle cell variant rs334 and UACR, we repeated analyses in individuals of Caribbean background after the exclusion of individuals imputed to have two copies of rs334.', {'entities': [(188, 195, 'imputation')]}),
 (' For genotyped SNPs the exact number of copies of an allele is known, but for imputed SNPs the estimate maybe less precise.', {'entities': [(78, 85, 'imputation')]}),
 ('01 or imputation quality scores\u2009<\u20090.', {'entities': [(6, 16, 'imputation')]}),
 ('6%, comparable to rates calculated for individuals of African descent imputed with the HapMap 2 YRI individuals.', {'entities': [(70, 77, 'imputation')]}),
 (' Imputed SNPs with high genotype information content (info >0.', {'entities': [(1, 8, 'imputation')]}),
 (' Each of the three data sets corresponding to the different chips were imputed separately and then merged to create a final concordant data set.', {'entities': [(71, 78, 'imputation')]}),
 (' A standard quality control procedure was used for all of the genotyping projects, prior to imputation.', {'entities': [(92, 102, 'imputation')]}),
 ('3 as estimated by Minimac were considered of poor imputation accuracy.', {'entities': [(50, 60, 'imputation')]}),
 (' To prepare for whole-genome imputation across the entire study cohort, we combined case samples across the 10 pAIDs with the shared control samples.', {'entities': [(29, 39, 'imputation')]}),
 (' All significant variants detected in the discovery study passed quality control filters in the UK biobank data (imputation quality info ≥ 0.', {'entities': [(113, 123, 'imputation')]}),
 (' Genotypes were prephased with SHAPEIT2 () and imputed through IMPUTE2 (; ) into the 1000 Genomes phase 1 reference panel (1000 ).', {'entities': [(47, 54, 'imputation'), (63, 69, 'imputation')]}),
 (' Imputation was performed using IMPUTE2, which adopts a two-stage approach using both a haploid reference panel and a diploid reference panel.', {'entities': [(1, 11, 'imputation'), (32, 38, 'imputation')]}),
 (' Initial imputation started with 23,284,435 loci, but after filters, using conservative thresholds to avoid biasing the association results by adding unmatched controls typed with different platforms, a final 3,922,209 variants were used in the association analysis.', {'entities': [(9, 19, 'imputation')]}),
 (' For unrelated samples, association was examined by the linear regression model with MACH2QTL (), in which allele dosage was taken as the predictor for the phenotype.', {'entities': [(85, 90, 'imputation')]}),
 ('00048, the r_2  estimate from imputation, and a PCa prevalence=0.', {'entities': [(30, 40, 'imputation')]}),
 (' Prior to meta-analysis, the imputed SNPs were filtered to exclude poorly imputed SNPs (IMPUTE filter PROPER INFO <0.', {'entities': [(29, 36, 'imputation'), (88, 94, 'imputation')]}),
 (' Imputed SNPs were checked for consistent frequency with the continental populations represented in 1KG Phase I; SNPs with a frequency difference >30% were removed.', {'entities': [(1, 8, 'imputation')]}),
 ('5M HapMap-imputed SNPs) of both phenotypes using VEGAS (see  and ).', {'entities': [(10, 17, 'imputation')]}),
 (' Any of these endophenotype-general candidate SNPs not on the Illumina array were imputed ().', {'entities': [(82, 89, 'imputation'), (51, 54, 'negation')]}),
 (' Tests of association were conducted using linear regression as implemented in the publicly available program, mach2qtl  ().', {'entities': [(111, 116, 'imputation')]}),
 (' For the purpose of developing a genetic risk score, SNPs with missing information within the replication datasets were imputed by random sampling with replacement, from individuals with the SNP information available, and conditional on case-control status.', {'entities': [(120, 127, 'imputation')]}),
 (' Only variants with more than one minor copy across all 1000Genome populations were imputed.', {'entities': [(84, 91, 'imputation')]}),
 (' This data was imputed to the density of 1000 genomes project using IMPUTE V2.', {'entities': [(15, 22, 'imputation'), (68, 74, 'imputation')]}),
 (' We used the recommended parameters for the imputation, with the exception of a different number of copying states (κ = 60 for Germans, κ = 80 for Dutch) and a larger buffer size for the Dutch (500 kb instead of 250 kb).', {'entities': [(44, 54, 'imputation')]}),
 (' This imputation was conducted on QC-ed data using the positive strand as the reference.', {'entities': [(6, 16, 'imputation')]})]